date generated: 2022-06-06
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## -468.74375579
## A1BG -0.19116969
## A1CF 1.55834102
## A2M -0.29772738
## A3GALT2 1.30005608
## A4GALT 0.01967718
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 2408 |
num_genes_in_profile | 16477 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8847 |
num_profile_genes_not_in_sets | 7630 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 2408 |
num_genesets_excluded | 1004 |
num_genesets_included | 1404 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
Major pathway of rRNA processing in the nucleolus and cytosol | 148 | 7.55e-15 | -0.3700 | 1.06e-11 |
SRP-dependent cotranslational protein targeting to membrane | 83 | 2.52e-14 | -0.4840 | 1.24e-11 |
rRNA processing in the nucleus and cytosol | 155 | 2.66e-14 | -0.3540 | 1.24e-11 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 72 | 1.15e-12 | -0.4850 | 3.56e-10 |
Peptide chain elongation | 60 | 1.66e-12 | -0.5270 | 3.56e-10 |
Eukaryotic Translation Termination | 63 | 1.73e-12 | -0.5140 | 3.56e-10 |
Viral mRNA Translation | 60 | 1.88e-12 | -0.5260 | 3.56e-10 |
Selenocysteine synthesis | 63 | 2.03e-12 | -0.5120 | 3.56e-10 |
Metabolism | 1845 | 2.70e-12 | 0.0997 | 3.92e-10 |
Eukaryotic Translation Elongation | 63 | 2.79e-12 | -0.5090 | 3.92e-10 |
Cap-dependent Translation Initiation | 87 | 9.53e-12 | -0.4230 | 1.12e-09 |
Eukaryotic Translation Initiation | 87 | 9.53e-12 | -0.4230 | 1.12e-09 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 65 | 1.98e-11 | -0.4810 | 2.01e-09 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 81 | 2.00e-11 | -0.4310 | 2.01e-09 |
Formation of a pool of free 40S subunits | 71 | 2.96e-11 | -0.4560 | 2.77e-09 |
L13a-mediated translational silencing of Ceruloplasmin expression | 79 | 3.62e-11 | -0.4310 | 3.18e-09 |
The citric acid (TCA) cycle and respiratory electron transport | 150 | 6.21e-11 | 0.3090 | 5.13e-09 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 83 | 1.19e-10 | -0.4090 | 8.76e-09 |
Nonsense-Mediated Decay (NMD) | 83 | 1.19e-10 | -0.4090 | 8.76e-09 |
rRNA processing | 176 | 1.45e-09 | -0.2650 | 1.01e-07 |
Metabolism of lipids | 669 | 2.49e-09 | 0.1360 | 1.67e-07 |
Regulation of expression of SLITs and ROBOs | 133 | 2.86e-09 | -0.2980 | 1.82e-07 |
Metabolism of RNA | 604 | 2.49e-08 | -0.1330 | 1.52e-06 |
Influenza Viral RNA Transcription and Replication | 103 | 4.97e-08 | -0.3110 | 2.91e-06 |
Formation of the ternary complex, and subsequently, the 43S complex | 42 | 4.75e-07 | -0.4490 | 2.67e-05 |
Influenza Infection | 120 | 6.95e-07 | -0.2620 | 3.75e-05 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 102 | 7.85e-07 | 0.2830 | 4.08e-05 |
Mitochondrial Fatty Acid Beta-Oxidation | 34 | 9.41e-07 | 0.4860 | 4.72e-05 |
Selenoamino acid metabolism | 84 | 1.09e-06 | -0.3080 | 5.17e-05 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 106 | 1.11e-06 | -0.2740 | 5.17e-05 |
Fatty acid metabolism | 160 | 1.41e-06 | 0.2210 | 6.40e-05 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 48 | 2.23e-06 | -0.3950 | 9.77e-05 |
Citric acid cycle (TCA cycle) | 22 | 2.43e-06 | 0.5800 | 1.03e-04 |
Respiratory electron transport | 83 | 2.51e-06 | 0.2990 | 1.04e-04 |
Signaling by ROBO receptors | 178 | 2.76e-06 | -0.2040 | 1.10e-04 |
Ribosomal scanning and start codon recognition | 48 | 2.82e-06 | -0.3910 | 1.10e-04 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 4.40e-06 | 0.3680 | 1.67e-04 |
Translation initiation complex formation | 47 | 4.56e-06 | -0.3870 | 1.68e-04 |
Bile acid and bile salt metabolism | 37 | 1.16e-05 | 0.4170 | 4.19e-04 |
Adaptive Immune System | 643 | 2.24e-05 | -0.0985 | 7.85e-04 |
Transport of small molecules | 656 | 3.34e-05 | 0.0954 | 1.14e-03 |
Peroxisomal lipid metabolism | 27 | 3.54e-05 | 0.4600 | 1.18e-03 |
Synthesis of bile acids and bile salts | 29 | 6.39e-05 | 0.4290 | 2.09e-03 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 8.00e-05 | 0.5230 | 2.55e-03 |
Separation of Sister Chromatids | 157 | 1.67e-04 | -0.1740 | 5.20e-03 |
Generation of second messenger molecules | 24 | 2.00e-04 | -0.4380 | 6.12e-03 |
TCR signaling | 96 | 2.89e-04 | -0.2140 | 8.63e-03 |
Complex I biogenesis | 46 | 3.44e-04 | 0.3050 | 1.01e-02 |
PD-1 signaling | 15 | 5.93e-04 | -0.5120 | 1.70e-02 |
Protein localization | 144 | 6.18e-04 | 0.1650 | 1.73e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
Major pathway of rRNA processing in the nucleolus and cytosol | 148 | 7.55e-15 | -3.70e-01 | 1.06e-11 |
SRP-dependent cotranslational protein targeting to membrane | 83 | 2.52e-14 | -4.84e-01 | 1.24e-11 |
rRNA processing in the nucleus and cytosol | 155 | 2.66e-14 | -3.54e-01 | 1.24e-11 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 72 | 1.15e-12 | -4.85e-01 | 3.56e-10 |
Peptide chain elongation | 60 | 1.66e-12 | -5.27e-01 | 3.56e-10 |
Eukaryotic Translation Termination | 63 | 1.73e-12 | -5.14e-01 | 3.56e-10 |
Viral mRNA Translation | 60 | 1.88e-12 | -5.26e-01 | 3.56e-10 |
Selenocysteine synthesis | 63 | 2.03e-12 | -5.12e-01 | 3.56e-10 |
Metabolism | 1845 | 2.70e-12 | 9.97e-02 | 3.92e-10 |
Eukaryotic Translation Elongation | 63 | 2.79e-12 | -5.09e-01 | 3.92e-10 |
Cap-dependent Translation Initiation | 87 | 9.53e-12 | -4.23e-01 | 1.12e-09 |
Eukaryotic Translation Initiation | 87 | 9.53e-12 | -4.23e-01 | 1.12e-09 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 65 | 1.98e-11 | -4.81e-01 | 2.01e-09 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 81 | 2.00e-11 | -4.31e-01 | 2.01e-09 |
Formation of a pool of free 40S subunits | 71 | 2.96e-11 | -4.56e-01 | 2.77e-09 |
L13a-mediated translational silencing of Ceruloplasmin expression | 79 | 3.62e-11 | -4.31e-01 | 3.18e-09 |
The citric acid (TCA) cycle and respiratory electron transport | 150 | 6.21e-11 | 3.09e-01 | 5.13e-09 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 83 | 1.19e-10 | -4.09e-01 | 8.76e-09 |
Nonsense-Mediated Decay (NMD) | 83 | 1.19e-10 | -4.09e-01 | 8.76e-09 |
rRNA processing | 176 | 1.45e-09 | -2.65e-01 | 1.01e-07 |
Metabolism of lipids | 669 | 2.49e-09 | 1.36e-01 | 1.67e-07 |
Regulation of expression of SLITs and ROBOs | 133 | 2.86e-09 | -2.98e-01 | 1.82e-07 |
Metabolism of RNA | 604 | 2.49e-08 | -1.33e-01 | 1.52e-06 |
Influenza Viral RNA Transcription and Replication | 103 | 4.97e-08 | -3.11e-01 | 2.91e-06 |
Formation of the ternary complex, and subsequently, the 43S complex | 42 | 4.75e-07 | -4.49e-01 | 2.67e-05 |
Influenza Infection | 120 | 6.95e-07 | -2.62e-01 | 3.75e-05 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 102 | 7.85e-07 | 2.83e-01 | 4.08e-05 |
Mitochondrial Fatty Acid Beta-Oxidation | 34 | 9.41e-07 | 4.86e-01 | 4.72e-05 |
Selenoamino acid metabolism | 84 | 1.09e-06 | -3.08e-01 | 5.17e-05 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 106 | 1.11e-06 | -2.74e-01 | 5.17e-05 |
Fatty acid metabolism | 160 | 1.41e-06 | 2.21e-01 | 6.40e-05 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 48 | 2.23e-06 | -3.95e-01 | 9.77e-05 |
Citric acid cycle (TCA cycle) | 22 | 2.43e-06 | 5.80e-01 | 1.03e-04 |
Respiratory electron transport | 83 | 2.51e-06 | 2.99e-01 | 1.04e-04 |
Signaling by ROBO receptors | 178 | 2.76e-06 | -2.04e-01 | 1.10e-04 |
Ribosomal scanning and start codon recognition | 48 | 2.82e-06 | -3.91e-01 | 1.10e-04 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 4.40e-06 | 3.68e-01 | 1.67e-04 |
Translation initiation complex formation | 47 | 4.56e-06 | -3.87e-01 | 1.68e-04 |
Bile acid and bile salt metabolism | 37 | 1.16e-05 | 4.17e-01 | 4.19e-04 |
Adaptive Immune System | 643 | 2.24e-05 | -9.85e-02 | 7.85e-04 |
Transport of small molecules | 656 | 3.34e-05 | 9.54e-02 | 1.14e-03 |
Peroxisomal lipid metabolism | 27 | 3.54e-05 | 4.60e-01 | 1.18e-03 |
Synthesis of bile acids and bile salts | 29 | 6.39e-05 | 4.29e-01 | 2.09e-03 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 8.00e-05 | 5.23e-01 | 2.55e-03 |
Separation of Sister Chromatids | 157 | 1.67e-04 | -1.74e-01 | 5.20e-03 |
Generation of second messenger molecules | 24 | 2.00e-04 | -4.38e-01 | 6.12e-03 |
TCR signaling | 96 | 2.89e-04 | -2.14e-01 | 8.63e-03 |
Complex I biogenesis | 46 | 3.44e-04 | 3.05e-01 | 1.01e-02 |
PD-1 signaling | 15 | 5.93e-04 | -5.12e-01 | 1.70e-02 |
Protein localization | 144 | 6.18e-04 | 1.65e-01 | 1.73e-02 |
TNFR2 non-canonical NF-kB pathway | 86 | 6.31e-04 | -2.13e-01 | 1.74e-02 |
Fc epsilon receptor (FCERI) signaling | 129 | 7.14e-04 | -1.73e-01 | 1.93e-02 |
Intrinsic Pathway of Fibrin Clot Formation | 22 | 7.80e-04 | 4.14e-01 | 2.07e-02 |
Cellular responses to stress | 442 | 8.29e-04 | -9.30e-02 | 2.16e-02 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 67 | 9.08e-04 | -2.34e-01 | 2.32e-02 |
Cellular responses to external stimuli | 449 | 1.01e-03 | -9.08e-02 | 2.52e-02 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 66 | 1.03e-03 | -2.34e-01 | 2.52e-02 |
Recycling of bile acids and salts | 15 | 1.05e-03 | 4.89e-01 | 2.52e-02 |
rRNA modification in the nucleus and cytosol | 54 | 1.06e-03 | -2.58e-01 | 2.52e-02 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.14e-03 | 5.42e-01 | 2.63e-02 |
alpha-linolenic acid (ALA) metabolism | 12 | 1.14e-03 | 5.42e-01 | 2.63e-02 |
SLC-mediated transmembrane transport | 233 | 1.19e-03 | 1.23e-01 | 2.69e-02 |
tRNA processing in the mitochondrion | 18 | 1.34e-03 | 4.37e-01 | 2.99e-02 |
TNFs bind their physiological receptors | 25 | 1.43e-03 | -3.69e-01 | 3.13e-02 |
Metabolism of porphyrins | 23 | 1.52e-03 | 3.82e-01 | 3.29e-02 |
rRNA processing in the mitochondrion | 21 | 1.58e-03 | 3.98e-01 | 3.36e-02 |
Downstream TCR signaling | 76 | 1.63e-03 | -2.09e-01 | 3.37e-02 |
Collagen chain trimerization | 35 | 1.63e-03 | -3.08e-01 | 3.37e-02 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 64 | 1.76e-03 | -2.26e-01 | 3.49e-02 |
Regulation of APC/C activators between G1/S and early anaphase | 71 | 1.76e-03 | -2.15e-01 | 3.49e-02 |
Transcriptional activation of mitochondrial biogenesis | 51 | 1.76e-03 | 2.53e-01 | 3.49e-02 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 63 | 1.84e-03 | -2.27e-01 | 3.58e-02 |
C-type lectin receptors (CLRs) | 114 | 1.89e-03 | -1.69e-01 | 3.63e-02 |
Sphingolipid metabolism | 79 | 2.05e-03 | 2.01e-01 | 3.89e-02 |
Downstream signaling events of B Cell Receptor (BCR) | 69 | 2.14e-03 | -2.14e-01 | 4.01e-02 |
Mitochondrial biogenesis | 82 | 2.53e-03 | 1.93e-01 | 4.60e-02 |
Regulation of insulin secretion | 72 | 2.55e-03 | 2.06e-01 | 4.60e-02 |
Prolactin receptor signaling | 15 | 2.56e-03 | -4.50e-01 | 4.60e-02 |
Unblocking of NMDA receptors, glutamate binding and activation | 20 | 2.66e-03 | -3.88e-01 | 4.73e-02 |
L1CAM interactions | 96 | 2.89e-03 | 1.76e-01 | 5.04e-02 |
APC/C-mediated degradation of cell cycle proteins | 78 | 2.94e-03 | -1.95e-01 | 5.04e-02 |
Regulation of mitotic cell cycle | 78 | 2.94e-03 | -1.95e-01 | 5.04e-02 |
Assembly of collagen fibrils and other multimeric structures | 49 | 2.98e-03 | -2.45e-01 | 5.04e-02 |
Mitochondrial calcium ion transport | 20 | 3.12e-03 | 3.82e-01 | 5.22e-02 |
RNA Polymerase II Transcription | 1008 | 3.27e-03 | -5.52e-02 | 5.41e-02 |
Sema4D in semaphorin signaling | 23 | 3.60e-03 | 3.51e-01 | 5.82e-02 |
Long-term potentiation | 22 | 3.61e-03 | -3.58e-01 | 5.82e-02 |
Heme degradation | 12 | 3.87e-03 | 4.82e-01 | 6.11e-02 |
Phospholipid metabolism | 196 | 3.89e-03 | 1.20e-01 | 6.11e-02 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 103 | 3.92e-03 | 1.65e-01 | 6.11e-02 |
Translocation of ZAP-70 to Immunological synapse | 10 | 4.33e-03 | -5.21e-01 | 6.68e-02 |
APC/C:Cdc20 mediated degradation of Securin | 58 | 4.42e-03 | -2.16e-01 | 6.75e-02 |
Glyoxylate metabolism and glycine degradation | 29 | 4.62e-03 | 3.04e-01 | 6.97e-02 |
tRNA Aminoacylation | 38 | 4.81e-03 | 2.64e-01 | 7.18e-02 |
Collagen formation | 78 | 5.16e-03 | -1.83e-01 | 7.60e-02 |
Stabilization of p53 | 46 | 5.20e-03 | -2.38e-01 | 7.60e-02 |
Cell Cycle Checkpoints | 235 | 5.62e-03 | -1.05e-01 | 8.13e-02 |
LDL clearance | 18 | 5.75e-03 | 3.76e-01 | 8.24e-02 |
Gene expression (Transcription) | 1138 | 5.84e-03 | -4.89e-02 | 8.28e-02 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 37 | 5.95e-03 | 2.61e-01 | 8.29e-02 |
Apoptotic cleavage of cell adhesion proteins | 11 | 6.07e-03 | 4.78e-01 | 8.29e-02 |
Mitotic Spindle Checkpoint | 104 | 6.11e-03 | -1.56e-01 | 8.29e-02 |
Branched-chain amino acid catabolism | 20 | 6.11e-03 | 3.54e-01 | 8.29e-02 |
Mitochondrial protein import | 54 | 6.14e-03 | 2.16e-01 | 8.29e-02 |
Processing of SMDT1 | 13 | 6.61e-03 | 4.35e-01 | 8.84e-02 |
Resolution of Sister Chromatid Cohesion | 101 | 6.70e-03 | -1.56e-01 | 8.87e-02 |
Immune System | 1805 | 6.78e-03 | -3.90e-02 | 8.87e-02 |
Collagen biosynthesis and modifying enzymes | 57 | 6.83e-03 | -2.07e-01 | 8.87e-02 |
Mitotic Metaphase and Anaphase | 208 | 7.12e-03 | -1.08e-01 | 9.17e-02 |
Dectin-2 family | 15 | 7.42e-03 | -3.99e-01 | 9.47e-02 |
Mitochondrial tRNA aminoacylation | 18 | 7.57e-03 | 3.64e-01 | 9.57e-02 |
Cross-presentation of soluble exogenous antigens (endosomes) | 43 | 7.80e-03 | -2.35e-01 | 9.78e-02 |
Metabolism of vitamins and cofactors | 168 | 8.17e-03 | 1.18e-01 | 9.91e-02 |
Antigen processing-Cross presentation | 86 | 8.18e-03 | -1.65e-01 | 9.91e-02 |
Phosphorylation of CD3 and TCR zeta chains | 14 | 8.19e-03 | -4.08e-01 | 9.91e-02 |
FCGR activation | 25 | 8.19e-03 | -3.06e-01 | 9.91e-02 |
Hemostasis | 536 | 8.47e-03 | 6.67e-02 | 1.01e-01 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 49 | 8.48e-03 | -2.17e-01 | 1.01e-01 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 66 | 8.72e-03 | -1.87e-01 | 1.03e-01 |
Mitotic Anaphase | 207 | 8.78e-03 | -1.06e-01 | 1.03e-01 |
Mitochondrial translation | 88 | 8.85e-03 | 1.62e-01 | 1.03e-01 |
Transport of vitamins, nucleosides, and related molecules | 39 | 8.96e-03 | 2.42e-01 | 1.03e-01 |
Miscellaneous transport and binding events | 21 | 9.02e-03 | 3.29e-01 | 1.03e-01 |
Adrenaline,noradrenaline inhibits insulin secretion | 24 | 9.08e-03 | 3.08e-01 | 1.03e-01 |
Nucleobase catabolism | 32 | 9.29e-03 | 2.66e-01 | 1.04e-01 |
Generic Transcription Pathway | 894 | 9.33e-03 | -5.16e-02 | 1.04e-01 |
Sphingolipid de novo biosynthesis | 39 | 1.01e-02 | 2.38e-01 | 1.12e-01 |
Neuronal System | 353 | 1.07e-02 | 7.93e-02 | 1.17e-01 |
Organelle biogenesis and maintenance | 257 | 1.08e-02 | 9.25e-02 | 1.18e-01 |
Interaction between L1 and Ankyrins | 28 | 1.16e-02 | 2.76e-01 | 1.25e-01 |
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | 13 | 1.17e-02 | -4.04e-01 | 1.25e-01 |
Cristae formation | 24 | 1.20e-02 | 2.96e-01 | 1.27e-01 |
Beta-oxidation of very long chain fatty acids | 10 | 1.24e-02 | 4.57e-01 | 1.31e-01 |
cGMP effects | 15 | 1.25e-02 | 3.72e-01 | 1.31e-01 |
M Phase | 323 | 1.30e-02 | -8.06e-02 | 1.35e-01 |
Vif-mediated degradation of APOBEC3G | 44 | 1.34e-02 | -2.15e-01 | 1.38e-01 |
Assembly and cell surface presentation of NMDA receptors | 22 | 1.35e-02 | -3.04e-01 | 1.38e-01 |
MAPK6/MAPK4 signaling | 78 | 1.36e-02 | -1.62e-01 | 1.39e-01 |
Deposition of new CENPA-containing nucleosomes at the centromere | 29 | 1.40e-02 | -2.64e-01 | 1.40e-01 |
Nucleosome assembly | 29 | 1.40e-02 | -2.64e-01 | 1.40e-01 |
Autodegradation of Cdh1 by Cdh1:APC/C | 55 | 1.43e-02 | -1.91e-01 | 1.42e-01 |
Regulation of RUNX3 expression and activity | 47 | 1.46e-02 | -2.06e-01 | 1.44e-01 |
ER to Golgi Anterograde Transport | 124 | 1.47e-02 | -1.27e-01 | 1.44e-01 |
GABA synthesis, release, reuptake and degradation | 17 | 1.52e-02 | 3.40e-01 | 1.48e-01 |
Regulation of TP53 Expression and Degradation | 32 | 1.54e-02 | -2.47e-01 | 1.49e-01 |
FCERI mediated NF-kB activation | 79 | 1.55e-02 | -1.58e-01 | 1.49e-01 |
Assembly Of The HIV Virion | 14 | 1.59e-02 | -3.72e-01 | 1.52e-01 |
Recycling pathway of L1 | 27 | 1.64e-02 | 2.67e-01 | 1.56e-01 |
APC/C:Cdc20 mediated degradation of Cyclin B | 20 | 1.67e-02 | -3.09e-01 | 1.56e-01 |
Triglyceride metabolism | 34 | 1.69e-02 | 2.37e-01 | 1.56e-01 |
Costimulation by the CD28 family | 60 | 1.69e-02 | -1.78e-01 | 1.56e-01 |
Pyrimidine catabolism | 10 | 1.72e-02 | 4.35e-01 | 1.56e-01 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 27 | 1.72e-02 | -2.65e-01 | 1.56e-01 |
Trafficking of AMPA receptors | 27 | 1.72e-02 | -2.65e-01 | 1.56e-01 |
Formation of Fibrin Clot (Clotting Cascade) | 36 | 1.73e-02 | 2.29e-01 | 1.56e-01 |
Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 10 | 1.74e-02 | 4.34e-01 | 1.56e-01 |
Phase I - Functionalization of compounds | 88 | 1.81e-02 | 1.46e-01 | 1.62e-01 |
Sema4D induced cell migration and growth-cone collapse | 19 | 1.82e-02 | 3.13e-01 | 1.62e-01 |
Regulation of TP53 Degradation | 31 | 1.87e-02 | -2.44e-01 | 1.65e-01 |
Mitochondrial translation elongation | 83 | 1.92e-02 | 1.49e-01 | 1.66e-01 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 64 | 1.92e-02 | -1.69e-01 | 1.66e-01 |
Transcriptional regulation by RUNX2 | 107 | 1.92e-02 | -1.31e-01 | 1.66e-01 |
Extracellular matrix organization | 265 | 1.97e-02 | -8.34e-02 | 1.68e-01 |
p53-Dependent G1 DNA Damage Response | 55 | 1.98e-02 | -1.82e-01 | 1.68e-01 |
p53-Dependent G1/S DNA damage checkpoint | 55 | 1.98e-02 | -1.82e-01 | 1.68e-01 |
SCF-beta-TrCP mediated degradation of Emi1 | 47 | 2.01e-02 | -1.96e-01 | 1.68e-01 |
Biotin transport and metabolism | 10 | 2.03e-02 | 4.24e-01 | 1.68e-01 |
Glycerophospholipid biosynthesis | 120 | 2.03e-02 | 1.23e-01 | 1.68e-01 |
Removal of aminoterminal propeptides from gamma-carboxylated proteins | 10 | 2.05e-02 | 4.23e-01 | 1.68e-01 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 89 | 2.05e-02 | -1.42e-01 | 1.68e-01 |
Amplification of signal from the kinetochores | 89 | 2.05e-02 | -1.42e-01 | 1.68e-01 |
Potassium Channels | 90 | 2.06e-02 | 1.41e-01 | 1.68e-01 |
Infectious disease | 698 | 2.13e-02 | -5.14e-02 | 1.73e-01 |
Signaling by the B Cell Receptor (BCR) | 112 | 2.14e-02 | -1.26e-01 | 1.73e-01 |
Phospholipase C-mediated cascade; FGFR3 | 12 | 2.16e-02 | 3.83e-01 | 1.73e-01 |
Aflatoxin activation and detoxification | 17 | 2.17e-02 | 3.22e-01 | 1.73e-01 |
Metabolism of steroids | 130 | 2.23e-02 | 1.16e-01 | 1.77e-01 |
ER-Phagosome pathway | 74 | 2.30e-02 | -1.53e-01 | 1.80e-01 |
Scavenging by Class A Receptors | 17 | 2.31e-02 | -3.18e-01 | 1.80e-01 |
Interleukin-10 signaling | 37 | 2.31e-02 | -2.16e-01 | 1.80e-01 |
Autodegradation of the E3 ubiquitin ligase COP1 | 42 | 2.32e-02 | -2.02e-01 | 1.80e-01 |
EML4 and NUDC in mitotic spindle formation | 93 | 2.40e-02 | -1.36e-01 | 1.85e-01 |
Cytosolic sulfonation of small molecules | 22 | 2.41e-02 | 2.78e-01 | 1.85e-01 |
Regulation of RAS by GAPs | 58 | 2.46e-02 | -1.71e-01 | 1.87e-01 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 42 | 2.47e-02 | -2.00e-01 | 1.87e-01 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 36 | 2.48e-02 | -2.16e-01 | 1.87e-01 |
Hedgehog ‘on’ state | 74 | 2.50e-02 | -1.51e-01 | 1.87e-01 |
Triglyceride biosynthesis | 13 | 2.51e-02 | 3.59e-01 | 1.87e-01 |
Translation | 248 | 2.53e-02 | -8.26e-02 | 1.88e-01 |
Interconversion of nucleotide di- and triphosphates | 27 | 2.57e-02 | -2.48e-01 | 1.90e-01 |
Transcriptional regulation by RUNX3 | 82 | 2.60e-02 | -1.42e-01 | 1.91e-01 |
Nitric oxide stimulates guanylate cyclase | 19 | 2.63e-02 | 2.94e-01 | 1.92e-01 |
Mismatch Repair | 13 | 2.70e-02 | 3.54e-01 | 1.95e-01 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 13 | 2.70e-02 | 3.54e-01 | 1.95e-01 |
Classical antibody-mediated complement activation | 18 | 2.70e-02 | -3.01e-01 | 1.95e-01 |
Activation of NF-kappaB in B cells | 57 | 2.75e-02 | -1.69e-01 | 1.97e-01 |
Peroxisomal protein import | 58 | 2.79e-02 | 1.67e-01 | 1.99e-01 |
STING mediated induction of host immune responses | 15 | 2.80e-02 | -3.28e-01 | 1.99e-01 |
G alpha (12/13) signalling events | 71 | 2.83e-02 | 1.51e-01 | 1.99e-01 |
Mitochondrial translation termination | 83 | 2.84e-02 | 1.39e-01 | 1.99e-01 |
FGFR3 mutant receptor activation | 11 | 2.86e-02 | 3.81e-01 | 1.99e-01 |
Signaling by activated point mutants of FGFR3 | 11 | 2.86e-02 | 3.81e-01 | 1.99e-01 |
Post-translational protein phosphorylation | 100 | 2.91e-02 | 1.26e-01 | 2.01e-01 |
O-glycosylation of TSR domain-containing proteins | 37 | 2.94e-02 | -2.07e-01 | 2.02e-01 |
CDK-mediated phosphorylation and removal of Cdc6 | 63 | 2.96e-02 | -1.59e-01 | 2.02e-01 |
Negative regulation of NOTCH4 signaling | 47 | 2.96e-02 | -1.83e-01 | 2.02e-01 |
Cytochrome P450 - arranged by substrate type | 58 | 3.00e-02 | 1.65e-01 | 2.02e-01 |
Degradation of the extracellular matrix | 99 | 3.00e-02 | -1.26e-01 | 2.02e-01 |
SCF(Skp2)-mediated degradation of p27/p21 | 53 | 3.04e-02 | -1.72e-01 | 2.04e-01 |
G1/S DNA Damage Checkpoints | 56 | 3.09e-02 | -1.67e-01 | 2.07e-01 |
Cell-extracellular matrix interactions | 16 | 3.14e-02 | 3.11e-01 | 2.08e-01 |
Creation of C4 and C2 activators | 24 | 3.15e-02 | -2.54e-01 | 2.08e-01 |
Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 3.18e-02 | 3.20e-01 | 2.10e-01 |
IRF3-mediated induction of type I IFN | 12 | 3.21e-02 | -3.57e-01 | 2.11e-01 |
NIK–>noncanonical NF-kB signaling | 51 | 3.25e-02 | -1.73e-01 | 2.12e-01 |
Integration of energy metabolism | 100 | 3.29e-02 | 1.24e-01 | 2.14e-01 |
Membrane binding and targetting of GAG proteins | 12 | 3.33e-02 | -3.55e-01 | 2.15e-01 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 12 | 3.33e-02 | -3.55e-01 | 2.15e-01 |
APC-Cdc20 mediated degradation of Nek2A | 22 | 3.36e-02 | -2.62e-01 | 2.15e-01 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 15 | 3.38e-02 | 3.17e-01 | 2.15e-01 |
Diseases of hemostasis | 15 | 3.38e-02 | 3.17e-01 | 2.15e-01 |
DAP12 interactions | 35 | 3.46e-02 | -2.06e-01 | 2.19e-01 |
Apoptotic execution phase | 50 | 3.51e-02 | 1.72e-01 | 2.21e-01 |
Class I MHC mediated antigen processing & presentation | 331 | 3.53e-02 | -6.75e-02 | 2.21e-01 |
Signal regulatory protein family interactions | 12 | 3.60e-02 | -3.50e-01 | 2.25e-01 |
Mitochondrial translation initiation | 82 | 3.65e-02 | 1.34e-01 | 2.26e-01 |
Signaling by Interleukins | 387 | 3.67e-02 | -6.20e-02 | 2.26e-01 |
Metabolism of fat-soluble vitamins | 41 | 3.70e-02 | 1.88e-01 | 2.26e-01 |
Bicarbonate transporters | 10 | 3.70e-02 | 3.81e-01 | 2.26e-01 |
Regulation of ornithine decarboxylase (ODC) | 45 | 3.72e-02 | -1.80e-01 | 2.26e-01 |
PI-3K cascade:FGFR3 | 17 | 3.73e-02 | 2.92e-01 | 2.26e-01 |
CD28 dependent Vav1 pathway | 12 | 3.80e-02 | -3.46e-01 | 2.29e-01 |
Ovarian tumor domain proteases | 33 | 3.82e-02 | 2.09e-01 | 2.29e-01 |
Initiation of Nuclear Envelope (NE) Reformation | 16 | 3.83e-02 | 2.99e-01 | 2.29e-01 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 114 | 3.83e-02 | 1.12e-01 | 2.29e-01 |
Formation of TC-NER Pre-Incision Complex | 49 | 3.90e-02 | -1.71e-01 | 2.31e-01 |
RHO GTPases activate IQGAPs | 11 | 3.90e-02 | 3.59e-01 | 2.31e-01 |
GLI3 is processed to GLI3R by the proteasome | 50 | 3.99e-02 | -1.68e-01 | 2.35e-01 |
CLEC7A (Dectin-1) signaling | 88 | 4.04e-02 | -1.26e-01 | 2.37e-01 |
Phosphorylation of the APC/C | 18 | 4.07e-02 | -2.79e-01 | 2.38e-01 |
Miscellaneous substrates | 12 | 4.13e-02 | 3.40e-01 | 2.38e-01 |
VEGFR2 mediated vascular permeability | 25 | 4.13e-02 | 2.36e-01 | 2.38e-01 |
Signaling by FGFR3 in disease | 20 | 4.19e-02 | 2.63e-01 | 2.38e-01 |
Signaling by FGFR3 point mutants in cancer | 20 | 4.19e-02 | 2.63e-01 | 2.38e-01 |
Vpu mediated degradation of CD4 | 43 | 4.20e-02 | -1.79e-01 | 2.38e-01 |
Dectin-1 mediated noncanonical NF-kB signaling | 54 | 4.20e-02 | -1.60e-01 | 2.38e-01 |
Neddylation | 213 | 4.21e-02 | -8.09e-02 | 2.38e-01 |
Retinoid metabolism and transport | 38 | 4.21e-02 | 1.91e-01 | 2.38e-01 |
COPI-mediated anterograde transport | 75 | 4.36e-02 | -1.35e-01 | 2.46e-01 |
Hedgehog ‘off’ state | 89 | 4.44e-02 | -1.23e-01 | 2.49e-01 |
Metabolism of polyamines | 53 | 4.49e-02 | -1.59e-01 | 2.50e-01 |
Cell junction organization | 80 | 4.49e-02 | 1.30e-01 | 2.50e-01 |
Regulation of Apoptosis | 45 | 4.56e-02 | -1.72e-01 | 2.51e-01 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 43 | 4.59e-02 | -1.76e-01 | 2.51e-01 |
p53-Independent DNA Damage Response | 43 | 4.59e-02 | -1.76e-01 | 2.51e-01 |
p53-Independent G1/S DNA damage checkpoint | 43 | 4.59e-02 | -1.76e-01 | 2.51e-01 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 4.81e-02 | 3.44e-01 | 2.62e-01 |
O2/CO2 exchange in erythrocytes | 11 | 4.81e-02 | 3.44e-01 | 2.62e-01 |
Apoptotic cleavage of cellular proteins | 38 | 4.83e-02 | 1.85e-01 | 2.62e-01 |
Initial triggering of complement | 28 | 4.86e-02 | -2.15e-01 | 2.62e-01 |
Glycogen breakdown (glycogenolysis) | 14 | 4.90e-02 | -3.04e-01 | 2.63e-01 |
Transport to the Golgi and subsequent modification | 149 | 4.91e-02 | -9.35e-02 | 2.63e-01 |
Signaling by Hedgehog | 123 | 5.01e-02 | -1.02e-01 | 2.65e-01 |
Keratan sulfate degradation | 12 | 5.02e-02 | -3.26e-01 | 2.65e-01 |
COPII-mediated vesicle transport | 61 | 5.05e-02 | -1.45e-01 | 2.65e-01 |
FGFR3 ligand binding and activation | 12 | 5.06e-02 | 3.26e-01 | 2.65e-01 |
FGFR3c ligand binding and activation | 12 | 5.06e-02 | 3.26e-01 | 2.65e-01 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 47 | 5.09e-02 | -1.65e-01 | 2.65e-01 |
Response of EIF2AK1 (HRI) to heme deficiency | 14 | 5.09e-02 | -3.01e-01 | 2.65e-01 |
Glycogen metabolism | 24 | 5.10e-02 | -2.30e-01 | 2.65e-01 |
Degradation of DVL | 49 | 5.30e-02 | -1.60e-01 | 2.75e-01 |
Nuclear Receptor transcription pathway | 52 | 5.52e-02 | 1.54e-01 | 2.85e-01 |
Cytosolic tRNA aminoacylation | 22 | 5.54e-02 | 2.36e-01 | 2.85e-01 |
Nephrin family interactions | 20 | 5.60e-02 | 2.47e-01 | 2.87e-01 |
CDT1 association with the CDC6:ORC:origin complex | 51 | 5.66e-02 | -1.54e-01 | 2.87e-01 |
HS-GAG degradation | 18 | 5.66e-02 | 2.60e-01 | 2.87e-01 |
Laminin interactions | 23 | 5.67e-02 | 2.30e-01 | 2.87e-01 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 19 | 5.70e-02 | -2.52e-01 | 2.87e-01 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 19 | 5.70e-02 | -2.52e-01 | 2.87e-01 |
Regulation of TP53 Activity through Methylation | 15 | 5.72e-02 | -2.84e-01 | 2.87e-01 |
ABC transporters in lipid homeostasis | 17 | 5.74e-02 | 2.66e-01 | 2.87e-01 |
HATs acetylate histones | 74 | 5.77e-02 | -1.28e-01 | 2.88e-01 |
Metabolism of cofactors | 17 | 5.86e-02 | 2.65e-01 | 2.91e-01 |
Signaling by Leptin | 10 | 6.07e-02 | -3.43e-01 | 3.00e-01 |
Condensation of Prophase Chromosomes | 16 | 6.14e-02 | -2.70e-01 | 3.02e-01 |
Pre-NOTCH Processing in Golgi | 18 | 6.25e-02 | 2.54e-01 | 3.07e-01 |
RHO GTPases Activate ROCKs | 18 | 6.33e-02 | 2.53e-01 | 3.07e-01 |
Cytosolic iron-sulfur cluster assembly | 12 | 6.34e-02 | 3.10e-01 | 3.07e-01 |
Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 11 | 6.36e-02 | 3.23e-01 | 3.07e-01 |
RUNX2 regulates osteoblast differentiation | 22 | 6.36e-02 | -2.29e-01 | 3.07e-01 |
Degradation of AXIN | 46 | 6.37e-02 | -1.58e-01 | 3.07e-01 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 56 | 6.43e-02 | -1.43e-01 | 3.09e-01 |
Ras activation upon Ca2+ influx through NMDA receptor | 18 | 6.46e-02 | -2.52e-01 | 3.09e-01 |
Intrinsic Pathway for Apoptosis | 44 | 6.47e-02 | 1.61e-01 | 3.09e-01 |
Signaling by SCF-KIT | 41 | 6.57e-02 | -1.66e-01 | 3.12e-01 |
Degradation of GLI2 by the proteasome | 49 | 6.57e-02 | -1.52e-01 | 3.12e-01 |
Pentose phosphate pathway | 13 | 6.64e-02 | -2.94e-01 | 3.14e-01 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 19 | 6.68e-02 | 2.43e-01 | 3.15e-01 |
DNA Damage Recognition in GG-NER | 36 | 6.74e-02 | -1.76e-01 | 3.16e-01 |
A tetrasaccharide linker sequence is required for GAG synthesis | 24 | 6.77e-02 | 2.15e-01 | 3.16e-01 |
Pyruvate metabolism | 28 | 6.78e-02 | 1.99e-01 | 3.16e-01 |
Cell Cycle | 579 | 6.83e-02 | -4.45e-02 | 3.18e-01 |
Degradation of GLI1 by the proteasome | 51 | 6.95e-02 | -1.47e-01 | 3.22e-01 |
FCERI mediated MAPK activation | 40 | 6.98e-02 | -1.66e-01 | 3.22e-01 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 12 | 7.07e-02 | 3.01e-01 | 3.26e-01 |
Establishment of Sister Chromatid Cohesion | 11 | 7.12e-02 | -3.14e-01 | 3.27e-01 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 13 | 7.17e-02 | 2.89e-01 | 3.28e-01 |
Glycosphingolipid metabolism | 40 | 7.37e-02 | 1.63e-01 | 3.34e-01 |
Crosslinking of collagen fibrils | 10 | 7.37e-02 | -3.27e-01 | 3.34e-01 |
Activation of BAD and translocation to mitochondria | 14 | 7.39e-02 | 2.76e-01 | 3.34e-01 |
Cellular response to hypoxia | 65 | 7.42e-02 | -1.28e-01 | 3.34e-01 |
Cytokine Signaling in Immune system | 750 | 7.43e-02 | -3.85e-02 | 3.34e-01 |
DARPP-32 events | 23 | 7.47e-02 | -2.15e-01 | 3.35e-01 |
Gamma-carboxylation of protein precursors | 10 | 7.57e-02 | 3.24e-01 | 3.37e-01 |
Defective B4GALT7 causes EDS, progeroid type | 19 | 7.57e-02 | 2.35e-01 | 3.37e-01 |
Chromosome Maintenance | 90 | 7.60e-02 | -1.08e-01 | 3.38e-01 |
Biological oxidations | 169 | 7.70e-02 | 7.90e-02 | 3.41e-01 |
ADP signalling through P2Y purinoceptor 12 | 18 | 7.75e-02 | 2.40e-01 | 3.42e-01 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 72 | 7.83e-02 | -1.20e-01 | 3.44e-01 |
Synaptic adhesion-like molecules | 21 | 7.85e-02 | -2.22e-01 | 3.44e-01 |
IKK complex recruitment mediated by RIP1 | 16 | 7.89e-02 | -2.54e-01 | 3.45e-01 |
Switching of origins to a post-replicative state | 81 | 8.02e-02 | -1.13e-01 | 3.48e-01 |
Lysine catabolism | 12 | 8.02e-02 | 2.92e-01 | 3.48e-01 |
Cell Cycle, Mitotic | 460 | 8.03e-02 | -4.77e-02 | 3.48e-01 |
RHO GTPases Activate Formins | 116 | 8.05e-02 | -9.40e-02 | 3.48e-01 |
FGFR1c ligand binding and activation | 10 | 8.20e-02 | 3.18e-01 | 3.52e-01 |
Signaling by activated point mutants of FGFR1 | 10 | 8.20e-02 | 3.18e-01 | 3.52e-01 |
SIRT1 negatively regulates rRNA expression | 12 | 8.24e-02 | -2.90e-01 | 3.53e-01 |
Heme biosynthesis | 12 | 8.29e-02 | 2.89e-01 | 3.53e-01 |
G-protein activation | 24 | 8.33e-02 | 2.04e-01 | 3.53e-01 |
XBP1(S) activates chaperone genes | 47 | 8.33e-02 | 1.46e-01 | 3.53e-01 |
YAP1- and WWTR1 (TAZ)-stimulated gene expression | 14 | 8.37e-02 | -2.67e-01 | 3.54e-01 |
FGFR2 alternative splicing | 22 | 8.39e-02 | -2.13e-01 | 3.54e-01 |
PECAM1 interactions | 11 | 8.46e-02 | -3.00e-01 | 3.55e-01 |
Translesion synthesis by POLK | 15 | 8.48e-02 | -2.57e-01 | 3.56e-01 |
Signaling by VEGF | 97 | 8.58e-02 | 1.01e-01 | 3.59e-01 |
HIV Infection | 207 | 8.64e-02 | -6.92e-02 | 3.60e-01 |
Mitotic Telophase/Cytokinesis | 13 | 8.66e-02 | -2.75e-01 | 3.60e-01 |
Nucleotide Excision Repair | 103 | 8.73e-02 | -9.76e-02 | 3.60e-01 |
Acetylcholine binding and downstream events | 11 | 8.76e-02 | 2.97e-01 | 3.60e-01 |
Postsynaptic nicotinic acetylcholine receptors | 11 | 8.76e-02 | 2.97e-01 | 3.60e-01 |
Synthesis, secretion, and deacylation of Ghrelin | 19 | 8.79e-02 | -2.26e-01 | 3.60e-01 |
Innate Immune System | 882 | 8.80e-02 | -3.41e-02 | 3.60e-01 |
Synthesis of DNA | 109 | 8.86e-02 | -9.45e-02 | 3.61e-01 |
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 11 | 8.89e-02 | 2.96e-01 | 3.62e-01 |
Ubiquitin-dependent degradation of Cyclin D | 44 | 8.99e-02 | -1.48e-01 | 3.65e-01 |
SARS-CoV Infections | 131 | 9.17e-02 | 8.54e-02 | 3.70e-01 |
tRNA modification in the nucleus and cytosol | 41 | 9.18e-02 | -1.52e-01 | 3.70e-01 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 13 | 9.49e-02 | 2.68e-01 | 3.80e-01 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 13 | 9.49e-02 | 2.68e-01 | 3.80e-01 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 46 | 9.53e-02 | -1.42e-01 | 3.80e-01 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 78 | 9.59e-02 | -1.09e-01 | 3.80e-01 |
Cell-Cell communication | 111 | 9.60e-02 | 9.15e-02 | 3.80e-01 |
Mitotic Prometaphase | 175 | 9.61e-02 | -7.30e-02 | 3.80e-01 |
Extra-nuclear estrogen signaling | 65 | 9.61e-02 | 1.19e-01 | 3.80e-01 |
Regulation of KIT signaling | 16 | 9.64e-02 | -2.40e-01 | 3.80e-01 |
GPVI-mediated activation cascade | 31 | 9.66e-02 | -1.72e-01 | 3.80e-01 |
NGF-stimulated transcription | 37 | 9.83e-02 | -1.57e-01 | 3.85e-01 |
Defective CFTR causes cystic fibrosis | 53 | 9.85e-02 | -1.31e-01 | 3.85e-01 |
DNA Replication | 116 | 9.89e-02 | -8.88e-02 | 3.85e-01 |
Platelet homeostasis | 77 | 9.91e-02 | 1.09e-01 | 3.85e-01 |
Defensins | 20 | 9.95e-02 | 2.13e-01 | 3.86e-01 |
Budding and maturation of HIV virion | 24 | 1.00e-01 | -1.94e-01 | 3.86e-01 |
Smooth Muscle Contraction | 32 | 1.00e-01 | 1.68e-01 | 3.86e-01 |
Incretin synthesis, secretion, and inactivation | 22 | 1.00e-01 | -2.02e-01 | 3.86e-01 |
Trafficking and processing of endosomal TLR | 12 | 1.02e-01 | -2.73e-01 | 3.90e-01 |
Prolonged ERK activation events | 13 | 1.04e-01 | 2.61e-01 | 3.96e-01 |
Reduction of cytosolic Ca++ levels | 12 | 1.05e-01 | 2.71e-01 | 3.99e-01 |
SHC-mediated cascade:FGFR3 | 16 | 1.06e-01 | 2.34e-01 | 4.03e-01 |
Signaling by Retinoic Acid | 35 | 1.06e-01 | 1.58e-01 | 4.04e-01 |
Aspartate and asparagine metabolism | 10 | 1.07e-01 | 2.94e-01 | 4.04e-01 |
Lysosphingolipid and LPA receptors | 13 | 1.07e-01 | 2.58e-01 | 4.05e-01 |
IRE1alpha activates chaperones | 49 | 1.08e-01 | 1.33e-01 | 4.05e-01 |
Visual phototransduction | 85 | 1.08e-01 | 1.01e-01 | 4.06e-01 |
MTOR signalling | 37 | 1.10e-01 | -1.52e-01 | 4.12e-01 |
ER Quality Control Compartment (ERQC) | 18 | 1.12e-01 | 2.16e-01 | 4.18e-01 |
Heparan sulfate/heparin (HS-GAG) metabolism | 46 | 1.13e-01 | 1.35e-01 | 4.19e-01 |
Cell surface interactions at the vascular wall | 132 | 1.13e-01 | 8.00e-02 | 4.19e-01 |
S Phase | 151 | 1.14e-01 | -7.47e-02 | 4.20e-01 |
Early Phase of HIV Life Cycle | 12 | 1.14e-01 | -2.63e-01 | 4.22e-01 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 18 | 1.15e-01 | -2.15e-01 | 4.22e-01 |
RHO GTPases activate PKNs | 35 | 1.15e-01 | 1.54e-01 | 4.22e-01 |
Common Pathway of Fibrin Clot Formation | 20 | 1.16e-01 | 2.03e-01 | 4.24e-01 |
VEGFA-VEGFR2 Pathway | 88 | 1.18e-01 | 9.65e-02 | 4.30e-01 |
Defective B3GAT3 causes JDSSDHD | 18 | 1.19e-01 | 2.12e-01 | 4.30e-01 |
Caspase activation via extrinsic apoptotic signalling pathway | 20 | 1.19e-01 | -2.01e-01 | 4.30e-01 |
Adenylate cyclase inhibitory pathway | 14 | 1.19e-01 | 2.41e-01 | 4.30e-01 |
Regulation of RUNX2 expression and activity | 63 | 1.20e-01 | -1.13e-01 | 4.30e-01 |
SLC transporter disorders | 92 | 1.20e-01 | 9.39e-02 | 4.30e-01 |
Leading Strand Synthesis | 13 | 1.20e-01 | -2.49e-01 | 4.30e-01 |
Polymerase switching | 13 | 1.20e-01 | -2.49e-01 | 4.30e-01 |
Formation of ATP by chemiosmotic coupling | 13 | 1.21e-01 | 2.48e-01 | 4.35e-01 |
Ion homeostasis | 45 | 1.22e-01 | 1.33e-01 | 4.37e-01 |
Carboxyterminal post-translational modifications of tubulin | 30 | 1.23e-01 | -1.63e-01 | 4.37e-01 |
Signaling by NOTCH4 | 72 | 1.23e-01 | -1.05e-01 | 4.38e-01 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 20 | 1.24e-01 | -1.99e-01 | 4.40e-01 |
Translesion synthesis by REV1 | 14 | 1.25e-01 | -2.37e-01 | 4.44e-01 |
Platelet calcium homeostasis | 27 | 1.26e-01 | 1.70e-01 | 4.44e-01 |
Global Genome Nucleotide Excision Repair (GG-NER) | 79 | 1.27e-01 | -9.93e-02 | 4.48e-01 |
PI Metabolism | 77 | 1.31e-01 | 9.97e-02 | 4.59e-01 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 40 | 1.32e-01 | -1.38e-01 | 4.61e-01 |
Processing of Capped Intron-Containing Pre-mRNA | 223 | 1.33e-01 | -5.85e-02 | 4.61e-01 |
Post NMDA receptor activation events | 57 | 1.33e-01 | -1.15e-01 | 4.61e-01 |
Activation of NMDA receptors and postsynaptic events | 68 | 1.34e-01 | -1.05e-01 | 4.61e-01 |
Acyl chain remodelling of PS | 20 | 1.34e-01 | -1.94e-01 | 4.61e-01 |
CTLA4 inhibitory signaling | 21 | 1.34e-01 | -1.89e-01 | 4.61e-01 |
VLDLR internalisation and degradation | 12 | 1.34e-01 | 2.50e-01 | 4.61e-01 |
Signaling by Insulin receptor | 67 | 1.34e-01 | 1.06e-01 | 4.61e-01 |
Retrograde neurotrophin signalling | 14 | 1.35e-01 | 2.31e-01 | 4.62e-01 |
RHO GTPases activate KTN1 | 10 | 1.35e-01 | 2.73e-01 | 4.62e-01 |
Signaling by ERBB2 in Cancer | 22 | 1.35e-01 | 1.84e-01 | 4.62e-01 |
DAP12 signaling | 27 | 1.36e-01 | -1.66e-01 | 4.63e-01 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 24 | 1.37e-01 | 1.75e-01 | 4.63e-01 |
CD22 mediated BCR regulation | 19 | 1.37e-01 | -1.97e-01 | 4.63e-01 |
IRS-related events triggered by IGF1R | 45 | 1.37e-01 | 1.28e-01 | 4.63e-01 |
Nuclear Envelope (NE) Reassembly | 62 | 1.37e-01 | 1.09e-01 | 4.63e-01 |
Muscle contraction | 166 | 1.37e-01 | 6.69e-02 | 4.63e-01 |
Activation of Matrix Metalloproteinases | 26 | 1.38e-01 | -1.68e-01 | 4.63e-01 |
SUMOylation of DNA methylation proteins | 15 | 1.39e-01 | 2.21e-01 | 4.63e-01 |
Phospholipase C-mediated cascade: FGFR1 | 14 | 1.39e-01 | 2.28e-01 | 4.63e-01 |
Negative regulation of FGFR3 signaling | 24 | 1.39e-01 | 1.74e-01 | 4.63e-01 |
DNA Repair | 265 | 1.40e-01 | -5.28e-02 | 4.63e-01 |
TGF-beta receptor signaling activates SMADs | 27 | 1.40e-01 | 1.64e-01 | 4.63e-01 |
Asparagine N-linked glycosylation | 259 | 1.40e-01 | -5.33e-02 | 4.63e-01 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 11 | 1.40e-01 | 2.57e-01 | 4.63e-01 |
PKMTs methylate histone lysines | 40 | 1.41e-01 | 1.34e-01 | 4.63e-01 |
E2F mediated regulation of DNA replication | 21 | 1.42e-01 | -1.85e-01 | 4.63e-01 |
Synthesis of PIPs at the plasma membrane | 49 | 1.42e-01 | 1.21e-01 | 4.63e-01 |
Signaling by Nuclear Receptors | 219 | 1.42e-01 | 5.77e-02 | 4.63e-01 |
Frs2-mediated activation | 11 | 1.42e-01 | 2.55e-01 | 4.63e-01 |
Metabolism of non-coding RNA | 51 | 1.43e-01 | -1.19e-01 | 4.63e-01 |
snRNP Assembly | 51 | 1.43e-01 | -1.19e-01 | 4.63e-01 |
RHO GTPases activate PAKs | 20 | 1.43e-01 | 1.89e-01 | 4.63e-01 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 28 | 1.43e-01 | -1.60e-01 | 4.63e-01 |
HIV Life Cycle | 134 | 1.44e-01 | -7.32e-02 | 4.63e-01 |
RHO GTPases activate CIT | 18 | 1.44e-01 | 1.99e-01 | 4.63e-01 |
Potential therapeutics for SARS | 72 | 1.44e-01 | 9.96e-02 | 4.63e-01 |
Metabolism of steroid hormones | 27 | 1.45e-01 | 1.62e-01 | 4.63e-01 |
Signaling by RAF1 mutants | 36 | 1.45e-01 | -1.40e-01 | 4.64e-01 |
Eicosanoids | 12 | 1.46e-01 | 2.43e-01 | 4.65e-01 |
Presynaptic depolarization and calcium channel opening | 11 | 1.46e-01 | -2.53e-01 | 4.66e-01 |
The canonical retinoid cycle in rods (twilight vision) | 21 | 1.47e-01 | 1.83e-01 | 4.68e-01 |
Calnexin/calreticulin cycle | 23 | 1.49e-01 | 1.74e-01 | 4.70e-01 |
Rap1 signalling | 14 | 1.49e-01 | 2.23e-01 | 4.70e-01 |
Transcriptional regulation of granulopoiesis | 34 | 1.50e-01 | -1.43e-01 | 4.74e-01 |
Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 1.51e-01 | -1.60e-01 | 4.75e-01 |
Downstream signaling of activated FGFR3 | 23 | 1.52e-01 | 1.73e-01 | 4.75e-01 |
Transport of organic anions | 12 | 1.52e-01 | 2.39e-01 | 4.75e-01 |
G alpha (q) signalling events | 180 | 1.53e-01 | 6.19e-02 | 4.75e-01 |
Sialic acid metabolism | 30 | 1.53e-01 | 1.51e-01 | 4.75e-01 |
p130Cas linkage to MAPK signaling for integrins | 15 | 1.54e-01 | -2.13e-01 | 4.75e-01 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 1.54e-01 | -2.12e-01 | 4.75e-01 |
Signaling by Non-Receptor Tyrosine Kinases | 49 | 1.55e-01 | 1.18e-01 | 4.75e-01 |
Signaling by PTK6 | 49 | 1.55e-01 | 1.18e-01 | 4.75e-01 |
Activation of GABAB receptors | 36 | 1.56e-01 | 1.37e-01 | 4.75e-01 |
GABA B receptor activation | 36 | 1.56e-01 | 1.37e-01 | 4.75e-01 |
Plasma lipoprotein assembly, remodeling, and clearance | 66 | 1.56e-01 | 1.01e-01 | 4.75e-01 |
Gene Silencing by RNA | 77 | 1.56e-01 | -9.36e-02 | 4.75e-01 |
Anchoring of the basal body to the plasma membrane | 91 | 1.56e-01 | 8.60e-02 | 4.75e-01 |
Ub-specific processing proteases | 146 | 1.57e-01 | -6.80e-02 | 4.75e-01 |
Regulation of HSF1-mediated heat shock response | 74 | 1.57e-01 | 9.53e-02 | 4.75e-01 |
mRNA Splicing - Minor Pathway | 47 | 1.57e-01 | -1.19e-01 | 4.75e-01 |
PI-3K cascade:FGFR1 | 19 | 1.57e-01 | 1.87e-01 | 4.75e-01 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 27 | 1.57e-01 | -1.57e-01 | 4.75e-01 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 19 | 1.57e-01 | 1.87e-01 | 4.75e-01 |
Hh mutants that don’t undergo autocatalytic processing are degraded by ERAD | 48 | 1.58e-01 | -1.18e-01 | 4.75e-01 |
UCH proteinases | 77 | 1.59e-01 | -9.29e-02 | 4.77e-01 |
Adherens junctions interactions | 31 | 1.60e-01 | 1.46e-01 | 4.79e-01 |
Cyclin E associated events during G1/S transition | 76 | 1.61e-01 | -9.30e-02 | 4.83e-01 |
LGI-ADAM interactions | 10 | 1.62e-01 | -2.55e-01 | 4.83e-01 |
IGF1R signaling cascade | 46 | 1.62e-01 | 1.19e-01 | 4.83e-01 |
Orc1 removal from chromatin | 63 | 1.63e-01 | -1.02e-01 | 4.84e-01 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 37 | 1.67e-01 | 1.31e-01 | 4.95e-01 |
Regulation of beta-cell development | 36 | 1.68e-01 | 1.33e-01 | 4.95e-01 |
Metabolism of amino acids and derivatives | 317 | 1.68e-01 | -4.52e-02 | 4.95e-01 |
Signaling by FGFR1 | 41 | 1.68e-01 | 1.24e-01 | 4.95e-01 |
Signal Transduction | 2155 | 1.68e-01 | 1.84e-02 | 4.95e-01 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 28 | 1.69e-01 | 1.50e-01 | 4.95e-01 |
Metabolism of proteins | 1732 | 1.70e-01 | -2.01e-02 | 4.95e-01 |
Eicosanoid ligand-binding receptors | 11 | 1.70e-01 | -2.39e-01 | 4.95e-01 |
Activation of HOX genes during differentiation | 59 | 1.70e-01 | -1.03e-01 | 4.95e-01 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 59 | 1.70e-01 | -1.03e-01 | 4.95e-01 |
Degradation of beta-catenin by the destruction complex | 75 | 1.71e-01 | -9.15e-02 | 4.95e-01 |
mTORC1-mediated signalling | 21 | 1.71e-01 | -1.73e-01 | 4.95e-01 |
Transferrin endocytosis and recycling | 26 | 1.71e-01 | 1.55e-01 | 4.95e-01 |
Phospholipase C-mediated cascade; FGFR4 | 13 | 1.71e-01 | 2.19e-01 | 4.95e-01 |
Late endosomal microautophagy | 26 | 1.72e-01 | -1.55e-01 | 4.95e-01 |
Inhibition of DNA recombination at telomere | 22 | 1.72e-01 | -1.68e-01 | 4.95e-01 |
Biosynthesis of specialized proresolving mediators (SPMs) | 17 | 1.74e-01 | -1.91e-01 | 4.98e-01 |
Caspase activation via Death Receptors in the presence of ligand | 10 | 1.74e-01 | -2.48e-01 | 4.99e-01 |
Condensation of Prometaphase Chromosomes | 10 | 1.76e-01 | -2.47e-01 | 5.02e-01 |
Xenobiotics | 20 | 1.77e-01 | 1.74e-01 | 5.06e-01 |
Glutathione conjugation | 28 | 1.78e-01 | -1.47e-01 | 5.06e-01 |
PI3K Cascade | 39 | 1.79e-01 | 1.24e-01 | 5.08e-01 |
Platelet sensitization by LDL | 16 | 1.79e-01 | -1.94e-01 | 5.08e-01 |
FGFR1 ligand binding and activation | 13 | 1.80e-01 | 2.15e-01 | 5.08e-01 |
Purine catabolism | 15 | 1.80e-01 | 2.00e-01 | 5.08e-01 |
Antigen processing: Ubiquitination & Proteasome degradation | 277 | 1.80e-01 | -4.69e-02 | 5.08e-01 |
Mitochondrial iron-sulfur cluster biogenesis | 11 | 1.81e-01 | 2.33e-01 | 5.09e-01 |
RIP-mediated NFkB activation via ZBP1 | 15 | 1.82e-01 | 1.99e-01 | 5.09e-01 |
RUNX2 regulates bone development | 28 | 1.82e-01 | -1.46e-01 | 5.09e-01 |
p75 NTR receptor-mediated signalling | 89 | 1.82e-01 | 8.19e-02 | 5.09e-01 |
FGFR2 ligand binding and activation | 17 | 1.82e-01 | 1.87e-01 | 5.09e-01 |
Processing of DNA double-strand break ends | 56 | 1.83e-01 | -1.03e-01 | 5.09e-01 |
RET signaling | 38 | 1.83e-01 | 1.25e-01 | 5.09e-01 |
Rab regulation of trafficking | 115 | 1.83e-01 | 7.19e-02 | 5.09e-01 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 1.84e-01 | -1.57e-01 | 5.10e-01 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 25 | 1.85e-01 | -1.53e-01 | 5.10e-01 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 19 | 1.85e-01 | -1.76e-01 | 5.10e-01 |
Regulation of localization of FOXO transcription factors | 11 | 1.85e-01 | 2.31e-01 | 5.10e-01 |
Downregulation of TGF-beta receptor signaling | 22 | 1.86e-01 | 1.63e-01 | 5.10e-01 |
RNA Polymerase I Promoter Escape | 32 | 1.86e-01 | -1.35e-01 | 5.10e-01 |
DNA Double-Strand Break Repair | 119 | 1.87e-01 | -7.02e-02 | 5.10e-01 |
Phospholipase C-mediated cascade; FGFR2 | 16 | 1.87e-01 | 1.91e-01 | 5.10e-01 |
RNA Polymerase II Pre-transcription Events | 74 | 1.88e-01 | -8.85e-02 | 5.11e-01 |
Interleukin-4 and Interleukin-13 signaling | 95 | 1.89e-01 | -7.81e-02 | 5.11e-01 |
RMTs methylate histone arginines | 33 | 1.89e-01 | -1.32e-01 | 5.11e-01 |
Metalloprotease DUBs | 15 | 1.89e-01 | -1.96e-01 | 5.11e-01 |
Fatty acids | 14 | 1.90e-01 | 2.03e-01 | 5.11e-01 |
Insulin receptor recycling | 22 | 1.90e-01 | 1.62e-01 | 5.11e-01 |
PI-3K cascade:FGFR4 | 18 | 1.90e-01 | 1.79e-01 | 5.11e-01 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 1.90e-01 | -2.18e-01 | 5.12e-01 |
Ca-dependent events | 34 | 1.91e-01 | -1.30e-01 | 5.13e-01 |
Neurexins and neuroligins | 53 | 1.92e-01 | 1.04e-01 | 5.13e-01 |
Regulation of TP53 Activity through Phosphorylation | 81 | 1.92e-01 | -8.39e-02 | 5.14e-01 |
Receptor-type tyrosine-protein phosphatases | 19 | 1.93e-01 | 1.73e-01 | 5.14e-01 |
AKT phosphorylates targets in the cytosol | 14 | 1.93e-01 | 2.01e-01 | 5.14e-01 |
mRNA Splicing | 172 | 1.94e-01 | -5.75e-02 | 5.16e-01 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 47 | 1.95e-01 | 1.09e-01 | 5.17e-01 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 1.97e-01 | -1.55e-01 | 5.20e-01 |
Regulation of gene expression in beta cells | 20 | 1.97e-01 | 1.67e-01 | 5.20e-01 |
PI-3K cascade:FGFR2 | 21 | 1.97e-01 | 1.63e-01 | 5.20e-01 |
Plasma lipoprotein remodeling | 29 | 1.99e-01 | 1.38e-01 | 5.23e-01 |
FGFR1 mutant receptor activation | 29 | 2.00e-01 | 1.38e-01 | 5.25e-01 |
FCERI mediated Ca+2 mobilization | 41 | 2.00e-01 | -1.16e-01 | 5.25e-01 |
Receptor Mediated Mitophagy | 11 | 2.01e-01 | -2.23e-01 | 5.25e-01 |
CaM pathway | 32 | 2.01e-01 | -1.31e-01 | 5.25e-01 |
Calmodulin induced events | 32 | 2.01e-01 | -1.31e-01 | 5.25e-01 |
Regulation of FZD by ubiquitination | 16 | 2.02e-01 | 1.84e-01 | 5.25e-01 |
Metabolism of water-soluble vitamins and cofactors | 111 | 2.02e-01 | 7.01e-02 | 5.25e-01 |
Triglyceride catabolism | 21 | 2.02e-01 | 1.61e-01 | 5.25e-01 |
Cohesin Loading onto Chromatin | 10 | 2.05e-01 | -2.31e-01 | 5.31e-01 |
COPI-independent Golgi-to-ER retrograde traffic | 32 | 2.05e-01 | -1.29e-01 | 5.31e-01 |
Assembly of active LPL and LIPC lipase complexes | 18 | 2.06e-01 | 1.72e-01 | 5.31e-01 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 32 | 2.07e-01 | 1.29e-01 | 5.31e-01 |
Synthesis of PIPs at the early endosome membrane | 16 | 2.07e-01 | 1.82e-01 | 5.31e-01 |
Regulated proteolysis of p75NTR | 11 | 2.07e-01 | 2.20e-01 | 5.31e-01 |
Regulation of TP53 Activity through Association with Co-factors | 12 | 2.08e-01 | 2.10e-01 | 5.32e-01 |
Biosynthesis of DHA-derived SPMs | 15 | 2.09e-01 | -1.87e-01 | 5.35e-01 |
RHO GTPases Activate NADPH Oxidases | 22 | 2.10e-01 | -1.54e-01 | 5.37e-01 |
MHC class II antigen presentation | 90 | 2.11e-01 | -7.63e-02 | 5.37e-01 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 2.12e-01 | 2.08e-01 | 5.37e-01 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 13 | 2.13e-01 | 2.00e-01 | 5.37e-01 |
Class I peroxisomal membrane protein import | 18 | 2.14e-01 | 1.69e-01 | 5.37e-01 |
ROS and RNS production in phagocytes | 31 | 2.14e-01 | 1.29e-01 | 5.37e-01 |
Disorders of Developmental Biology | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
Disorders of Nervous System Development | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
Loss of function of MECP2 in Rett syndrome | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
Pervasive developmental disorders | 13 | 2.14e-01 | 1.99e-01 | 5.37e-01 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 12 | 2.14e-01 | -2.07e-01 | 5.37e-01 |
Cardiac conduction | 109 | 2.15e-01 | 6.87e-02 | 5.39e-01 |
Meiotic recombination | 29 | 2.16e-01 | -1.33e-01 | 5.40e-01 |
Reversible hydration of carbon dioxide | 12 | 2.18e-01 | 2.06e-01 | 5.43e-01 |
Binding and Uptake of Ligands by Scavenger Receptors | 49 | 2.19e-01 | -1.02e-01 | 5.45e-01 |
Inositol phosphate metabolism | 45 | 2.20e-01 | 1.06e-01 | 5.46e-01 |
Signaling by WNT in cancer | 29 | 2.20e-01 | 1.31e-01 | 5.47e-01 |
FGFR4 ligand binding and activation | 12 | 2.22e-01 | 2.04e-01 | 5.49e-01 |
RAS processing | 18 | 2.23e-01 | 1.66e-01 | 5.51e-01 |
The NLRP3 inflammasome | 15 | 2.23e-01 | -1.82e-01 | 5.51e-01 |
Dissolution of Fibrin Clot | 11 | 2.24e-01 | -2.12e-01 | 5.51e-01 |
NOD1/2 Signaling Pathway | 30 | 2.24e-01 | -1.28e-01 | 5.51e-01 |
Signaling by FGFR3 | 34 | 2.25e-01 | 1.20e-01 | 5.51e-01 |
Protein folding | 88 | 2.25e-01 | 7.48e-02 | 5.51e-01 |
FGFRL1 modulation of FGFR1 signaling | 10 | 2.25e-01 | 2.21e-01 | 5.51e-01 |
Apoptotic factor-mediated response | 13 | 2.26e-01 | 1.94e-01 | 5.51e-01 |
G beta:gamma signalling through PLC beta | 16 | 2.27e-01 | 1.75e-01 | 5.51e-01 |
EGFR downregulation | 29 | 2.27e-01 | 1.30e-01 | 5.51e-01 |
Other semaphorin interactions | 19 | 2.27e-01 | -1.60e-01 | 5.51e-01 |
Unwinding of DNA | 12 | 2.28e-01 | 2.01e-01 | 5.51e-01 |
PI3K events in ERBB2 signaling | 15 | 2.28e-01 | 1.80e-01 | 5.51e-01 |
Cyclin A:Cdk2-associated events at S phase entry | 78 | 2.28e-01 | -7.90e-02 | 5.51e-01 |
Transcriptional regulation by small RNAs | 47 | 2.29e-01 | -1.01e-01 | 5.53e-01 |
Signal transduction by L1 | 20 | 2.31e-01 | 1.55e-01 | 5.55e-01 |
Cellular hexose transport | 19 | 2.32e-01 | 1.58e-01 | 5.57e-01 |
Tryptophan catabolism | 14 | 2.32e-01 | 1.84e-01 | 5.57e-01 |
Signaling by ERBB2 KD Mutants | 21 | 2.33e-01 | 1.50e-01 | 5.57e-01 |
Chaperone Mediated Autophagy | 14 | 2.34e-01 | -1.84e-01 | 5.57e-01 |
Signaling by FGFR1 in disease | 35 | 2.34e-01 | 1.16e-01 | 5.57e-01 |
Oncogenic MAPK signaling | 74 | 2.34e-01 | 8.00e-02 | 5.57e-01 |
Removal of the Flap Intermediate from the C-strand | 16 | 2.34e-01 | 1.72e-01 | 5.57e-01 |
Glutamate Neurotransmitter Release Cycle | 23 | 2.34e-01 | 1.43e-01 | 5.57e-01 |
Synthesis of PA | 36 | 2.35e-01 | 1.14e-01 | 5.57e-01 |
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 11 | 2.36e-01 | 2.06e-01 | 5.58e-01 |
p38MAPK events | 12 | 2.37e-01 | -1.97e-01 | 5.58e-01 |
Activated point mutants of FGFR2 | 15 | 2.37e-01 | 1.77e-01 | 5.58e-01 |
Late Phase of HIV Life Cycle | 123 | 2.37e-01 | -6.18e-02 | 5.58e-01 |
Golgi-to-ER retrograde transport | 109 | 2.38e-01 | -6.55e-02 | 5.59e-01 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 25 | 2.40e-01 | -1.36e-01 | 5.64e-01 |
Polymerase switching on the C-strand of the telomere | 25 | 2.41e-01 | -1.36e-01 | 5.64e-01 |
Prefoldin mediated transfer of substrate to CCT/TriC | 22 | 2.41e-01 | -1.44e-01 | 5.64e-01 |
RNA Polymerase I Promoter Clearance | 49 | 2.42e-01 | -9.66e-02 | 5.64e-01 |
RNA Polymerase I Transcription | 49 | 2.42e-01 | -9.66e-02 | 5.64e-01 |
Thrombin signalling through proteinase activated receptors (PARs) | 24 | 2.42e-01 | 1.38e-01 | 5.64e-01 |
Na+/Cl- dependent neurotransmitter transporters | 17 | 2.45e-01 | 1.63e-01 | 5.68e-01 |
Nonhomologous End-Joining (NHEJ) | 33 | 2.46e-01 | -1.17e-01 | 5.68e-01 |
Deactivation of the beta-catenin transactivating complex | 35 | 2.46e-01 | 1.13e-01 | 5.68e-01 |
Protein-protein interactions at synapses | 83 | 2.46e-01 | 7.37e-02 | 5.68e-01 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models | 17 | 2.46e-01 | 1.62e-01 | 5.68e-01 |
Neurodegenerative Diseases | 17 | 2.46e-01 | 1.62e-01 | 5.68e-01 |
Aquaporin-mediated transport | 43 | 2.47e-01 | 1.02e-01 | 5.68e-01 |
Translesion Synthesis by POLH | 15 | 2.47e-01 | -1.72e-01 | 5.68e-01 |
B-WICH complex positively regulates rRNA expression | 32 | 2.48e-01 | -1.18e-01 | 5.68e-01 |
Non-integrin membrane-ECM interactions | 41 | 2.48e-01 | 1.04e-01 | 5.68e-01 |
Chaperonin-mediated protein folding | 82 | 2.50e-01 | 7.36e-02 | 5.71e-01 |
Golgi Cisternae Pericentriolar Stack Reorganization | 11 | 2.52e-01 | -1.99e-01 | 5.75e-01 |
IRS-mediated signalling | 42 | 2.52e-01 | 1.02e-01 | 5.75e-01 |
Cytosolic sensors of pathogen-associated DNA | 53 | 2.53e-01 | -9.08e-02 | 5.75e-01 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 37 | 2.53e-01 | 1.09e-01 | 5.75e-01 |
Golgi Associated Vesicle Biogenesis | 54 | 2.54e-01 | -8.98e-02 | 5.75e-01 |
Translesion synthesis by POLI | 15 | 2.58e-01 | -1.69e-01 | 5.84e-01 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 10 | 2.59e-01 | -2.06e-01 | 5.84e-01 |
Processive synthesis on the C-strand of the telomere | 18 | 2.59e-01 | 1.54e-01 | 5.84e-01 |
Endogenous sterols | 24 | 2.60e-01 | 1.33e-01 | 5.84e-01 |
Other interleukin signaling | 21 | 2.60e-01 | -1.42e-01 | 5.84e-01 |
Plasma lipoprotein clearance | 32 | 2.61e-01 | 1.15e-01 | 5.87e-01 |
Toll-like Receptor Cascades | 134 | 2.62e-01 | -5.62e-02 | 5.87e-01 |
Signaling by ERBB2 ECD mutants | 13 | 2.62e-01 | 1.80e-01 | 5.87e-01 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 48 | 2.62e-01 | -9.35e-02 | 5.87e-01 |
Diseases of programmed cell death | 23 | 2.63e-01 | 1.35e-01 | 5.87e-01 |
NOTCH1 Intracellular Domain Regulates Transcription | 41 | 2.64e-01 | -1.01e-01 | 5.88e-01 |
Growth hormone receptor signaling | 22 | 2.65e-01 | -1.37e-01 | 5.89e-01 |
Signaling by GPCR | 734 | 2.66e-01 | 2.42e-02 | 5.91e-01 |
Uptake and actions of bacterial toxins | 25 | 2.68e-01 | 1.28e-01 | 5.93e-01 |
Senescence-Associated Secretory Phenotype (SASP) | 47 | 2.71e-01 | -9.29e-02 | 5.98e-01 |
Negative regulation of MAPK pathway | 38 | 2.71e-01 | 1.03e-01 | 5.98e-01 |
Formation of the beta-catenin:TCF transactivating complex | 33 | 2.71e-01 | -1.11e-01 | 5.98e-01 |
NRAGE signals death through JNK | 54 | 2.71e-01 | 8.66e-02 | 5.98e-01 |
Downregulation of ERBB2 signaling | 24 | 2.73e-01 | 1.29e-01 | 5.98e-01 |
Signaling by NOTCH3 | 42 | 2.73e-01 | 9.78e-02 | 5.98e-01 |
Post-translational protein modification | 1214 | 2.75e-01 | -1.88e-02 | 5.98e-01 |
Insulin receptor signalling cascade | 47 | 2.75e-01 | 9.21e-02 | 5.98e-01 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 2.76e-01 | 1.01e-01 | 5.98e-01 |
ESR-mediated signaling | 153 | 2.76e-01 | 5.11e-02 | 5.98e-01 |
Thromboxane signalling through TP receptor | 18 | 2.76e-01 | 1.48e-01 | 5.98e-01 |
N-glycan antennae elongation in the medial/trans-Golgi | 21 | 2.76e-01 | 1.37e-01 | 5.98e-01 |
FRS-mediated FGFR3 signaling | 18 | 2.77e-01 | 1.48e-01 | 5.98e-01 |
HCMV Infection | 80 | 2.77e-01 | -7.03e-02 | 5.98e-01 |
Diseases associated with O-glycosylation of proteins | 56 | 2.78e-01 | -8.39e-02 | 5.98e-01 |
HS-GAG biosynthesis | 26 | 2.78e-01 | 1.23e-01 | 5.98e-01 |
Pre-NOTCH Transcription and Translation | 39 | 2.79e-01 | -1.00e-01 | 5.98e-01 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 2.79e-01 | 1.98e-01 | 5.98e-01 |
FGFR2c ligand binding and activation | 12 | 2.79e-01 | 1.80e-01 | 5.98e-01 |
G2/M Checkpoints | 120 | 2.80e-01 | -5.72e-02 | 5.98e-01 |
CRMPs in Sema3A signaling | 15 | 2.80e-01 | -1.61e-01 | 5.98e-01 |
Meiosis | 58 | 2.81e-01 | -8.19e-02 | 5.98e-01 |
HIV Transcription Initiation | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
RNA Polymerase II HIV Promoter Escape | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
RNA Polymerase II Promoter Escape | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
RNA Polymerase II Transcription Initiation | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 42 | 2.82e-01 | -9.60e-02 | 5.98e-01 |
SARS-CoV-1 Infection | 44 | 2.84e-01 | 9.34e-02 | 6.03e-01 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 22 | 2.86e-01 | 1.32e-01 | 6.04e-01 |
Developmental Biology | 826 | 2.86e-01 | -2.20e-02 | 6.04e-01 |
RA biosynthesis pathway | 16 | 2.87e-01 | -1.54e-01 | 6.06e-01 |
Diseases of carbohydrate metabolism | 26 | 2.88e-01 | 1.20e-01 | 6.07e-01 |
Nucleobase biosynthesis | 12 | 2.90e-01 | 1.76e-01 | 6.11e-01 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 170 | 2.91e-01 | -4.70e-02 | 6.12e-01 |
Host Interactions of HIV factors | 115 | 2.92e-01 | -5.69e-02 | 6.12e-01 |
Nuclear Events (kinase and transcription factor activation) | 57 | 2.94e-01 | -8.04e-02 | 6.12e-01 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
Signaling by RAS mutants | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
Signaling by moderate kinase activity BRAF mutants | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
Signaling downstream of RAS mutants | 39 | 2.94e-01 | -9.71e-02 | 6.12e-01 |
Transcriptional regulation by RUNX1 | 164 | 2.94e-01 | -4.75e-02 | 6.12e-01 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 2.95e-01 | 1.68e-01 | 6.12e-01 |
Metabolism of Angiotensinogen to Angiotensins | 17 | 2.96e-01 | 1.47e-01 | 6.12e-01 |
RAB GEFs exchange GTP for GDP on RABs | 84 | 2.96e-01 | 6.60e-02 | 6.12e-01 |
ERKs are inactivated | 11 | 2.96e-01 | 1.82e-01 | 6.12e-01 |
Signaling by KIT in disease | 19 | 2.97e-01 | -1.38e-01 | 6.12e-01 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 19 | 2.97e-01 | -1.38e-01 | 6.12e-01 |
N-Glycan antennae elongation | 13 | 2.98e-01 | 1.67e-01 | 6.13e-01 |
Signaling by FGFR in disease | 57 | 2.98e-01 | 7.96e-02 | 6.14e-01 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 2.99e-01 | 1.81e-01 | 6.14e-01 |
RIPK1-mediated regulated necrosis | 22 | 3.00e-01 | -1.28e-01 | 6.14e-01 |
Regulated Necrosis | 22 | 3.00e-01 | -1.28e-01 | 6.14e-01 |
Regulation of necroptotic cell death | 22 | 3.00e-01 | -1.28e-01 | 6.14e-01 |
Sema3A PAK dependent Axon repulsion | 15 | 3.01e-01 | -1.54e-01 | 6.14e-01 |
G alpha (z) signalling events | 44 | 3.02e-01 | 8.99e-02 | 6.16e-01 |
Hh mutants abrogate ligand secretion | 51 | 3.03e-01 | -8.34e-02 | 6.16e-01 |
Signaling by NODAL | 18 | 3.04e-01 | -1.40e-01 | 6.18e-01 |
CD209 (DC-SIGN) signaling | 18 | 3.06e-01 | -1.39e-01 | 6.21e-01 |
Regulation of TP53 Activity | 144 | 3.07e-01 | -4.94e-02 | 6.22e-01 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 21 | 3.08e-01 | 1.28e-01 | 6.24e-01 |
Signal amplification | 27 | 3.10e-01 | 1.13e-01 | 6.25e-01 |
Transcription of the HIV genome | 63 | 3.13e-01 | -7.35e-02 | 6.29e-01 |
Cilium Assembly | 175 | 3.14e-01 | 4.42e-02 | 6.29e-01 |
Downstream signaling of activated FGFR1 | 28 | 3.14e-01 | 1.10e-01 | 6.29e-01 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 25 | 3.15e-01 | -1.16e-01 | 6.29e-01 |
TP53 Regulates Metabolic Genes | 78 | 3.15e-01 | 6.59e-02 | 6.29e-01 |
PERK regulates gene expression | 30 | 3.15e-01 | -1.06e-01 | 6.29e-01 |
Formation of RNA Pol II elongation complex | 54 | 3.16e-01 | -7.90e-02 | 6.29e-01 |
RNA Polymerase II Transcription Elongation | 54 | 3.16e-01 | -7.90e-02 | 6.29e-01 |
G beta:gamma signalling through PI3Kgamma | 21 | 3.16e-01 | 1.26e-01 | 6.29e-01 |
TICAM1, RIP1-mediated IKK complex recruitment | 14 | 3.16e-01 | -1.55e-01 | 6.29e-01 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 3.16e-01 | 1.67e-01 | 6.29e-01 |
Suppression of phagosomal maturation | 11 | 3.18e-01 | -1.74e-01 | 6.31e-01 |
Telomere Maintenance | 65 | 3.18e-01 | -7.16e-02 | 6.31e-01 |
Assembly of the pre-replicative complex | 60 | 3.19e-01 | -7.45e-02 | 6.31e-01 |
Cellular response to heat stress | 90 | 3.20e-01 | 6.07e-02 | 6.32e-01 |
Cargo concentration in the ER | 29 | 3.20e-01 | -1.07e-01 | 6.32e-01 |
ISG15 antiviral mechanism | 66 | 3.21e-01 | -7.07e-02 | 6.32e-01 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 3.22e-01 | -1.43e-01 | 6.34e-01 |
Transcriptional regulation of white adipocyte differentiation | 79 | 3.23e-01 | -6.43e-02 | 6.36e-01 |
MASTL Facilitates Mitotic Progression | 10 | 3.25e-01 | -1.80e-01 | 6.39e-01 |
RNA Polymerase III Transcription Initiation | 32 | 3.26e-01 | -1.00e-01 | 6.39e-01 |
Synthesis of PE | 13 | 3.27e-01 | 1.57e-01 | 6.39e-01 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 18 | 3.28e-01 | -1.33e-01 | 6.39e-01 |
TBC/RABGAPs | 43 | 3.28e-01 | 8.63e-02 | 6.39e-01 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 86 | 3.28e-01 | -6.11e-02 | 6.39e-01 |
NCAM signaling for neurite out-growth | 50 | 3.28e-01 | 7.99e-02 | 6.40e-01 |
Neurotransmitter release cycle | 47 | 3.30e-01 | 8.22e-02 | 6.41e-01 |
Sulfur amino acid metabolism | 24 | 3.30e-01 | 1.15e-01 | 6.41e-01 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 3.31e-01 | -1.36e-01 | 6.42e-01 |
Cell-cell junction organization | 56 | 3.33e-01 | 7.48e-02 | 6.45e-01 |
Vesicle-mediated transport | 608 | 3.34e-01 | -2.31e-02 | 6.45e-01 |
Platelet degranulation | 120 | 3.34e-01 | 5.11e-02 | 6.45e-01 |
E3 ubiquitin ligases ubiquitinate target proteins | 40 | 3.36e-01 | -8.80e-02 | 6.47e-01 |
G alpha (i) signalling events | 331 | 3.38e-01 | 3.07e-02 | 6.51e-01 |
Regulation of PTEN stability and activity | 61 | 3.38e-01 | -7.09e-02 | 6.51e-01 |
Metabolism of amine-derived hormones | 15 | 3.39e-01 | -1.43e-01 | 6.51e-01 |
SHC-mediated cascade:FGFR1 | 18 | 3.40e-01 | 1.30e-01 | 6.51e-01 |
Zinc transporters | 15 | 3.41e-01 | -1.42e-01 | 6.51e-01 |
ADP signalling through P2Y purinoceptor 1 | 20 | 3.41e-01 | 1.23e-01 | 6.51e-01 |
RNA polymerase II transcribes snRNA genes | 68 | 3.41e-01 | -6.68e-02 | 6.51e-01 |
Synthesis of IP2, IP, and Ins in the cytosol | 13 | 3.42e-01 | 1.52e-01 | 6.51e-01 |
Glucose metabolism | 86 | 3.42e-01 | 5.93e-02 | 6.51e-01 |
Negative regulation of FGFR1 signaling | 26 | 3.45e-01 | 1.07e-01 | 6.56e-01 |
Regulation of IFNG signaling | 13 | 3.45e-01 | -1.51e-01 | 6.56e-01 |
SARS-CoV-2 Infection | 61 | 3.46e-01 | 6.98e-02 | 6.56e-01 |
Negative regulation of the PI3K/AKT network | 104 | 3.47e-01 | 5.34e-02 | 6.56e-01 |
mRNA Splicing - Major Pathway | 164 | 3.47e-01 | -4.26e-02 | 6.56e-01 |
Dermatan sulfate biosynthesis | 11 | 3.48e-01 | -1.64e-01 | 6.56e-01 |
Death Receptor Signalling | 125 | 3.48e-01 | 4.87e-02 | 6.56e-01 |
trans-Golgi Network Vesicle Budding | 69 | 3.48e-01 | -6.53e-02 | 6.56e-01 |
Formation of tubulin folding intermediates by CCT/TriC | 20 | 3.49e-01 | -1.21e-01 | 6.57e-01 |
GPCR ligand binding | 362 | 3.50e-01 | 2.87e-02 | 6.58e-01 |
RNA Polymerase II Transcription Termination | 61 | 3.51e-01 | -6.91e-02 | 6.58e-01 |
Presynaptic function of Kainate receptors | 17 | 3.51e-01 | 1.31e-01 | 6.58e-01 |
mRNA decay by 3’ to 5’ exoribonuclease | 15 | 3.51e-01 | -1.39e-01 | 6.58e-01 |
Postmitotic nuclear pore complex (NPC) reformation | 25 | 3.55e-01 | 1.07e-01 | 6.62e-01 |
Antimicrobial peptides | 48 | 3.55e-01 | 7.72e-02 | 6.62e-01 |
VEGFR2 mediated cell proliferation | 18 | 3.57e-01 | 1.25e-01 | 6.66e-01 |
Dual incision in TC-NER | 59 | 3.58e-01 | -6.92e-02 | 6.66e-01 |
FCGR3A-mediated IL10 synthesis | 50 | 3.59e-01 | -7.50e-02 | 6.66e-01 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 11 | 3.59e-01 | -1.60e-01 | 6.66e-01 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 13 | 3.59e-01 | 1.47e-01 | 6.66e-01 |
Defective EXT2 causes exostoses 2 | 13 | 3.59e-01 | 1.47e-01 | 6.66e-01 |
Cell death signalling via NRAGE, NRIF and NADE | 69 | 3.65e-01 | 6.31e-02 | 6.74e-01 |
Arachidonic acid metabolism | 51 | 3.65e-01 | 7.34e-02 | 6.74e-01 |
Negative regulation of MET activity | 19 | 3.66e-01 | -1.20e-01 | 6.76e-01 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 3.67e-01 | -1.65e-01 | 6.77e-01 |
GPCR downstream signalling | 670 | 3.69e-01 | 2.05e-02 | 6.79e-01 |
Interleukin-1 family signaling | 124 | 3.72e-01 | -4.65e-02 | 6.82e-01 |
Molecules associated with elastic fibres | 27 | 3.73e-01 | 9.91e-02 | 6.82e-01 |
Selective autophagy | 52 | 3.73e-01 | -7.14e-02 | 6.82e-01 |
HDACs deacetylate histones | 30 | 3.73e-01 | 9.39e-02 | 6.82e-01 |
Defects in vitamin and cofactor metabolism | 21 | 3.73e-01 | 1.12e-01 | 6.82e-01 |
Synthesis of PIPs at the late endosome membrane | 11 | 3.73e-01 | 1.55e-01 | 6.82e-01 |
Acetylcholine Neurotransmitter Release Cycle | 15 | 3.74e-01 | 1.33e-01 | 6.82e-01 |
Regulation of lipid metabolism by PPARalpha | 115 | 3.74e-01 | 4.80e-02 | 6.82e-01 |
HCMV Late Events | 52 | 3.78e-01 | -7.08e-02 | 6.87e-01 |
Folding of actin by CCT/TriC | 10 | 3.79e-01 | -1.61e-01 | 6.88e-01 |
Nicotinamide salvaging | 18 | 3.80e-01 | 1.20e-01 | 6.88e-01 |
Lysosome Vesicle Biogenesis | 33 | 3.81e-01 | 8.81e-02 | 6.91e-01 |
Axon guidance | 470 | 3.82e-01 | -2.36e-02 | 6.91e-01 |
TRP channels | 24 | 3.83e-01 | -1.03e-01 | 6.91e-01 |
Fanconi Anemia Pathway | 32 | 3.83e-01 | -8.92e-02 | 6.91e-01 |
DNA Replication Pre-Initiation | 76 | 3.84e-01 | -5.78e-02 | 6.91e-01 |
Activation of the pre-replicative complex | 32 | 3.84e-01 | 8.89e-02 | 6.91e-01 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 3.84e-01 | -7.95e-02 | 6.91e-01 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 3.86e-01 | -5.92e-02 | 6.93e-01 |
Regulation of commissural axon pathfinding by SLIT and ROBO | 10 | 3.87e-01 | 1.58e-01 | 6.93e-01 |
Apoptosis | 152 | 3.88e-01 | 4.06e-02 | 6.94e-01 |
Negative regulation of FGFR2 signaling | 28 | 3.88e-01 | 9.42e-02 | 6.94e-01 |
Protein ubiquitination | 59 | 3.89e-01 | -6.49e-02 | 6.94e-01 |
Homology Directed Repair | 92 | 3.90e-01 | -5.19e-02 | 6.94e-01 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 18 | 3.90e-01 | -1.17e-01 | 6.94e-01 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 3.90e-01 | 1.50e-01 | 6.94e-01 |
Asymmetric localization of PCP proteins | 53 | 3.91e-01 | -6.82e-02 | 6.94e-01 |
HDMs demethylate histones | 20 | 3.91e-01 | 1.11e-01 | 6.94e-01 |
eNOS activation | 10 | 3.91e-01 | 1.57e-01 | 6.94e-01 |
ABC transporter disorders | 69 | 3.93e-01 | -5.95e-02 | 6.95e-01 |
Glycogen synthesis | 13 | 3.93e-01 | -1.37e-01 | 6.96e-01 |
Passive transport by Aquaporins | 10 | 3.94e-01 | 1.56e-01 | 6.96e-01 |
SHC-mediated cascade:FGFR2 | 20 | 3.96e-01 | 1.10e-01 | 6.98e-01 |
Translation of structural proteins | 24 | 3.96e-01 | 1.00e-01 | 6.98e-01 |
Trafficking of GluR2-containing AMPA receptors | 17 | 3.98e-01 | -1.19e-01 | 6.98e-01 |
Oxidative Stress Induced Senescence | 59 | 3.98e-01 | -6.37e-02 | 6.98e-01 |
Caspase activation via Dependence Receptors in the absence of ligand | 10 | 3.98e-01 | -1.54e-01 | 6.98e-01 |
Negative regulation of FGFR4 signaling | 25 | 3.99e-01 | 9.74e-02 | 6.98e-01 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 39 | 4.00e-01 | -7.79e-02 | 6.98e-01 |
HIV Transcription Elongation | 39 | 4.00e-01 | -7.79e-02 | 6.98e-01 |
Tat-mediated elongation of the HIV-1 transcript | 39 | 4.00e-01 | -7.79e-02 | 6.98e-01 |
Clathrin-mediated endocytosis | 132 | 4.01e-01 | 4.24e-02 | 7.00e-01 |
G beta:gamma signalling through BTK | 14 | 4.03e-01 | 1.29e-01 | 7.02e-01 |
SHC-mediated cascade:FGFR4 | 17 | 4.03e-01 | 1.17e-01 | 7.02e-01 |
Activation of RAC1 | 13 | 4.06e-01 | -1.33e-01 | 7.06e-01 |
Acyl chain remodelling of PC | 24 | 4.09e-01 | 9.73e-02 | 7.10e-01 |
activated TAK1 mediates p38 MAPK activation | 17 | 4.10e-01 | 1.15e-01 | 7.11e-01 |
Processive synthesis on the lagging strand | 14 | 4.11e-01 | 1.27e-01 | 7.12e-01 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 13 | 4.14e-01 | -1.31e-01 | 7.15e-01 |
Deubiquitination | 217 | 4.14e-01 | -3.22e-02 | 7.15e-01 |
Formation of HIV elongation complex in the absence of HIV Tat | 41 | 4.15e-01 | -7.37e-02 | 7.15e-01 |
Regulation of PTEN gene transcription | 54 | 4.15e-01 | 6.41e-02 | 7.16e-01 |
Reproduction | 77 | 4.18e-01 | -5.34e-02 | 7.17e-01 |
Activation of BH3-only proteins | 26 | 4.18e-01 | 9.17e-02 | 7.17e-01 |
Recruitment of NuMA to mitotic centrosomes | 73 | 4.19e-01 | 5.47e-02 | 7.17e-01 |
Signaling by ERBB2 TMD/JMD mutants | 18 | 4.20e-01 | 1.10e-01 | 7.17e-01 |
Downstream signaling of activated FGFR2 | 27 | 4.20e-01 | 8.97e-02 | 7.17e-01 |
Regulation of TLR by endogenous ligand | 15 | 4.20e-01 | -1.20e-01 | 7.17e-01 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 16 | 4.20e-01 | 1.16e-01 | 7.17e-01 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 16 | 4.20e-01 | 1.16e-01 | 7.17e-01 |
Hedgehog ligand biogenesis | 56 | 4.21e-01 | -6.21e-02 | 7.18e-01 |
Acyl chain remodelling of PI | 15 | 4.24e-01 | 1.19e-01 | 7.20e-01 |
Activation of SMO | 16 | 4.24e-01 | -1.15e-01 | 7.20e-01 |
Iron uptake and transport | 50 | 4.24e-01 | 6.53e-02 | 7.20e-01 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 10 | 4.25e-01 | -1.46e-01 | 7.20e-01 |
FOXO-mediated transcription of cell cycle genes | 16 | 4.25e-01 | -1.15e-01 | 7.20e-01 |
Chondroitin sulfate/dermatan sulfate metabolism | 46 | 4.27e-01 | 6.77e-02 | 7.23e-01 |
Voltage gated Potassium channels | 39 | 4.28e-01 | 7.34e-02 | 7.23e-01 |
NCAM1 interactions | 31 | 4.28e-01 | 8.22e-02 | 7.23e-01 |
Constitutive Signaling by EGFRvIII | 13 | 4.31e-01 | 1.26e-01 | 7.25e-01 |
Signaling by EGFRvIII in Cancer | 13 | 4.31e-01 | 1.26e-01 | 7.25e-01 |
Downstream signaling of activated FGFR4 | 24 | 4.33e-01 | 9.26e-02 | 7.25e-01 |
GABA receptor activation | 52 | 4.33e-01 | 6.29e-02 | 7.25e-01 |
Glucagon signaling in metabolic regulation | 29 | 4.33e-01 | 8.41e-02 | 7.25e-01 |
Programmed Cell Death | 162 | 4.33e-01 | 3.57e-02 | 7.25e-01 |
G1/S Transition | 122 | 4.33e-01 | -4.11e-02 | 7.25e-01 |
CS/DS degradation | 12 | 4.35e-01 | 1.30e-01 | 7.27e-01 |
Signaling by FGFR4 | 34 | 4.36e-01 | 7.72e-02 | 7.27e-01 |
TP53 Regulates Transcription of DNA Repair Genes | 55 | 4.36e-01 | -6.07e-02 | 7.27e-01 |
Telomere C-strand synthesis initiation | 13 | 4.39e-01 | -1.24e-01 | 7.31e-01 |
Vasopressin regulates renal water homeostasis via Aquaporins | 37 | 4.40e-01 | 7.34e-02 | 7.31e-01 |
Signaling by FGFR2 in disease | 38 | 4.40e-01 | 7.23e-02 | 7.32e-01 |
TRAF6 mediated NF-kB activation | 19 | 4.41e-01 | 1.02e-01 | 7.32e-01 |
Signalling to RAS | 18 | 4.44e-01 | -1.04e-01 | 7.35e-01 |
CD28 dependent PI3K/Akt signaling | 21 | 4.44e-01 | 9.65e-02 | 7.35e-01 |
Mitotic Prophase | 80 | 4.45e-01 | -4.94e-02 | 7.35e-01 |
CD28 co-stimulation | 32 | 4.45e-01 | -7.80e-02 | 7.35e-01 |
Gap junction trafficking | 24 | 4.46e-01 | 9.00e-02 | 7.35e-01 |
Gap junction trafficking and regulation | 26 | 4.47e-01 | 8.61e-02 | 7.35e-01 |
Formation of the Early Elongation Complex | 31 | 4.47e-01 | -7.89e-02 | 7.35e-01 |
Formation of the HIV-1 Early Elongation Complex | 31 | 4.47e-01 | -7.89e-02 | 7.35e-01 |
Acyl chain remodelling of PG | 16 | 4.48e-01 | 1.10e-01 | 7.35e-01 |
Cell recruitment (pro-inflammatory response) | 23 | 4.49e-01 | -9.12e-02 | 7.36e-01 |
Purinergic signaling in leishmaniasis infection | 23 | 4.49e-01 | -9.12e-02 | 7.36e-01 |
Regulation of IFNA signaling | 11 | 4.51e-01 | 1.31e-01 | 7.39e-01 |
Autophagy | 116 | 4.52e-01 | -4.04e-02 | 7.39e-01 |
RHO GTPases Activate WASPs and WAVEs | 34 | 4.53e-01 | 7.43e-02 | 7.39e-01 |
ERBB2 Regulates Cell Motility | 14 | 4.54e-01 | 1.16e-01 | 7.39e-01 |
SUMOylation of transcription cofactors | 41 | 4.55e-01 | 6.75e-02 | 7.39e-01 |
RNA Polymerase III Chain Elongation | 14 | 4.56e-01 | -1.15e-01 | 7.39e-01 |
Integrin cell surface interactions | 60 | 4.56e-01 | 5.57e-02 | 7.39e-01 |
IRAK4 deficiency (TLR2/4) | 10 | 4.56e-01 | -1.36e-01 | 7.39e-01 |
Signaling by FGFR4 in disease | 10 | 4.56e-01 | 1.36e-01 | 7.39e-01 |
EPH-Ephrin signaling | 88 | 4.57e-01 | 4.59e-02 | 7.40e-01 |
Activated NTRK2 signals through FRS2 and FRS3 | 10 | 4.58e-01 | -1.36e-01 | 7.40e-01 |
Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 4.60e-01 | 1.14e-01 | 7.43e-01 |
Aggrephagy | 18 | 4.62e-01 | -1.00e-01 | 7.46e-01 |
Transport of Mature Transcript to Cytoplasm | 80 | 4.63e-01 | -4.75e-02 | 7.46e-01 |
Norepinephrine Neurotransmitter Release Cycle | 17 | 4.65e-01 | 1.02e-01 | 7.49e-01 |
Signaling by WNT | 243 | 4.67e-01 | 2.71e-02 | 7.50e-01 |
Mitotic G1 phase and G1/S transition | 137 | 4.68e-01 | -3.60e-02 | 7.50e-01 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 12 | 4.69e-01 | 1.21e-01 | 7.50e-01 |
Membrane Trafficking | 561 | 4.70e-01 | -1.79e-02 | 7.50e-01 |
Regulation of RUNX1 Expression and Activity | 18 | 4.71e-01 | -9.82e-02 | 7.50e-01 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 71 | 4.71e-01 | -4.95e-02 | 7.50e-01 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 59 | 4.71e-01 | -5.43e-02 | 7.50e-01 |
G beta:gamma signalling through CDC42 | 16 | 4.72e-01 | 1.04e-01 | 7.50e-01 |
Blood group systems biosynthesis | 17 | 4.72e-01 | 1.01e-01 | 7.50e-01 |
Nucleotide-like (purinergic) receptors | 13 | 4.73e-01 | 1.15e-01 | 7.50e-01 |
Activated NOTCH1 Transmits Signal to the Nucleus | 29 | 4.73e-01 | 7.70e-02 | 7.50e-01 |
Peptide ligand-binding receptors | 150 | 4.74e-01 | 3.39e-02 | 7.50e-01 |
NOTCH3 Intracellular Domain Regulates Transcription | 21 | 4.75e-01 | 9.01e-02 | 7.50e-01 |
Centrosome maturation | 74 | 4.75e-01 | 4.81e-02 | 7.50e-01 |
Recruitment of mitotic centrosome proteins and complexes | 74 | 4.75e-01 | 4.81e-02 | 7.50e-01 |
Loss of Nlp from mitotic centrosomes | 65 | 4.75e-01 | 5.12e-02 | 7.50e-01 |
Loss of proteins required for interphase microtubule organization from the centrosome | 65 | 4.75e-01 | 5.12e-02 | 7.50e-01 |
Interactions of Rev with host cellular proteins | 35 | 4.77e-01 | 6.94e-02 | 7.52e-01 |
Interferon alpha/beta signaling | 49 | 4.79e-01 | 5.85e-02 | 7.52e-01 |
MyD88 cascade initiated on plasma membrane | 73 | 4.79e-01 | 4.79e-02 | 7.52e-01 |
Toll Like Receptor 10 (TLR10) Cascade | 73 | 4.79e-01 | 4.79e-02 | 7.52e-01 |
Toll Like Receptor 5 (TLR5) Cascade | 73 | 4.79e-01 | 4.79e-02 | 7.52e-01 |
DCC mediated attractive signaling | 14 | 4.80e-01 | 1.09e-01 | 7.52e-01 |
MECP2 regulates neuronal receptors and channels | 16 | 4.80e-01 | 1.02e-01 | 7.52e-01 |
Semaphorin interactions | 61 | 4.80e-01 | 5.23e-02 | 7.52e-01 |
MET activates RAS signaling | 10 | 4.82e-01 | -1.28e-01 | 7.53e-01 |
Deadenylation of mRNA | 20 | 4.82e-01 | 9.07e-02 | 7.53e-01 |
AURKA Activation by TPX2 | 68 | 4.85e-01 | 4.90e-02 | 7.57e-01 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 4.86e-01 | 9.24e-02 | 7.57e-01 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 34 | 4.87e-01 | -6.89e-02 | 7.58e-01 |
Meiotic synapsis | 33 | 4.89e-01 | -6.96e-02 | 7.60e-01 |
MAP2K and MAPK activation | 36 | 4.91e-01 | -6.64e-02 | 7.62e-01 |
Synthesis of very long-chain fatty acyl-CoAs | 24 | 4.92e-01 | 8.10e-02 | 7.64e-01 |
Role of LAT2/NTAL/LAB on calcium mobilization | 25 | 4.94e-01 | -7.90e-02 | 7.65e-01 |
Complement cascade | 57 | 4.95e-01 | -5.23e-02 | 7.66e-01 |
Phase 4 - resting membrane potential | 16 | 4.95e-01 | -9.85e-02 | 7.66e-01 |
Apoptosis induced DNA fragmentation | 11 | 4.98e-01 | 1.18e-01 | 7.69e-01 |
Positive epigenetic regulation of rRNA expression | 45 | 5.00e-01 | -5.81e-02 | 7.70e-01 |
CREB1 phosphorylation through the activation of Adenylate Cyclase | 11 | 5.00e-01 | -1.17e-01 | 7.70e-01 |
Resolution of Abasic Sites (AP sites) | 37 | 5.03e-01 | 6.37e-02 | 7.72e-01 |
NF-kB is activated and signals survival | 10 | 5.03e-01 | 1.22e-01 | 7.72e-01 |
tRNA processing in the nucleus | 53 | 5.03e-01 | -5.32e-02 | 7.72e-01 |
Vitamin D (calciferol) metabolism | 10 | 5.04e-01 | -1.22e-01 | 7.72e-01 |
Cyclin D associated events in G1 | 41 | 5.05e-01 | -6.03e-02 | 7.72e-01 |
G1 Phase | 41 | 5.05e-01 | -6.03e-02 | 7.72e-01 |
PIWI-interacting RNA (piRNA) biogenesis | 26 | 5.05e-01 | -7.56e-02 | 7.72e-01 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 16 | 5.06e-01 | -9.61e-02 | 7.73e-01 |
Nuclear Pore Complex (NPC) Disassembly | 34 | 5.07e-01 | -6.57e-02 | 7.74e-01 |
Creatine metabolism | 10 | 5.09e-01 | -1.21e-01 | 7.76e-01 |
Serotonin Neurotransmitter Release Cycle | 17 | 5.11e-01 | 9.21e-02 | 7.78e-01 |
Signaling by ERBB4 | 52 | 5.12e-01 | -5.25e-02 | 7.78e-01 |
Keratan sulfate biosynthesis | 25 | 5.13e-01 | -7.57e-02 | 7.78e-01 |
HDR through Homologous Recombination (HRR) | 60 | 5.13e-01 | -4.88e-02 | 7.78e-01 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 12 | 5.13e-01 | -1.09e-01 | 7.78e-01 |
PPARA activates gene expression | 113 | 5.14e-01 | 3.56e-02 | 7.79e-01 |
Signaling by Receptor Tyrosine Kinases | 449 | 5.15e-01 | 1.80e-02 | 7.79e-01 |
Dual Incision in GG-NER | 37 | 5.16e-01 | -6.17e-02 | 7.80e-01 |
RNA Polymerase I Transcription Initiation | 44 | 5.17e-01 | -5.65e-02 | 7.80e-01 |
Class A/1 (Rhodopsin-like receptors) | 255 | 5.17e-01 | 2.36e-02 | 7.80e-01 |
Amine ligand-binding receptors | 35 | 5.18e-01 | 6.32e-02 | 7.80e-01 |
Interferon Signaling | 159 | 5.19e-01 | -2.97e-02 | 7.80e-01 |
Striated Muscle Contraction | 31 | 5.19e-01 | -6.69e-02 | 7.80e-01 |
Diseases of signal transduction by growth factor receptors and second messengers | 347 | 5.19e-01 | 2.02e-02 | 7.80e-01 |
Role of phospholipids in phagocytosis | 36 | 5.20e-01 | -6.20e-02 | 7.80e-01 |
Metabolism of nucleotides | 89 | 5.21e-01 | 3.94e-02 | 7.81e-01 |
Post-translational modification: synthesis of GPI-anchored proteins | 75 | 5.22e-01 | 4.27e-02 | 7.81e-01 |
Glycogen storage diseases | 12 | 5.23e-01 | 1.07e-01 | 7.81e-01 |
Glycosaminoglycan metabolism | 108 | 5.23e-01 | 3.56e-02 | 7.81e-01 |
Signaling by BMP | 25 | 5.24e-01 | 7.36e-02 | 7.82e-01 |
mRNA 3’-end processing | 54 | 5.25e-01 | -5.00e-02 | 7.82e-01 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 24 | 5.25e-01 | -7.49e-02 | 7.82e-01 |
Transmission across Chemical Synapses | 221 | 5.27e-01 | 2.47e-02 | 7.84e-01 |
Vitamin B5 (pantothenate) metabolism | 14 | 5.28e-01 | 9.74e-02 | 7.85e-01 |
Interleukin-15 signaling | 13 | 5.31e-01 | 1.00e-01 | 7.88e-01 |
EPHB-mediated forward signaling | 33 | 5.32e-01 | -6.28e-02 | 7.89e-01 |
Regulation of innate immune responses to cytosolic DNA | 12 | 5.35e-01 | -1.03e-01 | 7.91e-01 |
Signaling by NOTCH | 169 | 5.36e-01 | -2.76e-02 | 7.91e-01 |
Platelet activation, signaling and aggregation | 240 | 5.36e-01 | 2.32e-02 | 7.91e-01 |
Stimuli-sensing channels | 94 | 5.37e-01 | -3.69e-02 | 7.91e-01 |
Disorders of transmembrane transporters | 161 | 5.37e-01 | 2.82e-02 | 7.91e-01 |
Formation of the cornified envelope | 33 | 5.37e-01 | 6.21e-02 | 7.91e-01 |
Effects of PIP2 hydrolysis | 26 | 5.38e-01 | 6.97e-02 | 7.92e-01 |
Association of TriC/CCT with target proteins during biosynthesis | 38 | 5.39e-01 | 5.76e-02 | 7.92e-01 |
Elastic fibre formation | 37 | 5.41e-01 | -5.81e-02 | 7.92e-01 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 29 | 5.41e-01 | 6.56e-02 | 7.92e-01 |
ZBP1(DAI) mediated induction of type I IFNs | 19 | 5.41e-01 | 8.10e-02 | 7.92e-01 |
Activation of Ca-permeable Kainate Receptor | 10 | 5.41e-01 | -1.12e-01 | 7.92e-01 |
Ionotropic activity of kainate receptors | 10 | 5.41e-01 | -1.12e-01 | 7.92e-01 |
Fatty acyl-CoA biosynthesis | 35 | 5.42e-01 | 5.95e-02 | 7.92e-01 |
Glutamate and glutamine metabolism | 12 | 5.46e-01 | 1.01e-01 | 7.96e-01 |
p75NTR recruits signalling complexes | 11 | 5.47e-01 | -1.05e-01 | 7.98e-01 |
Elevation of cytosolic Ca2+ levels | 15 | 5.48e-01 | 8.96e-02 | 7.98e-01 |
Rho GTPase cycle | 129 | 5.49e-01 | 3.06e-02 | 7.99e-01 |
Factors involved in megakaryocyte development and platelet production | 110 | 5.49e-01 | 3.31e-02 | 7.99e-01 |
Telomere Extension By Telomerase | 22 | 5.51e-01 | 7.35e-02 | 8.00e-01 |
Interleukin-6 signaling | 10 | 5.56e-01 | 1.08e-01 | 8.06e-01 |
COPI-dependent Golgi-to-ER retrograde traffic | 77 | 5.57e-01 | -3.87e-02 | 8.07e-01 |
Carnitine metabolism | 11 | 5.58e-01 | 1.02e-01 | 8.07e-01 |
Killing mechanisms | 12 | 5.59e-01 | 9.74e-02 | 8.07e-01 |
WNT5:FZD7-mediated leishmania damping | 12 | 5.59e-01 | 9.74e-02 | 8.07e-01 |
Processing of Capped Intronless Pre-mRNA | 24 | 5.59e-01 | -6.89e-02 | 8.07e-01 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 5.60e-01 | 1.01e-01 | 8.07e-01 |
Nicotinate metabolism | 30 | 5.61e-01 | 6.14e-02 | 8.07e-01 |
Ion transport by P-type ATPases | 49 | 5.66e-01 | 4.75e-02 | 8.09e-01 |
EPH-ephrin mediated repulsion of cells | 47 | 5.66e-01 | 4.84e-02 | 8.09e-01 |
Pausing and recovery of Tat-mediated HIV elongation | 27 | 5.66e-01 | -6.39e-02 | 8.09e-01 |
Tat-mediated HIV elongation arrest and recovery | 27 | 5.66e-01 | -6.39e-02 | 8.09e-01 |
Regulation of TP53 Activity through Acetylation | 28 | 5.67e-01 | 6.25e-02 | 8.09e-01 |
Activation of G protein gated Potassium channels | 22 | 5.67e-01 | 7.05e-02 | 8.09e-01 |
G protein gated Potassium channels | 22 | 5.67e-01 | 7.05e-02 | 8.09e-01 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 22 | 5.67e-01 | 7.05e-02 | 8.09e-01 |
Activation of kainate receptors upon glutamate binding | 26 | 5.69e-01 | 6.46e-02 | 8.09e-01 |
Integrin signaling | 27 | 5.69e-01 | -6.33e-02 | 8.09e-01 |
Regulation of gene expression by Hypoxia-inducible Factor | 11 | 5.69e-01 | 9.91e-02 | 8.09e-01 |
Nervous system development | 491 | 5.71e-01 | -1.50e-02 | 8.09e-01 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 21 | 5.71e-01 | -7.15e-02 | 8.09e-01 |
Signaling by NOTCH2 | 28 | 5.72e-01 | 6.18e-02 | 8.09e-01 |
Anti-inflammatory response favouring Leishmania parasite infection | 151 | 5.72e-01 | -2.66e-02 | 8.09e-01 |
Leishmania parasite growth and survival | 151 | 5.72e-01 | -2.66e-02 | 8.09e-01 |
Lewis blood group biosynthesis | 13 | 5.73e-01 | 9.04e-02 | 8.09e-01 |
Toll Like Receptor 9 (TLR9) Cascade | 81 | 5.73e-01 | 3.63e-02 | 8.09e-01 |
Gastrin-CREB signalling pathway via PKC and MAPK | 15 | 5.73e-01 | -8.41e-02 | 8.09e-01 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 23 | 5.73e-01 | 6.79e-02 | 8.09e-01 |
Regulation of PLK1 Activity at G2/M Transition | 80 | 5.79e-01 | 3.59e-02 | 8.16e-01 |
WNT5A-dependent internalization of FZD4 | 14 | 5.79e-01 | 8.56e-02 | 8.16e-01 |
Nuclear signaling by ERBB4 | 29 | 5.81e-01 | 5.92e-02 | 8.17e-01 |
Removal of the Flap Intermediate | 13 | 5.84e-01 | 8.77e-02 | 8.18e-01 |
HIV elongation arrest and recovery | 29 | 5.84e-01 | -5.88e-02 | 8.18e-01 |
Pausing and recovery of HIV elongation | 29 | 5.84e-01 | -5.88e-02 | 8.18e-01 |
Misspliced GSK3beta mutants stabilize beta-catenin | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
S33 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
S37 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
S45 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
T41 mutants of beta-catenin aren’t phosphorylated | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 13 | 5.86e-01 | 8.72e-02 | 8.18e-01 |
FGFR2 mutant receptor activation | 29 | 5.88e-01 | 5.81e-02 | 8.18e-01 |
Negative epigenetic regulation of rRNA expression | 51 | 5.88e-01 | 4.38e-02 | 8.18e-01 |
Phase 2 - plateau phase | 12 | 5.88e-01 | 9.03e-02 | 8.18e-01 |
Base-Excision Repair, AP Site Formation | 20 | 5.89e-01 | 6.97e-02 | 8.18e-01 |
MyD88 dependent cascade initiated on endosome | 77 | 5.91e-01 | 3.54e-02 | 8.20e-01 |
Transcriptional regulation of pluripotent stem cells | 27 | 5.92e-01 | -5.97e-02 | 8.20e-01 |
Metabolism of folate and pterines | 17 | 5.92e-01 | -7.51e-02 | 8.20e-01 |
Diseases of glycosylation | 126 | 5.93e-01 | -2.76e-02 | 8.20e-01 |
Inflammasomes | 19 | 5.96e-01 | -7.02e-02 | 8.24e-01 |
Prostacyclin signalling through prostacyclin receptor | 15 | 5.97e-01 | 7.89e-02 | 8.24e-01 |
Rev-mediated nuclear export of HIV RNA | 33 | 5.97e-01 | 5.32e-02 | 8.24e-01 |
NR1H2 and NR1H3-mediated signaling | 48 | 5.98e-01 | 4.40e-02 | 8.24e-01 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 21 | 6.00e-01 | -6.62e-02 | 8.25e-01 |
Cholesterol biosynthesis | 21 | 6.00e-01 | 6.61e-02 | 8.25e-01 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 12 | 6.02e-01 | -8.70e-02 | 8.26e-01 |
Telomere C-strand (Lagging Strand) Synthesis | 33 | 6.02e-01 | -5.24e-02 | 8.26e-01 |
Adenylate cyclase activating pathway | 10 | 6.04e-01 | 9.47e-02 | 8.28e-01 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 97 | 6.05e-01 | 3.04e-02 | 8.28e-01 |
O-linked glycosylation | 90 | 6.06e-01 | -3.15e-02 | 8.29e-01 |
TP53 Regulates Transcription of Cell Death Genes | 34 | 6.06e-01 | -5.11e-02 | 8.29e-01 |
Activation of gene expression by SREBF (SREBP) | 40 | 6.07e-01 | 4.70e-02 | 8.29e-01 |
RAF activation | 31 | 6.11e-01 | -5.28e-02 | 8.33e-01 |
Signaling by FGFR2 IIIa TM | 17 | 6.11e-01 | -7.12e-02 | 8.33e-01 |
HSF1 activation | 24 | 6.13e-01 | 5.97e-02 | 8.34e-01 |
Regulation of PTEN mRNA translation | 19 | 6.14e-01 | -6.69e-02 | 8.35e-01 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
Toll Like Receptor 2 (TLR2) Cascade | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
Toll Like Receptor TLR1:TLR2 Cascade | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
Toll Like Receptor TLR6:TLR2 Cascade | 83 | 6.17e-01 | 3.17e-02 | 8.35e-01 |
Signaling by PDGFRA extracellular domain mutants | 10 | 6.18e-01 | 9.12e-02 | 8.35e-01 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 10 | 6.18e-01 | 9.12e-02 | 8.35e-01 |
HDR through Single Strand Annealing (SSA) | 35 | 6.19e-01 | -4.86e-02 | 8.36e-01 |
Repression of WNT target genes | 14 | 6.21e-01 | 7.63e-02 | 8.38e-01 |
Chemokine receptors bind chemokines | 41 | 6.21e-01 | 4.46e-02 | 8.38e-01 |
Termination of translesion DNA synthesis | 27 | 6.22e-01 | 5.48e-02 | 8.39e-01 |
FRS-mediated FGFR1 signaling | 20 | 6.24e-01 | 6.34e-02 | 8.40e-01 |
NoRC negatively regulates rRNA expression | 48 | 6.25e-01 | 4.08e-02 | 8.40e-01 |
Epigenetic regulation of gene expression | 87 | 6.29e-01 | 3.00e-02 | 8.43e-01 |
Peptide hormone metabolism | 81 | 6.29e-01 | -3.11e-02 | 8.43e-01 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 53 | 6.29e-01 | 3.83e-02 | 8.43e-01 |
G alpha (s) signalling events | 195 | 6.32e-01 | -1.99e-02 | 8.43e-01 |
Infection with Mycobacterium tuberculosis | 24 | 6.32e-01 | -5.65e-02 | 8.43e-01 |
Acyl chain remodelling of PE | 25 | 6.32e-01 | 5.53e-02 | 8.43e-01 |
NRIF signals cell death from the nucleus | 14 | 6.32e-01 | -7.39e-02 | 8.43e-01 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 39 | 6.33e-01 | -4.42e-02 | 8.43e-01 |
Interleukin-20 family signaling | 16 | 6.34e-01 | -6.88e-02 | 8.43e-01 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 76 | 6.34e-01 | 3.16e-02 | 8.43e-01 |
Transcriptional Regulation by TP53 | 325 | 6.34e-01 | -1.54e-02 | 8.43e-01 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 16 | 6.36e-01 | -6.84e-02 | 8.45e-01 |
MET activates RAP1 and RAC1 | 11 | 6.36e-01 | 8.23e-02 | 8.45e-01 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 78 | 6.38e-01 | 3.09e-02 | 8.46e-01 |
Syndecan interactions | 19 | 6.38e-01 | 6.23e-02 | 8.46e-01 |
Regulation of signaling by CBL | 17 | 6.40e-01 | -6.55e-02 | 8.48e-01 |
Signaling by EGFR in Cancer | 21 | 6.44e-01 | 5.83e-02 | 8.52e-01 |
BBSome-mediated cargo-targeting to cilium | 21 | 6.46e-01 | -5.79e-02 | 8.54e-01 |
Class B/2 (Secretin family receptors) | 78 | 6.48e-01 | 3.00e-02 | 8.55e-01 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 19 | 6.49e-01 | 6.04e-02 | 8.56e-01 |
The role of Nef in HIV-1 replication and disease pathogenesis | 26 | 6.51e-01 | 5.13e-02 | 8.57e-01 |
Listeria monocytogenes entry into host cells | 18 | 6.51e-01 | 6.15e-02 | 8.57e-01 |
DNA strand elongation | 31 | 6.52e-01 | 4.68e-02 | 8.57e-01 |
Regulation of Complement cascade | 49 | 6.52e-01 | -3.73e-02 | 8.57e-01 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 30 | 6.52e-01 | 4.76e-02 | 8.57e-01 |
Organic cation/anion/zwitterion transport | 12 | 6.53e-01 | 7.49e-02 | 8.57e-01 |
Signaling by Hippo | 20 | 6.54e-01 | 5.79e-02 | 8.57e-01 |
Inwardly rectifying K+ channels | 28 | 6.55e-01 | 4.88e-02 | 8.57e-01 |
G2/M Transition | 165 | 6.56e-01 | -2.01e-02 | 8.57e-01 |
Synthesis of PC | 28 | 6.56e-01 | 4.87e-02 | 8.57e-01 |
Transport of the SLBP Dependant Mature mRNA | 35 | 6.57e-01 | -4.34e-02 | 8.58e-01 |
Mitotic G2-G2/M phases | 167 | 6.58e-01 | -1.99e-02 | 8.58e-01 |
TP53 Regulates Transcription of Cell Cycle Genes | 47 | 6.62e-01 | 3.68e-02 | 8.63e-01 |
ERK/MAPK targets | 20 | 6.64e-01 | 5.61e-02 | 8.65e-01 |
Unfolded Protein Response (UPR) | 89 | 6.65e-01 | 2.66e-02 | 8.65e-01 |
Interleukin-2 family signaling | 38 | 6.65e-01 | -4.06e-02 | 8.65e-01 |
MET promotes cell motility | 28 | 6.68e-01 | 4.69e-02 | 8.67e-01 |
Ca2+ pathway | 54 | 6.71e-01 | 3.35e-02 | 8.70e-01 |
Amyloid fiber formation | 48 | 6.72e-01 | 3.54e-02 | 8.71e-01 |
Diseases associated with glycosylation precursor biosynthesis | 17 | 6.74e-01 | 5.89e-02 | 8.73e-01 |
Interleukin-6 family signaling | 23 | 6.75e-01 | 5.05e-02 | 8.73e-01 |
Physiological factors | 12 | 6.76e-01 | 6.98e-02 | 8.73e-01 |
Glutathione synthesis and recycling | 11 | 6.76e-01 | 7.27e-02 | 8.73e-01 |
Antiviral mechanism by IFN-stimulated genes | 74 | 6.78e-01 | -2.80e-02 | 8.74e-01 |
Interleukin-35 Signalling | 11 | 6.78e-01 | 7.23e-02 | 8.74e-01 |
Beta-catenin phosphorylation cascade | 15 | 6.79e-01 | 6.18e-02 | 8.74e-01 |
FRS-mediated FGFR2 signaling | 22 | 6.79e-01 | 5.10e-02 | 8.74e-01 |
Termination of O-glycan biosynthesis | 14 | 6.80e-01 | 6.37e-02 | 8.74e-01 |
MicroRNA (miRNA) biogenesis | 22 | 6.85e-01 | -5.00e-02 | 8.80e-01 |
PCP/CE pathway | 80 | 6.85e-01 | -2.62e-02 | 8.80e-01 |
Recognition of DNA damage by PCNA-containing replication complex | 27 | 6.87e-01 | -4.48e-02 | 8.80e-01 |
Signaling by BRAF and RAF fusions | 59 | 6.88e-01 | 3.02e-02 | 8.80e-01 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 22 | 6.88e-01 | -4.95e-02 | 8.80e-01 |
Downregulation of ERBB2:ERBB3 signaling | 11 | 6.88e-01 | 6.98e-02 | 8.80e-01 |
Erythropoietin activates RAS | 13 | 6.91e-01 | 6.37e-02 | 8.81e-01 |
Response to elevated platelet cytosolic Ca2+ | 125 | 6.91e-01 | 2.06e-02 | 8.81e-01 |
Interleukin-1 signaling | 89 | 6.92e-01 | -2.43e-02 | 8.81e-01 |
Detoxification of Reactive Oxygen Species | 32 | 6.92e-01 | 4.05e-02 | 8.81e-01 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 17 | 6.92e-01 | -5.54e-02 | 8.81e-01 |
Signaling by NOTCH1 | 67 | 6.93e-01 | -2.79e-02 | 8.82e-01 |
Insulin processing | 25 | 6.94e-01 | -4.55e-02 | 8.82e-01 |
NS1 Mediated Effects on Host Pathways | 39 | 6.95e-01 | -3.63e-02 | 8.82e-01 |
ERBB2 Activates PTK6 Signaling | 12 | 6.95e-01 | 6.53e-02 | 8.82e-01 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 6.97e-01 | 4.04e-02 | 8.83e-01 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 6.97e-01 | 4.04e-02 | 8.83e-01 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 28 | 6.99e-01 | -4.22e-02 | 8.84e-01 |
Signaling by NTRK3 (TRKC) | 16 | 7.01e-01 | 5.55e-02 | 8.86e-01 |
Lagging Strand Synthesis | 19 | 7.02e-01 | -5.07e-02 | 8.86e-01 |
Platelet Adhesion to exposed collagen | 12 | 7.04e-01 | 6.35e-02 | 8.87e-01 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 15 | 7.04e-01 | 5.66e-02 | 8.87e-01 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 15 | 7.04e-01 | 5.66e-02 | 8.87e-01 |
DSCAM interactions | 11 | 7.06e-01 | -6.57e-02 | 8.88e-01 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 21 | 7.06e-01 | 4.75e-02 | 8.88e-01 |
Digestion and absorption | 20 | 7.07e-01 | -4.85e-02 | 8.88e-01 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 51 | 7.07e-01 | -3.04e-02 | 8.88e-01 |
Interleukin-27 signaling | 11 | 7.08e-01 | 6.52e-02 | 8.88e-01 |
Oncogene Induced Senescence | 28 | 7.09e-01 | -4.07e-02 | 8.88e-01 |
Synthesis of substrates in N-glycan biosythesis | 57 | 7.10e-01 | -2.85e-02 | 8.89e-01 |
Signaling by MET | 62 | 7.12e-01 | -2.72e-02 | 8.90e-01 |
Plasma lipoprotein assembly | 18 | 7.14e-01 | -4.99e-02 | 8.91e-01 |
Transcriptional Regulation by VENTX | 35 | 7.15e-01 | -3.57e-02 | 8.91e-01 |
FRS-mediated FGFR4 signaling | 19 | 7.15e-01 | 4.84e-02 | 8.91e-01 |
Signaling by Rho GTPases | 356 | 7.15e-01 | 1.13e-02 | 8.91e-01 |
GRB2 events in ERBB2 signaling | 14 | 7.17e-01 | 5.61e-02 | 8.92e-01 |
Vpr-mediated nuclear import of PICs | 32 | 7.19e-01 | -3.67e-02 | 8.93e-01 |
Protein methylation | 14 | 7.20e-01 | -5.53e-02 | 8.93e-01 |
RNA Polymerase III Abortive And Retractive Initiation | 37 | 7.20e-01 | -3.40e-02 | 8.93e-01 |
RNA Polymerase III Transcription | 37 | 7.20e-01 | -3.40e-02 | 8.93e-01 |
Presynaptic phase of homologous DNA pairing and strand exchange | 36 | 7.20e-01 | -3.45e-02 | 8.93e-01 |
MAPK family signaling cascades | 292 | 7.21e-01 | -1.22e-02 | 8.93e-01 |
HCMV Early Events | 59 | 7.22e-01 | -2.67e-02 | 8.94e-01 |
RNA Polymerase I Transcription Termination | 28 | 7.23e-01 | -3.87e-02 | 8.94e-01 |
DNA Damage/Telomere Stress Induced Senescence | 33 | 7.24e-01 | -3.55e-02 | 8.94e-01 |
Gap junction assembly | 16 | 7.25e-01 | 5.08e-02 | 8.94e-01 |
Free fatty acids regulate insulin secretion | 10 | 7.26e-01 | 6.39e-02 | 8.95e-01 |
Formation of Incision Complex in GG-NER | 39 | 7.27e-01 | -3.23e-02 | 8.95e-01 |
Myogenesis | 29 | 7.27e-01 | -3.74e-02 | 8.95e-01 |
Diseases associated with the TLR signaling cascade | 20 | 7.29e-01 | -4.48e-02 | 8.95e-01 |
Diseases of Immune System | 20 | 7.29e-01 | -4.48e-02 | 8.95e-01 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 7.35e-01 | -3.99e-02 | 9.01e-01 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 12 | 7.36e-01 | 5.62e-02 | 9.01e-01 |
MyD88-independent TLR4 cascade | 83 | 7.36e-01 | -2.14e-02 | 9.01e-01 |
TRIF(TICAM1)-mediated TLR4 signaling | 83 | 7.36e-01 | -2.14e-02 | 9.01e-01 |
Signaling by FGFR | 72 | 7.38e-01 | 2.28e-02 | 9.02e-01 |
Basigin interactions | 25 | 7.40e-01 | 3.84e-02 | 9.04e-01 |
Nuclear import of Rev protein | 32 | 7.40e-01 | 3.39e-02 | 9.04e-01 |
Activation of the TFAP2 (AP-2) family of transcription factors | 11 | 7.43e-01 | 5.72e-02 | 9.06e-01 |
PLC beta mediated events | 50 | 7.43e-01 | 2.68e-02 | 9.06e-01 |
MAP kinase activation | 57 | 7.45e-01 | 2.49e-02 | 9.06e-01 |
DNA Damage Bypass | 41 | 7.45e-01 | 2.93e-02 | 9.06e-01 |
DAG and IP3 signaling | 38 | 7.45e-01 | -3.05e-02 | 9.06e-01 |
Digestion | 15 | 7.47e-01 | -4.81e-02 | 9.07e-01 |
Intra-Golgi traffic | 40 | 7.48e-01 | -2.94e-02 | 9.07e-01 |
Interleukin-7 signaling | 21 | 7.49e-01 | -4.03e-02 | 9.07e-01 |
Signaling by high-kinase activity BRAF mutants | 32 | 7.49e-01 | -3.26e-02 | 9.07e-01 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 14 | 7.49e-01 | -4.93e-02 | 9.07e-01 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 23 | 7.54e-01 | 3.77e-02 | 9.12e-01 |
Degradation of cysteine and homocysteine | 10 | 7.56e-01 | 5.69e-02 | 9.13e-01 |
Chromatin modifying enzymes | 195 | 7.58e-01 | -1.28e-02 | 9.14e-01 |
Chromatin organization | 195 | 7.58e-01 | -1.28e-02 | 9.14e-01 |
Cargo recognition for clathrin-mediated endocytosis | 96 | 7.59e-01 | -1.81e-02 | 9.15e-01 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 7.61e-01 | -5.07e-02 | 9.16e-01 |
SHC1 events in EGFR signaling | 13 | 7.61e-01 | -4.87e-02 | 9.16e-01 |
Regulation of actin dynamics for phagocytic cup formation | 70 | 7.65e-01 | 2.07e-02 | 9.19e-01 |
Retrograde transport at the Trans-Golgi-Network | 44 | 7.66e-01 | -2.60e-02 | 9.19e-01 |
Amino acid transport across the plasma membrane | 31 | 7.66e-01 | 3.09e-02 | 9.19e-01 |
Signaling by FGFR2 | 61 | 7.68e-01 | -2.19e-02 | 9.20e-01 |
Sodium/Calcium exchangers | 11 | 7.69e-01 | 5.12e-02 | 9.21e-01 |
TRAF3-dependent IRF activation pathway | 12 | 7.70e-01 | 4.87e-02 | 9.21e-01 |
Tie2 Signaling | 16 | 7.70e-01 | -4.21e-02 | 9.21e-01 |
Diseases associated with glycosaminoglycan metabolism | 38 | 7.70e-01 | 2.74e-02 | 9.21e-01 |
G2/M DNA damage checkpoint | 56 | 7.72e-01 | -2.24e-02 | 9.21e-01 |
Nucleotide salvage | 21 | 7.72e-01 | 3.66e-02 | 9.21e-01 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 31 | 7.73e-01 | -2.99e-02 | 9.22e-01 |
PRC2 methylates histones and DNA | 17 | 7.74e-01 | 4.01e-02 | 9.22e-01 |
SUMOylation of intracellular receptors | 29 | 7.76e-01 | -3.06e-02 | 9.23e-01 |
Pregnenolone biosynthesis | 11 | 7.77e-01 | 4.92e-02 | 9.24e-01 |
Signaling by TGFB family members | 91 | 7.78e-01 | 1.71e-02 | 9.24e-01 |
Platelet Aggregation (Plug Formation) | 36 | 7.78e-01 | -2.71e-02 | 9.24e-01 |
FOXO-mediated transcription | 63 | 7.82e-01 | 2.02e-02 | 9.27e-01 |
Cytochrome c-mediated apoptotic response | 10 | 7.83e-01 | 5.03e-02 | 9.28e-01 |
Signaling by PDGF | 48 | 7.87e-01 | -2.26e-02 | 9.31e-01 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 32 | 7.89e-01 | 2.74e-02 | 9.32e-01 |
ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 7.89e-01 | -3.09e-02 | 9.32e-01 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 24 | 7.90e-01 | 3.14e-02 | 9.33e-01 |
EPHA-mediated growth cone collapse | 14 | 7.92e-01 | -4.07e-02 | 9.33e-01 |
Regulation of TNFR1 signaling | 30 | 7.93e-01 | -2.77e-02 | 9.33e-01 |
Response of Mtb to phagocytosis | 20 | 7.94e-01 | -3.37e-02 | 9.33e-01 |
PTEN Regulation | 134 | 7.94e-01 | -1.31e-02 | 9.33e-01 |
Signaling by EGFR | 47 | 7.94e-01 | 2.20e-02 | 9.33e-01 |
Interleukin-17 signaling | 64 | 7.94e-01 | 1.88e-02 | 9.33e-01 |
TNFR1-induced NFkappaB signaling pathway | 23 | 7.95e-01 | 3.14e-02 | 9.33e-01 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 7.97e-01 | 3.96e-02 | 9.35e-01 |
ECM proteoglycans | 52 | 7.98e-01 | 2.05e-02 | 9.35e-01 |
ABC-family proteins mediated transport | 92 | 7.99e-01 | -1.53e-02 | 9.35e-01 |
Fertilization | 19 | 8.00e-01 | 3.36e-02 | 9.35e-01 |
Signaling by NTRK1 (TRKA) | 107 | 8.01e-01 | 1.41e-02 | 9.35e-01 |
Viral Messenger RNA Synthesis | 41 | 8.02e-01 | -2.27e-02 | 9.35e-01 |
Surfactant metabolism | 24 | 8.02e-01 | 2.96e-02 | 9.35e-01 |
Ion channel transport | 161 | 8.03e-01 | 1.14e-02 | 9.35e-01 |
Signalling to ERKs | 30 | 8.03e-01 | 2.63e-02 | 9.35e-01 |
Transport of bile salts and organic acids, metal ions and amine compounds | 77 | 8.04e-01 | 1.64e-02 | 9.35e-01 |
Beta-catenin independent WNT signaling | 127 | 8.04e-01 | -1.28e-02 | 9.35e-01 |
Metal ion SLC transporters | 24 | 8.05e-01 | -2.92e-02 | 9.35e-01 |
Depolymerisation of the Nuclear Lamina | 15 | 8.05e-01 | 3.68e-02 | 9.35e-01 |
Tandem pore domain potassium channels | 10 | 8.12e-01 | 4.34e-02 | 9.42e-01 |
RAF-independent MAPK1/3 activation | 21 | 8.13e-01 | 2.98e-02 | 9.42e-01 |
SUMOylation of SUMOylation proteins | 33 | 8.14e-01 | -2.37e-02 | 9.42e-01 |
Metabolic disorders of biological oxidation enzymes | 32 | 8.15e-01 | 2.39e-02 | 9.43e-01 |
Chondroitin sulfate biosynthesis | 20 | 8.18e-01 | -2.97e-02 | 9.46e-01 |
RAF/MAP kinase cascade | 250 | 8.19e-01 | 8.42e-03 | 9.46e-01 |
mRNA Capping | 27 | 8.20e-01 | -2.54e-02 | 9.46e-01 |
G-protein beta:gamma signalling | 28 | 8.26e-01 | 2.40e-02 | 9.48e-01 |
AMER1 mutants destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
APC truncation mutants have impaired AXIN binding | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
AXIN missense mutants destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
Truncations of AMER1 destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
truncated APC mutants destabilize the destruction complex | 12 | 8.26e-01 | 3.66e-02 | 9.48e-01 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 22 | 8.27e-01 | 2.69e-02 | 9.48e-01 |
CDC6 association with the ORC:origin complex | 11 | 8.28e-01 | -3.79e-02 | 9.48e-01 |
Netrin-1 signaling | 47 | 8.29e-01 | 1.82e-02 | 9.48e-01 |
PI3K/AKT Signaling in Cancer | 95 | 8.31e-01 | 1.27e-02 | 9.48e-01 |
Neurotransmitter receptors and postsynaptic signal transmission | 160 | 8.31e-01 | 9.80e-03 | 9.48e-01 |
Base Excision Repair | 47 | 8.31e-01 | 1.80e-02 | 9.48e-01 |
Keratinization | 84 | 8.31e-01 | -1.34e-02 | 9.48e-01 |
RUNX3 regulates NOTCH signaling | 12 | 8.31e-01 | -3.55e-02 | 9.48e-01 |
Transport of the SLBP independent Mature mRNA | 34 | 8.32e-01 | -2.11e-02 | 9.48e-01 |
Ephrin signaling | 18 | 8.34e-01 | 2.86e-02 | 9.49e-01 |
SUMO E3 ligases SUMOylate target proteins | 155 | 8.36e-01 | 9.66e-03 | 9.49e-01 |
Cleavage of the damaged pyrimidine | 18 | 8.37e-01 | 2.80e-02 | 9.49e-01 |
Depyrimidination | 18 | 8.37e-01 | 2.80e-02 | 9.49e-01 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 18 | 8.37e-01 | 2.80e-02 | 9.49e-01 |
SUMOylation of immune response proteins | 10 | 8.37e-01 | -3.75e-02 | 9.49e-01 |
Interleukin-12 family signaling | 49 | 8.38e-01 | 1.69e-02 | 9.49e-01 |
Mitophagy | 24 | 8.39e-01 | -2.40e-02 | 9.49e-01 |
InlB-mediated entry of Listeria monocytogenes into host cell | 13 | 8.39e-01 | -3.25e-02 | 9.49e-01 |
Purine salvage | 13 | 8.40e-01 | 3.24e-02 | 9.49e-01 |
SUMOylation of DNA replication proteins | 43 | 8.40e-01 | 1.77e-02 | 9.49e-01 |
Leishmania infection | 230 | 8.42e-01 | -7.66e-03 | 9.49e-01 |
Chylomicron assembly | 10 | 8.42e-01 | -3.64e-02 | 9.49e-01 |
SHC1 events in ERBB2 signaling | 20 | 8.43e-01 | -2.56e-02 | 9.49e-01 |
FCGR3A-mediated phagocytosis | 69 | 8.44e-01 | -1.37e-02 | 9.49e-01 |
Leishmania phagocytosis | 69 | 8.44e-01 | -1.37e-02 | 9.49e-01 |
Parasite infection | 69 | 8.44e-01 | -1.37e-02 | 9.49e-01 |
WNT ligand biogenesis and trafficking | 25 | 8.46e-01 | 2.25e-02 | 9.49e-01 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 16 | 8.46e-01 | 2.80e-02 | 9.49e-01 |
Toll Like Receptor 4 (TLR4) Cascade | 110 | 8.47e-01 | -1.07e-02 | 9.49e-01 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 8.48e-01 | 2.54e-02 | 9.49e-01 |
Signaling by cytosolic FGFR1 fusion mutants | 17 | 8.48e-01 | -2.68e-02 | 9.49e-01 |
RAB geranylgeranylation | 58 | 8.49e-01 | 1.45e-02 | 9.49e-01 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 37 | 8.50e-01 | 1.80e-02 | 9.49e-01 |
Phase II - Conjugation of compounds | 76 | 8.51e-01 | -1.25e-02 | 9.49e-01 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 13 | 8.51e-01 | -3.00e-02 | 9.49e-01 |
Regulation of signaling by NODAL | 11 | 8.51e-01 | -3.26e-02 | 9.49e-01 |
Nuclear Envelope Breakdown | 50 | 8.52e-01 | -1.52e-02 | 9.49e-01 |
Dopamine Neurotransmitter Release Cycle | 21 | 8.54e-01 | -2.32e-02 | 9.49e-01 |
VxPx cargo-targeting to cilium | 20 | 8.56e-01 | 2.34e-02 | 9.49e-01 |
PIP3 activates AKT signaling | 252 | 8.56e-01 | 6.64e-03 | 9.49e-01 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 33 | 8.56e-01 | -1.82e-02 | 9.49e-01 |
Diseases of mitotic cell cycle | 33 | 8.56e-01 | -1.82e-02 | 9.49e-01 |
Synthesis of IP3 and IP4 in the cytosol | 26 | 8.56e-01 | 2.05e-02 | 9.49e-01 |
GRB2 events in EGFR signaling | 12 | 8.61e-01 | -2.91e-02 | 9.49e-01 |
Estrogen-dependent gene expression | 90 | 8.61e-01 | 1.07e-02 | 9.49e-01 |
mRNA decay by 5’ to 3’ exoribonuclease | 14 | 8.62e-01 | -2.69e-02 | 9.49e-01 |
Activation of ATR in response to replication stress | 36 | 8.62e-01 | 1.67e-02 | 9.49e-01 |
Signaling by Erythropoietin | 23 | 8.63e-01 | -2.08e-02 | 9.49e-01 |
Constitutive Signaling by Aberrant PI3K in Cancer | 70 | 8.64e-01 | 1.19e-02 | 9.49e-01 |
KSRP (KHSRP) binds and destabilizes mRNA | 16 | 8.64e-01 | 2.48e-02 | 9.49e-01 |
Tight junction interactions | 24 | 8.64e-01 | 2.03e-02 | 9.49e-01 |
Macroautophagy | 103 | 8.64e-01 | -9.78e-03 | 9.49e-01 |
Negative regulators of DDX58/IFIH1 signaling | 28 | 8.64e-01 | 1.87e-02 | 9.49e-01 |
Downstream signal transduction | 27 | 8.66e-01 | 1.88e-02 | 9.49e-01 |
Spry regulation of FGF signaling | 12 | 8.66e-01 | 2.82e-02 | 9.49e-01 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
Signaling by NOTCH1 in Cancer | 52 | 8.67e-01 | -1.34e-02 | 9.49e-01 |
O-linked glycosylation of mucins | 43 | 8.68e-01 | 1.47e-02 | 9.49e-01 |
NOTCH2 intracellular domain regulates transcription | 10 | 8.68e-01 | -3.03e-02 | 9.49e-01 |
Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 13 | 8.70e-01 | 2.63e-02 | 9.50e-01 |
PINK1-PRKN Mediated Mitophagy | 17 | 8.71e-01 | 2.28e-02 | 9.50e-01 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 30 | 8.71e-01 | -1.71e-02 | 9.50e-01 |
Deadenylation-dependent mRNA decay | 49 | 8.73e-01 | -1.32e-02 | 9.51e-01 |
TNF signaling | 39 | 8.74e-01 | -1.46e-02 | 9.52e-01 |
SUMOylation of chromatin organization proteins | 53 | 8.76e-01 | -1.24e-02 | 9.52e-01 |
Diseases associated with N-glycosylation of proteins | 16 | 8.78e-01 | -2.22e-02 | 9.52e-01 |
GAB1 signalosome | 17 | 8.79e-01 | 2.14e-02 | 9.52e-01 |
Hyaluronan metabolism | 14 | 8.79e-01 | 2.35e-02 | 9.52e-01 |
G0 and Early G1 | 27 | 8.79e-01 | -1.69e-02 | 9.52e-01 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 8.80e-01 | -1.45e-02 | 9.52e-01 |
Interferon gamma signaling | 74 | 8.81e-01 | -1.01e-02 | 9.52e-01 |
Transport of Mature mRNA Derived from an Intronless Transcript | 40 | 8.82e-01 | 1.35e-02 | 9.52e-01 |
RNA Pol II CTD phosphorylation and interaction with CE | 25 | 8.83e-01 | -1.70e-02 | 9.52e-01 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 25 | 8.83e-01 | -1.70e-02 | 9.52e-01 |
TNFR1-induced proapoptotic signaling | 11 | 8.83e-01 | 2.55e-02 | 9.52e-01 |
Signaling by NTRKs | 126 | 8.84e-01 | 7.53e-03 | 9.52e-01 |
Kinesins | 39 | 8.84e-01 | 1.35e-02 | 9.52e-01 |
Signaling by TGF-beta Receptor Complex | 65 | 8.85e-01 | 1.04e-02 | 9.52e-01 |
Inactivation, recovery and regulation of the phototransduction cascade | 29 | 8.85e-01 | 1.55e-02 | 9.52e-01 |
Neutrophil degranulation | 429 | 8.86e-01 | 4.03e-03 | 9.52e-01 |
Pre-NOTCH Expression and Processing | 55 | 8.87e-01 | -1.11e-02 | 9.52e-01 |
Resolution of D-Loop Structures | 31 | 8.87e-01 | 1.47e-02 | 9.52e-01 |
Attenuation phase | 21 | 8.89e-01 | 1.76e-02 | 9.53e-01 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 8.92e-01 | -1.14e-02 | 9.55e-01 |
Regulation of MECP2 expression and activity | 30 | 8.92e-01 | 1.44e-02 | 9.55e-01 |
Signaling by PDGFR in disease | 16 | 8.94e-01 | 1.92e-02 | 9.56e-01 |
RNA Polymerase III Transcription Termination | 19 | 8.94e-01 | 1.76e-02 | 9.56e-01 |
G1/S-Specific Transcription | 29 | 8.96e-01 | -1.41e-02 | 9.56e-01 |
Extension of Telomeres | 49 | 8.96e-01 | -1.08e-02 | 9.56e-01 |
Methylation | 13 | 8.97e-01 | -2.08e-02 | 9.56e-01 |
tRNA processing | 113 | 8.97e-01 | -7.06e-03 | 9.56e-01 |
Constitutive Signaling by AKT1 E17K in Cancer | 24 | 8.97e-01 | 1.52e-02 | 9.56e-01 |
PKA-mediated phosphorylation of CREB | 18 | 9.00e-01 | 1.70e-02 | 9.58e-01 |
Cellular Senescence | 123 | 9.03e-01 | -6.37e-03 | 9.60e-01 |
Signaling by ERBB2 | 44 | 9.05e-01 | 1.05e-02 | 9.61e-01 |
SUMOylation of ubiquitinylation proteins | 38 | 9.06e-01 | -1.10e-02 | 9.63e-01 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 9.08e-01 | 1.86e-02 | 9.63e-01 |
Beta defensins | 14 | 9.09e-01 | 1.76e-02 | 9.64e-01 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 20 | 9.10e-01 | -1.46e-02 | 9.64e-01 |
Synthesis of glycosylphosphatidylinositol (GPI) | 15 | 9.10e-01 | -1.69e-02 | 9.64e-01 |
FLT3 Signaling | 264 | 9.14e-01 | 3.87e-03 | 9.67e-01 |
Notch-HLH transcription pathway | 26 | 9.18e-01 | -1.17e-02 | 9.68e-01 |
Intracellular signaling by second messengers | 289 | 9.18e-01 | 3.55e-03 | 9.68e-01 |
Cargo trafficking to the periciliary membrane | 47 | 9.18e-01 | -8.72e-03 | 9.68e-01 |
Export of Viral Ribonucleoproteins from Nucleus | 31 | 9.19e-01 | 1.06e-02 | 9.68e-01 |
MAPK targets/ Nuclear events mediated by MAP kinases | 29 | 9.20e-01 | -1.08e-02 | 9.68e-01 |
Cyclin A/B1/B2 associated events during G2/M transition | 23 | 9.20e-01 | 1.21e-02 | 9.68e-01 |
Phase 0 - rapid depolarisation | 27 | 9.21e-01 | -1.11e-02 | 9.68e-01 |
FOXO-mediated transcription of cell death genes | 14 | 9.21e-01 | -1.54e-02 | 9.68e-01 |
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 12 | 9.22e-01 | 1.64e-02 | 9.68e-01 |
SHC1 events in ERBB4 signaling | 12 | 9.23e-01 | 1.62e-02 | 9.68e-01 |
Intraflagellar transport | 39 | 9.23e-01 | -8.90e-03 | 9.68e-01 |
Signaling by Activin | 13 | 9.25e-01 | -1.50e-02 | 9.68e-01 |
ADORA2B mediated anti-inflammatory cytokines production | 105 | 9.26e-01 | 5.25e-03 | 9.68e-01 |
HDR through MMEJ (alt-NHEJ) | 10 | 9.27e-01 | 1.68e-02 | 9.68e-01 |
Cleavage of the damaged purine | 13 | 9.27e-01 | -1.47e-02 | 9.68e-01 |
Depurination | 13 | 9.27e-01 | -1.47e-02 | 9.68e-01 |
Recognition and association of DNA glycosylase with site containing an affected purine | 13 | 9.27e-01 | -1.47e-02 | 9.68e-01 |
IL-6-type cytokine receptor ligand interactions | 17 | 9.28e-01 | 1.27e-02 | 9.68e-01 |
G-protein mediated events | 51 | 9.28e-01 | 7.32e-03 | 9.68e-01 |
The phototransduction cascade | 30 | 9.31e-01 | 9.20e-03 | 9.69e-01 |
Interleukin-2 signaling | 10 | 9.31e-01 | 1.59e-02 | 9.69e-01 |
Endosomal/Vacuolar pathway | 10 | 9.33e-01 | 1.53e-02 | 9.70e-01 |
MET activates PTK2 signaling | 18 | 9.34e-01 | -1.13e-02 | 9.70e-01 |
NOTCH4 Intracellular Domain Regulates Transcription | 17 | 9.34e-01 | 1.16e-02 | 9.70e-01 |
SUMOylation | 161 | 9.34e-01 | 3.77e-03 | 9.70e-01 |
Polo-like kinase mediated events | 15 | 9.36e-01 | 1.21e-02 | 9.70e-01 |
TCF dependent signaling in response to WNT | 155 | 9.36e-01 | -3.75e-03 | 9.70e-01 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 9.36e-01 | 1.33e-02 | 9.70e-01 |
Glucagon-type ligand receptors | 28 | 9.38e-01 | -8.51e-03 | 9.71e-01 |
Homologous DNA Pairing and Strand Exchange | 39 | 9.41e-01 | -6.85e-03 | 9.74e-01 |
HSF1-dependent transactivation | 30 | 9.43e-01 | -7.57e-03 | 9.75e-01 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 41 | 9.44e-01 | -6.37e-03 | 9.75e-01 |
Keratan sulfate/keratin metabolism | 30 | 9.45e-01 | -7.30e-03 | 9.75e-01 |
Disease | 1337 | 9.46e-01 | 1.13e-03 | 9.75e-01 |
PKA activation | 16 | 9.46e-01 | -9.77e-03 | 9.75e-01 |
Interleukin-37 signaling | 20 | 9.46e-01 | 8.74e-03 | 9.75e-01 |
Interleukin receptor SHC signaling | 23 | 9.51e-01 | -7.47e-03 | 9.78e-01 |
Synthesis of PIPs at the Golgi membrane | 17 | 9.51e-01 | -8.56e-03 | 9.78e-01 |
Processing of Intronless Pre-mRNAs | 17 | 9.53e-01 | -8.32e-03 | 9.79e-01 |
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 10 | 9.57e-01 | 9.86e-03 | 9.82e-01 |
Diseases of metabolism | 215 | 9.58e-01 | 2.11e-03 | 9.82e-01 |
Toll Like Receptor 3 (TLR3) Cascade | 81 | 9.58e-01 | 3.40e-03 | 9.82e-01 |
DNA Double Strand Break Response | 38 | 9.58e-01 | 4.96e-03 | 9.82e-01 |
Interleukin-12 signaling | 39 | 9.59e-01 | 4.76e-03 | 9.82e-01 |
MAPK1/MAPK3 signaling | 256 | 9.61e-01 | 1.79e-03 | 9.83e-01 |
Fcgamma receptor (FCGR) dependent phagocytosis | 93 | 9.61e-01 | 2.92e-03 | 9.83e-01 |
Signaling by NTRK2 (TRKB) | 23 | 9.66e-01 | 5.12e-03 | 9.87e-01 |
Glycolysis | 68 | 9.67e-01 | -2.92e-03 | 9.87e-01 |
Olfactory Signaling Pathway | 79 | 9.67e-01 | -2.65e-03 | 9.87e-01 |
Transcriptional Regulation by MECP2 | 56 | 9.71e-01 | -2.84e-03 | 9.88e-01 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 17 | 9.71e-01 | 5.09e-03 | 9.88e-01 |
Transport of Ribonucleoproteins into the Host Nucleus | 31 | 9.72e-01 | -3.61e-03 | 9.88e-01 |
Interactions of Vpr with host cellular proteins | 34 | 9.73e-01 | 3.42e-03 | 9.88e-01 |
p75NTR signals via NF-kB | 13 | 9.73e-01 | 5.49e-03 | 9.88e-01 |
PKA activation in glucagon signalling | 16 | 9.73e-01 | -4.81e-03 | 9.88e-01 |
RORA activates gene expression | 18 | 9.73e-01 | 4.53e-03 | 9.88e-01 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 44 | 9.74e-01 | -2.83e-03 | 9.88e-01 |
SUMOylation of RNA binding proteins | 43 | 9.75e-01 | -2.76e-03 | 9.88e-01 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 27 | 9.76e-01 | 3.39e-03 | 9.88e-01 |
Collagen degradation | 36 | 9.76e-01 | 2.94e-03 | 9.88e-01 |
Defects in cobalamin (B12) metabolism | 13 | 9.78e-01 | 4.39e-03 | 9.89e-01 |
PCNA-Dependent Long Patch Base Excision Repair | 20 | 9.79e-01 | -3.38e-03 | 9.90e-01 |
Post-chaperonin tubulin folding pathway | 17 | 9.82e-01 | -3.15e-03 | 9.92e-01 |
TRAF6 mediated IRF7 activation | 14 | 9.82e-01 | -3.40e-03 | 9.92e-01 |
SUMOylation of transcription factors | 16 | 9.86e-01 | 2.61e-03 | 9.94e-01 |
Metabolism of carbohydrates | 261 | 9.86e-01 | -6.36e-04 | 9.94e-01 |
Phenylalanine and tyrosine metabolism | 10 | 9.88e-01 | -2.82e-03 | 9.94e-01 |
Scavenging of heme from plasma | 24 | 9.88e-01 | -1.77e-03 | 9.94e-01 |
SUMOylation of DNA damage response and repair proteins | 71 | 9.89e-01 | 9.35e-04 | 9.95e-01 |
Amino acids regulate mTORC1 | 46 | 9.90e-01 | 1.10e-03 | 9.95e-01 |
NEP/NS2 Interacts with the Cellular Export Machinery | 30 | 9.92e-01 | 1.11e-03 | 9.96e-01 |
Gluconeogenesis | 30 | 9.95e-01 | 6.22e-04 | 9.98e-01 |
Circadian Clock | 66 | 9.96e-01 | -3.89e-04 | 9.98e-01 |
Opioid Signalling | 83 | 9.96e-01 | 3.37e-04 | 9.98e-01 |
Transcriptional Regulation by E2F6 | 32 | 9.99e-01 | -1.01e-04 | 1.00e+00 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 9.99e-01 | -1.21e-04 | 1.00e+00 |
RHO GTPase Effectors | 236 | 1.00e+00 | 1.98e-05 | 1.00e+00 |
Major pathway of rRNA processing in the nucleolus and cytosol
648 | |
---|---|
set | Major pathway of rRNA processing in the nucleolus and cytosol |
setSize | 148 |
pANOVA | 7.55e-15 |
s.dist | -0.37 |
p.adjustANOVA | 1.06e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
TSR1 | -8237 |
RPS17 | -8231 |
LAS1L | -8220 |
HEATR1 | -8214 |
EXOSC1 | -8073 |
RPP40 | -7990 |
RPS3A | -7929 |
RPS28 | -7809 |
WDR75 | -7780 |
RPL29 | -7770 |
RPS21 | -7764 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
BMS1 | -7297 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
TSR1 | -8237.0 |
RPS17 | -8231.0 |
LAS1L | -8220.0 |
HEATR1 | -8214.0 |
EXOSC1 | -8073.0 |
RPP40 | -7990.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
WDR75 | -7780.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
BMS1 | -7297.0 |
RPL13A | -7282.0 |
RCL1 | -7096.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
MPHOSPH6 | -6988.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RIOK3 | -6733.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EXOSC9 | -6555.0 |
EMG1 | -6502.0 |
EBNA1BP2 | -6480.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
NOP14 | -5999.0 |
LTV1 | -5990.5 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
PNO1 | -5857.0 |
WDR12 | -5752.0 |
RPL5 | -5749.0 |
TEX10 | -5719.0 |
IMP4 | -5693.0 |
PWP2 | -5683.5 |
NOC4L | -5659.0 |
RPS19 | -5609.0 |
DDX52 | -5552.0 |
NOL12 | -5510.5 |
RPL37A | -5473.0 |
NOP58 | -5436.0 |
DDX21 | -5435.0 |
DHX37 | -5426.0 |
IMP3 | -5333.0 |
NOL9 | -5210.0 |
UTP6 | -5198.0 |
NIP7 | -5163.0 |
RPL19 | -5108.0 |
UTP15 | -4961.0 |
RPP30 | -4931.0 |
WDR36 | -4849.0 |
FAU | -4829.0 |
RPP25 | -4689.0 |
BOP1 | -4674.0 |
FTSJ3 | -4563.0 |
WDR3 | -4529.0 |
RPL35A | -4460.0 |
C1D | -4432.0 |
RPL13 | -4424.0 |
UTP18 | -4374.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RRP9 | -3702.0 |
DDX49 | -3628.0 |
NOP56 | -3482.0 |
EXOSC4 | -3421.0 |
EXOSC5 | -3356.0 |
WDR43 | -3348.0 |
NCL | -3329.0 |
GNL3 | -3174.0 |
UTP20 | -3157.0 |
FCF1 | -2809.0 |
MTREX | -2791.0 |
RPL7 | -2750.0 |
DCAF13 | -2707.0 |
PELP1 | -2654.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EXOSC3 | -2219.0 |
NOL11 | -1943.0 |
DDX47 | -1644.0 |
DIS3 | -1452.0 |
RPL23A | -1088.0 |
RIOK1 | -1046.0 |
BYSL | -877.0 |
RIOK2 | -834.0 |
UTP14A | -381.5 |
UTP14C | -381.5 |
ERI1 | -324.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
SNU13 | 188.0 |
UTP11 | 411.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
UTP3 | 843.0 |
MPHOSPH10 | 991.0 |
NOB1 | 1300.0 |
TBL3 | 1340.0 |
RPL7A | 1400.0 |
UTP4 | 1419.0 |
RRP7A | 1528.0 |
EXOSC10 | 1617.0 |
PDCD11 | 1804.0 |
EXOSC7 | 2356.0 |
RRP36 | 2367.0 |
RPL37 | 2677.0 |
SENP3 | 2732.5 |
KRR1 | 2965.0 |
EXOSC6 | 3010.0 |
RBM28 | 3020.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
PES1 | 3220.0 |
ISG20L2 | 3698.0 |
FBL | 3970.0 |
EXOSC8 | 4292.0 |
RPL3L | 4494.0 |
XRN2 | 4993.0 |
RPL22 | 5158.0 |
WDR46 | 5939.0 |
CSNK1D | 6028.0 |
RRP1 | 6389.0 |
NOL6 | 7692.0 |
CSNK1E | 7737.5 |
EXOSC2 | 7761.0 |
WDR18 | 7833.0 |
SRP-dependent cotranslational protein targeting to membrane
1073 | |
---|---|
set | SRP-dependent cotranslational protein targeting to membrane |
setSize | 83 |
pANOVA | 2.52e-14 |
s.dist | -0.484 |
p.adjustANOVA | 1.24e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
SEC61A2 | -7949 |
RPS3A | -7929 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
SSR2 | -7472 |
RPS11 | -7379 |
SPCS3 | -7363 |
RPS14 | -7325 |
RPN2 | -7299 |
RPL38 | -7298 |
RPL13A | -7282 |
SRP72 | -7203 |
RPL24 | -7065 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
SEC61A2 | -7949.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
SSR2 | -7472.0 |
RPS11 | -7379.0 |
SPCS3 | -7363.0 |
RPS14 | -7325.0 |
RPN2 | -7299.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
SRP72 | -7203.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
SSR4 | -6987.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
SRP14 | -6394.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
SEC61G | -5830.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
SRP9 | -5584.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
SEC61B | -4808.0 |
SEC11A | -4525.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
SPCS1 | -4020.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
SRP19 | -3584.0 |
SSR1 | -3579.0 |
SSR3 | -2883.0 |
SRP54 | -2836.0 |
SEC11C | -2812.0 |
RPL7 | -2750.0 |
SRPRA | -2690.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
RPL23A | -1088.0 |
RPN1 | -1071.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
SPCS2 | 959.0 |
RPL7A | 1400.0 |
SEC61A1 | 2087.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
TRAM1 | 5163.0 |
DDOST | 6465.0 |
SRPRB | 6995.0 |
SRP68 | 7282.0 |
rRNA processing in the nucleus and cytosol
1396 | |
---|---|
set | rRNA processing in the nucleus and cytosol |
setSize | 155 |
pANOVA | 2.66e-14 |
s.dist | -0.354 |
p.adjustANOVA | 1.24e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
TSR1 | -8237 |
RPS17 | -8231 |
LAS1L | -8220 |
HEATR1 | -8214 |
EXOSC1 | -8073 |
RPP40 | -7990 |
RPS3A | -7929 |
RPS28 | -7809 |
WDR75 | -7780 |
RPL29 | -7770 |
RPS21 | -7764 |
NAT10 | -7652 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
TSR1 | -8237.0 |
RPS17 | -8231.0 |
LAS1L | -8220.0 |
HEATR1 | -8214.0 |
EXOSC1 | -8073.0 |
RPP40 | -7990.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
WDR75 | -7780.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
NAT10 | -7652.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
BMS1 | -7297.0 |
RPL13A | -7282.0 |
RCL1 | -7096.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
MPHOSPH6 | -6988.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RIOK3 | -6733.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EXOSC9 | -6555.0 |
EMG1 | -6502.0 |
EBNA1BP2 | -6480.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
NOP14 | -5999.0 |
LTV1 | -5990.5 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
PNO1 | -5857.0 |
WDR12 | -5752.0 |
RPL5 | -5749.0 |
TEX10 | -5719.0 |
IMP4 | -5693.0 |
PWP2 | -5683.5 |
NOC4L | -5659.0 |
RPS19 | -5609.0 |
DDX52 | -5552.0 |
NOL12 | -5510.5 |
RPL37A | -5473.0 |
NOP58 | -5436.0 |
DDX21 | -5435.0 |
DHX37 | -5426.0 |
NOP10 | -5374.0 |
IMP3 | -5333.0 |
NOL9 | -5210.0 |
UTP6 | -5198.0 |
NIP7 | -5163.0 |
RPL19 | -5108.0 |
UTP15 | -4961.0 |
RPP30 | -4931.0 |
WDR36 | -4849.0 |
FAU | -4829.0 |
RPP25 | -4689.0 |
BOP1 | -4674.0 |
FTSJ3 | -4563.0 |
WDR3 | -4529.0 |
RPL35A | -4460.0 |
C1D | -4432.0 |
RPL13 | -4424.0 |
UTP18 | -4374.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RRP9 | -3702.0 |
DDX49 | -3628.0 |
NOP56 | -3482.0 |
EXOSC4 | -3421.0 |
EXOSC5 | -3356.0 |
WDR43 | -3348.0 |
NCL | -3329.0 |
GNL3 | -3174.0 |
UTP20 | -3157.0 |
FCF1 | -2809.0 |
MTREX | -2791.0 |
RPL7 | -2750.0 |
DCAF13 | -2707.0 |
PELP1 | -2654.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
DIMT1 | -2344.0 |
EXOSC3 | -2219.0 |
NOL11 | -1943.0 |
DDX47 | -1644.0 |
DIS3 | -1452.0 |
RPL23A | -1088.0 |
THUMPD1 | -1054.0 |
RIOK1 | -1046.0 |
BYSL | -877.0 |
RIOK2 | -834.0 |
UTP14A | -381.5 |
UTP14C | -381.5 |
ERI1 | -324.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
SNU13 | 188.0 |
TSR3 | 320.0 |
UTP11 | 411.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
UTP3 | 843.0 |
MPHOSPH10 | 991.0 |
NOB1 | 1300.0 |
TBL3 | 1340.0 |
RPL7A | 1400.0 |
UTP4 | 1419.0 |
RRP7A | 1528.0 |
EXOSC10 | 1617.0 |
PDCD11 | 1804.0 |
EXOSC7 | 2356.0 |
RRP36 | 2367.0 |
RPL37 | 2677.0 |
SENP3 | 2732.5 |
KRR1 | 2965.0 |
EXOSC6 | 3010.0 |
RBM28 | 3020.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
PES1 | 3220.0 |
ISG20L2 | 3698.0 |
FBL | 3970.0 |
EXOSC8 | 4292.0 |
RPL3L | 4494.0 |
XRN2 | 4993.0 |
RPL22 | 5158.0 |
WDR46 | 5939.0 |
CSNK1D | 6028.0 |
RRP1 | 6389.0 |
DKC1 | 7024.0 |
NOL6 | 7692.0 |
CSNK1E | 7737.5 |
EXOSC2 | 7761.0 |
GAR1 | 7789.0 |
WDR18 | 7833.0 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
1040 | |
---|---|
set | Response of EIF2AK4 (GCN2) to amino acid deficiency |
setSize | 72 |
pANOVA | 1.15e-12 |
s.dist | -0.485 |
p.adjustANOVA | 3.56e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
RPS3A | -7929 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
ATF4 | -7426 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
RPL13A | -7282 |
RPL24 | -7065 |
RPL32 | -7023 |
EIF2S1 | -7018 |
ATF3 | -7015 |
RPL6 | -6916 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
ATF4 | -7426.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
ATF3 | -7015.0 |
RPL6 | -6916.0 |
IMPACT | -6882.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
EIF2AK4 | -4948.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
ASNS | -2006.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
CEBPB | 1323.0 |
RPL7A | 1400.0 |
CEBPG | 2139.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
GCN1 | 3486.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
TRIB3 | 5887.0 |
ATF2 | 5957.0 |
DDIT3 | 6317.0 |
Peptide chain elongation
833 | |
---|---|
set | Peptide chain elongation |
setSize | 60 |
pANOVA | 1.66e-12 |
s.dist | -0.527 |
p.adjustANOVA | 3.56e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EEF1A1 | -1278.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EEF2 | 6302.0 |
Eukaryotic Translation Termination
365 | |
---|---|
set | Eukaryotic Translation Termination |
setSize | 63 |
pANOVA | 1.73e-12 |
s.dist | -0.514 |
p.adjustANOVA | 3.56e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
N6AMT1 | -4431.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
ETF1 | -4323.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
APEH | 5520.0 |
GSPT1 | 6438.0 |
Viral mRNA Translation
1353 | |
---|---|
set | Viral mRNA Translation |
setSize | 60 |
pANOVA | 1.88e-12 |
s.dist | -0.526 |
p.adjustANOVA | 3.56e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
DNAJC3 | -2019.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
GRSF1 | 7696.0 |
Selenocysteine synthesis
1093 | |
---|---|
set | Selenocysteine synthesis |
setSize | 63 |
pANOVA | 2.03e-12 |
s.dist | -0.512 |
p.adjustANOVA | 3.56e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
SEPSECS | -6470.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
EEFSEC | -4655.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
SECISBP2 | -4050.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
PSTK | 7348.0 |
SARS1 | 7350.0 |
Metabolism
655 | |
---|---|
set | Metabolism |
setSize | 1845 |
pANOVA | 2.7e-12 |
s.dist | 0.0997 |
p.adjustANOVA | 3.92e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NEU1 | 8176.0 |
PPIP5K1 | 8159.0 |
OPLAH | 8158.0 |
SLC19A2 | 8155.0 |
RXRB | 8151.0 |
SLC37A2 | 8145.0 |
ABCB4 | 8143.0 |
GK | 8138.5 |
GK3P | 8138.5 |
PPT2 | 8132.5 |
PAPSS1 | 8121.0 |
IMPA2 | 8120.0 |
PITPNM2 | 8100.0 |
ASS1 | 8096.0 |
CYP2A13 | 8073.0 |
CYP2A6 | 8073.0 |
CYP2A7 | 8073.0 |
ACACB | 8064.0 |
NUDT7 | 8063.0 |
SULT2A1 | 8062.0 |
GeneID | Gene Rank |
---|---|
NEU1 | 8176.0 |
PPIP5K1 | 8159.0 |
OPLAH | 8158.0 |
SLC19A2 | 8155.0 |
RXRB | 8151.0 |
SLC37A2 | 8145.0 |
ABCB4 | 8143.0 |
GK | 8138.5 |
GK3P | 8138.5 |
PPT2 | 8132.5 |
PAPSS1 | 8121.0 |
IMPA2 | 8120.0 |
PITPNM2 | 8100.0 |
ASS1 | 8096.0 |
CYP2A13 | 8073.0 |
CYP2A6 | 8073.0 |
CYP2A7 | 8073.0 |
ACACB | 8064.0 |
NUDT7 | 8063.0 |
SULT2A1 | 8062.0 |
PPM1K | 8055.0 |
SGMS1 | 8040.0 |
ALAS1 | 8037.0 |
ALAD | 8036.0 |
PLA2G6 | 8032.0 |
HMOX2 | 8031.0 |
MGLL | 8020.0 |
SLC2A1 | 8017.0 |
OGDH | 8010.0 |
PPARA | 7997.0 |
GMPS | 7992.0 |
PRKD1 | 7988.0 |
AZIN2 | 7979.0 |
GPAM | 7972.0 |
BPNT1 | 7970.0 |
GBE1 | 7961.0 |
ACOT7 | 7952.0 |
SLCO1A2 | 7943.0 |
ACSM1 | 7940.0 |
AHCYL1 | 7929.0 |
AKR1D1 | 7924.0 |
STXBP1 | 7922.0 |
TXNRD1 | 7917.0 |
ACSL6 | 7907.5 |
PHKG2 | 7896.0 |
COQ7 | 7888.0 |
SELENOI | 7885.0 |
EPHX1 | 7880.0 |
GSTO1 | 7872.0 |
ADCY4 | 7870.0 |
GGT5 | 7852.0 |
DGAT2 | 7843.0 |
CHST15 | 7804.0 |
GSR | 7801.0 |
SLC5A6 | 7796.0 |
GOT1 | 7788.0 |
SLC27A2 | 7786.0 |
ACSL1 | 7784.0 |
HSD17B8 | 7780.0 |
SCAP | 7769.0 |
TPMT | 7768.0 |
SIN3A | 7728.0 |
AGRN | 7727.0 |
CYP1B1 | 7721.0 |
NAMPT | 7697.0 |
RAPGEF4 | 7690.0 |
GYS1 | 7689.0 |
NEU3 | 7685.0 |
MTMR3 | 7682.0 |
CDIPT | 7681.0 |
GNB3 | 7673.0 |
HAO2 | 7672.0 |
ACAA2 | 7671.0 |
DPYD | 7658.0 |
PAPSS2 | 7656.0 |
OSBPL1A | 7651.0 |
ACOX2 | 7644.0 |
GDPD1 | 7639.0 |
OSBPL9 | 7624.0 |
PPP1CC | 7613.0 |
LDHC | 7609.0 |
CD36 | 7608.0 |
ABCB7 | 7604.0 |
PCCA | 7601.0 |
ALDH1L1 | 7595.0 |
FAM120B | 7582.0 |
SRR | 7575.0 |
GUSB | 7571.0 |
BSG | 7570.0 |
GOT2 | 7568.0 |
PFKL | 7566.0 |
SLC2A2 | 7562.0 |
PPIP5K2 | 7553.0 |
PSMB8 | 7523.0 |
ACOT1 | 7508.5 |
ACOT2 | 7508.5 |
SLC44A1 | 7506.0 |
GBA2 | 7505.0 |
CA2 | 7502.0 |
HSD17B4 | 7497.0 |
MIGA1 | 7495.0 |
ESRRA | 7493.0 |
SYNJ1 | 7489.0 |
NDUFA10 | 7483.0 |
PHYKPL | 7482.0 |
LIPE | 7475.0 |
CACNA1D | 7472.0 |
PDHX | 7471.0 |
ADCY8 | 7470.0 |
ACO2 | 7469.0 |
PDHB | 7468.0 |
AKR7L | 7460.0 |
PIK3R1 | 7450.0 |
DMGDH | 7433.0 |
SLC22A1 | 7430.0 |
PIP5K1C | 7429.0 |
ADCY6 | 7405.0 |
COX10 | 7392.0 |
OSBPL6 | 7390.0 |
FMO1 | 7389.0 |
PLPP3 | 7387.5 |
PTPN13 | 7381.0 |
OAZ3 | 7380.0 |
DEGS1 | 7375.0 |
CRAT | 7368.0 |
UGCG | 7366.0 |
PKLR | 7362.0 |
CS | 7355.0 |
SARS1 | 7350.0 |
PSTK | 7348.0 |
SLC35B2 | 7343.0 |
MTHFD1L | 7328.0 |
AIMP2 | 7324.0 |
DLAT | 7320.0 |
CKMT1A | 7304.5 |
HIBCH | 7300.0 |
GNAI2 | 7291.0 |
HADHB | 7290.0 |
RGL1 | 7289.0 |
HGD | 7287.0 |
PPARGC1A | 7286.0 |
NUDT5 | 7278.0 |
PLA2G12A | 7271.0 |
PPARD | 7270.0 |
SLC25A28 | 7261.0 |
ACOX1 | 7255.0 |
RDH11 | 7225.5 |
TM7SF2 | 7221.0 |
NCOA1 | 7218.0 |
PTGES2 | 7214.0 |
MECR | 7210.0 |
PPA2 | 7187.0 |
SYNJ2 | 7186.0 |
CYP4A11 | 7182.5 |
CYP4A22 | 7182.5 |
CYP4F11 | 7182.5 |
CYP4F12 | 7182.5 |
HK1 | 7172.0 |
HPD | 7170.0 |
CACNB2 | 7168.0 |
G6PC3 | 7163.0 |
MAT2B | 7160.0 |
CYP3A4 | 7151.0 |
CYP3A43 | 7151.0 |
CYP3A5 | 7151.0 |
CYP3A7 | 7151.0 |
GLUD1 | 7147.5 |
GLUD2 | 7147.5 |
FDFT1 | 7140.0 |
ITPR3 | 7138.0 |
HK2 | 7136.0 |
KYAT3 | 7134.0 |
SMPD1 | 7133.0 |
SLC52A3 | 7132.0 |
NDUFA8 | 7131.0 |
NDUFA12 | 7130.0 |
KDSR | 7127.0 |
SLCO1B1 | 7114.0 |
SLCO1B3 | 7114.0 |
ME3 | 7099.0 |
MVK | 7089.0 |
RAB14 | 7078.0 |
RAPGEF3 | 7075.0 |
DLST | 7073.0 |
CA4 | 7059.0 |
ACSF3 | 7053.0 |
ACOT13 | 7051.0 |
PTGR2 | 7049.5 |
PHYH | 7045.0 |
SLC27A5 | 7037.0 |
MIGA2 | 7028.0 |
CTH | 7025.0 |
SPR | 7022.0 |
MT-CYB | 7011.0 |
ACADVL | 7006.0 |
NDST2 | 7004.5 |
NDUFAB1 | 6996.0 |
CSPG4 | 6993.0 |
ALDH3A2 | 6988.0 |
MVD | 6987.0 |
GCK | 6985.0 |
LRAT | 6979.0 |
ECSIT | 6963.0 |
UQCRC1 | 6960.0 |
ACER2 | 6955.0 |
ITPR1 | 6954.0 |
OXCT1 | 6953.0 |
HAGH | 6949.0 |
MCCC2 | 6930.0 |
ELOVL1 | 6929.0 |
NUDT11 | 6928.0 |
SERINC3 | 6922.0 |
THEM4 | 6916.0 |
PISD | 6915.0 |
DDHD1 | 6907.0 |
CIAO3 | 6903.0 |
FAHD1 | 6902.0 |
HEXB | 6896.0 |
PCYT2 | 6881.0 |
THTPA | 6880.0 |
NMRAL1 | 6858.0 |
ADRA2C | 6852.0 |
ALAS2 | 6834.0 |
L2HGDH | 6828.0 |
DGAT1 | 6818.0 |
PLBD1 | 6813.0 |
ECI1 | 6811.0 |
HMGCS2 | 6810.0 |
SLC25A27 | 6807.0 |
ST3GAL6 | 6802.0 |
AUH | 6798.0 |
SLC27A1 | 6792.0 |
NNT | 6791.0 |
APOC2 | 6777.5 |
ARSB | 6768.0 |
AMACR | 6750.0 |
NUP155 | 6749.0 |
PLCD3 | 6748.0 |
MCEE | 6734.0 |
SMPD2 | 6732.0 |
ABHD14B | 6728.0 |
DHTKD1 | 6727.0 |
PRPS1 | 6718.0 |
CYP4F2 | 6710.0 |
LIPH | 6703.0 |
MMAB | 6701.0 |
PANK1 | 6687.0 |
NDST1 | 6686.0 |
D2HGDH | 6672.0 |
RETSAT | 6670.0 |
MCCC1 | 6666.0 |
NAPRT | 6662.0 |
AK4 | 6653.0 |
ADK | 6650.0 |
ADCY9 | 6648.0 |
STARD7 | 6643.0 |
BDH1 | 6632.0 |
CBS | 6623.5 |
CBSL | 6623.5 |
MTMR14 | 6619.0 |
PTDSS2 | 6618.0 |
PSME1 | 6608.0 |
NAALAD2 | 6593.0 |
CIDEA | 6565.0 |
CKMT2 | 6560.0 |
BCKDK | 6559.0 |
PAH | 6547.0 |
ACSS3 | 6546.0 |
ADH7 | 6545.0 |
GPC3 | 6542.0 |
ACOT11 | 6541.0 |
UROC1 | 6538.0 |
SLC26A1 | 6532.0 |
KCNC2 | 6530.0 |
PFKP | 6516.0 |
NDUFV1 | 6489.0 |
LRP12 | 6488.0 |
ATP5F1B | 6480.0 |
GPD1L | 6475.0 |
PLCD1 | 6467.0 |
B3GALT6 | 6461.0 |
ACAD9 | 6453.0 |
CPT1B | 6451.0 |
SLC25A20 | 6449.0 |
ITPKB | 6447.0 |
COX5B | 6442.0 |
SDC3 | 6440.0 |
ABCD1 | 6427.0 |
MMAA | 6426.0 |
CHPT1 | 6423.0 |
PNPO | 6410.0 |
FTCD | 6406.0 |
VAMP2 | 6400.5 |
BCKDHB | 6380.0 |
HADHA | 6375.0 |
PLCE1 | 6370.0 |
KARS1 | 6365.0 |
B4GAT1 | 6339.0 |
KYNU | 6336.0 |
PRKG2 | 6322.0 |
CAV1 | 6314.0 |
MTM1 | 6305.0 |
FUT11 | 6301.0 |
IDH3G | 6298.0 |
DCTD | 6296.0 |
ALOX12 | 6295.0 |
MARS1 | 6293.0 |
ABCB11 | 6290.0 |
FIG4 | 6289.0 |
GNPAT | 6274.0 |
MGST3 | 6268.0 |
LPCAT1 | 6266.0 |
SLC25A37 | 6264.0 |
ACAT1 | 6251.0 |
PNPLA6 | 6241.0 |
TAZ | 6238.0 |
NOS3 | 6235.0 |
INPP5E | 6233.0 |
SLC35D1 | 6230.0 |
GNA11 | 6218.0 |
CIAPIN1 | 6211.0 |
NDUFA9 | 6209.0 |
PFKFB1 | 6194.0 |
NUP50 | 6188.0 |
PSMF1 | 6184.0 |
CHP1 | 6183.0 |
TK1 | 6181.0 |
HYAL2 | 6167.0 |
ATP5F1D | 6163.0 |
MT-CO1 | 6162.0 |
LDHB | 6149.5 |
SLC25A12 | 6148.0 |
GSTM2 | 6146.0 |
SLC9A1 | 6140.0 |
MAPKAPK2 | 6139.0 |
TRAP1 | 6126.0 |
ACAA1 | 6125.0 |
DPYS | 6124.0 |
SDHC | 6123.0 |
NDUFB10 | 6086.0 |
SCD | 6085.0 |
HELZ2 | 6066.0 |
SLC52A1 | 6063.5 |
SLC52A2 | 6063.5 |
ESYT1 | 6061.0 |
RIMKLA | 6059.0 |
STARD3 | 6047.0 |
B3GALT2 | 6029.0 |
GLYAT | 6027.0 |
COX5A | 6026.0 |
EHHADH | 6024.0 |
IDH2 | 6021.0 |
CD38 | 6012.0 |
COX4I1 | 6009.0 |
POLD1 | 6006.0 |
ARSL | 5997.0 |
NAGLU | 5992.0 |
ACADM | 5984.0 |
PLA2G3 | 5983.0 |
SHMT2 | 5982.0 |
SLC25A15 | 5980.0 |
ACADL | 5978.0 |
ADSL | 5973.0 |
MTMR4 | 5959.0 |
SPHK2 | 5954.0 |
MTARC2 | 5951.0 |
PIAS4 | 5949.0 |
ST3GAL2 | 5935.0 |
CYP2S1 | 5928.0 |
IMPDH1 | 5924.0 |
MBOAT7 | 5900.0 |
COX18 | 5890.0 |
TRIB3 | 5887.0 |
NR1H4 | 5883.0 |
GNG8 | 5873.0 |
PPCDC | 5868.0 |
ABHD3 | 5864.0 |
FABP3 | 5858.0 |
SPTLC3 | 5843.0 |
ADA | 5832.0 |
NDC1 | 5827.0 |
HADH | 5813.0 |
APOA5 | 5800.0 |
NUP58 | 5787.0 |
BAAT | 5784.0 |
CYP26B1 | 5783.0 |
PYCR2 | 5775.5 |
SLC25A19 | 5771.0 |
MDH1 | 5761.0 |
ETFB | 5756.0 |
GART | 5752.0 |
UPB1 | 5745.0 |
PANK4 | 5739.0 |
PLA2G15 | 5737.0 |
SPNS2 | 5733.0 |
HSD17B3 | 5727.0 |
PPP2R5D | 5723.0 |
OSBPL2 | 5717.0 |
ACSS2 | 5711.0 |
ELOVL5 | 5710.0 |
NUP133 | 5700.0 |
NAT8L | 5686.0 |
NADK2 | 5681.0 |
ABCD4 | 5673.0 |
SRD5A3 | 5664.0 |
PRKD2 | 5653.0 |
SDHB | 5629.0 |
EPHX2 | 5626.0 |
CPT2 | 5615.0 |
NDUFS5 | 5612.0 |
PTPMT1 | 5611.0 |
PI4KA | 5609.0 |
GNA14 | 5590.0 |
ATP5MC3 | 5582.0 |
MT-ND1 | 5579.0 |
IDO2 | 5575.0 |
NDUFB7 | 5573.0 |
SLC35D2 | 5569.5 |
PITPNM1 | 5555.0 |
CPNE7 | 5543.0 |
GLTP | 5539.0 |
CHKB | 5535.0 |
NDUFV3 | 5524.0 |
PLEKHA5 | 5521.0 |
TSPO | 5508.0 |
ENTPD4 | 5505.0 |
MT-ATP8 | 5500.0 |
SPHK1 | 5497.0 |
GDPD3 | 5492.0 |
MTHFD1 | 5481.0 |
NDUFAF7 | 5479.0 |
IQGAP1 | 5465.0 |
NUDT19 | 5464.0 |
DPEP3 | 5463.0 |
LHPP | 5454.0 |
FUT4 | 5450.0 |
POR | 5441.0 |
NCOA3 | 5428.0 |
TTPA | 5425.0 |
CPOX | 5413.0 |
GLRX5 | 5404.0 |
HDAC3 | 5383.0 |
TKFC | 5376.0 |
ETFDH | 5372.0 |
SULT2B1 | 5346.0 |
COQ10A | 5345.0 |
APOA2 | 5339.0 |
LPIN2 | 5328.0 |
LPL | 5325.0 |
NCOA2 | 5324.0 |
GNG12 | 5320.0 |
MDH2 | 5314.0 |
FLAD1 | 5296.0 |
HSD17B11 | 5290.0 |
B4GALT7 | 5289.0 |
MED20 | 5287.0 |
MED11 | 5275.0 |
FABP1 | 5273.0 |
PCK2 | 5270.0 |
ETFA | 5269.0 |
ABCC1 | 5260.0 |
LRP8 | 5255.0 |
CPT1A | 5252.0 |
CA14 | 5251.0 |
KPNB1 | 5247.0 |
NQO2 | 5239.0 |
AHR | 5235.5 |
AGPAT3 | 5234.0 |
ISCU | 5231.0 |
RBP1 | 5230.0 |
SULT1E1 | 5228.5 |
NUDT12 | 5225.0 |
CPTP | 5212.0 |
GUK1 | 5202.0 |
BPHL | 5199.0 |
LPIN3 | 5191.0 |
APRT | 5190.0 |
VDR | 5181.0 |
PON2 | 5161.0 |
RPL22 | 5158.0 |
CERS5 | 5142.0 |
AGPAT2 | 5125.0 |
RAB5A | 5118.0 |
GCH1 | 5114.0 |
AGMAT | 5096.0 |
PARP14 | 5095.0 |
CSNK2B | 5077.0 |
ITPR2 | 5073.0 |
MTHFD2L | 5050.0 |
AK2 | 5044.0 |
NCOR2 | 5040.0 |
ALDH7A1 | 5036.0 |
PDPR | 5035.0 |
GCKR | 5033.0 |
PPP1CA | 5029.0 |
PSMB9 | 5019.0 |
OSBPL3 | 4992.0 |
LTA4H | 4990.0 |
B3GNT7 | 4989.0 |
NDUFB6 | 4983.0 |
OTC | 4960.0 |
FITM2 | 4958.0 |
IDH3A | 4957.0 |
CYP7A1 | 4954.0 |
ST3GAL3 | 4940.0 |
MT-ND5 | 4937.0 |
CA7 | 4924.0 |
IPMK | 4921.0 |
INPP4B | 4919.0 |
IDH3B | 4913.0 |
INPPL1 | 4912.0 |
GNAI1 | 4905.0 |
AHCY | 4901.0 |
NT5C3A | 4888.0 |
CYC1 | 4883.0 |
MT-ND2 | 4879.0 |
TIMMDC1 | 4862.0 |
ARSG | 4846.0 |
ESYT3 | 4844.0 |
ANKRD1 | 4842.0 |
INPP5A | 4841.0 |
HMGCS1 | 4840.0 |
SERPINA6 | 4838.0 |
NUDT13 | 4824.0 |
ACOT6 | 4818.0 |
GLP1R | 4816.0 |
NADK | 4808.0 |
SPTLC1 | 4801.0 |
MTMR2 | 4800.0 |
PSAP | 4789.0 |
SLC10A1 | 4785.0 |
GAA | 4773.0 |
MT-ND6 | 4767.0 |
TDO2 | 4761.0 |
CA12 | 4759.0 |
PRKAR1A | 4751.0 |
MLYCD | 4748.0 |
PARP9 | 4747.0 |
PON1 | 4745.0 |
MMACHC | 4740.0 |
ALDH3B1 | 4733.0 |
ACADS | 4701.0 |
CYP21A2 | 4683.0 |
PRODH | 4680.5 |
APOA4 | 4672.0 |
FBP1 | 4657.0 |
HPSE | 4653.0 |
HSD17B1 | 4651.0 |
ACY1 | 4649.5 |
LPGAT1 | 4643.0 |
BGN | 4642.0 |
FH | 4639.0 |
SDC4 | 4637.0 |
HIBADH | 4633.0 |
MT-ATP6 | 4629.0 |
SBF1 | 4623.0 |
ITPA | 4619.0 |
IARS1 | 4606.0 |
NHLRC1 | 4600.0 |
ACSF2 | 4566.0 |
CHPF2 | 4563.0 |
PLA2G4C | 4558.0 |
ETNK1 | 4555.0 |
PIK3R3 | 4535.5 |
QDPR | 4524.0 |
NUP98 | 4522.0 |
PCCB | 4518.0 |
COQ9 | 4517.0 |
PRKACA | 4516.0 |
NUP93 | 4512.0 |
ENPP1 | 4507.0 |
NCAN | 4501.0 |
PSMD13 | 4498.0 |
RPL3L | 4494.0 |
MCAT | 4486.0 |
PLAAT3 | 4482.0 |
PARP16 | 4481.0 |
LPCAT4 | 4480.0 |
COASY | 4460.0 |
MBOAT2 | 4446.0 |
BTD | 4442.0 |
MPC2 | 4435.0 |
SIN3B | 4433.0 |
PLA2G4F | 4411.0 |
BMX | 4404.0 |
ENTPD5 | 4385.0 |
MT-ND4 | 4382.0 |
NDUFS3 | 4380.0 |
NDOR1 | 4367.0 |
ADCY5 | 4361.0 |
CYP27A1 | 4354.0 |
SLC5A5 | 4347.0 |
PIK3R4 | 4339.0 |
PDHA1 | 4337.0 |
CYP2C18 | 4328.5 |
ELOVL2 | 4317.0 |
IP6K3 | 4313.0 |
PPCS | 4307.0 |
NR1D1 | 4304.0 |
COX11 | 4280.0 |
GSS | 4276.0 |
CAD | 4271.0 |
TCN2 | 4268.0 |
CHST7 | 4266.0 |
FABP12 | 4262.0 |
FA2H | 4252.0 |
DNPH1 | 4246.0 |
CYGB | 4243.0 |
CRYL1 | 4217.0 |
CHDH | 4204.0 |
AIP | 4203.0 |
SAMHD1 | 4197.0 |
PAOX | 4192.5 |
CERK | 4167.0 |
ORMDL2 | 4164.0 |
MORC2 | 4155.0 |
ACBD5 | 4146.0 |
GBA3 | 4143.0 |
HK3 | 4114.0 |
PSMD12 | 4108.0 |
ABHD4 | 4098.0 |
TACO1 | 4096.0 |
PDK4 | 4094.0 |
AASS | 4076.0 |
MED30 | 4073.0 |
NDUFB11 | 4068.0 |
ELOVL3 | 4059.0 |
CPS1 | 4058.0 |
HAL | 4053.0 |
FMO2 | 4047.0 |
DMAC2L | 4044.0 |
GYG1 | 4039.0 |
SLC46A1 | 4034.0 |
GCAT | 4033.0 |
NFYC | 4019.0 |
GNS | 4017.0 |
THRAP3 | 4012.0 |
SLC25A10 | 4009.5 |
DNM2 | 3996.0 |
MT-CO2 | 3989.0 |
ATP5ME | 3979.0 |
NDUFAF3 | 3956.0 |
SLC6A12 | 3944.0 |
PTGR1 | 3940.0 |
BCKDHA | 3938.5 |
SLC25A11 | 3937.0 |
ACLY | 3933.0 |
INPP5F | 3921.0 |
PRODH2 | 3914.0 |
MRI1 | 3905.0 |
BLVRB | 3893.0 |
SLC44A4 | 3892.0 |
ENTPD1 | 3885.0 |
RFK | 3881.0 |
MT-CO3 | 3879.0 |
SRD5A1 | 3839.0 |
LYPLA1 | 3830.0 |
NDUFS1 | 3819.0 |
GCSH | 3817.0 |
ALB | 3808.0 |
PPP2R1A | 3805.0 |
ENOPH1 | 3801.0 |
HSPG2 | 3786.0 |
IVD | 3772.0 |
AMT | 3769.5 |
UCP2 | 3761.0 |
PLD6 | 3759.0 |
CNDP2 | 3758.0 |
BHMT | 3748.0 |
SLC3A2 | 3743.0 |
NMNAT1 | 3733.0 |
LIPT2 | 3725.0 |
STK11 | 3719.0 |
B4GALT1 | 3685.0 |
SLC25A14 | 3669.0 |
LIAS | 3668.0 |
CYP2U1 | 3661.0 |
VDAC1 | 3653.0 |
GLB1 | 3652.0 |
GGT1 | 3624.0 |
CDK19 | 3619.0 |
LRP10 | 3616.0 |
PI4K2A | 3614.0 |
PLCB3 | 3610.0 |
PDSS2 | 3586.0 |
SUCLG1 | 3584.0 |
GPAT3 | 3583.0 |
SLC44A5 | 3580.0 |
COQ5 | 3578.0 |
ALOXE3 | 3570.0 |
CERS4 | 3565.0 |
NOSTRIN | 3557.0 |
DEGS2 | 3556.0 |
COX6B1 | 3551.0 |
NAXD | 3541.0 |
PNP | 3539.0 |
BST1 | 3532.0 |
AKT1 | 3530.0 |
POM121 | 3523.5 |
POM121C | 3523.5 |
DCK | 3522.0 |
VAPB | 3515.0 |
ARG2 | 3514.0 |
UPP1 | 3510.0 |
NDUFS8 | 3493.0 |
COX7A2L | 3473.0 |
ACER3 | 3467.0 |
INPP5J | 3451.0 |
UROS | 3436.0 |
SLC25A44 | 3433.0 |
ADPGK | 3429.0 |
GMPR | 3427.0 |
AS3MT | 3419.0 |
CDA | 3407.0 |
CIAO1 | 3399.0 |
IDO1 | 3376.0 |
PLCH2 | 3374.0 |
PDK2 | 3361.0 |
ATP5PD | 3350.0 |
ANGPTL4 | 3332.0 |
CDS2 | 3330.0 |
COQ6 | 3306.0 |
ALDOC | 3305.0 |
ELOVL7 | 3264.0 |
PLCG1 | 3263.0 |
HSD11B2 | 3260.0 |
GPC4 | 3253.0 |
AGPAT1 | 3237.0 |
SLC44A2 | 3226.0 |
DBT | 3223.0 |
XYLT2 | 3222.0 |
B3GALT1 | 3217.0 |
ACOT8 | 3216.0 |
UGT8 | 3214.0 |
UQCRC2 | 3202.0 |
CHST2 | 3199.0 |
GPX2 | 3181.0 |
HEXA | 3177.5 |
CYB5R3 | 3176.0 |
GPC2 | 3173.0 |
AAAS | 3172.0 |
ACP6 | 3169.0 |
MED13 | 3167.0 |
MED16 | 3165.0 |
GALT | 3160.0 |
CRYM | 3157.0 |
PXMP2 | 3147.0 |
RPS3 | 3136.0 |
ASAH1 | 3132.0 |
PFKFB3 | 3131.0 |
CSPG5 | 3130.0 |
NQO1 | 3127.0 |
SDHA | 3123.5 |
ALDOB | 3122.0 |
PNPLA7 | 3113.0 |
MED25 | 3110.0 |
NAXE | 3109.0 |
AKR7A3 | 3107.0 |
DLD | 3101.0 |
SLC16A1 | 3094.0 |
MTMR9 | 3093.0 |
NDUFS7 | 3090.0 |
SULT1B1 | 3083.0 |
HAO1 | 3075.0 |
UQCRFS1 | 3065.0 |
GSTP1 | 3048.0 |
TPST2 | 3036.0 |
RPS9 | 3031.0 |
TYMS | 3027.0 |
BHMT2 | 3019.0 |
CYP4B1 | 3008.0 |
PLEKHA1 | 2999.0 |
MOGAT2 | 2998.0 |
ITPK1 | 2994.0 |
MTMR1 | 2992.0 |
CYP46A1 | 2984.0 |
ATP5PO | 2966.5 |
PDP2 | 2951.0 |
PTGS1 | 2945.0 |
CA5B | 2939.0 |
ELOVL6 | 2936.0 |
SDS | 2931.0 |
NUBP2 | 2930.0 |
FABP5 | 2903.0 |
NDUFB4 | 2890.0 |
FHL2 | 2888.0 |
PFKFB2 | 2887.0 |
NDUFAF6 | 2862.0 |
MMUT | 2827.0 |
EPRS1 | 2820.0 |
HS6ST1 | 2818.0 |
CACNA2D2 | 2816.0 |
PYGB | 2807.0 |
AKAP5 | 2803.0 |
B4GALT6 | 2792.0 |
GPC1 | 2787.0 |
B4GALT2 | 2782.0 |
B4GALT4 | 2769.0 |
RHCE | 2752.5 |
RHD | 2752.5 |
DIO1 | 2734.0 |
SLC25A13 | 2731.0 |
PIK3C2G | 2726.0 |
NUP85 | 2708.0 |
TBL1X | 2701.5 |
LALBA | 2697.0 |
PCYT1A | 2694.0 |
LSS | 2690.0 |
UBIAD1 | 2682.0 |
RPL37 | 2677.0 |
HMOX1 | 2671.0 |
PTGIS | 2632.0 |
ERCC2 | 2618.0 |
UPP2 | 2616.0 |
OSBP | 2607.0 |
SLC7A5 | 2601.0 |
GNB2 | 2595.0 |
GNB1 | 2583.0 |
DHCR24 | 2582.0 |
ENO2 | 2577.0 |
HACL1 | 2573.0 |
EBP | 2569.5 |
AMPD3 | 2560.0 |
FABP9 | 2555.0 |
MTAP | 2547.5 |
CYP8B1 | 2544.0 |
ISCA1 | 2527.0 |
ACSL5 | 2484.0 |
ACOX3 | 2479.0 |
APOM | 2476.0 |
MFSD2A | 2468.0 |
ADAL | 2466.0 |
CRLS1 | 2459.0 |
COX6A1 | 2441.0 |
CHRM3 | 2433.0 |
PLEKHA4 | 2428.0 |
NDUFA4 | 2427.0 |
STAB2 | 2402.0 |
SLC22A2 | 2395.0 |
NUP153 | 2394.0 |
GLS2 | 2379.0 |
SLCO2B1 | 2372.0 |
SORD | 2363.0 |
FMO3 | 2351.0 |
ENTPD3 | 2340.0 |
GC | 2339.0 |
GCDH | 2330.0 |
UMPS | 2328.0 |
NEU4 | 2309.0 |
SGPP1 | 2300.0 |
CPNE6 | 2292.0 |
NT5E | 2278.0 |
PIP5K1B | 2275.0 |
PSMC3 | 2256.0 |
PSME2 | 2230.0 |
NDUFA6 | 2222.0 |
NT5C2 | 2210.0 |
GPAT4 | 2166.0 |
RBP4 | 2158.0 |
ENTPD8 | 2150.0 |
ADH5 | 2145.0 |
NDUFS4 | 2132.0 |
GNG7 | 2130.0 |
GNB5 | 2123.0 |
ACOXL | 2122.0 |
PITPNM3 | 2118.0 |
TXN2 | 2111.0 |
ARV1 | 2104.0 |
HSD17B14 | 2069.0 |
PLB1 | 2066.0 |
SUMF1 | 2058.0 |
COMT | 2047.0 |
SACM1L | 2044.0 |
GDA | 2042.0 |
PDK1 | 2031.0 |
NT5M | 2013.0 |
CDS1 | 1993.0 |
CYP1A2 | 1984.0 |
TIAM2 | 1970.0 |
BPNT2 | 1965.0 |
DHFR | 1944.5 |
DHFR2 | 1944.5 |
GPT | 1940.0 |
TPR | 1935.0 |
PLCG2 | 1922.0 |
PLA2G2A | 1916.0 |
FXN | 1911.0 |
ACER1 | 1906.0 |
NT5C | 1896.0 |
UCKL1 | 1893.0 |
DERA | 1883.0 |
PPP2CB | 1876.0 |
HMGCL | 1875.0 |
NUDT18 | 1867.0 |
GSTM4 | 1859.0 |
CYP4V2 | 1840.0 |
SUCLG2 | 1833.0 |
DECR1 | 1813.0 |
PIP4K2C | 1803.0 |
PIP5K1A | 1793.0 |
GNG2 | 1781.0 |
HMGCR | 1772.0 |
HS3ST3A1 | 1761.0 |
NUDT4 | 1756.5 |
HSD17B10 | 1753.0 |
CHAT | 1738.0 |
MTMR12 | 1733.0 |
SLC45A2 | 1727.0 |
FDX1 | 1690.0 |
SULT4A1 | 1685.0 |
PDXK | 1638.0 |
GLDC | 1630.0 |
AMDHD1 | 1625.0 |
PPARG | 1599.0 |
HSP90AB1 | 1597.0 |
TSPOAP1 | 1582.0 |
ACSS1 | 1581.0 |
DDAH1 | 1571.0 |
PECR | 1557.0 |
MED19 | 1555.0 |
SRD5A2 | 1549.0 |
PSMB2 | 1548.0 |
KCNG2 | 1519.0 |
INPP1 | 1515.0 |
PSME4 | 1510.0 |
PRKAR1B | 1495.0 |
BDH2 | 1484.0 |
SCO1 | 1481.0 |
PLPP6 | 1469.0 |
FITM1 | 1457.0 |
ETNPPL | 1441.0 |
GNB4 | 1440.0 |
NUP62 | 1422.0 |
ACSM4 | 1420.0 |
AOC3 | 1403.0 |
COQ3 | 1402.0 |
RPL7A | 1400.0 |
UCP1 | 1390.0 |
BCHE | 1382.0 |
PTGDS | 1364.5 |
TNFAIP8L3 | 1336.0 |
CYP4F22 | 1324.0 |
AMN | 1309.0 |
NDUFAF4 | 1307.0 |
NUDT9 | 1283.0 |
MAOB | 1278.0 |
HYKK | 1271.0 |
CA3 | 1268.0 |
TECR | 1244.0 |
PODXL2 | 1242.0 |
ETHE1 | 1214.0 |
INS | 1207.5 |
HS6ST2 | 1202.0 |
NDUFAF1 | 1191.0 |
CYP11A1 | 1187.0 |
BCO1 | 1128.0 |
ADI1 | 1124.0 |
PSMC1 | 1107.0 |
CYP19A1 | 1077.0 |
FFAR1 | 1077.0 |
TYR | 1077.0 |
AANAT | 1063.5 |
KCNB1 | 1044.0 |
NDUFB8 | 1015.5 |
UBC | 1013.0 |
ABCC2 | 1006.0 |
SLC36A4 | 997.0 |
PLIN2 | 985.0 |
GNPDA1 | 966.0 |
NUP188 | 957.0 |
HAAO | 944.0 |
STAR | 921.0 |
PNLIP | 915.0 |
ABO | 914.0 |
B3GAT2 | 894.0 |
HACD3 | 849.0 |
CIAO2B | 845.0 |
AOC1 | 786.0 |
PLAAT1 | 782.0 |
THEM5 | 765.0 |
TALDO1 | 753.0 |
COQ2 | 749.0 |
XDH | 745.0 |
CBR1 | 743.0 |
RPL27 | 706.0 |
ALOX12B | 627.0 |
SHPK | 615.5 |
HMBS | 610.0 |
SUCLA2 | 608.0 |
STARD5 | 594.0 |
SUOX | 589.0 |
GNMT | 585.0 |
CHST3 | 565.0 |
NDUFA13 | 544.0 |
CSNK1G2 | 527.0 |
RPS27L | 522.0 |
NCOR1 | 513.0 |
SGMS2 | 511.0 |
SP1 | 506.0 |
DGAT2L6 | 503.0 |
ARSA | 498.0 |
PPP2CA | 497.0 |
SNAP25 | 491.0 |
ELOVL4 | 485.0 |
AGPS | 484.0 |
CSGALNACT2 | 479.0 |
ADRA2A | 478.0 |
SULT1C2 | 473.0 |
CEMIP | 447.0 |
AKR1B1 | 438.0 |
POMC | 432.0 |
NUP37 | 424.0 |
MPC1 | 407.0 |
FABP6 | 393.5 |
ST3GAL4 | 357.0 |
PLA2G4D | 356.0 |
MID1IP1 | 349.0 |
PSMD7 | 321.0 |
PANK3 | 310.0 |
SLC5A8 | 302.0 |
NDST4 | 263.0 |
NCOA6 | 255.0 |
GLYATL3 | 246.0 |
GCG | 188.0 |
RIMKLB | 188.0 |
ACAT2 | 54.0 |
IPPK | 27.0 |
HACD4 | 7.0 |
CHST14 | 5.0 |
PTEN | 0.0 |
PPOX | -1.0 |
PGP | -4.0 |
MED15 | -8.0 |
MAN2B1 | -33.5 |
MMS19 | -48.0 |
CSAD | -92.0 |
TPTE | -98.5 |
TPTE2 | -98.5 |
PLCB4 | -100.0 |
GGCT | -116.5 |
MED13L | -127.0 |
MOGAT1 | -129.0 |
APOE | -136.0 |
GALC | -145.0 |
PC | -150.0 |
PRKAA2 | -151.0 |
PSMB5 | -153.0 |
RRM1 | -157.0 |
SEC24B | -161.0 |
MED7 | -167.0 |
SLC6A11 | -176.0 |
AADAC | -188.0 |
ENO1 | -219.0 |
GNG10 | -219.0 |
RPS2 | -219.0 |
TAT | -219.0 |
PFKM | -255.0 |
PHGDH | -257.0 |
RAE1 | -259.0 |
CGA | -264.0 |
ACBD4 | -269.0 |
RPL31 | -303.0 |
TPH1 | -304.0 |
MOCS3 | -315.0 |
INPP5B | -319.0 |
SERINC5 | -323.0 |
AGK | -326.0 |
NAGS | -332.0 |
PIK3C3 | -335.0 |
RBP2 | -340.0 |
INSIG2 | -349.0 |
SDHD | -389.5 |
GDE1 | -397.0 |
KCNS3 | -398.0 |
ADPRM | -403.0 |
FOLH1 | -423.0 |
ISYNA1 | -469.0 |
ACAD10 | -476.0 |
SERINC4 | -479.0 |
GSTK1 | -481.0 |
UGT2A3 | -484.0 |
AIMP1 | -487.0 |
TECRL | -489.0 |
PLCZ1 | -491.0 |
FAAH | -494.0 |
ACBD6 | -500.0 |
B3GALT5 | -504.0 |
GGPS1 | -505.0 |
PNPLA4 | -507.0 |
KCNJ11 | -540.0 |
HS3ST3B1 | -547.0 |
PDK3 | -549.0 |
ALDH1B1 | -557.0 |
AFMID | -564.0 |
NUP210 | -565.0 |
PLA2G4E | -576.0 |
CA1 | -581.0 |
PSMA5 | -604.0 |
GALE | -606.0 |
SLC37A1 | -608.0 |
PLA2G1B | -633.0 |
PNPLA5 | -633.0 |
TH | -720.5 |
TPO | -720.5 |
UGT3A2 | -720.5 |
CA13 | -800.0 |
SLC19A1 | -820.0 |
INPP4A | -824.0 |
MBTPS2 | -837.0 |
TYRP1 | -874.0 |
CHD9 | -885.0 |
ACMSD | -901.0 |
RUFY1 | -910.0 |
CYP2W1 | -912.0 |
CERS3 | -915.0 |
AGPAT4 | -928.0 |
DBH | -942.0 |
NDUFA3 | -953.0 |
ABHD10 | -956.0 |
PARP6 | -973.0 |
GPX1 | -981.0 |
SLC23A2 | -991.0 |
PLEKHA3 | -993.0 |
CHSY1 | -998.0 |
MGST2 | -1004.0 |
INMT | -1055.5 |
IYD | -1079.0 |
RPL23A | -1088.0 |
B3GAT1 | -1126.0 |
TSHB | -1126.0 |
PSMD3 | -1168.0 |
PSMD11 | -1181.0 |
PAICS | -1184.0 |
NR1H3 | -1186.0 |
OLAH | -1201.0 |
ATP5PF | -1203.0 |
PLCB1 | -1249.0 |
PSPH | -1263.0 |
GALK1 | -1270.0 |
CA5A | -1322.0 |
GK2 | -1329.0 |
GLCE | -1342.0 |
EPM2A | -1357.0 |
NR1H2 | -1366.0 |
ABHD5 | -1376.0 |
MAN2B2 | -1433.0 |
B4GALT3 | -1440.0 |
PIP4K2A | -1448.0 |
SULT1A1 | -1455.0 |
SULT1A2 | -1455.0 |
AGXT2 | -1462.0 |
SMS | -1473.0 |
SLC22A3 | -1492.0 |
ATIC | -1526.0 |
DDC | -1527.0 |
FUT2 | -1539.0 |
PSMC6 | -1541.0 |
PLA2G2F | -1548.0 |
SYT5 | -1557.0 |
AGPAT5 | -1570.0 |
ACOT12 | -1585.0 |
CES2 | -1591.0 |
IDUA | -1594.0 |
IDH1 | -1627.0 |
CREBBP | -1636.0 |
PANK2 | -1640.0 |
GATM | -1643.0 |
SAMD8 | -1654.0 |
MGST1 | -1655.0 |
GGT7 | -1675.0 |
PSMA8 | -1679.0 |
CYP17A1 | -1685.0 |
HS3ST6 | -1686.0 |
CTSA | -1693.0 |
ARG1 | -1696.0 |
RAB4A | -1698.0 |
APOB | -1729.0 |
FABP7 | -1750.0 |
TNFAIP8 | -1764.0 |
UCP3 | -1769.0 |
NUDT1 | -1771.0 |
CHST9 | -1774.0 |
CHST1 | -1780.0 |
GLA | -1815.0 |
UBE2I | -1820.0 |
CARM1 | -1862.0 |
B3GALNT1 | -1886.0 |
ATP5MF | -1892.0 |
PARP10 | -1918.0 |
NDUFB5 | -1930.0 |
DUOX2 | -1935.0 |
GNG11 | -1937.0 |
CHAC1 | -1970.0 |
RXRA | -1980.0 |
STARD3NL | -1991.0 |
MED1 | -2004.0 |
ASNS | -2006.0 |
DBI | -2008.0 |
PIK3R2 | -2014.5 |
NDST3 | -2026.0 |
LCLAT1 | -2037.0 |
DPEP1 | -2058.0 |
APOC3 | -2065.5 |
NFS1 | -2085.0 |
ACSBG2 | -2092.0 |
CYP51A1 | -2093.0 |
ALDH3A1 | -2094.0 |
PSMD1 | -2102.0 |
PMVK | -2107.0 |
EP300 | -2111.0 |
KHK | -2119.0 |
SERINC1 | -2128.0 |
CYP1A1 | -2131.0 |
PGM2 | -2150.0 |
PLCB2 | -2167.0 |
MED17 | -2171.5 |
NDUFV2 | -2183.0 |
PHKA2 | -2203.0 |
STX1A | -2228.0 |
FUT1 | -2236.0 |
COX7B | -2241.0 |
SRM | -2260.0 |
LARS1 | -2263.0 |
ADCY3 | -2277.0 |
PPP1CB | -2278.0 |
CHST12 | -2284.0 |
ODC1 | -2302.0 |
ASPG | -2305.0 |
PSMD2 | -2319.0 |
NME2 | -2324.0 |
ENTPD6 | -2327.0 |
ISCA2 | -2335.0 |
GPS2 | -2353.0 |
SLC19A3 | -2361.0 |
WASL | -2377.0 |
HSD3B7 | -2383.0 |
PFKFB4 | -2384.0 |
PSMA1 | -2388.0 |
ALOX15B | -2390.0 |
RARS1 | -2400.0 |
FDX2 | -2403.5 |
RRM2B | -2406.0 |
FADS2 | -2411.0 |
CERT1 | -2435.0 |
LGMN | -2445.0 |
CERS2 | -2467.0 |
RPS18 | -2478.0 |
SPTLC2 | -2485.0 |
CKB | -2496.0 |
GLUL | -2505.0 |
XYLB | -2515.0 |
MTMR10 | -2519.0 |
B3GNT3 | -2523.0 |
HSD17B2 | -2550.0 |
B4GALT5 | -2557.0 |
PLEKHA8 | -2559.0 |
MAN2C1 | -2560.0 |
PSMA7 | -2576.0 |
RPL8 | -2587.0 |
STARD6 | -2592.0 |
PLD2 | -2600.0 |
ACOT4 | -2617.0 |
GPC6 | -2630.0 |
ME2 | -2641.0 |
NMNAT2 | -2651.0 |
PLA2G5 | -2658.0 |
GPAT2 | -2660.0 |
SMPD3 | -2703.0 |
CYP24A1 | -2704.0 |
PIK3CA | -2711.0 |
UGDH | -2712.0 |
FAR2 | -2715.0 |
MINPP1 | -2737.0 |
RPL7 | -2750.0 |
CEPT1 | -2753.0 |
LRP2 | -2756.0 |
PIK3C2A | -2762.0 |
TBL1XR1 | -2764.0 |
BCAN | -2767.0 |
CYP2R1 | -2805.0 |
SLC26A2 | -2832.0 |
CYP2F1 | -2838.0 |
MMADHC | -2847.0 |
SREBF2 | -2861.0 |
RAP1A | -2869.0 |
HSD17B13 | -2870.0 |
NUP88 | -2879.0 |
CTRB1 | -2885.5 |
CTRB2 | -2885.5 |
AHRR | -2888.0 |
LIPT1 | -2889.0 |
ACAD11 | -2890.0 |
BRIP1 | -2904.0 |
CPNE3 | -2918.0 |
PIP4K2B | -2963.0 |
CHST11 | -2967.0 |
GNG5 | -2972.0 |
ACSM3 | -2985.0 |
ENTPD2 | -2996.0 |
HSCB | -3003.0 |
PLA2G4B | -3004.5 |
PSMC4 | -3007.0 |
UROD | -3027.0 |
NDUFC2 | -3052.5 |
SMPD4 | -3098.0 |
SLC6A8 | -3103.5 |
MT-ND3 | -3112.0 |
PSMD4 | -3118.0 |
NUDT3 | -3135.0 |
ORMDL3 | -3146.0 |
VAC14 | -3150.0 |
ALDH6A1 | -3168.0 |
CSNK2A2 | -3177.0 |
CHST13 | -3208.0 |
UQCR11 | -3215.5 |
PGLS | -3223.0 |
ACADSB | -3225.0 |
AGMO | -3234.0 |
IMPA1 | -3238.0 |
TKT | -3243.0 |
BBOX1 | -3284.0 |
OSBPL10 | -3302.0 |
UCK1 | -3319.0 |
NDUFA11 | -3345.5 |
PSMD6 | -3353.0 |
NUBPL | -3355.0 |
PIPOX | -3372.0 |
NDUFA2 | -3380.0 |
PEMT | -3381.0 |
INPP5K | -3389.0 |
CD320 | -3394.0 |
NDUFS2 | -3401.0 |
PTGS2 | -3418.0 |
PSMC2 | -3419.0 |
PLD3 | -3441.0 |
SLC23A1 | -3445.0 |
MED23 | -3449.0 |
INPP5D | -3469.0 |
BCAT2 | -3476.0 |
DHODH | -3496.0 |
PI4K2B | -3521.0 |
RIDA | -3529.0 |
CACNB3 | -3530.0 |
TGS1 | -3538.0 |
MED10 | -3546.0 |
OCA2 | -3562.0 |
TTR | -3574.0 |
HLCS | -3583.0 |
G6PD | -3588.0 |
CACNA1A | -3590.0 |
ASRGL1 | -3599.0 |
COX7C | -3618.0 |
AK8 | -3635.0 |
TNFRSF21 | -3652.0 |
PSMB3 | -3665.0 |
SMOX | -3678.0 |
PIK3R6 | -3686.0 |
MPST | -3696.0 |
FAH | -3704.0 |
GMPR2 | -3708.0 |
RPS13 | -3718.0 |
ENPP3 | -3728.0 |
PPT1 | -3753.0 |
NME1 | -3770.0 |
OSBPL5 | -3773.0 |
SQLE | -3782.0 |
SULT1A3 | -3792.5 |
SULT1A4 | -3792.5 |
PON3 | -3794.0 |
SDC1 | -3814.0 |
SERINC2 | -3821.0 |
RPL10A | -3822.0 |
AGT | -3831.0 |
MED29 | -3833.0 |
SARDH | -3844.0 |
KMO | -3849.0 |
PSMD8 | -3851.0 |
PNMT | -3860.0 |
PIK3R5 | -3873.0 |
KYAT1 | -3903.5 |
RPIA | -3910.0 |
FUT10 | -3918.0 |
AWAT2 | -3928.0 |
TK2 | -3952.0 |
CARNMT1 | -3953.0 |
ENTPD7 | -3961.0 |
ADIPOR2 | -3965.0 |
RPL3 | -3968.0 |
NAT1 | -3974.5 |
NAT2 | -3974.5 |
GLYCTK | -3989.0 |
MED22 | -3992.0 |
ACAD8 | -3994.0 |
UQCR10 | -3998.0 |
XYLT1 | -4000.0 |
FADS1 | -4018.0 |
RPSA | -4027.0 |
CMBL | -4036.0 |
SECISBP2 | -4050.0 |
PSMD14 | -4055.0 |
NRF1 | -4104.0 |
ARF1 | -4106.0 |
SPTSSA | -4118.0 |
HS3ST5 | -4128.0 |
CSNK2A1 | -4141.5 |
CCNC | -4162.0 |
PRPS2 | -4167.0 |
ALPI | -4177.0 |
PDSS1 | -4194.0 |
ALOX15 | -4198.0 |
SCLY | -4215.0 |
ASL | -4221.5 |
SLC25A21 | -4239.0 |
GLB1L | -4268.0 |
COQ10B | -4282.0 |
PHOSPHO1 | -4283.0 |
PLA2G4A | -4306.0 |
STS | -4310.0 |
ADHFE1 | -4312.0 |
CARNS1 | -4324.0 |
HAS1 | -4328.0 |
VKORC1 | -4349.0 |
HMGCLL1 | -4359.0 |
SMARCD3 | -4369.0 |
RPS6 | -4373.0 |
DARS1 | -4385.0 |
PLAAT5 | -4389.0 |
RPL13 | -4424.0 |
CYP39A1 | -4425.0 |
N6AMT1 | -4431.0 |
SDC2 | -4440.0 |
HACD2 | -4442.0 |
LMBRD1 | -4449.0 |
RPL35A | -4460.0 |
RRM2 | -4468.0 |
PHKG1 | -4479.0 |
SEC24D | -4488.0 |
GNA15 | -4495.0 |
GNG3 | -4499.0 |
NADSYN1 | -4517.0 |
GCLC | -4521.0 |
OAZ1 | -4538.0 |
MAT1A | -4559.0 |
HMMR | -4596.0 |
FECH | -4603.0 |
NSDHL | -4612.0 |
NUP35 | -4632.0 |
NUP107 | -4634.0 |
EEFSEC | -4655.0 |
AK9 | -4676.0 |
MTF1 | -4679.0 |
PLPP2 | -4680.0 |
DSEL | -4682.0 |
NMRK1 | -4705.0 |
MTHFR | -4706.0 |
ABCC8 | -4720.0 |
MED4 | -4721.0 |
ACSL4 | -4736.0 |
DAO | -4749.0 |
ADCY2 | -4754.0 |
PLPP1 | -4758.0 |
GYS2 | -4766.0 |
ITPKC | -4772.0 |
GLIPR1 | -4774.0 |
ESYT2 | -4775.0 |
APOA1 | -4811.0 |
ST6GALNAC6 | -4815.5 |
B4GALNT1 | -4824.0 |
NDUFAF5 | -4827.0 |
FAU | -4829.0 |
PGM1 | -4856.0 |
MTHFS | -4859.5 |
CYP26A1 | -4873.0 |
GPI | -4891.0 |
CHPF | -4909.0 |
NUP54 | -4913.0 |
CYP27B1 | -4916.0 |
ARSK | -4920.0 |
PIK3CG | -4924.0 |
MTHFD2 | -4932.0 |
MED24 | -4941.0 |
DDO | -4966.0 |
LPCAT2 | -4982.0 |
MARCKS | -5000.0 |
ACOT9 | -5006.0 |
UQCRB | -5007.0 |
ADCY1 | -5008.0 |
CBR4 | -5009.0 |
CHSY3 | -5014.0 |
NUDT15 | -5027.0 |
MBOAT1 | -5042.0 |
HSD17B7 | -5043.0 |
LRP1 | -5044.0 |
SLC16A8 | -5046.0 |
SGPL1 | -5047.0 |
PSMA2 | -5050.5 |
PCK1 | -5060.0 |
ENO3 | -5070.0 |
PSMA3 | -5078.0 |
GRHL1 | -5079.0 |
SLC22A13 | -5093.0 |
RPL19 | -5108.0 |
SLC35B3 | -5115.0 |
CA6 | -5117.0 |
FASN | -5133.0 |
NOSIP | -5142.0 |
MED6 | -5143.0 |
UQCRH | -5150.5 |
NUP42 | -5168.0 |
PTDSS1 | -5228.0 |
ACP5 | -5237.0 |
CKM | -5253.0 |
AGL | -5258.0 |
SLC44A3 | -5267.0 |
CYP2E1 | -5268.0 |
MED28 | -5278.0 |
VNN1 | -5284.0 |
GNPDA2 | -5305.0 |
PARP8 | -5316.0 |
TMEM126B | -5318.0 |
PYGM | -5322.0 |
PRKD3 | -5324.0 |
ITPKA | -5325.0 |
MSMO1 | -5327.0 |
DHCR7 | -5329.0 |
AASDHPPT | -5346.0 |
DCN | -5361.0 |
CHKA | -5389.0 |
RBKS | -5394.0 |
PLA1A | -5396.0 |
GSTM3 | -5409.0 |
PSMD5 | -5412.0 |
MED21 | -5422.0 |
OGN | -5441.0 |
PGS1 | -5459.0 |
MTMR7 | -5471.0 |
RPL37A | -5473.0 |
CTPS2 | -5477.0 |
TXN | -5519.0 |
CSGALNACT1 | -5528.0 |
SEC13 | -5544.0 |
DPEP2 | -5556.0 |
B3GNT2 | -5587.0 |
LPCAT3 | -5589.0 |
QPRT | -5597.0 |
PSMB4 | -5607.0 |
RPS19 | -5609.0 |
NUP160 | -5641.0 |
SLC25A17 | -5644.0 |
SLC27A3 | -5657.0 |
PIKFYVE | -5658.0 |
PLA2G2D | -5665.0 |
RNLS | -5667.0 |
TPK1 | -5669.0 |
KERA | -5674.0 |
UST | -5678.0 |
NMNAT3 | -5680.0 |
ATP5MG | -5696.5 |
PCTP | -5715.0 |
HS2ST1 | -5747.5 |
RPL5 | -5749.0 |
PI4KB | -5750.0 |
PLD1 | -5751.0 |
ARNT2 | -5773.0 |
AADAT | -5792.0 |
AMD1 | -5826.0 |
CYP26C1 | -5829.0 |
AMPD1 | -5835.0 |
FABP4 | -5849.0 |
GPCPD1 | -5855.0 |
RPS23 | -5865.0 |
TNFAIP8L2 | -5866.0 |
RPL35 | -5900.0 |
FMOD | -5918.0 |
G0S2 | -5922.0 |
PSMB1 | -5931.0 |
PDP1 | -5939.0 |
RPL28 | -5981.0 |
RPS4X | -6019.0 |
GNAS | -6021.0 |
PGAM2 | -6024.0 |
RPL15 | -6030.0 |
B3GALT4 | -6036.0 |
ALDH1A1 | -6037.0 |
IDS | -6043.5 |
MED27 | -6062.0 |
THRSP | -6068.0 |
DGUOK | -6071.0 |
PPP1R3C | -6072.0 |
DUT | -6073.0 |
RORA | -6076.0 |
CMPK1 | -6086.0 |
PCYT1B | -6101.0 |
OAZ2 | -6139.0 |
PIK3CD | -6147.0 |
RPL30 | -6152.0 |
NMRK2 | -6159.0 |
FBP2 | -6162.0 |
FOLR2 | -6185.0 |
DDHD2 | -6193.0 |
RPL23 | -6194.0 |
ZDHHC21 | -6207.0 |
EXT1 | -6236.0 |
PSMB7 | -6252.0 |
EXT2 | -6253.0 |
CA9 | -6259.0 |
PGM2L1 | -6262.0 |
AGXT | -6265.0 |
AACS | -6268.0 |
ASMT | -6271.0 |
RPLP2 | -6273.0 |
LDLR | -6289.0 |
LTC4S | -6307.0 |
INSIG1 | -6310.0 |
PRKACB | -6340.0 |
ABCA1 | -6344.0 |
RPL36 | -6366.0 |
ENPP6 | -6377.0 |
PEX11A | -6415.0 |
PLA2R1 | -6447.0 |
SEPSECS | -6470.0 |
PLD4 | -6472.0 |
ECI2 | -6476.0 |
ADCY7 | -6487.0 |
OAT | -6490.0 |
MED31 | -6496.0 |
MTMR6 | -6513.0 |
HPGD | -6516.0 |
SDSL | -6518.0 |
SLC25A1 | -6520.0 |
COX16 | -6527.0 |
SAR1B | -6531.0 |
MOCS1 | -6532.0 |
HACD1 | -6539.0 |
STARD4 | -6556.0 |
MLX | -6572.0 |
PSMC5 | -6575.0 |
ADIPOR1 | -6590.0 |
PTS | -6591.0 |
TBXAS1 | -6596.0 |
RPS8 | -6597.0 |
GCLM | -6619.0 |
CUBN | -6631.0 |
GM2A | -6634.0 |
IP6K2 | -6646.0 |
RPLP1 | -6661.0 |
CALM1 | -6675.0 |
GBA | -6677.0 |
RPL18A | -6679.0 |
GPD1 | -6680.0 |
RPL18 | -6689.0 |
RPS26 | -6692.0 |
GLS | -6702.0 |
AOX1 | -6706.0 |
SLC16A3 | -6714.0 |
PTGES3 | -6729.0 |
TMLHE | -6738.0 |
GAPDHS | -6739.0 |
NUP43 | -6740.0 |
GPD2 | -6755.0 |
ACSL3 | -6761.0 |
PYGL | -6766.0 |
CDO1 | -6767.0 |
PRELP | -6795.0 |
CD44 | -6801.0 |
SBF2 | -6804.0 |
ALDOA | -6806.0 |
GGT6 | -6808.0 |
RPS10 | -6822.5 |
ST3GAL1 | -6845.0 |
LUM | -6863.0 |
AKR1A1 | -6866.0 |
ABCC5 | -6870.0 |
GDPD5 | -6872.0 |
PFAS | -6896.0 |
RPL6 | -6916.0 |
PRKAG2 | -6923.0 |
DCTPP1 | -6925.0 |
HPGDS | -6927.0 |
NDUFB3 | -6948.0 |
NNMT | -6950.0 |
FPGS | -6953.0 |
ESD | -6972.0 |
PPP2R1B | -6978.0 |
PSMB6 | -6996.0 |
DTYMK | -6999.0 |
PRKAR2A | -7003.0 |
TPST1 | -7010.0 |
RPL32 | -7023.0 |
CH25H | -7050.0 |
RPL24 | -7065.0 |
PIK3C2B | -7081.0 |
AK1 | -7082.0 |
GLO1 | -7083.0 |
PRKCA | -7092.0 |
CERS6 | -7111.0 |
HPRT1 | -7123.0 |
ALDH1L2 | -7133.0 |
HAS2 | -7148.0 |
GSTA5 | -7174.0 |
NFYA | -7197.0 |
CTPS1 | -7200.0 |
NUP205 | -7210.0 |
BLVRA | -7225.0 |
GSTM1 | -7232.0 |
HDC | -7234.0 |
NUP214 | -7243.0 |
AK5 | -7249.0 |
PSMA6 | -7250.0 |
MBTPS1 | -7280.0 |
RPL13A | -7282.0 |
MAT2A | -7283.0 |
GSTZ1 | -7293.0 |
RPL38 | -7298.0 |
CYP4F8 | -7313.0 |
RPS14 | -7325.0 |
HAS3 | -7330.0 |
ARSI | -7339.0 |
FUT7 | -7349.0 |
GLRX | -7364.0 |
MTRR | -7367.0 |
CIDEC | -7371.0 |
RPS11 | -7379.0 |
PYCR1 | -7391.0 |
PSMA4 | -7394.0 |
LDHA | -7395.0 |
VAPA | -7396.0 |
LPIN1 | -7406.0 |
RANBP2 | -7410.0 |
MED26 | -7415.5 |
SAT1 | -7423.0 |
APIP | -7433.0 |
MAOA | -7453.0 |
PNPLA3 | -7463.0 |
PPARGC1B | -7464.0 |
PKM | -7469.0 |
ARNT | -7477.0 |
OSBPL7 | -7479.0 |
SHMT1 | -7480.0 |
GAMT | -7485.0 |
IDI1 | -7502.0 |
ACSBG1 | -7512.0 |
ARNTL | -7523.0 |
ASAH2 | -7526.0 |
MTR | -7527.0 |
OCRL | -7541.0 |
DDAH2 | -7547.0 |
RPS15 | -7548.0 |
SLC37A4 | -7558.0 |
UGP2 | -7573.0 |
COX19 | -7585.0 |
NFYB | -7587.0 |
TPI1 | -7603.0 |
ALOX5AP | -7609.0 |
IL4I1 | -7612.0 |
BCO2 | -7616.0 |
STARD10 | -7620.0 |
PGK1 | -7636.0 |
RPS27A | -7640.0 |
CACNA1E | -7644.0 |
RPS5 | -7648.0 |
OMD | -7649.0 |
PRKAB2 | -7660.0 |
AZIN1 | -7688.0 |
HOGA1 | -7689.0 |
PM20D1 | -7706.0 |
SEC23A | -7718.0 |
AMPD2 | -7721.0 |
MANBA | -7725.0 |
CACNA1C | -7730.0 |
CYP2J2 | -7731.0 |
PITPNB | -7740.0 |
CYP2D6 | -7746.5 |
CYP4F3 | -7751.0 |
RPS21 | -7764.0 |
PLCD4 | -7765.0 |
SLC25A32 | -7766.5 |
RPL29 | -7770.0 |
MOCOS | -7784.0 |
BCAT1 | -7785.0 |
PLCH1 | -7799.0 |
RPS28 | -7809.0 |
GSTT2 | -7816.5 |
GSTT2B | -7816.5 |
MED12 | -7822.0 |
ABCC3 | -7823.0 |
PNPLA8 | -7824.0 |
ETNK2 | -7825.0 |
NEU2 | -7830.0 |
CYP7B1 | -7839.0 |
PSAT1 | -7845.0 |
TST | -7850.0 |
PPAT | -7851.0 |
DUOX1 | -7858.0 |
NPAS2 | -7864.0 |
GPT2 | -7865.0 |
HSD17B12 | -7912.0 |
RPS3A | -7929.0 |
BPGM | -7934.0 |
ADIPOQ | -7940.0 |
UCK2 | -7942.0 |
CTRC | -7943.0 |
SREBF1 | -7944.0 |
ACACA | -7955.0 |
CYB5B | -7964.0 |
ACHE | -7966.0 |
MED9 | -7970.0 |
ME1 | -7972.0 |
AK6 | -7987.0 |
AK7 | -7999.0 |
ACSM5 | -8005.0 |
GAPDH | -8006.0 |
OSBPL8 | -8008.0 |
DHRS7B | -8015.0 |
PHKB | -8035.0 |
RTEL1 | -8038.5 |
PPA1 | -8054.0 |
FLVCR1 | -8055.0 |
MOCS2 | -8058.0 |
DSE | -8059.5 |
AKR1B10 | -8061.0 |
ACAN | -8071.0 |
ALOX5 | -8075.0 |
GRHPR | -8084.0 |
ATP5F1E | -8086.0 |
ASPA | -8103.0 |
ENPP2 | -8119.0 |
CLOCK | -8141.0 |
PLIN1 | -8142.0 |
SEC24A | -8147.0 |
SLC6A7 | -8151.0 |
VCAN | -8165.0 |
PRKAR2B | -8171.0 |
PHKA1 | -8179.0 |
CROT | -8187.0 |
FAR1 | -8198.0 |
GPX4 | -8221.0 |
RPS17 | -8231.0 |
RPS16 | -8246.0 |
RPE | -8252.5 |
RPEL1 | -8252.5 |
MED14 | -8255.0 |
UGT1A1 | -8268.0 |
CES1 | -8279.0 |
RPS15A | -8282.0 |
Eukaryotic Translation Elongation
363 | |
---|---|
set | Eukaryotic Translation Elongation |
setSize | 63 |
pANOVA | 2.79e-12 |
s.dist | -0.509 |
p.adjustANOVA | 3.92e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
EEF1B2 | -7570.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
EEF1B2 | -7570.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EEF1A1 | -1278.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
EEF1D | 748.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
EEF1G | 3002.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EEF2 | 6302.0 |
Cap-dependent Translation Initiation
149 | |
---|---|
set | Cap-dependent Translation Initiation |
setSize | 87 |
pANOVA | 9.53e-12 |
s.dist | -0.423 |
p.adjustANOVA | 1.12e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
EIF2B1 | -8218.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
EIF2B1 | -8218.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EIF4EBP1 | -6482.0 |
EIF2S2 | -6402.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
EIF4A2 | -5979.0 |
RPL35 | -5900.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
EIF3K | -5288.0 |
RPL19 | -5108.0 |
EIF5 | -4910.0 |
FAU | -4829.0 |
EIF2B5 | -4627.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
EIF2B2 | -2977.0 |
RPL7 | -2750.0 |
EIF3H | -2613.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EIF5B | -2410.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
RPL23A | -1088.0 |
EIF3J | -866.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
RPL37 | 2677.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF2B3 | 3266.0 |
EIF1AX | 3460.0 |
EIF2B4 | 3594.0 |
EIF4G1 | 4151.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
Eukaryotic Translation Initiation
364 | |
---|---|
set | Eukaryotic Translation Initiation |
setSize | 87 |
pANOVA | 9.53e-12 |
s.dist | -0.423 |
p.adjustANOVA | 1.12e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
EIF2B1 | -8218.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
EIF2B1 | -8218.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EIF4EBP1 | -6482.0 |
EIF2S2 | -6402.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
EIF4A2 | -5979.0 |
RPL35 | -5900.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
EIF3K | -5288.0 |
RPL19 | -5108.0 |
EIF5 | -4910.0 |
FAU | -4829.0 |
EIF2B5 | -4627.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
EIF2B2 | -2977.0 |
RPL7 | -2750.0 |
EIF3H | -2613.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EIF5B | -2410.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
RPL23A | -1088.0 |
EIF3J | -866.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
RPL37 | 2677.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF2B3 | 3266.0 |
EIF1AX | 3460.0 |
EIF2B4 | 3594.0 |
EIF4G1 | 4151.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
765 | |
---|---|
set | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
setSize | 65 |
pANOVA | 1.98e-11 |
s.dist | -0.481 |
p.adjustANOVA | 2.01e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
ETF1 | -4323.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
NCBP1 | -3144.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
RPL23A | -1088.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
NCBP2 | 898.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF4G1 | 4151.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
GSPT1 | 6438.0 |
UPF1 | 8167.0 |
GTP hydrolysis and joining of the 60S ribosomal subunit
456 | |
---|---|
set | GTP hydrolysis and joining of the 60S ribosomal subunit |
setSize | 81 |
pANOVA | 2e-11 |
s.dist | -0.431 |
p.adjustANOVA | 2.01e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
EIF4A2 | -5979.0 |
RPL35 | -5900.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
EIF3K | -5288.0 |
RPL19 | -5108.0 |
EIF5 | -4910.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
EIF3H | -2613.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EIF5B | -2410.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
RPL23A | -1088.0 |
EIF3J | -866.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
RPL37 | 2677.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
EIF4G1 | 4151.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
Formation of a pool of free 40S subunits
415 | |
---|---|
set | Formation of a pool of free 40S subunits |
setSize | 71 |
pANOVA | 2.96e-11 |
s.dist | -0.456 |
p.adjustANOVA | 2.77e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
EIF3K | -5288.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
EIF3H | -2613.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
RPL23A | -1088.0 |
EIF3J | -866.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
EIF3B | -78.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
RPL37 | 2677.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EIF3F | 5628.0 |
L13a-mediated translational silencing of Ceruloplasmin expression
610 | |
---|---|
set | L13a-mediated translational silencing of Ceruloplasmin expression |
setSize | 79 |
pANOVA | 3.62e-11 |
s.dist | -0.431 |
p.adjustANOVA | 3.18e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
EIF2S1 | -7018.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
EIF4A2 | -5979.0 |
RPL35 | -5900.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
EIF3K | -5288.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
EIF3H | -2613.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
RPL23A | -1088.0 |
EIF3J | -866.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
RPL37 | 2677.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
EIF4G1 | 4151.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
The citric acid (TCA) cycle and respiratory electron transport
1265 | |
---|---|
set | The citric acid (TCA) cycle and respiratory electron transport |
setSize | 150 |
pANOVA | 6.21e-11 |
s.dist | 0.309 |
p.adjustANOVA | 5.13e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
OGDH | 8010 |
LDHC | 7609 |
BSG | 7570 |
NDUFA10 | 7483 |
PDHX | 7471 |
ACO2 | 7469 |
PDHB | 7468 |
CS | 7355 |
DLAT | 7320 |
PPARD | 7270 |
NDUFA8 | 7131 |
NDUFA12 | 7130 |
ME3 | 7099 |
DLST | 7073 |
MT-CYB | 7011 |
NDUFAB1 | 6996 |
ECSIT | 6963 |
UQCRC1 | 6960 |
HAGH | 6949 |
FAHD1 | 6902 |
GeneID | Gene Rank |
---|---|
OGDH | 8010.0 |
LDHC | 7609.0 |
BSG | 7570.0 |
NDUFA10 | 7483.0 |
PDHX | 7471.0 |
ACO2 | 7469.0 |
PDHB | 7468.0 |
CS | 7355.0 |
DLAT | 7320.0 |
PPARD | 7270.0 |
NDUFA8 | 7131.0 |
NDUFA12 | 7130.0 |
ME3 | 7099.0 |
DLST | 7073.0 |
MT-CYB | 7011.0 |
NDUFAB1 | 6996.0 |
ECSIT | 6963.0 |
UQCRC1 | 6960.0 |
HAGH | 6949.0 |
FAHD1 | 6902.0 |
L2HGDH | 6828.0 |
SLC25A27 | 6807.0 |
NNT | 6791.0 |
D2HGDH | 6672.0 |
NDUFV1 | 6489.0 |
ATP5F1B | 6480.0 |
ACAD9 | 6453.0 |
COX5B | 6442.0 |
IDH3G | 6298.0 |
NDUFA9 | 6209.0 |
ATP5F1D | 6163.0 |
MT-CO1 | 6162.0 |
LDHB | 6149.5 |
TRAP1 | 6126.0 |
SDHC | 6123.0 |
NDUFB10 | 6086.0 |
COX5A | 6026.0 |
IDH2 | 6021.0 |
COX4I1 | 6009.0 |
COX18 | 5890.0 |
ETFB | 5756.0 |
SDHB | 5629.0 |
NDUFS5 | 5612.0 |
ATP5MC3 | 5582.0 |
MT-ND1 | 5579.0 |
NDUFB7 | 5573.0 |
NDUFV3 | 5524.0 |
MT-ATP8 | 5500.0 |
NDUFAF7 | 5479.0 |
ETFDH | 5372.0 |
COQ10A | 5345.0 |
MDH2 | 5314.0 |
ETFA | 5269.0 |
PDPR | 5035.0 |
NDUFB6 | 4983.0 |
IDH3A | 4957.0 |
MT-ND5 | 4937.0 |
IDH3B | 4913.0 |
CYC1 | 4883.0 |
MT-ND2 | 4879.0 |
TIMMDC1 | 4862.0 |
MT-ND6 | 4767.0 |
FH | 4639.0 |
MT-ATP6 | 4629.0 |
MPC2 | 4435.0 |
MT-ND4 | 4382.0 |
NDUFS3 | 4380.0 |
PDHA1 | 4337.0 |
COX11 | 4280.0 |
TACO1 | 4096.0 |
PDK4 | 4094.0 |
NDUFB11 | 4068.0 |
DMAC2L | 4044.0 |
MT-CO2 | 3989.0 |
ATP5ME | 3979.0 |
NDUFAF3 | 3956.0 |
MT-CO3 | 3879.0 |
NDUFS1 | 3819.0 |
UCP2 | 3761.0 |
SLC25A14 | 3669.0 |
VDAC1 | 3653.0 |
SUCLG1 | 3584.0 |
COX6B1 | 3551.0 |
NDUFS8 | 3493.0 |
COX7A2L | 3473.0 |
PDK2 | 3361.0 |
ATP5PD | 3350.0 |
UQCRC2 | 3202.0 |
SDHA | 3123.5 |
DLD | 3101.0 |
SLC16A1 | 3094.0 |
NDUFS7 | 3090.0 |
UQCRFS1 | 3065.0 |
ATP5PO | 2966.5 |
PDP2 | 2951.0 |
NDUFB4 | 2890.0 |
NDUFAF6 | 2862.0 |
COX6A1 | 2441.0 |
NDUFA4 | 2427.0 |
NDUFA6 | 2222.0 |
NDUFS4 | 2132.0 |
PDK1 | 2031.0 |
SUCLG2 | 1833.0 |
SCO1 | 1481.0 |
UCP1 | 1390.0 |
NDUFAF4 | 1307.0 |
NDUFAF1 | 1191.0 |
NDUFB8 | 1015.5 |
SUCLA2 | 608.0 |
NDUFA13 | 544.0 |
MPC1 | 407.0 |
SDHD | -389.5 |
PDK3 | -549.0 |
NDUFA3 | -953.0 |
ATP5PF | -1203.0 |
UCP3 | -1769.0 |
ATP5MF | -1892.0 |
NDUFB5 | -1930.0 |
RXRA | -1980.0 |
NDUFV2 | -2183.0 |
COX7B | -2241.0 |
ME2 | -2641.0 |
NDUFC2 | -3052.5 |
MT-ND3 | -3112.0 |
UQCR11 | -3215.5 |
NDUFA11 | -3345.5 |
NUBPL | -3355.0 |
NDUFA2 | -3380.0 |
NDUFS2 | -3401.0 |
COX7C | -3618.0 |
UQCR10 | -3998.0 |
COQ10B | -4282.0 |
ADHFE1 | -4312.0 |
NDUFAF5 | -4827.0 |
UQCRB | -5007.0 |
SLC16A8 | -5046.0 |
UQCRH | -5150.5 |
TMEM126B | -5318.0 |
ATP5MG | -5696.5 |
PDP1 | -5939.0 |
COX16 | -6527.0 |
SLC16A3 | -6714.0 |
NDUFB3 | -6948.0 |
GLO1 | -7083.0 |
GSTZ1 | -7293.0 |
LDHA | -7395.0 |
COX19 | -7585.0 |
PM20D1 | -7706.0 |
ME1 | -7972.0 |
ATP5F1E | -8086.0 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
764 | |
---|---|
set | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
setSize | 83 |
pANOVA | 1.19e-10 |
s.dist | -0.409 |
p.adjustANOVA | 8.76e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
UPF2 | -8156 |
RPS3A | -7929 |
SMG7 | -7916 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
SMG6 | -7760 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
RPL13A | -7282 |
RPL24 | -7065 |
RPL32 | -7023 |
RPL6 | -6916 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
UPF2 | -8156.0 |
RPS3A | -7929.0 |
SMG7 | -7916.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
SMG6 | -7760.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
SMG5 | -6279.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
UPF3A | -4384.0 |
RPS6 | -4373.0 |
ETF1 | -4323.0 |
MAGOH | -4309.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
NCBP1 | -3144.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RBM8A | -2564.0 |
RPS18 | -2478.0 |
RPL23A | -1088.0 |
DCP1A | -1050.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
PPP2CA | 497.0 |
RPS27L | 522.0 |
SMG9 | 582.0 |
RPL27 | 706.0 |
RNPS1 | 803.0 |
NCBP2 | 898.0 |
EIF4A3 | 950.0 |
RPL7A | 1400.0 |
MAGOHB | 1608.0 |
UPF3B | 2124.0 |
CASC3 | 2399.0 |
RPL37 | 2677.0 |
PPP2R2A | 2684.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
PPP2R1A | 3805.0 |
EIF4G1 | 4151.0 |
SMG8 | 4226.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
GSPT1 | 6438.0 |
UPF1 | 8167.0 |
Nonsense-Mediated Decay (NMD)
766 | |
---|---|
set | Nonsense-Mediated Decay (NMD) |
setSize | 83 |
pANOVA | 1.19e-10 |
s.dist | -0.409 |
p.adjustANOVA | 8.76e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
UPF2 | -8156 |
RPS3A | -7929 |
SMG7 | -7916 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
SMG6 | -7760 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
RPL13A | -7282 |
RPL24 | -7065 |
RPL32 | -7023 |
RPL6 | -6916 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
UPF2 | -8156.0 |
RPS3A | -7929.0 |
SMG7 | -7916.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
SMG6 | -7760.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
SMG5 | -6279.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
UPF3A | -4384.0 |
RPS6 | -4373.0 |
ETF1 | -4323.0 |
MAGOH | -4309.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
NCBP1 | -3144.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RBM8A | -2564.0 |
RPS18 | -2478.0 |
RPL23A | -1088.0 |
DCP1A | -1050.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
PPP2CA | 497.0 |
RPS27L | 522.0 |
SMG9 | 582.0 |
RPL27 | 706.0 |
RNPS1 | 803.0 |
NCBP2 | 898.0 |
EIF4A3 | 950.0 |
RPL7A | 1400.0 |
MAGOHB | 1608.0 |
UPF3B | 2124.0 |
CASC3 | 2399.0 |
RPL37 | 2677.0 |
PPP2R2A | 2684.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
PPP2R1A | 3805.0 |
EIF4G1 | 4151.0 |
SMG8 | 4226.0 |
RPL3L | 4494.0 |
RPL22 | 5158.0 |
GSPT1 | 6438.0 |
UPF1 | 8167.0 |
rRNA processing
1394 | |
---|---|
set | rRNA processing |
setSize | 176 |
pANOVA | 1.45e-09 |
s.dist | -0.265 |
p.adjustANOVA | 1.01e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
TSR1 | -8237 |
RPS17 | -8231 |
LAS1L | -8220 |
HEATR1 | -8214 |
EXOSC1 | -8073 |
RPP40 | -7990 |
RPS3A | -7929 |
RPS28 | -7809 |
WDR75 | -7780 |
RPL29 | -7770 |
RPS21 | -7764 |
NAT10 | -7652 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
TSR1 | -8237.0 |
RPS17 | -8231.0 |
LAS1L | -8220.0 |
HEATR1 | -8214.0 |
EXOSC1 | -8073.0 |
RPP40 | -7990.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
WDR75 | -7780.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
NAT10 | -7652.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
BMS1 | -7297.0 |
RPL13A | -7282.0 |
RCL1 | -7096.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
MPHOSPH6 | -6988.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RIOK3 | -6733.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
EXOSC9 | -6555.0 |
EMG1 | -6502.0 |
EBNA1BP2 | -6480.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
NOP14 | -5999.0 |
LTV1 | -5990.5 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
PNO1 | -5857.0 |
WDR12 | -5752.0 |
RPL5 | -5749.0 |
TEX10 | -5719.0 |
IMP4 | -5693.0 |
PWP2 | -5683.5 |
NOC4L | -5659.0 |
RPS19 | -5609.0 |
DDX52 | -5552.0 |
NOL12 | -5510.5 |
RPL37A | -5473.0 |
NOP58 | -5436.0 |
DDX21 | -5435.0 |
DHX37 | -5426.0 |
NOP10 | -5374.0 |
IMP3 | -5333.0 |
NOL9 | -5210.0 |
UTP6 | -5198.0 |
NIP7 | -5163.0 |
RPL19 | -5108.0 |
UTP15 | -4961.0 |
RPP30 | -4931.0 |
WDR36 | -4849.0 |
FAU | -4829.0 |
RPP25 | -4689.0 |
BOP1 | -4674.0 |
FTSJ3 | -4563.0 |
WDR3 | -4529.0 |
RPL35A | -4460.0 |
C1D | -4432.0 |
RPL13 | -4424.0 |
UTP18 | -4374.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RRP9 | -3702.0 |
DDX49 | -3628.0 |
NOP56 | -3482.0 |
EXOSC4 | -3421.0 |
EXOSC5 | -3356.0 |
WDR43 | -3348.0 |
NCL | -3329.0 |
GNL3 | -3174.0 |
UTP20 | -3157.0 |
TRMT10C | -3148.0 |
MT-ND3 | -3112.0 |
FCF1 | -2809.0 |
MTREX | -2791.0 |
RPL7 | -2750.0 |
DCAF13 | -2707.0 |
PELP1 | -2654.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
DIMT1 | -2344.0 |
EXOSC3 | -2219.0 |
NOL11 | -1943.0 |
DDX47 | -1644.0 |
DIS3 | -1452.0 |
MRM1 | -1343.0 |
RPL23A | -1088.0 |
THUMPD1 | -1054.0 |
RIOK1 | -1046.0 |
BYSL | -877.0 |
RIOK2 | -834.0 |
UTP14A | -381.5 |
UTP14C | -381.5 |
ERI1 | -324.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
SNU13 | 188.0 |
TSR3 | 320.0 |
UTP11 | 411.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
TFB1M | 788.0 |
UTP3 | 843.0 |
MRM2 | 930.5 |
MPHOSPH10 | 991.0 |
PRORP | 1105.5 |
NOB1 | 1300.0 |
TBL3 | 1340.0 |
RPL7A | 1400.0 |
UTP4 | 1419.0 |
RRP7A | 1528.0 |
EXOSC10 | 1617.0 |
HSD17B10 | 1753.0 |
PDCD11 | 1804.0 |
EXOSC7 | 2356.0 |
RRP36 | 2367.0 |
RPL37 | 2677.0 |
SENP3 | 2732.5 |
KRR1 | 2965.0 |
EXOSC6 | 3010.0 |
RBM28 | 3020.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
PES1 | 3220.0 |
MT-ND4L | 3569.0 |
ISG20L2 | 3698.0 |
MT-CO3 | 3879.0 |
FBL | 3970.0 |
MT-CO2 | 3989.0 |
EXOSC8 | 4292.0 |
MT-ND4 | 4382.0 |
RPL3L | 4494.0 |
MT-ATP6 | 4629.0 |
MRM3 | 4729.0 |
MT-ND2 | 4879.0 |
MT-ND5 | 4937.0 |
XRN2 | 4993.0 |
RPL22 | 5158.0 |
MTERF4 | 5363.0 |
MT-ATP8 | 5500.0 |
MT-ND1 | 5579.0 |
WDR46 | 5939.0 |
CSNK1D | 6028.0 |
ELAC2 | 6048.0 |
MT-CO1 | 6162.0 |
RRP1 | 6389.0 |
MT-CYB | 7011.0 |
DKC1 | 7024.0 |
NOL6 | 7692.0 |
CSNK1E | 7737.5 |
EXOSC2 | 7761.0 |
GAR1 | 7789.0 |
WDR18 | 7833.0 |
Metabolism of lipids
664 | |
---|---|
set | Metabolism of lipids |
setSize | 669 |
pANOVA | 2.49e-09 |
s.dist | 0.136 |
p.adjustANOVA | 1.67e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NEU1 | 8176.0 |
RXRB | 8151.0 |
ABCB4 | 8143.0 |
GK | 8138.5 |
GK3P | 8138.5 |
PPT2 | 8132.5 |
PITPNM2 | 8100.0 |
ACACB | 8064.0 |
NUDT7 | 8063.0 |
SULT2A1 | 8062.0 |
SGMS1 | 8040.0 |
ALAS1 | 8037.0 |
PLA2G6 | 8032.0 |
MGLL | 8020.0 |
PPARA | 7997.0 |
PRKD1 | 7988.0 |
GPAM | 7972.0 |
ACOT7 | 7952.0 |
SLCO1A2 | 7943.0 |
AKR1D1 | 7924.0 |
GeneID | Gene Rank |
---|---|
NEU1 | 8176.0 |
RXRB | 8151.0 |
ABCB4 | 8143.0 |
GK | 8138.5 |
GK3P | 8138.5 |
PPT2 | 8132.5 |
PITPNM2 | 8100.0 |
ACACB | 8064.0 |
NUDT7 | 8063.0 |
SULT2A1 | 8062.0 |
SGMS1 | 8040.0 |
ALAS1 | 8037.0 |
PLA2G6 | 8032.0 |
MGLL | 8020.0 |
PPARA | 7997.0 |
PRKD1 | 7988.0 |
GPAM | 7972.0 |
ACOT7 | 7952.0 |
SLCO1A2 | 7943.0 |
AKR1D1 | 7924.0 |
TXNRD1 | 7917.0 |
ACSL6 | 7907.5 |
SELENOI | 7885.0 |
GGT5 | 7852.0 |
DGAT2 | 7843.0 |
SLC27A2 | 7786.0 |
ACSL1 | 7784.0 |
HSD17B8 | 7780.0 |
SCAP | 7769.0 |
SIN3A | 7728.0 |
CYP1B1 | 7721.0 |
NEU3 | 7685.0 |
MTMR3 | 7682.0 |
CDIPT | 7681.0 |
HAO2 | 7672.0 |
ACAA2 | 7671.0 |
OSBPL1A | 7651.0 |
ACOX2 | 7644.0 |
GDPD1 | 7639.0 |
OSBPL9 | 7624.0 |
PPP1CC | 7613.0 |
CD36 | 7608.0 |
PCCA | 7601.0 |
FAM120B | 7582.0 |
ACOT1 | 7508.5 |
ACOT2 | 7508.5 |
SLC44A1 | 7506.0 |
GBA2 | 7505.0 |
HSD17B4 | 7497.0 |
MIGA1 | 7495.0 |
ESRRA | 7493.0 |
SYNJ1 | 7489.0 |
LIPE | 7475.0 |
PIK3R1 | 7450.0 |
PIP5K1C | 7429.0 |
OSBPL6 | 7390.0 |
PLPP3 | 7387.5 |
PTPN13 | 7381.0 |
DEGS1 | 7375.0 |
CRAT | 7368.0 |
UGCG | 7366.0 |
HADHB | 7290.0 |
RGL1 | 7289.0 |
PPARGC1A | 7286.0 |
PLA2G12A | 7271.0 |
PPARD | 7270.0 |
ACOX1 | 7255.0 |
TM7SF2 | 7221.0 |
NCOA1 | 7218.0 |
PTGES2 | 7214.0 |
MECR | 7210.0 |
SYNJ2 | 7186.0 |
CYP4A11 | 7182.5 |
CYP4A22 | 7182.5 |
CYP4F11 | 7182.5 |
CYP3A4 | 7151.0 |
FDFT1 | 7140.0 |
SMPD1 | 7133.0 |
KDSR | 7127.0 |
SLCO1B1 | 7114.0 |
SLCO1B3 | 7114.0 |
MVK | 7089.0 |
RAB14 | 7078.0 |
ACSF3 | 7053.0 |
ACOT13 | 7051.0 |
PTGR2 | 7049.5 |
PHYH | 7045.0 |
SLC27A5 | 7037.0 |
MIGA2 | 7028.0 |
ACADVL | 7006.0 |
NDUFAB1 | 6996.0 |
ALDH3A2 | 6988.0 |
MVD | 6987.0 |
ACER2 | 6955.0 |
OXCT1 | 6953.0 |
ELOVL1 | 6929.0 |
THEM4 | 6916.0 |
PISD | 6915.0 |
DDHD1 | 6907.0 |
HEXB | 6896.0 |
PCYT2 | 6881.0 |
DGAT1 | 6818.0 |
PLBD1 | 6813.0 |
ECI1 | 6811.0 |
HMGCS2 | 6810.0 |
SLC27A1 | 6792.0 |
ARSB | 6768.0 |
AMACR | 6750.0 |
MCEE | 6734.0 |
SMPD2 | 6732.0 |
CYP4F2 | 6710.0 |
LIPH | 6703.0 |
STARD7 | 6643.0 |
BDH1 | 6632.0 |
MTMR14 | 6619.0 |
PTDSS2 | 6618.0 |
CIDEA | 6565.0 |
ACSS3 | 6546.0 |
ACOT11 | 6541.0 |
GPD1L | 6475.0 |
CPT1B | 6451.0 |
SLC25A20 | 6449.0 |
ABCD1 | 6427.0 |
MMAA | 6426.0 |
CHPT1 | 6423.0 |
HADHA | 6375.0 |
CAV1 | 6314.0 |
MTM1 | 6305.0 |
ALOX12 | 6295.0 |
ABCB11 | 6290.0 |
FIG4 | 6289.0 |
GNPAT | 6274.0 |
LPCAT1 | 6266.0 |
ACAT1 | 6251.0 |
PNPLA6 | 6241.0 |
TAZ | 6238.0 |
INPP5E | 6233.0 |
MAPKAPK2 | 6139.0 |
ACAA1 | 6125.0 |
SCD | 6085.0 |
HELZ2 | 6066.0 |
ESYT1 | 6061.0 |
STARD3 | 6047.0 |
EHHADH | 6024.0 |
ARSL | 5997.0 |
ACADM | 5984.0 |
PLA2G3 | 5983.0 |
ACADL | 5978.0 |
MTMR4 | 5959.0 |
SPHK2 | 5954.0 |
PIAS4 | 5949.0 |
MBOAT7 | 5900.0 |
TRIB3 | 5887.0 |
NR1H4 | 5883.0 |
ABHD3 | 5864.0 |
FABP3 | 5858.0 |
SPTLC3 | 5843.0 |
HADH | 5813.0 |
APOA5 | 5800.0 |
BAAT | 5784.0 |
PLA2G15 | 5737.0 |
SPNS2 | 5733.0 |
HSD17B3 | 5727.0 |
OSBPL2 | 5717.0 |
ELOVL5 | 5710.0 |
SRD5A3 | 5664.0 |
PRKD2 | 5653.0 |
EPHX2 | 5626.0 |
CPT2 | 5615.0 |
PTPMT1 | 5611.0 |
PI4KA | 5609.0 |
PITPNM1 | 5555.0 |
CPNE7 | 5543.0 |
GLTP | 5539.0 |
CHKB | 5535.0 |
PLEKHA5 | 5521.0 |
TSPO | 5508.0 |
SPHK1 | 5497.0 |
GDPD3 | 5492.0 |
NUDT19 | 5464.0 |
DPEP3 | 5463.0 |
NCOA3 | 5428.0 |
HDAC3 | 5383.0 |
APOA2 | 5339.0 |
LPIN2 | 5328.0 |
NCOA2 | 5324.0 |
HSD17B11 | 5290.0 |
MED20 | 5287.0 |
MED11 | 5275.0 |
FABP1 | 5273.0 |
ABCC1 | 5260.0 |
CPT1A | 5252.0 |
KPNB1 | 5247.0 |
AHR | 5235.5 |
AGPAT3 | 5234.0 |
CPTP | 5212.0 |
LPIN3 | 5191.0 |
VDR | 5181.0 |
PON2 | 5161.0 |
CERS5 | 5142.0 |
AGPAT2 | 5125.0 |
RAB5A | 5118.0 |
CSNK2B | 5077.0 |
NCOR2 | 5040.0 |
PPP1CA | 5029.0 |
OSBPL3 | 4992.0 |
LTA4H | 4990.0 |
FITM2 | 4958.0 |
CYP7A1 | 4954.0 |
INPP4B | 4919.0 |
INPPL1 | 4912.0 |
ARSG | 4846.0 |
ESYT3 | 4844.0 |
ANKRD1 | 4842.0 |
HMGCS1 | 4840.0 |
SERPINA6 | 4838.0 |
ACOT6 | 4818.0 |
SPTLC1 | 4801.0 |
MTMR2 | 4800.0 |
PSAP | 4789.0 |
SLC10A1 | 4785.0 |
MLYCD | 4748.0 |
PON1 | 4745.0 |
ALDH3B1 | 4733.0 |
ACADS | 4701.0 |
CYP21A2 | 4683.0 |
HSD17B1 | 4651.0 |
LPGAT1 | 4643.0 |
SBF1 | 4623.0 |
ACSF2 | 4566.0 |
PLA2G4C | 4558.0 |
ETNK1 | 4555.0 |
PIK3R3 | 4535.5 |
PCCB | 4518.0 |
PRKACA | 4516.0 |
MCAT | 4486.0 |
PLAAT3 | 4482.0 |
LPCAT4 | 4480.0 |
MBOAT2 | 4446.0 |
SIN3B | 4433.0 |
PLA2G4F | 4411.0 |
BMX | 4404.0 |
CYP27A1 | 4354.0 |
PIK3R4 | 4339.0 |
ELOVL2 | 4317.0 |
NR1D1 | 4304.0 |
FABP12 | 4262.0 |
FA2H | 4252.0 |
CERK | 4167.0 |
ORMDL2 | 4164.0 |
MORC2 | 4155.0 |
ACBD5 | 4146.0 |
GBA3 | 4143.0 |
ABHD4 | 4098.0 |
MED30 | 4073.0 |
ELOVL3 | 4059.0 |
NFYC | 4019.0 |
THRAP3 | 4012.0 |
PTGR1 | 3940.0 |
ACLY | 3933.0 |
INPP5F | 3921.0 |
SLC44A4 | 3892.0 |
SRD5A1 | 3839.0 |
ALB | 3808.0 |
PLD6 | 3759.0 |
CYP2U1 | 3661.0 |
GLB1 | 3652.0 |
GGT1 | 3624.0 |
CDK19 | 3619.0 |
PI4K2A | 3614.0 |
GPAT3 | 3583.0 |
SLC44A5 | 3580.0 |
ALOXE3 | 3570.0 |
CERS4 | 3565.0 |
DEGS2 | 3556.0 |
VAPB | 3515.0 |
ACER3 | 3467.0 |
INPP5J | 3451.0 |
ANGPTL4 | 3332.0 |
CDS2 | 3330.0 |
ELOVL7 | 3264.0 |
HSD11B2 | 3260.0 |
AGPAT1 | 3237.0 |
SLC44A2 | 3226.0 |
ACOT8 | 3216.0 |
UGT8 | 3214.0 |
GPX2 | 3181.0 |
HEXA | 3177.5 |
ACP6 | 3169.0 |
MED13 | 3167.0 |
MED16 | 3165.0 |
ASAH1 | 3132.0 |
PNPLA7 | 3113.0 |
MED25 | 3110.0 |
MTMR9 | 3093.0 |
CYP4B1 | 3008.0 |
PLEKHA1 | 2999.0 |
MOGAT2 | 2998.0 |
MTMR1 | 2992.0 |
CYP46A1 | 2984.0 |
PTGS1 | 2945.0 |
ELOVL6 | 2936.0 |
FABP5 | 2903.0 |
FHL2 | 2888.0 |
MMUT | 2827.0 |
PIK3C2G | 2726.0 |
TBL1X | 2701.5 |
PCYT1A | 2694.0 |
LSS | 2690.0 |
PTGIS | 2632.0 |
OSBP | 2607.0 |
DHCR24 | 2582.0 |
HACL1 | 2573.0 |
EBP | 2569.5 |
FABP9 | 2555.0 |
CYP8B1 | 2544.0 |
ACSL5 | 2484.0 |
ACOX3 | 2479.0 |
MFSD2A | 2468.0 |
CRLS1 | 2459.0 |
PLEKHA4 | 2428.0 |
GC | 2339.0 |
NEU4 | 2309.0 |
SGPP1 | 2300.0 |
CPNE6 | 2292.0 |
PIP5K1B | 2275.0 |
GPAT4 | 2166.0 |
ACOXL | 2122.0 |
PITPNM3 | 2118.0 |
ARV1 | 2104.0 |
HSD17B14 | 2069.0 |
PLB1 | 2066.0 |
SUMF1 | 2058.0 |
SACM1L | 2044.0 |
CDS1 | 1993.0 |
CYP1A2 | 1984.0 |
TIAM2 | 1970.0 |
PLA2G2A | 1916.0 |
ACER1 | 1906.0 |
HMGCL | 1875.0 |
GSTM4 | 1859.0 |
DECR1 | 1813.0 |
PIP4K2C | 1803.0 |
PIP5K1A | 1793.0 |
HMGCR | 1772.0 |
CHAT | 1738.0 |
MTMR12 | 1733.0 |
FDX1 | 1690.0 |
PPARG | 1599.0 |
TSPOAP1 | 1582.0 |
PECR | 1557.0 |
MED19 | 1555.0 |
SRD5A2 | 1549.0 |
BDH2 | 1484.0 |
PLPP6 | 1469.0 |
FITM1 | 1457.0 |
ETNPPL | 1441.0 |
BCHE | 1382.0 |
PTGDS | 1364.5 |
TNFAIP8L3 | 1336.0 |
CYP4F22 | 1324.0 |
TECR | 1244.0 |
CYP11A1 | 1187.0 |
CYP19A1 | 1077.0 |
PLIN2 | 985.0 |
STAR | 921.0 |
HACD3 | 849.0 |
PLAAT1 | 782.0 |
THEM5 | 765.0 |
CBR1 | 743.0 |
ALOX12B | 627.0 |
STARD5 | 594.0 |
CSNK1G2 | 527.0 |
NCOR1 | 513.0 |
SGMS2 | 511.0 |
SP1 | 506.0 |
DGAT2L6 | 503.0 |
ARSA | 498.0 |
ELOVL4 | 485.0 |
AGPS | 484.0 |
AKR1B1 | 438.0 |
POMC | 432.0 |
FABP6 | 393.5 |
PLA2G4D | 356.0 |
MID1IP1 | 349.0 |
NCOA6 | 255.0 |
ACAT2 | 54.0 |
HACD4 | 7.0 |
PTEN | 0.0 |
MED15 | -8.0 |
TPTE | -98.5 |
TPTE2 | -98.5 |
MED13L | -127.0 |
MOGAT1 | -129.0 |
GALC | -145.0 |
PRKAA2 | -151.0 |
SEC24B | -161.0 |
MED7 | -167.0 |
CGA | -264.0 |
ACBD4 | -269.0 |
AGK | -326.0 |
PIK3C3 | -335.0 |
INSIG2 | -349.0 |
GDE1 | -397.0 |
ACAD10 | -476.0 |
TECRL | -489.0 |
FAAH | -494.0 |
ACBD6 | -500.0 |
GGPS1 | -505.0 |
PNPLA4 | -507.0 |
PLA2G4E | -576.0 |
PLA2G1B | -633.0 |
PNPLA5 | -633.0 |
INPP4A | -824.0 |
MBTPS2 | -837.0 |
CHD9 | -885.0 |
RUFY1 | -910.0 |
CERS3 | -915.0 |
AGPAT4 | -928.0 |
GPX1 | -981.0 |
PLEKHA3 | -993.0 |
NR1H3 | -1186.0 |
OLAH | -1201.0 |
GK2 | -1329.0 |
NR1H2 | -1366.0 |
ABHD5 | -1376.0 |
PIP4K2A | -1448.0 |
PLA2G2F | -1548.0 |
AGPAT5 | -1570.0 |
ACOT12 | -1585.0 |
CREBBP | -1636.0 |
SAMD8 | -1654.0 |
CYP17A1 | -1685.0 |
CTSA | -1693.0 |
RAB4A | -1698.0 |
FABP7 | -1750.0 |
TNFAIP8 | -1764.0 |
GLA | -1815.0 |
UBE2I | -1820.0 |
CARM1 | -1862.0 |
B3GALNT1 | -1886.0 |
RXRA | -1980.0 |
STARD3NL | -1991.0 |
MED1 | -2004.0 |
DBI | -2008.0 |
PIK3R2 | -2014.5 |
LCLAT1 | -2037.0 |
DPEP1 | -2058.0 |
ACSBG2 | -2092.0 |
CYP51A1 | -2093.0 |
PMVK | -2107.0 |
EP300 | -2111.0 |
CYP1A1 | -2131.0 |
MED17 | -2171.5 |
PPP1CB | -2278.0 |
GPS2 | -2353.0 |
HSD3B7 | -2383.0 |
ALOX15B | -2390.0 |
FDX2 | -2403.5 |
FADS2 | -2411.0 |
CERT1 | -2435.0 |
LGMN | -2445.0 |
CERS2 | -2467.0 |
SPTLC2 | -2485.0 |
MTMR10 | -2519.0 |
HSD17B2 | -2550.0 |
PLEKHA8 | -2559.0 |
STARD6 | -2592.0 |
PLD2 | -2600.0 |
ACOT4 | -2617.0 |
PLA2G5 | -2658.0 |
GPAT2 | -2660.0 |
SMPD3 | -2703.0 |
CYP24A1 | -2704.0 |
PIK3CA | -2711.0 |
FAR2 | -2715.0 |
CEPT1 | -2753.0 |
LRP2 | -2756.0 |
PIK3C2A | -2762.0 |
TBL1XR1 | -2764.0 |
CYP2R1 | -2805.0 |
SREBF2 | -2861.0 |
HSD17B13 | -2870.0 |
AHRR | -2888.0 |
ACAD11 | -2890.0 |
CPNE3 | -2918.0 |
PIP4K2B | -2963.0 |
ACSM3 | -2985.0 |
PLA2G4B | -3004.5 |
SMPD4 | -3098.0 |
ORMDL3 | -3146.0 |
VAC14 | -3150.0 |
CSNK2A2 | -3177.0 |
AGMO | -3234.0 |
OSBPL10 | -3302.0 |
PEMT | -3381.0 |
INPP5K | -3389.0 |
PTGS2 | -3418.0 |
PLD3 | -3441.0 |
MED23 | -3449.0 |
INPP5D | -3469.0 |
PI4K2B | -3521.0 |
TGS1 | -3538.0 |
MED10 | -3546.0 |
TNFRSF21 | -3652.0 |
PIK3R6 | -3686.0 |
PPT1 | -3753.0 |
OSBPL5 | -3773.0 |
SQLE | -3782.0 |
PON3 | -3794.0 |
AGT | -3831.0 |
MED29 | -3833.0 |
PIK3R5 | -3873.0 |
AWAT2 | -3928.0 |
MED22 | -3992.0 |
FADS1 | -4018.0 |
NRF1 | -4104.0 |
ARF1 | -4106.0 |
SPTSSA | -4118.0 |
CSNK2A1 | -4141.5 |
CCNC | -4162.0 |
ALPI | -4177.0 |
ALOX15 | -4198.0 |
GLB1L | -4268.0 |
PHOSPHO1 | -4283.0 |
PLA2G4A | -4306.0 |
STS | -4310.0 |
HMGCLL1 | -4359.0 |
SMARCD3 | -4369.0 |
PLAAT5 | -4389.0 |
CYP39A1 | -4425.0 |
HACD2 | -4442.0 |
SEC24D | -4488.0 |
NSDHL | -4612.0 |
MTF1 | -4679.0 |
PLPP2 | -4680.0 |
MED4 | -4721.0 |
ACSL4 | -4736.0 |
PLPP1 | -4758.0 |
GLIPR1 | -4774.0 |
ESYT2 | -4775.0 |
APOA1 | -4811.0 |
B4GALNT1 | -4824.0 |
CYP27B1 | -4916.0 |
ARSK | -4920.0 |
PIK3CG | -4924.0 |
MED24 | -4941.0 |
LPCAT2 | -4982.0 |
ACOT9 | -5006.0 |
CBR4 | -5009.0 |
MBOAT1 | -5042.0 |
HSD17B7 | -5043.0 |
SGPL1 | -5047.0 |
GRHL1 | -5079.0 |
FASN | -5133.0 |
MED6 | -5143.0 |
PTDSS1 | -5228.0 |
SLC44A3 | -5267.0 |
CYP2E1 | -5268.0 |
MED28 | -5278.0 |
PRKD3 | -5324.0 |
MSMO1 | -5327.0 |
DHCR7 | -5329.0 |
CHKA | -5389.0 |
PLA1A | -5396.0 |
MED21 | -5422.0 |
PGS1 | -5459.0 |
MTMR7 | -5471.0 |
DPEP2 | -5556.0 |
LPCAT3 | -5589.0 |
SLC25A17 | -5644.0 |
SLC27A3 | -5657.0 |
PIKFYVE | -5658.0 |
PLA2G2D | -5665.0 |
PCTP | -5715.0 |
PI4KB | -5750.0 |
PLD1 | -5751.0 |
ARNT2 | -5773.0 |
FABP4 | -5849.0 |
GPCPD1 | -5855.0 |
TNFAIP8L2 | -5866.0 |
G0S2 | -5922.0 |
MED27 | -6062.0 |
THRSP | -6068.0 |
RORA | -6076.0 |
PCYT1B | -6101.0 |
PIK3CD | -6147.0 |
DDHD2 | -6193.0 |
AACS | -6268.0 |
LTC4S | -6307.0 |
INSIG1 | -6310.0 |
PRKACB | -6340.0 |
ABCA1 | -6344.0 |
ENPP6 | -6377.0 |
PEX11A | -6415.0 |
PLA2R1 | -6447.0 |
PLD4 | -6472.0 |
ECI2 | -6476.0 |
MED31 | -6496.0 |
MTMR6 | -6513.0 |
HPGD | -6516.0 |
SLC25A1 | -6520.0 |
SAR1B | -6531.0 |
HACD1 | -6539.0 |
STARD4 | -6556.0 |
TBXAS1 | -6596.0 |
CUBN | -6631.0 |
GM2A | -6634.0 |
GBA | -6677.0 |
GPD1 | -6680.0 |
PTGES3 | -6729.0 |
GPD2 | -6755.0 |
ACSL3 | -6761.0 |
SBF2 | -6804.0 |
GDPD5 | -6872.0 |
PRKAG2 | -6923.0 |
HPGDS | -6927.0 |
CH25H | -7050.0 |
PIK3C2B | -7081.0 |
CERS6 | -7111.0 |
NFYA | -7197.0 |
MBTPS1 | -7280.0 |
CYP4F8 | -7313.0 |
ARSI | -7339.0 |
CIDEC | -7371.0 |
VAPA | -7396.0 |
LPIN1 | -7406.0 |
MED26 | -7415.5 |
PNPLA3 | -7463.0 |
PPARGC1B | -7464.0 |
ARNT | -7477.0 |
OSBPL7 | -7479.0 |
IDI1 | -7502.0 |
ACSBG1 | -7512.0 |
ARNTL | -7523.0 |
ASAH2 | -7526.0 |
OCRL | -7541.0 |
NFYB | -7587.0 |
ALOX5AP | -7609.0 |
STARD10 | -7620.0 |
PRKAB2 | -7660.0 |
SEC23A | -7718.0 |
CYP2J2 | -7731.0 |
PITPNB | -7740.0 |
CYP2D6 | -7746.5 |
CYP4F3 | -7751.0 |
MED12 | -7822.0 |
ABCC3 | -7823.0 |
PNPLA8 | -7824.0 |
ETNK2 | -7825.0 |
NEU2 | -7830.0 |
CYP7B1 | -7839.0 |
NPAS2 | -7864.0 |
HSD17B12 | -7912.0 |
SREBF1 | -7944.0 |
ACACA | -7955.0 |
ACHE | -7966.0 |
MED9 | -7970.0 |
ME1 | -7972.0 |
OSBPL8 | -8008.0 |
DHRS7B | -8015.0 |
ALOX5 | -8075.0 |
CLOCK | -8141.0 |
PLIN1 | -8142.0 |
SEC24A | -8147.0 |
CROT | -8187.0 |
FAR1 | -8198.0 |
GPX4 | -8221.0 |
MED14 | -8255.0 |
Regulation of expression of SLITs and ROBOs
1010 | |
---|---|
set | Regulation of expression of SLITs and ROBOs |
setSize | 133 |
pANOVA | 2.86e-09 |
s.dist | -0.298 |
p.adjustANOVA | 1.82e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
ELOC | -8174 |
ROBO2 | -8163 |
UPF2 | -8156 |
RPS3A | -7929 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
PSMA4 | -7394 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
RPL13A | -7282 |
PSMA6 | -7250 |
RPL24 | -7065 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
ELOC | -8174.0 |
ROBO2 | -8163.0 |
UPF2 | -8156.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
PSMA4 | -7394.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
PSMA6 | -7250.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
PSMB6 | -6996.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
PSMC5 | -6575.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
PSMB7 | -6252.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
PSMB1 | -5931.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
PSMB4 | -5607.0 |
RPL37A | -5473.0 |
PSMD5 | -5412.0 |
RPL19 | -5108.0 |
PSMA3 | -5078.0 |
PSMA2 | -5050.5 |
FAU | -4829.0 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
UPF3A | -4384.0 |
RPS6 | -4373.0 |
COL4A5 | -4372.0 |
ETF1 | -4323.0 |
MAGOH | -4309.0 |
PSMD14 | -4055.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
ISL1 | -3924.0 |
PSMD8 | -3851.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
PSMB3 | -3665.0 |
LHX2 | -3561.0 |
PSMC2 | -3419.0 |
PSMD6 | -3353.0 |
RBX1 | -3219.0 |
NCBP1 | -3144.0 |
PSMD4 | -3118.0 |
PSMC4 | -3007.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
PSMA7 | -2576.0 |
RBM8A | -2564.0 |
RPS18 | -2478.0 |
PSMA1 | -2388.0 |
PSMD2 | -2319.0 |
PSMD1 | -2102.0 |
ROBO1 | -1904.0 |
PSMA8 | -1679.0 |
PSMC6 | -1541.0 |
LHX4 | -1469.0 |
PSMD11 | -1181.0 |
PSMD3 | -1168.0 |
RPL23A | -1088.0 |
PSMA5 | -604.0 |
CUL2 | -316.0 |
RPL31 | -303.0 |
ZSWIM8 | -287.0 |
RPS2 | -219.0 |
PSMB5 | -153.0 |
PSMD7 | 321.0 |
ROBO3 | 480.0 |
RPS27L | 522.0 |
LHX3 | 607.0 |
RPL27 | 706.0 |
RNPS1 | 803.0 |
NCBP2 | 898.0 |
EIF4A3 | 950.0 |
UBC | 1013.0 |
PSMC1 | 1107.0 |
RPL7A | 1400.0 |
PSME4 | 1510.0 |
PSMB2 | 1548.0 |
MAGOHB | 1608.0 |
UPF3B | 2124.0 |
PSME2 | 2230.0 |
PSMC3 | 2256.0 |
CASC3 | 2399.0 |
RPL37 | 2677.0 |
DAG1 | 2723.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
HOXA2 | 3282.0 |
USP33 | 3752.0 |
PSMD12 | 4108.0 |
EIF4G1 | 4151.0 |
LHX9 | 4232.0 |
RPL3L | 4494.0 |
PSMD13 | 4498.0 |
PSMB9 | 5019.0 |
RPL22 | 5158.0 |
SLIT1 | 5988.0 |
LDB1 | 5989.0 |
PSMF1 | 6184.0 |
GSPT1 | 6438.0 |
MSI1 | 6507.0 |
PSME1 | 6608.0 |
PSMB8 | 7523.0 |
SLIT2 | 7657.0 |
Metabolism of RNA
657 | |
---|---|
set | Metabolism of RNA |
setSize | 604 |
pANOVA | 2.49e-08 |
s.dist | -0.133 |
p.adjustANOVA | 1.52e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
BUD31 | -8277 |
RPS16 | -8246 |
TSR1 | -8237 |
RPS17 | -8231 |
MYC | -8227 |
LAS1L | -8220 |
HEATR1 | -8214 |
SF3A3 | -8199 |
UPF2 | -8156 |
ENPP2 | -8119 |
QTRT2 | -8113 |
EXOSC1 | -8073 |
HNRNPH1 | -8040 |
RPP40 | -7990 |
PPIH | -7952 |
RPS3A | -7929 |
CSTF3 | -7917 |
SMG7 | -7916 |
GTF2H1 | -7913 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
BUD31 | -8277.0 |
RPS16 | -8246.0 |
TSR1 | -8237.0 |
RPS17 | -8231.0 |
MYC | -8227.0 |
LAS1L | -8220.0 |
HEATR1 | -8214.0 |
SF3A3 | -8199.0 |
UPF2 | -8156.0 |
ENPP2 | -8119.0 |
QTRT2 | -8113.0 |
EXOSC1 | -8073.0 |
HNRNPH1 | -8040.0 |
RPP40 | -7990.0 |
PPIH | -7952.0 |
RPS3A | -7929.0 |
CSTF3 | -7917.0 |
SMG7 | -7916.0 |
GTF2H1 | -7913.0 |
CDKAL1 | -7811.0 |
RPS28 | -7809.0 |
WDR75 | -7780.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
SMG6 | -7760.0 |
RTRAF | -7745.0 |
HNRNPF | -7672.0 |
TPRKB | -7658.0 |
NAT10 | -7652.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
SNRPD3 | -7627.5 |
APOBEC1 | -7613.0 |
WDR77 | -7592.0 |
TRMT61A | -7560.0 |
APOBEC2 | -7555.0 |
RPS15 | -7548.0 |
PPIL1 | -7506.0 |
ZFP36 | -7486.0 |
POLR2D | -7461.0 |
GTF2H5 | -7457.0 |
RANBP2 | -7410.0 |
PSMA4 | -7394.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
PPIE | -7317.0 |
SRSF5 | -7315.0 |
SMNDC1 | -7314.0 |
PAIP1 | -7306.0 |
RPL38 | -7298.0 |
BMS1 | -7297.0 |
RPL13A | -7282.0 |
PSMA6 | -7250.0 |
NUP214 | -7243.0 |
NUP205 | -7210.0 |
SLU7 | -7196.0 |
SNRNP25 | -7143.0 |
RCL1 | -7096.0 |
PRKCA | -7092.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
CWC15 | -7021.0 |
THOC6 | -7012.0 |
PSMB6 | -6996.0 |
MPHOSPH6 | -6988.0 |
TRMT5 | -6970.0 |
RPL6 | -6916.0 |
TRMT13 | -6888.0 |
PPIL3 | -6875.0 |
PRPF40A | -6829.0 |
RPS10 | -6822.5 |
THG1L | -6817.0 |
CD44 | -6801.0 |
MAPK11 | -6774.0 |
NUP43 | -6740.0 |
ZMAT5 | -6736.0 |
RIOK3 | -6733.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
CNOT10 | -6663.0 |
RPLP1 | -6661.0 |
SLBP | -6655.0 |
POP5 | -6654.0 |
RPS8 | -6597.0 |
PSMC5 | -6575.0 |
EXOSC9 | -6555.0 |
THOC1 | -6514.0 |
EMG1 | -6502.0 |
ALKBH8 | -6484.0 |
EBNA1BP2 | -6480.0 |
TTC37 | -6455.0 |
NXT1 | -6449.0 |
DDX23 | -6407.0 |
RPL36 | -6366.0 |
SMG5 | -6279.0 |
RPLP2 | -6273.0 |
XRN1 | -6263.0 |
PSMB7 | -6252.0 |
IGF2BP3 | -6248.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
HBS1L | -6113.0 |
PUS3 | -6107.0 |
SRSF3 | -6066.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
NOP14 | -5999.0 |
LTV1 | -5990.5 |
RPL28 | -5981.0 |
EIF4A2 | -5979.0 |
ZC3H11A | -5961.5 |
PSMB1 | -5931.0 |
LSM5 | -5924.0 |
APOBEC3H | -5912.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
FTSJ1 | -5861.0 |
PNO1 | -5857.0 |
DDX6 | -5851.0 |
WDR61 | -5781.0 |
POP7 | -5763.0 |
WDR12 | -5752.0 |
RPL5 | -5749.0 |
SNRNP48 | -5745.0 |
TEX10 | -5719.0 |
IMP4 | -5693.0 |
PWP2 | -5683.5 |
GEMIN2 | -5661.0 |
NOC4L | -5659.0 |
TRMT6 | -5651.0 |
NUP160 | -5641.0 |
RPS19 | -5609.0 |
PRPF4 | -5608.0 |
PSMB4 | -5607.0 |
MAPK14 | -5555.0 |
DDX52 | -5552.0 |
SRSF11 | -5549.0 |
SEC13 | -5544.0 |
NOL12 | -5510.5 |
RPL37A | -5473.0 |
PQBP1 | -5466.0 |
NOP58 | -5436.0 |
DDX21 | -5435.0 |
DHX37 | -5426.0 |
PSMD5 | -5412.0 |
LSM4 | -5405.0 |
TP53RK | -5386.0 |
NOP10 | -5374.0 |
SF3B1 | -5370.0 |
DDX39A | -5351.0 |
IMP3 | -5333.0 |
DDX20 | -5321.0 |
NOL9 | -5210.0 |
GEMIN7 | -5204.0 |
UTP6 | -5198.0 |
NUP42 | -5168.0 |
NIP7 | -5163.0 |
RPL19 | -5108.0 |
PSMA3 | -5078.0 |
PSMA2 | -5050.5 |
CLNS1A | -5049.0 |
HNRNPA3 | -5022.0 |
UTP15 | -4961.0 |
BCAS2 | -4951.0 |
RPP30 | -4931.0 |
NUP54 | -4913.0 |
CWC27 | -4911.0 |
LAGE3 | -4890.0 |
PAN2 | -4866.0 |
WDR36 | -4849.0 |
FAU | -4829.0 |
NXF1 | -4803.0 |
PHAX | -4752.0 |
TRMT12 | -4731.0 |
LSM7 | -4729.0 |
TNFSF13 | -4724.0 |
RPP25 | -4689.0 |
POLR2C | -4681.0 |
BOP1 | -4674.0 |
PPIL6 | -4667.0 |
NUP107 | -4634.0 |
NUP35 | -4632.0 |
GEMIN8 | -4630.0 |
SRSF6 | -4629.0 |
PPIL4 | -4622.0 |
FTSJ3 | -4563.0 |
CNOT4 | -4531.0 |
WDR3 | -4529.0 |
GTF2H2 | -4507.5 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
SNRPD1 | -4459.0 |
C1D | -4432.0 |
RPL13 | -4424.0 |
WDR33 | -4408.0 |
RNPC3 | -4388.0 |
UPF3A | -4384.0 |
UTP18 | -4374.0 |
RPS6 | -4373.0 |
PCF11 | -4346.0 |
ETF1 | -4323.0 |
MAGOH | -4309.0 |
TRA2B | -4288.0 |
GEMIN6 | -4286.0 |
DUS2 | -4285.0 |
PRKCD | -4252.0 |
POLR2G | -4208.0 |
TSEN15 | -4205.0 |
PCBP2 | -4190.0 |
PSMD14 | -4055.0 |
METTL14 | -4046.0 |
RPSA | -4027.0 |
SNRPG | -4015.0 |
HSPA8 | -3970.0 |
RPL3 | -3968.0 |
DDX46 | -3929.0 |
SRRT | -3902.0 |
PSMD8 | -3851.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
ZBTB8OS | -3706.0 |
RRP9 | -3702.0 |
PSMB3 | -3665.0 |
METTL1 | -3645.0 |
DDX49 | -3628.0 |
PUS7 | -3589.0 |
LSM3 | -3545.0 |
TGS1 | -3538.0 |
THADA | -3532.0 |
PRMT5 | -3512.0 |
NOP56 | -3482.0 |
EXOSC4 | -3421.0 |
THOC7 | -3420.0 |
PSMC2 | -3419.0 |
GLE1 | -3391.0 |
EXOSC5 | -3356.0 |
PSMD6 | -3353.0 |
WDR43 | -3348.0 |
NCL | -3329.0 |
ISY1 | -3295.5 |
PAPOLA | -3280.0 |
SNRNP200 | -3275.0 |
GNL3 | -3174.0 |
UTP20 | -3157.0 |
DDX42 | -3155.0 |
TRMT10C | -3148.0 |
NCBP1 | -3144.0 |
PSMD4 | -3118.0 |
MT-ND3 | -3112.0 |
GTF2F2 | -3055.0 |
CWC22 | -3035.0 |
WTAP | -3021.0 |
PSMC4 | -3007.0 |
PRPF3 | -2927.0 |
ZNF473 | -2914.0 |
NUP88 | -2879.0 |
PRPF19 | -2878.0 |
IGF2BP2 | -2814.0 |
DDX5 | -2813.0 |
FCF1 | -2809.0 |
MTREX | -2791.0 |
THOC2 | -2790.0 |
RPL7 | -2750.0 |
SRSF1 | -2734.0 |
DCAF13 | -2707.0 |
PRPF38A | -2657.0 |
PELP1 | -2654.0 |
SRSF2 | -2590.0 |
RPL8 | -2587.0 |
PSMA7 | -2576.0 |
RBM8A | -2564.0 |
SNRPD2 | -2490.0 |
PLRG1 | -2479.0 |
RPS18 | -2478.0 |
POLR2L | -2471.0 |
CPSF4 | -2453.0 |
SNRPA | -2408.0 |
PSMA1 | -2388.0 |
CCNH | -2363.0 |
DIMT1 | -2344.0 |
CPSF7 | -2334.0 |
SRRM2 | -2320.0 |
PSMD2 | -2319.0 |
CTU2 | -2309.0 |
POLR2I | -2271.0 |
HNRNPK | -2251.0 |
C2orf49 | -2232.0 |
EXOSC3 | -2219.0 |
SNRNP40 | -2214.0 |
SRSF7 | -2197.0 |
PSMD1 | -2102.0 |
NOL11 | -1943.0 |
SF3B6 | -1936.0 |
PRPF6 | -1876.0 |
THOC5 | -1866.0 |
SNRNP35 | -1825.0 |
CSTF2 | -1811.0 |
SNRPB2 | -1742.0 |
TSEN2 | -1709.0 |
PSMA8 | -1679.0 |
CWC25 | -1677.0 |
ADAT1 | -1673.0 |
DDX47 | -1644.0 |
CNOT2 | -1622.0 |
DDX1 | -1572.0 |
MNAT1 | -1564.0 |
PSMC6 | -1541.0 |
HSPB1 | -1531.0 |
PHF5A | -1498.0 |
DIS3 | -1452.0 |
DNAJC8 | -1356.0 |
LCMT2 | -1353.0 |
MRM1 | -1343.0 |
SUGP1 | -1338.0 |
ZRSR2 | -1321.0 |
CCAR1 | -1243.0 |
PSMD11 | -1181.0 |
PSMD3 | -1168.0 |
IGF2BP1 | -1126.0 |
RPL23A | -1088.0 |
U2SURP | -1070.0 |
POLR2H | -1058.0 |
THUMPD1 | -1054.0 |
DCP1A | -1050.0 |
RIOK1 | -1046.0 |
SNRPC | -1045.0 |
ELAVL1 | -955.0 |
POLR2F | -932.0 |
BYSL | -877.0 |
RIOK2 | -834.0 |
PSMA5 | -604.0 |
POP4 | -571.0 |
U2AF1 | -569.5 |
NUP210 | -565.0 |
CNOT11 | -455.0 |
UTP14A | -381.5 |
UTP14C | -381.5 |
ERI1 | -324.0 |
RBM22 | -320.0 |
RPL31 | -303.0 |
DHX38 | -274.0 |
CLP1 | -273.0 |
RAE1 | -259.0 |
RPS2 | -219.0 |
SNRPE | -219.0 |
URM1 | -219.0 |
EIF4A1 | -181.0 |
RNMT | -179.0 |
RBM17 | -160.0 |
PSMB5 | -153.0 |
NSUN6 | -71.0 |
EIF4E | -29.0 |
PAN3 | -13.0 |
POLDIP3 | -9.0 |
HNRNPM | -5.0 |
SNU13 | 188.0 |
AQR | 242.0 |
TSR3 | 320.0 |
PSMD7 | 321.0 |
UTP11 | 411.0 |
NUP37 | 424.0 |
PPWD1 | 426.0 |
TYW5 | 430.0 |
PPP2CA | 497.0 |
RPS27L | 522.0 |
GTF2H3 | 553.0 |
SMG9 | 582.0 |
RPL27 | 706.0 |
SF3B5 | 715.0 |
SYMPK | 735.0 |
TFB1M | 788.0 |
RNPS1 | 803.0 |
UTP3 | 843.0 |
NCBP2 | 898.0 |
MRM2 | 930.5 |
PRPF31 | 934.0 |
CTU1 | 935.0 |
EIF4A3 | 950.0 |
NUP188 | 957.0 |
OSGEP | 990.0 |
MPHOSPH10 | 991.0 |
UBC | 1013.0 |
TRMT44 | 1039.0 |
PRORP | 1105.5 |
PSMC1 | 1107.0 |
RBM5 | 1159.0 |
SF3B3 | 1273.0 |
ZCRB1 | 1290.0 |
NOB1 | 1300.0 |
TBL3 | 1340.0 |
RPL7A | 1400.0 |
UTP4 | 1419.0 |
NUP62 | 1422.0 |
CTNNBL1 | 1424.0 |
PABPN1 | 1437.5 |
SNRPA1 | 1460.0 |
U2AF2 | 1467.0 |
PSME4 | 1510.0 |
RRP7A | 1528.0 |
USP39 | 1547.0 |
PSMB2 | 1548.0 |
TRIT1 | 1588.0 |
MAGOHB | 1608.0 |
EXOSC10 | 1617.0 |
CHERP | 1618.0 |
CDC40 | 1669.0 |
ACTB | 1684.0 |
TNPO1 | 1708.0 |
TRNT1 | 1725.0 |
HSD17B10 | 1753.0 |
PDCD7 | 1768.0 |
PDCD11 | 1804.0 |
LSM6 | 1811.0 |
GTF2H4 | 1930.0 |
TPR | 1935.0 |
EDC4 | 2001.0 |
XPO1 | 2059.0 |
TSEN54 | 2074.0 |
UPF3B | 2124.0 |
TSEN34 | 2164.0 |
XPOT | 2214.0 |
PSME2 | 2230.0 |
TRDMT1 | 2232.0 |
PSMC3 | 2256.0 |
PUF60 | 2268.0 |
EXOSC7 | 2356.0 |
RRP36 | 2367.0 |
HSPA1A | 2373.5 |
METTL3 | 2390.0 |
NUP153 | 2394.0 |
CASC3 | 2399.0 |
U2AF1L4 | 2416.5 |
TRMT1 | 2430.0 |
HNRNPA0 | 2449.0 |
POLR2B | 2513.0 |
GPKOW | 2516.0 |
QTRT1 | 2520.0 |
SRSF10 | 2596.0 |
ERCC2 | 2618.0 |
RTCB | 2647.0 |
RPL37 | 2677.0 |
PPP2R2A | 2684.0 |
NUP85 | 2708.0 |
GTF2F1 | 2709.0 |
SENP3 | 2732.5 |
ALYREF | 2748.0 |
SYF2 | 2768.0 |
EPRS1 | 2820.0 |
SRRM1 | 2836.0 |
TRMU | 2928.0 |
TRMT10A | 2938.0 |
FUS | 2948.0 |
KRR1 | 2965.0 |
DCP1B | 2978.0 |
EXOSC6 | 3010.0 |
SRSF4 | 3011.0 |
RBM28 | 3020.0 |
RPS9 | 3031.0 |
TNKS1BP1 | 3073.0 |
TFIP11 | 3096.0 |
RPS3 | 3136.0 |
AAAS | 3172.0 |
PES1 | 3220.0 |
SKIV2L | 3278.0 |
SNUPN | 3347.0 |
ZFP36L1 | 3380.0 |
SNRPB | 3448.0 |
SARNP | 3479.0 |
POM121 | 3523.5 |
POM121C | 3523.5 |
AKT1 | 3530.0 |
EDC3 | 3543.0 |
CNOT8 | 3544.0 |
GTPBP3 | 3564.0 |
MT-ND4L | 3569.0 |
CPSF2 | 3593.0 |
NUDT21 | 3672.0 |
DHX16 | 3676.0 |
ISG20L2 | 3698.0 |
DHX15 | 3789.0 |
PPP2R1A | 3805.0 |
MT-CO3 | 3879.0 |
PUS1 | 3916.0 |
FYTTD1 | 3957.0 |
FBL | 3970.0 |
DHX9 | 3976.0 |
MT-CO2 | 3989.0 |
SNW1 | 4003.0 |
PSMD12 | 4108.0 |
EIF4G1 | 4151.0 |
GPRC5A | 4169.0 |
SRSF9 | 4225.0 |
SMG8 | 4226.0 |
TYW1 | 4287.5 |
EXOSC8 | 4292.0 |
HNRNPR | 4294.0 |
HNRNPA2B1 | 4375.0 |
MT-ND4 | 4382.0 |
CD2BP2 | 4387.0 |
SMN1 | 4395.5 |
ADAR | 4425.0 |
MTO1 | 4449.0 |
NXF2 | 4458.0 |
RPL3L | 4494.0 |
PSMD13 | 4498.0 |
NUP93 | 4512.0 |
ERCC3 | 4515.0 |
NUP98 | 4522.0 |
CNOT1 | 4545.0 |
POP1 | 4612.0 |
MT-ATP6 | 4629.0 |
FAM98B | 4656.0 |
YWHAB | 4694.0 |
NT5C3B | 4710.0 |
SF3B2 | 4713.0 |
MRM3 | 4729.0 |
MT-ND6 | 4767.0 |
NSUN2 | 4779.0 |
ANP32A | 4822.5 |
TYW3 | 4832.0 |
HNRNPU | 4859.0 |
CNOT7 | 4870.0 |
MT-ND2 | 4879.0 |
MT-ND5 | 4937.0 |
CDK7 | 4949.0 |
CSTF1 | 4970.0 |
TRMT9B | 4973.0 |
GEMIN4 | 4978.0 |
CNOT6L | 4982.0 |
XRN2 | 4993.0 |
PSMB9 | 5019.0 |
CPSF3 | 5037.0 |
SART1 | 5045.0 |
ELAVL2 | 5064.0 |
LSM11 | 5145.0 |
RPL22 | 5158.0 |
LSM1 | 5165.0 |
WDR4 | 5261.0 |
GEMIN5 | 5282.0 |
MTERF4 | 5363.0 |
SF3B4 | 5375.0 |
ADAT2 | 5399.0 |
SUPT5H | 5401.0 |
XAB2 | 5426.0 |
PATL1 | 5473.0 |
CRNKL1 | 5484.0 |
MT-ATP8 | 5500.0 |
RNGTT | 5571.0 |
MT-ND1 | 5579.0 |
NUP133 | 5700.0 |
KHSRP | 5715.0 |
CNOT3 | 5744.0 |
NUP58 | 5787.0 |
NDC1 | 5827.0 |
HNRNPH2 | 5828.0 |
A1CF | 5886.0 |
IGF2 | 5925.0 |
WDR46 | 5939.0 |
SF3A2 | 5950.0 |
CSNK1D | 6028.0 |
ELAC2 | 6048.0 |
MAPKAPK2 | 6139.0 |
MT-CO1 | 6162.0 |
PSMF1 | 6184.0 |
NUP50 | 6188.0 |
PARN | 6220.0 |
CDC5L | 6282.0 |
POLR2A | 6384.0 |
RRP1 | 6389.0 |
GSPT1 | 6438.0 |
THOC3 | 6469.0 |
ADARB1 | 6485.0 |
HNRNPUL1 | 6548.0 |
RBMX | 6602.5 |
TRMT11 | 6607.0 |
PSME1 | 6608.0 |
PRCC | 6678.0 |
NUP155 | 6749.0 |
SF1 | 6765.0 |
YWHAZ | 6876.0 |
MT-CYB | 7011.0 |
DKC1 | 7024.0 |
WBP4 | 7252.0 |
SF3A1 | 7281.0 |
CNOT6 | 7360.0 |
GCFC2 | 7411.0 |
PRPF8 | 7446.0 |
CPSF1 | 7491.0 |
PSMB8 | 7523.0 |
CHTOP | 7574.0 |
NOL6 | 7692.0 |
CSNK1E | 7737.5 |
EXOSC2 | 7761.0 |
GAR1 | 7789.0 |
WDR18 | 7833.0 |
LSM2 | 7903.0 |
HNRNPL | 7955.5 |
POLR2E | 8049.0 |
HNRNPD | 8054.0 |
DDX39B | 8068.0 |
UPF1 | 8167.0 |
EFTUD2 | 8177.0 |
Influenza Viral RNA Transcription and Replication
547 | |
---|---|
set | Influenza Viral RNA Transcription and Replication |
setSize | 103 |
pANOVA | 4.97e-08 |
s.dist | -0.311 |
p.adjustANOVA | 2.91e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
RPS3A | -7929 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
POLR2D | -7461 |
RANBP2 | -7410 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
RPL13A | -7282 |
NUP214 | -7243 |
NUP205 | -7210 |
RPL24 | -7065 |
RPL32 | -7023 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
POLR2D | -7461.0 |
RANBP2 | -7410.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
NUP214 | -7243.0 |
NUP205 | -7210.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
NUP43 | -6740.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
NUP160 | -5641.0 |
RPS19 | -5609.0 |
SEC13 | -5544.0 |
RPL37A | -5473.0 |
NUP42 | -5168.0 |
RPL19 | -5108.0 |
NUP54 | -4913.0 |
FAU | -4829.0 |
POLR2C | -4681.0 |
NUP107 | -4634.0 |
NUP35 | -4632.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
POLR2G | -4208.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
GTF2F2 | -3055.0 |
NUP88 | -2879.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
POLR2L | -2471.0 |
POLR2I | -2271.0 |
DNAJC3 | -2019.0 |
PARP1 | -1776.0 |
RPL23A | -1088.0 |
POLR2H | -1058.0 |
POLR2F | -932.0 |
NUP210 | -565.0 |
RPL31 | -303.0 |
RAE1 | -259.0 |
RPS2 | -219.0 |
NUP37 | 424.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
NUP188 | 957.0 |
RPL7A | 1400.0 |
NUP62 | 1422.0 |
TPR | 1935.0 |
NUP153 | 2394.0 |
POLR2B | 2513.0 |
RPL37 | 2677.0 |
NUP85 | 2708.0 |
GTF2F1 | 2709.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
AAAS | 3172.0 |
POM121 | 3523.5 |
POM121C | 3523.5 |
RPL3L | 4494.0 |
NUP93 | 4512.0 |
NUP98 | 4522.0 |
RPL22 | 5158.0 |
NUP133 | 5700.0 |
NUP58 | 5787.0 |
NDC1 | 5827.0 |
IPO5 | 5863.0 |
NUP50 | 6188.0 |
POLR2A | 6384.0 |
NUP155 | 6749.0 |
GRSF1 | 7696.0 |
POLR2E | 8049.0 |
Formation of the ternary complex, and subsequently, the 43S complex
420 | |
---|---|
set | Formation of the ternary complex, and subsequently, the 43S complex |
setSize | 42 |
pANOVA | 4.75e-07 |
s.dist | -0.449 |
p.adjustANOVA | 2.67e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPS19 | -5609.0 |
EIF3K | -5288.0 |
FAU | -4829.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPS13 | -3718.0 |
EIF3H | -2613.0 |
RPS18 | -2478.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
EIF3J | -866.0 |
RPS2 | -219.0 |
EIF3B | -78.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
EIF3F | 5628.0 |
Influenza Infection
546 | |
---|---|
set | Influenza Infection |
setSize | 120 |
pANOVA | 6.95e-07 |
s.dist | -0.262 |
p.adjustANOVA | 3.75e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
RPS3A | -7929 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
RPS5 | -7648 |
RPS27A | -7640 |
RPS15 | -7548 |
POLR2D | -7461 |
RANBP2 | -7410 |
RPS11 | -7379 |
RPS14 | -7325 |
RPL38 | -7298 |
RPL13A | -7282 |
NUP214 | -7243 |
NUP205 | -7210 |
RPL24 | -7065 |
RPL32 | -7023 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
POLR2D | -7461.0 |
RANBP2 | -7410.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
NUP214 | -7243.0 |
NUP205 | -7210.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
NUP43 | -6740.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
NUP160 | -5641.0 |
RPS19 | -5609.0 |
SEC13 | -5544.0 |
RPL37A | -5473.0 |
KPNA3 | -5380.0 |
NUP42 | -5168.0 |
RPL19 | -5108.0 |
NUP54 | -4913.0 |
FAU | -4829.0 |
POLR2C | -4681.0 |
NUP107 | -4634.0 |
NUP35 | -4632.0 |
RPL35A | -4460.0 |
KPNA1 | -4441.0 |
RPL13 | -4424.0 |
RPS6 | -4373.0 |
POLR2G | -4208.0 |
RPSA | -4027.0 |
KPNA2 | -3986.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
KPNA5 | -3761.0 |
RPS13 | -3718.0 |
GTF2F2 | -3055.0 |
NUP88 | -2879.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
POLR2L | -2471.0 |
CPSF4 | -2453.0 |
KPNA4 | -2276.0 |
POLR2I | -2271.0 |
DNAJC3 | -2019.0 |
CLTC | -1818.0 |
PARP1 | -1776.0 |
RPL23A | -1088.0 |
POLR2H | -1058.0 |
CANX | -1011.0 |
POLR2F | -932.0 |
NUP210 | -565.0 |
RPL31 | -303.0 |
RAE1 | -259.0 |
RPS2 | -219.0 |
NUP37 | 424.0 |
RPS27L | 522.0 |
RPL27 | 706.0 |
NUP188 | 957.0 |
RPL7A | 1400.0 |
NUP62 | 1422.0 |
PABPN1 | 1437.5 |
CALR | 1483.0 |
KPNA7 | 1735.5 |
TPR | 1935.0 |
XPO1 | 2059.0 |
HSPA1A | 2373.5 |
NUP153 | 2394.0 |
POLR2B | 2513.0 |
RPL37 | 2677.0 |
NUP85 | 2708.0 |
GTF2F1 | 2709.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
AAAS | 3172.0 |
EIF2AK2 | 3497.0 |
POM121 | 3523.5 |
POM121C | 3523.5 |
TGFB1 | 3695.0 |
RPL3L | 4494.0 |
NUP93 | 4512.0 |
NUP98 | 4522.0 |
RPL22 | 5158.0 |
KPNB1 | 5247.0 |
NUP133 | 5700.0 |
NUP58 | 5787.0 |
NDC1 | 5827.0 |
IPO5 | 5863.0 |
NUP50 | 6188.0 |
POLR2A | 6384.0 |
NUP155 | 6749.0 |
CLTA | 7341.0 |
GRSF1 | 7696.0 |
POLR2E | 8049.0 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
1038 | |
---|---|
set | Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
setSize | 102 |
pANOVA | 7.85e-07 |
s.dist | 0.283 |
p.adjustANOVA | 4.08e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDUFA10 | 7483 |
NDUFA8 | 7131 |
NDUFA12 | 7130 |
MT-CYB | 7011 |
NDUFAB1 | 6996 |
ECSIT | 6963 |
UQCRC1 | 6960 |
SLC25A27 | 6807 |
NDUFV1 | 6489 |
ATP5F1B | 6480 |
ACAD9 | 6453 |
COX5B | 6442 |
NDUFA9 | 6209 |
ATP5F1D | 6163 |
MT-CO1 | 6162 |
TRAP1 | 6126 |
SDHC | 6123 |
NDUFB10 | 6086 |
COX5A | 6026 |
COX4I1 | 6009 |
GeneID | Gene Rank |
---|---|
NDUFA10 | 7483.0 |
NDUFA8 | 7131.0 |
NDUFA12 | 7130.0 |
MT-CYB | 7011.0 |
NDUFAB1 | 6996.0 |
ECSIT | 6963.0 |
UQCRC1 | 6960.0 |
SLC25A27 | 6807.0 |
NDUFV1 | 6489.0 |
ATP5F1B | 6480.0 |
ACAD9 | 6453.0 |
COX5B | 6442.0 |
NDUFA9 | 6209.0 |
ATP5F1D | 6163.0 |
MT-CO1 | 6162.0 |
TRAP1 | 6126.0 |
SDHC | 6123.0 |
NDUFB10 | 6086.0 |
COX5A | 6026.0 |
COX4I1 | 6009.0 |
COX18 | 5890.0 |
ETFB | 5756.0 |
SDHB | 5629.0 |
NDUFS5 | 5612.0 |
ATP5MC3 | 5582.0 |
MT-ND1 | 5579.0 |
NDUFB7 | 5573.0 |
NDUFV3 | 5524.0 |
MT-ATP8 | 5500.0 |
NDUFAF7 | 5479.0 |
ETFDH | 5372.0 |
COQ10A | 5345.0 |
ETFA | 5269.0 |
NDUFB6 | 4983.0 |
MT-ND5 | 4937.0 |
CYC1 | 4883.0 |
MT-ND2 | 4879.0 |
TIMMDC1 | 4862.0 |
MT-ND6 | 4767.0 |
MT-ATP6 | 4629.0 |
MT-ND4 | 4382.0 |
NDUFS3 | 4380.0 |
COX11 | 4280.0 |
TACO1 | 4096.0 |
NDUFB11 | 4068.0 |
DMAC2L | 4044.0 |
MT-CO2 | 3989.0 |
ATP5ME | 3979.0 |
NDUFAF3 | 3956.0 |
MT-CO3 | 3879.0 |
NDUFS1 | 3819.0 |
UCP2 | 3761.0 |
SLC25A14 | 3669.0 |
COX6B1 | 3551.0 |
NDUFS8 | 3493.0 |
COX7A2L | 3473.0 |
ATP5PD | 3350.0 |
UQCRC2 | 3202.0 |
SDHA | 3123.5 |
NDUFS7 | 3090.0 |
UQCRFS1 | 3065.0 |
ATP5PO | 2966.5 |
NDUFB4 | 2890.0 |
NDUFAF6 | 2862.0 |
COX6A1 | 2441.0 |
NDUFA4 | 2427.0 |
NDUFA6 | 2222.0 |
NDUFS4 | 2132.0 |
SCO1 | 1481.0 |
UCP1 | 1390.0 |
NDUFAF4 | 1307.0 |
NDUFAF1 | 1191.0 |
NDUFB8 | 1015.5 |
NDUFA13 | 544.0 |
SDHD | -389.5 |
NDUFA3 | -953.0 |
ATP5PF | -1203.0 |
UCP3 | -1769.0 |
ATP5MF | -1892.0 |
NDUFB5 | -1930.0 |
NDUFV2 | -2183.0 |
COX7B | -2241.0 |
NDUFC2 | -3052.5 |
MT-ND3 | -3112.0 |
UQCR11 | -3215.5 |
NDUFA11 | -3345.5 |
NUBPL | -3355.0 |
NDUFA2 | -3380.0 |
NDUFS2 | -3401.0 |
COX7C | -3618.0 |
UQCR10 | -3998.0 |
COQ10B | -4282.0 |
NDUFAF5 | -4827.0 |
UQCRB | -5007.0 |
UQCRH | -5150.5 |
TMEM126B | -5318.0 |
ATP5MG | -5696.5 |
COX16 | -6527.0 |
NDUFB3 | -6948.0 |
COX19 | -7585.0 |
PM20D1 | -7706.0 |
ATP5F1E | -8086.0 |
Mitochondrial Fatty Acid Beta-Oxidation
685 | |
---|---|
set | Mitochondrial Fatty Acid Beta-Oxidation |
setSize | 34 |
pANOVA | 9.41e-07 |
s.dist | 0.486 |
p.adjustANOVA | 4.72e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACOT7 | 7952.0 |
ACAA2 | 7671.0 |
PCCA | 7601.0 |
ACOT1 | 7508.5 |
ACOT2 | 7508.5 |
HADHB | 7290.0 |
MECR | 7210.0 |
ACOT13 | 7051.0 |
ACADVL | 7006.0 |
NDUFAB1 | 6996.0 |
THEM4 | 6916.0 |
ECI1 | 6811.0 |
MCEE | 6734.0 |
ACOT11 | 6541.0 |
MMAA | 6426.0 |
HADHA | 6375.0 |
ACADM | 5984.0 |
ACADL | 5978.0 |
HADH | 5813.0 |
ACADS | 4701.0 |
GeneID | Gene Rank |
---|---|
ACOT7 | 7952.0 |
ACAA2 | 7671.0 |
PCCA | 7601.0 |
ACOT1 | 7508.5 |
ACOT2 | 7508.5 |
HADHB | 7290.0 |
MECR | 7210.0 |
ACOT13 | 7051.0 |
ACADVL | 7006.0 |
NDUFAB1 | 6996.0 |
THEM4 | 6916.0 |
ECI1 | 6811.0 |
MCEE | 6734.0 |
ACOT11 | 6541.0 |
MMAA | 6426.0 |
HADHA | 6375.0 |
ACADM | 5984.0 |
ACADL | 5978.0 |
HADH | 5813.0 |
ACADS | 4701.0 |
ACSF2 | 4566.0 |
PCCB | 4518.0 |
MCAT | 4486.0 |
MMUT | 2827.0 |
DECR1 | 1813.0 |
THEM5 | 765.0 |
ACAD10 | -476.0 |
ACBD6 | -500.0 |
ACOT12 | -1585.0 |
DBI | -2008.0 |
ACAD11 | -2890.0 |
ACSM3 | -2985.0 |
ACOT9 | -5006.0 |
PCTP | -5715.0 |
Selenoamino acid metabolism
1092 | |
---|---|
set | Selenoamino acid metabolism |
setSize | 84 |
pANOVA | 1.09e-06 |
s.dist | -0.308 |
p.adjustANOVA | 5.17e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
NNMT | -6950.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
NNMT | -6950.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
SEPSECS | -6470.0 |
RPL36 | -6366.0 |
RPLP2 | -6273.0 |
RPL23 | -6194.0 |
RPL30 | -6152.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
RPL37A | -5473.0 |
RPL19 | -5108.0 |
FAU | -4829.0 |
EEFSEC | -4655.0 |
MAT1A | -4559.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
DARS1 | -4385.0 |
RPS6 | -4373.0 |
SCLY | -4215.0 |
SECISBP2 | -4050.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
RPS18 | -2478.0 |
RARS1 | -2400.0 |
LARS1 | -2263.0 |
RPL23A | -1088.0 |
INMT | -1055.5 |
AIMP1 | -487.0 |
RPL31 | -303.0 |
RPS2 | -219.0 |
RPS27L | 522.0 |
GNMT | 585.0 |
RPL27 | 706.0 |
RPL7A | 1400.0 |
RPL37 | 2677.0 |
EPRS1 | 2820.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
RPL3L | 4494.0 |
IARS1 | 4606.0 |
AHCY | 4901.0 |
RPL22 | 5158.0 |
MARS1 | 6293.0 |
KARS1 | 6365.0 |
CBS | 6623.5 |
CTH | 7025.0 |
AIMP2 | 7324.0 |
PSTK | 7348.0 |
SARS1 | 7350.0 |
PAPSS2 | 7656.0 |
GSR | 7801.0 |
TXNRD1 | 7917.0 |
PAPSS1 | 8121.0 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
539 | |
---|---|
set | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
setSize | 106 |
pANOVA | 1.11e-06 |
s.dist | -0.274 |
p.adjustANOVA | 5.17e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FCGR2B | -8284.0 |
CD300C | -8175.0 |
CD300LF | -8159.0 |
CD22 | -8146.0 |
LILRA1 | -8064.5 |
LILRA2 | -8064.5 |
LILRB1 | -8064.5 |
LILRB2 | -8064.5 |
CLEC2D | -8029.0 |
SIGLEC1 | -7792.0 |
CD200R1 | -7467.5 |
CD300A | -7398.5 |
CD300LD | -7398.5 |
TREML2 | -7173.0 |
FCGR1A | -7140.5 |
PVR | -7125.0 |
ITGA4 | -7054.0 |
CD33 | -6719.5 |
SIGLEC6 | -6719.5 |
TRBC1 | -6620.5 |
GeneID | Gene Rank |
---|---|
FCGR2B | -8284.0 |
CD300C | -8175.0 |
CD300LF | -8159.0 |
CD22 | -8146.0 |
LILRA1 | -8064.5 |
LILRA2 | -8064.5 |
LILRB1 | -8064.5 |
LILRB2 | -8064.5 |
CLEC2D | -8029.0 |
SIGLEC1 | -7792.0 |
CD200R1 | -7467.5 |
CD300A | -7398.5 |
CD300LD | -7398.5 |
TREML2 | -7173.0 |
FCGR1A | -7140.5 |
PVR | -7125.0 |
ITGA4 | -7054.0 |
CD33 | -6719.5 |
SIGLEC6 | -6719.5 |
TRBC1 | -6620.5 |
HCST | -6444.0 |
TYROBP | -6404.0 |
LAIR1 | -6386.0 |
ITGB7 | -6367.0 |
SIGLEC12 | -6057.5 |
SIGLEC7 | -6057.5 |
SIGLEC8 | -6057.5 |
SIGLEC9 | -6057.5 |
CRTAM | -5937.0 |
CD247 | -5933.0 |
ICAM5 | -5517.0 |
COLEC12 | -5439.0 |
TREM1 | -5414.0 |
CD1D | -5308.0 |
PIANP | -5292.0 |
SLAMF7 | -5287.0 |
TREM2 | -5197.0 |
KLRC1 | -5053.5 |
CD81 | -4889.0 |
CD3E | -4862.0 |
TREML4 | -3987.0 |
RAET1E | -3907.5 |
CD3D | -3905.0 |
SIGLEC10 | -3863.5 |
SIGLEC11 | -3863.5 |
CD8A | -3675.0 |
MADCAM1 | -3488.0 |
KIR2DL1 | -3436.0 |
KIR2DL3 | -3436.0 |
KIR2DL4 | -3436.0 |
KIR3DL1 | -3436.0 |
KIR3DL2 | -3436.0 |
CD3G | -3199.0 |
CD8B | -3184.5 |
KLRK1 | -3000.0 |
CD34 | -2848.0 |
SLAMF6 | -2843.0 |
KLRB1 | -2512.0 |
KLRD1 | -2105.0 |
IGKV1-12 | -1796.5 |
IGKV1-16 | -1796.5 |
IGKV1-17 | -1796.5 |
IGKV1-39 | -1796.5 |
IGKV1-5 | -1796.5 |
IGKV1D-12 | -1796.5 |
IGKV1D-16 | -1796.5 |
IGKV1D-39 | -1796.5 |
IFITM1 | -1331.0 |
IGLV6-57 | -1290.0 |
ITGB2 | -1161.0 |
SELL | -825.0 |
ICAM4 | -501.0 |
IGHV4-34 | -409.5 |
IGHV4-39 | -409.5 |
IGHV4-59 | -409.5 |
CD300E | 245.0 |
OSCAR | 529.0 |
HLA-A | 538.5 |
HLA-B | 538.5 |
HLA-C | 538.5 |
HLA-E | 538.5 |
HLA-F | 538.5 |
HLA-G | 538.5 |
ICAM1 | 971.0 |
TREML1 | 1797.0 |
CD40LG | 1866.0 |
B2M | 2072.0 |
NECTIN2 | 2095.0 |
ITGAL | 2183.0 |
NCR3 | 2749.0 |
IGKC | 2909.0 |
CD226 | 3085.0 |
CDH1 | 3439.0 |
CXADR | 3737.0 |
CD40 | 4249.0 |
ITGB1 | 4674.0 |
ICAM2 | 4707.0 |
KLRG1 | 4769.0 |
CLEC4G | 5542.0 |
C3 | 6951.0 |
CD19 | 7249.0 |
CD300LG | 7303.0 |
VCAM1 | 7321.0 |
CD96 | 7332.0 |
FCGR3A | 7385.5 |
CD200 | 7711.0 |
Fatty acid metabolism
400 | |
---|---|
set | Fatty acid metabolism |
setSize | 160 |
pANOVA | 1.41e-06 |
s.dist | 0.221 |
p.adjustANOVA | 6.4e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PPT2 | 8132.5 |
NUDT7 | 8063.0 |
ACOT7 | 7952.0 |
ACSL6 | 7907.5 |
GGT5 | 7852.0 |
SLC27A2 | 7786.0 |
ACSL1 | 7784.0 |
HSD17B8 | 7780.0 |
CYP1B1 | 7721.0 |
HAO2 | 7672.0 |
ACAA2 | 7671.0 |
ACOX2 | 7644.0 |
PCCA | 7601.0 |
ACOT1 | 7508.5 |
ACOT2 | 7508.5 |
HSD17B4 | 7497.0 |
CRAT | 7368.0 |
HADHB | 7290.0 |
PPARD | 7270.0 |
ACOX1 | 7255.0 |
GeneID | Gene Rank |
---|---|
PPT2 | 8132.5 |
NUDT7 | 8063.0 |
ACOT7 | 7952.0 |
ACSL6 | 7907.5 |
GGT5 | 7852.0 |
SLC27A2 | 7786.0 |
ACSL1 | 7784.0 |
HSD17B8 | 7780.0 |
CYP1B1 | 7721.0 |
HAO2 | 7672.0 |
ACAA2 | 7671.0 |
ACOX2 | 7644.0 |
PCCA | 7601.0 |
ACOT1 | 7508.5 |
ACOT2 | 7508.5 |
HSD17B4 | 7497.0 |
CRAT | 7368.0 |
HADHB | 7290.0 |
PPARD | 7270.0 |
ACOX1 | 7255.0 |
PTGES2 | 7214.0 |
MECR | 7210.0 |
CYP4A11 | 7182.5 |
CYP4A22 | 7182.5 |
CYP4F11 | 7182.5 |
ACSF3 | 7053.0 |
ACOT13 | 7051.0 |
PTGR2 | 7049.5 |
PHYH | 7045.0 |
ACADVL | 7006.0 |
NDUFAB1 | 6996.0 |
ALDH3A2 | 6988.0 |
ELOVL1 | 6929.0 |
THEM4 | 6916.0 |
ECI1 | 6811.0 |
AMACR | 6750.0 |
MCEE | 6734.0 |
CYP4F2 | 6710.0 |
ACOT11 | 6541.0 |
CPT1B | 6451.0 |
SLC25A20 | 6449.0 |
ABCD1 | 6427.0 |
MMAA | 6426.0 |
HADHA | 6375.0 |
ALOX12 | 6295.0 |
MAPKAPK2 | 6139.0 |
ACAA1 | 6125.0 |
SCD | 6085.0 |
EHHADH | 6024.0 |
ACADM | 5984.0 |
ACADL | 5978.0 |
HADH | 5813.0 |
HSD17B3 | 5727.0 |
ELOVL5 | 5710.0 |
EPHX2 | 5626.0 |
CPT2 | 5615.0 |
NUDT19 | 5464.0 |
DPEP3 | 5463.0 |
ABCC1 | 5260.0 |
CPT1A | 5252.0 |
PON2 | 5161.0 |
LTA4H | 4990.0 |
ACOT6 | 4818.0 |
MLYCD | 4748.0 |
PON1 | 4745.0 |
ACADS | 4701.0 |
ACSF2 | 4566.0 |
PCCB | 4518.0 |
MCAT | 4486.0 |
ELOVL2 | 4317.0 |
MORC2 | 4155.0 |
ACBD5 | 4146.0 |
ELOVL3 | 4059.0 |
PTGR1 | 3940.0 |
ACLY | 3933.0 |
CYP2U1 | 3661.0 |
GGT1 | 3624.0 |
ALOXE3 | 3570.0 |
ELOVL7 | 3264.0 |
ACOT8 | 3216.0 |
GPX2 | 3181.0 |
CYP4B1 | 3008.0 |
PTGS1 | 2945.0 |
ELOVL6 | 2936.0 |
MMUT | 2827.0 |
PTGIS | 2632.0 |
HACL1 | 2573.0 |
CYP8B1 | 2544.0 |
ACSL5 | 2484.0 |
ACOX3 | 2479.0 |
ACOXL | 2122.0 |
CYP1A2 | 1984.0 |
DECR1 | 1813.0 |
PECR | 1557.0 |
PTGDS | 1364.5 |
CYP4F22 | 1324.0 |
TECR | 1244.0 |
HACD3 | 849.0 |
THEM5 | 765.0 |
CBR1 | 743.0 |
ALOX12B | 627.0 |
ELOVL4 | 485.0 |
MID1IP1 | 349.0 |
HACD4 | 7.0 |
PRKAA2 | -151.0 |
ACBD4 | -269.0 |
ACAD10 | -476.0 |
TECRL | -489.0 |
FAAH | -494.0 |
ACBD6 | -500.0 |
GPX1 | -981.0 |
OLAH | -1201.0 |
ACOT12 | -1585.0 |
RXRA | -1980.0 |
DBI | -2008.0 |
DPEP1 | -2058.0 |
ACSBG2 | -2092.0 |
CYP1A1 | -2131.0 |
ALOX15B | -2390.0 |
FADS2 | -2411.0 |
ACOT4 | -2617.0 |
ACAD11 | -2890.0 |
ACSM3 | -2985.0 |
PTGS2 | -3418.0 |
PPT1 | -3753.0 |
PON3 | -3794.0 |
FADS1 | -4018.0 |
ALOX15 | -4198.0 |
PLA2G4A | -4306.0 |
HACD2 | -4442.0 |
ACSL4 | -4736.0 |
ACOT9 | -5006.0 |
CBR4 | -5009.0 |
FASN | -5133.0 |
DPEP2 | -5556.0 |
SLC25A17 | -5644.0 |
SLC27A3 | -5657.0 |
PCTP | -5715.0 |
THRSP | -6068.0 |
LTC4S | -6307.0 |
ECI2 | -6476.0 |
HPGD | -6516.0 |
SLC25A1 | -6520.0 |
HACD1 | -6539.0 |
TBXAS1 | -6596.0 |
PTGES3 | -6729.0 |
ACSL3 | -6761.0 |
PRKAG2 | -6923.0 |
HPGDS | -6927.0 |
CYP4F8 | -7313.0 |
ACSBG1 | -7512.0 |
ALOX5AP | -7609.0 |
PRKAB2 | -7660.0 |
CYP2J2 | -7731.0 |
CYP4F3 | -7751.0 |
HSD17B12 | -7912.0 |
ACACA | -7955.0 |
ALOX5 | -8075.0 |
CROT | -8187.0 |
GPX4 | -8221.0 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
52 | |
---|---|
set | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
setSize | 48 |
pANOVA | 2.23e-06 |
s.dist | -0.395 |
p.adjustANOVA | 9.77e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF4EBP1 | -6482.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF4A2 | -5979.0 |
EIF3M | -5875.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF4EBP1 | -6482.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF4A2 | -5979.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPS19 | -5609.0 |
EIF3K | -5288.0 |
FAU | -4829.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPS13 | -3718.0 |
EIF3H | -2613.0 |
RPS18 | -2478.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
EIF3J | -866.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
EIF4G1 | 4151.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
Citric acid cycle (TCA cycle)
191 | |
---|---|
set | Citric acid cycle (TCA cycle) |
setSize | 22 |
pANOVA | 2.43e-06 |
s.dist | 0.58 |
p.adjustANOVA | 0.000103 |
Top enriched genes
GeneID | Gene Rank |
---|---|
OGDH | 8010.0 |
ACO2 | 7469.0 |
CS | 7355.0 |
ME3 | 7099.0 |
DLST | 7073.0 |
FAHD1 | 6902.0 |
NNT | 6791.0 |
IDH3G | 6298.0 |
SDHC | 6123.0 |
IDH2 | 6021.0 |
SDHB | 5629.0 |
MDH2 | 5314.0 |
IDH3A | 4957.0 |
IDH3B | 4913.0 |
FH | 4639.0 |
SUCLG1 | 3584.0 |
SDHA | 3123.5 |
DLD | 3101.0 |
SUCLG2 | 1833.0 |
SUCLA2 | 608.0 |
GeneID | Gene Rank |
---|---|
OGDH | 8010.0 |
ACO2 | 7469.0 |
CS | 7355.0 |
ME3 | 7099.0 |
DLST | 7073.0 |
FAHD1 | 6902.0 |
NNT | 6791.0 |
IDH3G | 6298.0 |
SDHC | 6123.0 |
IDH2 | 6021.0 |
SDHB | 5629.0 |
MDH2 | 5314.0 |
IDH3A | 4957.0 |
IDH3B | 4913.0 |
FH | 4639.0 |
SUCLG1 | 3584.0 |
SDHA | 3123.5 |
DLD | 3101.0 |
SUCLG2 | 1833.0 |
SUCLA2 | 608.0 |
SDHD | -389.5 |
ME2 | -2641.0 |
Respiratory electron transport
1037 | |
---|---|
set | Respiratory electron transport |
setSize | 83 |
pANOVA | 2.51e-06 |
s.dist | 0.299 |
p.adjustANOVA | 0.000104 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDUFA10 | 7483 |
NDUFA8 | 7131 |
NDUFA12 | 7130 |
MT-CYB | 7011 |
NDUFAB1 | 6996 |
ECSIT | 6963 |
UQCRC1 | 6960 |
NDUFV1 | 6489 |
ACAD9 | 6453 |
COX5B | 6442 |
NDUFA9 | 6209 |
MT-CO1 | 6162 |
TRAP1 | 6126 |
SDHC | 6123 |
NDUFB10 | 6086 |
COX5A | 6026 |
COX4I1 | 6009 |
COX18 | 5890 |
ETFB | 5756 |
SDHB | 5629 |
GeneID | Gene Rank |
---|---|
NDUFA10 | 7483.0 |
NDUFA8 | 7131.0 |
NDUFA12 | 7130.0 |
MT-CYB | 7011.0 |
NDUFAB1 | 6996.0 |
ECSIT | 6963.0 |
UQCRC1 | 6960.0 |
NDUFV1 | 6489.0 |
ACAD9 | 6453.0 |
COX5B | 6442.0 |
NDUFA9 | 6209.0 |
MT-CO1 | 6162.0 |
TRAP1 | 6126.0 |
SDHC | 6123.0 |
NDUFB10 | 6086.0 |
COX5A | 6026.0 |
COX4I1 | 6009.0 |
COX18 | 5890.0 |
ETFB | 5756.0 |
SDHB | 5629.0 |
NDUFS5 | 5612.0 |
MT-ND1 | 5579.0 |
NDUFB7 | 5573.0 |
NDUFV3 | 5524.0 |
NDUFAF7 | 5479.0 |
ETFDH | 5372.0 |
COQ10A | 5345.0 |
ETFA | 5269.0 |
NDUFB6 | 4983.0 |
MT-ND5 | 4937.0 |
CYC1 | 4883.0 |
MT-ND2 | 4879.0 |
TIMMDC1 | 4862.0 |
MT-ND6 | 4767.0 |
MT-ND4 | 4382.0 |
NDUFS3 | 4380.0 |
COX11 | 4280.0 |
TACO1 | 4096.0 |
NDUFB11 | 4068.0 |
MT-CO2 | 3989.0 |
NDUFAF3 | 3956.0 |
MT-CO3 | 3879.0 |
NDUFS1 | 3819.0 |
COX6B1 | 3551.0 |
NDUFS8 | 3493.0 |
COX7A2L | 3473.0 |
UQCRC2 | 3202.0 |
SDHA | 3123.5 |
NDUFS7 | 3090.0 |
UQCRFS1 | 3065.0 |
NDUFB4 | 2890.0 |
NDUFAF6 | 2862.0 |
COX6A1 | 2441.0 |
NDUFA4 | 2427.0 |
NDUFA6 | 2222.0 |
NDUFS4 | 2132.0 |
SCO1 | 1481.0 |
NDUFAF4 | 1307.0 |
NDUFAF1 | 1191.0 |
NDUFB8 | 1015.5 |
NDUFA13 | 544.0 |
SDHD | -389.5 |
NDUFA3 | -953.0 |
NDUFB5 | -1930.0 |
NDUFV2 | -2183.0 |
COX7B | -2241.0 |
NDUFC2 | -3052.5 |
MT-ND3 | -3112.0 |
UQCR11 | -3215.5 |
NDUFA11 | -3345.5 |
NUBPL | -3355.0 |
NDUFA2 | -3380.0 |
NDUFS2 | -3401.0 |
COX7C | -3618.0 |
UQCR10 | -3998.0 |
COQ10B | -4282.0 |
NDUFAF5 | -4827.0 |
UQCRB | -5007.0 |
UQCRH | -5150.5 |
TMEM126B | -5318.0 |
COX16 | -6527.0 |
NDUFB3 | -6948.0 |
COX19 | -7585.0 |
Signaling by ROBO receptors
1163 | |
---|---|
set | Signaling by ROBO receptors |
setSize | 178 |
pANOVA | 2.76e-06 |
s.dist | -0.204 |
p.adjustANOVA | 0.00011 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282 |
RPS16 | -8246 |
RPS17 | -8231 |
ELOC | -8174 |
ROBO2 | -8163 |
UPF2 | -8156 |
RPS3A | -7929 |
RPS28 | -7809 |
RPL29 | -7770 |
RPS21 | -7764 |
PAK3 | -7738 |
RPS5 | -7648 |
RPS27A | -7640 |
PAK1 | -7605 |
PAK4 | -7549 |
RPS15 | -7548 |
PSMA4 | -7394 |
RPS11 | -7379 |
VASP | -7374 |
RPS14 | -7325 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
ELOC | -8174.0 |
ROBO2 | -8163.0 |
UPF2 | -8156.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPL29 | -7770.0 |
RPS21 | -7764.0 |
PAK3 | -7738.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
PAK1 | -7605.0 |
PAK4 | -7549.0 |
RPS15 | -7548.0 |
PSMA4 | -7394.0 |
RPS11 | -7379.0 |
VASP | -7374.0 |
RPS14 | -7325.0 |
RPL38 | -7298.0 |
RPL13A | -7282.0 |
PSMA6 | -7250.0 |
SRC | -7166.0 |
PRKCA | -7092.0 |
RPL24 | -7065.0 |
RPL32 | -7023.0 |
PRKAR2A | -7003.0 |
PSMB6 | -6996.0 |
RPL6 | -6916.0 |
RPS10 | -6822.5 |
PPP3CB | -6779.0 |
RPS26 | -6692.0 |
RPL18 | -6689.0 |
RPL18A | -6679.0 |
RPLP1 | -6661.0 |
RPS8 | -6597.0 |
PSMC5 | -6575.0 |
RPL36 | -6366.0 |
PRKACB | -6340.0 |
RPLP2 | -6273.0 |
PSMB7 | -6252.0 |
RPL23 | -6194.0 |
CDC42 | -6175.0 |
RPL30 | -6152.0 |
PAK2 | -6088.0 |
RPL15 | -6030.0 |
RPS4X | -6019.0 |
RPL28 | -5981.0 |
PSMB1 | -5931.0 |
RPL35 | -5900.0 |
RPS23 | -5865.0 |
SRGAP3 | -5850.0 |
RPL5 | -5749.0 |
RPS19 | -5609.0 |
PSMB4 | -5607.0 |
RPL37A | -5473.0 |
PSMD5 | -5412.0 |
RPL19 | -5108.0 |
PSMA3 | -5078.0 |
PSMA2 | -5050.5 |
SRGAP2 | -4905.0 |
FAU | -4829.0 |
PAK5 | -4805.0 |
FLRT3 | -4708.0 |
GSPT2 | -4504.0 |
RPL35A | -4460.0 |
RPL13 | -4424.0 |
NCK2 | -4387.0 |
UPF3A | -4384.0 |
RPS6 | -4373.0 |
COL4A5 | -4372.0 |
ETF1 | -4323.0 |
MAGOH | -4309.0 |
PSMD14 | -4055.0 |
RPSA | -4027.0 |
RPL3 | -3968.0 |
ISL1 | -3924.0 |
PSMD8 | -3851.0 |
RPL10A | -3822.0 |
RPS13 | -3718.0 |
PSMB3 | -3665.0 |
LHX2 | -3561.0 |
PSMC2 | -3419.0 |
PSMD6 | -3353.0 |
RBX1 | -3219.0 |
NCBP1 | -3144.0 |
PSMD4 | -3118.0 |
PSMC4 | -3007.0 |
RPL7 | -2750.0 |
RPL8 | -2587.0 |
PSMA7 | -2576.0 |
RBM8A | -2564.0 |
RPS18 | -2478.0 |
PSMA1 | -2388.0 |
PSMD2 | -2319.0 |
PSMD1 | -2102.0 |
ROBO1 | -1904.0 |
PSMA8 | -1679.0 |
PSMC6 | -1541.0 |
SOS1 | -1475.0 |
LHX4 | -1469.0 |
PSMD11 | -1181.0 |
PSMD3 | -1168.0 |
RPL23A | -1088.0 |
PSMA5 | -604.0 |
CUL2 | -316.0 |
RPL31 | -303.0 |
ZSWIM8 | -287.0 |
RPS2 | -219.0 |
PSMB5 | -153.0 |
PSMD7 | 321.0 |
ROBO3 | 480.0 |
RPS27L | 522.0 |
LHX3 | 607.0 |
RPL27 | 706.0 |
RNPS1 | 803.0 |
NCBP2 | 898.0 |
SOS2 | 945.0 |
EIF4A3 | 950.0 |
UBC | 1013.0 |
PSMC1 | 1107.0 |
RPL7A | 1400.0 |
DCC | 1508.0 |
PSME4 | 1510.0 |
PSMB2 | 1548.0 |
MAGOHB | 1608.0 |
CAP2 | 1689.0 |
UPF3B | 2124.0 |
PSME2 | 2230.0 |
PSMC3 | 2256.0 |
CASC3 | 2399.0 |
EVL | 2510.0 |
RPL37 | 2677.0 |
DAG1 | 2723.0 |
GPC1 | 2787.0 |
PFN1 | 2795.0 |
AKAP5 | 2803.0 |
PAK6 | 2950.0 |
SRGAP1 | 3023.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
HOXA2 | 3282.0 |
MYO9B | 3440.0 |
USP33 | 3752.0 |
CAP1 | 3974.0 |
ABL1 | 3993.0 |
RHOA | 4069.0 |
PSMD12 | 4108.0 |
EIF4G1 | 4151.0 |
NTN1 | 4195.0 |
LHX9 | 4232.0 |
ENAH | 4245.0 |
RPL3L | 4494.0 |
PSMD13 | 4498.0 |
PRKACA | 4516.0 |
ARHGAP39 | 4521.0 |
SLIT3 | 4902.0 |
NELL2 | 4955.0 |
ABL2 | 5010.0 |
PSMB9 | 5019.0 |
RPL22 | 5158.0 |
SLIT1 | 5988.0 |
LDB1 | 5989.0 |
PSMF1 | 6184.0 |
GSPT1 | 6438.0 |
MSI1 | 6507.0 |
PSME1 | 6608.0 |
CLASP2 | 6800.0 |
CXCL12 | 6840.0 |
NCK1 | 7272.0 |
CXCR4 | 7462.0 |
PSMB8 | 7523.0 |
SLIT2 | 7657.0 |
RAC1 | 7746.0 |
NRP1 | 7939.0 |
PFN2 | 7986.0 |
CLASP1 | 8148.0 |
Ribosomal scanning and start codon recognition
1049 | |
---|---|
set | Ribosomal scanning and start codon recognition |
setSize | 48 |
pANOVA | 2.82e-06 |
s.dist | -0.391 |
p.adjustANOVA | 0.00011 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF4A2 | -5979.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF4A2 | -5979.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPS19 | -5609.0 |
EIF3K | -5288.0 |
EIF5 | -4910.0 |
FAU | -4829.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPS13 | -3718.0 |
EIF3H | -2613.0 |
RPS18 | -2478.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
EIF3J | -866.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
EIF4G1 | 4151.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
Pyruvate metabolism and Citric Acid (TCA) cycle
906 | |
---|---|
set | Pyruvate metabolism and Citric Acid (TCA) cycle |
setSize | 52 |
pANOVA | 4.4e-06 |
s.dist | 0.368 |
p.adjustANOVA | 0.000167 |
Top enriched genes
GeneID | Gene Rank |
---|---|
OGDH | 8010.0 |
LDHC | 7609.0 |
BSG | 7570.0 |
PDHX | 7471.0 |
ACO2 | 7469.0 |
PDHB | 7468.0 |
CS | 7355.0 |
DLAT | 7320.0 |
PPARD | 7270.0 |
ME3 | 7099.0 |
DLST | 7073.0 |
HAGH | 6949.0 |
FAHD1 | 6902.0 |
L2HGDH | 6828.0 |
NNT | 6791.0 |
D2HGDH | 6672.0 |
IDH3G | 6298.0 |
LDHB | 6149.5 |
SDHC | 6123.0 |
IDH2 | 6021.0 |
GeneID | Gene Rank |
---|---|
OGDH | 8010.0 |
LDHC | 7609.0 |
BSG | 7570.0 |
PDHX | 7471.0 |
ACO2 | 7469.0 |
PDHB | 7468.0 |
CS | 7355.0 |
DLAT | 7320.0 |
PPARD | 7270.0 |
ME3 | 7099.0 |
DLST | 7073.0 |
HAGH | 6949.0 |
FAHD1 | 6902.0 |
L2HGDH | 6828.0 |
NNT | 6791.0 |
D2HGDH | 6672.0 |
IDH3G | 6298.0 |
LDHB | 6149.5 |
SDHC | 6123.0 |
IDH2 | 6021.0 |
SDHB | 5629.0 |
MDH2 | 5314.0 |
PDPR | 5035.0 |
IDH3A | 4957.0 |
IDH3B | 4913.0 |
FH | 4639.0 |
MPC2 | 4435.0 |
PDHA1 | 4337.0 |
PDK4 | 4094.0 |
VDAC1 | 3653.0 |
SUCLG1 | 3584.0 |
PDK2 | 3361.0 |
SDHA | 3123.5 |
DLD | 3101.0 |
SLC16A1 | 3094.0 |
PDP2 | 2951.0 |
PDK1 | 2031.0 |
SUCLG2 | 1833.0 |
SUCLA2 | 608.0 |
MPC1 | 407.0 |
SDHD | -389.5 |
PDK3 | -549.0 |
RXRA | -1980.0 |
ME2 | -2641.0 |
ADHFE1 | -4312.0 |
SLC16A8 | -5046.0 |
PDP1 | -5939.0 |
SLC16A3 | -6714.0 |
GLO1 | -7083.0 |
GSTZ1 | -7293.0 |
LDHA | -7395.0 |
ME1 | -7972.0 |
Translation initiation complex formation
1306 | |
---|---|
set | Translation initiation complex formation |
setSize | 47 |
pANOVA | 4.56e-06 |
s.dist | -0.387 |
p.adjustANOVA | 0.000168 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF4A2 | -5979.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
GeneID | Gene Rank |
---|---|
RPS15A | -8282.0 |
RPS16 | -8246.0 |
RPS17 | -8231.0 |
RPS3A | -7929.0 |
RPS28 | -7809.0 |
RPS21 | -7764.0 |
RPS5 | -7648.0 |
RPS27A | -7640.0 |
RPS15 | -7548.0 |
RPS11 | -7379.0 |
RPS14 | -7325.0 |
EIF2S1 | -7018.0 |
RPS10 | -6822.5 |
RPS26 | -6692.0 |
RPS8 | -6597.0 |
EIF2S2 | -6402.0 |
RPS4X | -6019.0 |
EIF4A2 | -5979.0 |
EIF3M | -5875.0 |
RPS23 | -5865.0 |
EIF2S3 | -5766.5 |
RPS19 | -5609.0 |
EIF3K | -5288.0 |
FAU | -4829.0 |
RPS6 | -4373.0 |
RPSA | -4027.0 |
RPS13 | -3718.0 |
EIF3H | -2613.0 |
RPS18 | -2478.0 |
EIF3E | -1890.0 |
EIF3G | -1499.0 |
EIF3J | -866.0 |
RPS2 | -219.0 |
EIF4A1 | -181.0 |
EIF3B | -78.0 |
EIF4E | -29.0 |
EIF3A | -12.0 |
RPS27L | 522.0 |
EIF3C | 1656.5 |
EIF3D | 2550.0 |
EIF3L | 2985.0 |
RPS9 | 3031.0 |
RPS3 | 3136.0 |
EIF1AX | 3460.0 |
EIF4G1 | 4151.0 |
EIF3F | 5628.0 |
EIF4H | 7514.0 |
Bile acid and bile salt metabolism
113 | |
---|---|
set | Bile acid and bile salt metabolism |
setSize | 37 |
pANOVA | 1.16e-05 |
s.dist | 0.417 |
p.adjustANOVA | 0.000419 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SLCO1A2 | 7943 |
AKR1D1 | 7924 |
SLC27A2 | 7786 |
OSBPL1A | 7651 |
ACOX2 | 7644 |
OSBPL9 | 7624 |
HSD17B4 | 7497 |
OSBPL6 | 7390 |
NCOA1 | 7218 |
SLCO1B1 | 7114 |
SLCO1B3 | 7114 |
SLC27A5 | 7037 |
AMACR | 6750 |
ABCB11 | 6290 |
NR1H4 | 5883 |
BAAT | 5784 |
OSBPL2 | 5717 |
NCOA2 | 5324 |
OSBPL3 | 4992 |
CYP7A1 | 4954 |
GeneID | Gene Rank |
---|---|
SLCO1A2 | 7943.0 |
AKR1D1 | 7924.0 |
SLC27A2 | 7786.0 |
OSBPL1A | 7651.0 |
ACOX2 | 7644.0 |
OSBPL9 | 7624.0 |
HSD17B4 | 7497.0 |
OSBPL6 | 7390.0 |
NCOA1 | 7218.0 |
SLCO1B1 | 7114.0 |
SLCO1B3 | 7114.0 |
SLC27A5 | 7037.0 |
AMACR | 6750.0 |
ABCB11 | 6290.0 |
NR1H4 | 5883.0 |
BAAT | 5784.0 |
OSBPL2 | 5717.0 |
NCOA2 | 5324.0 |
OSBPL3 | 4992.0 |
CYP7A1 | 4954.0 |
SLC10A1 | 4785.0 |
CYP27A1 | 4354.0 |
ALB | 3808.0 |
ACOT8 | 3216.0 |
CYP46A1 | 2984.0 |
PTGIS | 2632.0 |
OSBP | 2607.0 |
CYP8B1 | 2544.0 |
STARD5 | 594.0 |
FABP6 | 393.5 |
RXRA | -1980.0 |
HSD3B7 | -2383.0 |
CYP39A1 | -4425.0 |
CH25H | -7050.0 |
OSBPL7 | -7479.0 |
ABCC3 | -7823.0 |
CYP7B1 | -7839.0 |
Adaptive Immune System
59 | |
---|---|
set | Adaptive Immune System |
setSize | 643 |
pANOVA | 2.24e-05 |
s.dist | -0.0985 |
p.adjustANOVA | 0.000785 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PTPRC | -8287.0 |
FCGR2B | -8284.0 |
TRIP12 | -8280.0 |
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
PTPN6 | -8219.0 |
IGHM | -8190.0 |
CD300C | -8175.0 |
ELOC | -8174.0 |
KLHL20 | -8164.0 |
CD300LF | -8159.0 |
SEC24A | -8147.0 |
CD22 | -8146.0 |
HLA-DRA | -8140.0 |
CD86 | -8127.0 |
DYNC1LI2 | -8117.0 |
LILRA1 | -8064.5 |
LILRA2 | -8064.5 |
LILRB1 | -8064.5 |
LILRB2 | -8064.5 |
GeneID | Gene Rank |
---|---|
PTPRC | -8287.0 |
FCGR2B | -8284.0 |
TRIP12 | -8280.0 |
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
PTPN6 | -8219.0 |
IGHM | -8190.0 |
CD300C | -8175.0 |
ELOC | -8174.0 |
KLHL20 | -8164.0 |
CD300LF | -8159.0 |
SEC24A | -8147.0 |
CD22 | -8146.0 |
HLA-DRA | -8140.0 |
CD86 | -8127.0 |
DYNC1LI2 | -8117.0 |
LILRA1 | -8064.5 |
LILRA2 | -8064.5 |
LILRB1 | -8064.5 |
LILRB2 | -8064.5 |
ASB12 | -8049.0 |
CLEC2D | -8029.0 |
PPIA | -8021.5 |
UBE3C | -7971.0 |
FBXW7 | -7963.0 |
SEC61A2 | -7949.0 |
KIF18A | -7894.0 |
ASB9 | -7893.0 |
CUL3 | -7874.0 |
DCTN4 | -7862.0 |
HECTD2 | -7859.0 |
CD101 | -7849.0 |
FBXL4 | -7829.0 |
BTK | -7804.0 |
SIGLEC1 | -7792.0 |
PIK3AP1 | -7781.0 |
HRAS | -7755.0 |
PAK3 | -7738.0 |
STX4 | -7729.0 |
UBE2F | -7727.5 |
SEC23A | -7718.0 |
NEDD4 | -7710.0 |
RASGRP3 | -7692.0 |
YES1 | -7678.0 |
WSB1 | -7676.0 |
CD74 | -7670.0 |
RPS27A | -7640.0 |
PRKCB | -7632.0 |
PAK1 | -7605.0 |
LNX1 | -7568.0 |
CD200R1 | -7467.5 |
UBE2D3 | -7462.0 |
RNF19B | -7429.0 |
FBXW4 | -7425.0 |
CUL1 | -7405.0 |
CD300A | -7398.5 |
CD300LD | -7398.5 |
PSMA4 | -7394.0 |
KLHL22 | -7386.5 |
VASP | -7374.0 |
RNF7 | -7356.0 |
TIRAP | -7316.0 |
DYNC1I2 | -7307.0 |
RNF25 | -7281.0 |
CUL7 | -7264.0 |
PSMA6 | -7250.0 |
TREML2 | -7173.0 |
SRC | -7166.0 |
FCGR1A | -7140.5 |
FCGR1B | -7140.5 |
PVR | -7125.0 |
ANAPC10 | -7079.0 |
ITGA4 | -7054.0 |
PPP2R5A | -7024.0 |
PSMB6 | -6996.0 |
TAB2 | -6989.0 |
CTSH | -6980.0 |
PPP2R1B | -6978.0 |
UBE2E2 | -6976.0 |
TLR2 | -6961.0 |
PJA1 | -6959.0 |
WAS | -6934.0 |
MRC1 | -6930.0 |
DZIP3 | -6887.0 |
FBXO4 | -6846.0 |
SPSB1 | -6841.0 |
MEX3C | -6814.0 |
FBXO31 | -6782.0 |
PPP3CB | -6779.0 |
PPP2R5C | -6762.0 |
UBE3A | -6726.0 |
CD33 | -6719.5 |
SIGLEC6 | -6719.5 |
NFATC3 | -6716.0 |
UBOX5 | -6711.0 |
FBXO41 | -6697.0 |
CTSK | -6682.0 |
CALM1 | -6675.0 |
HERC2 | -6623.0 |
TRBC1 | -6620.5 |
CAPZA2 | -6618.0 |
RASGRP2 | -6609.0 |
PSMC5 | -6575.0 |
KIFAP3 | -6571.0 |
SAR1B | -6531.0 |
UBE2J1 | -6515.0 |
PDCD1 | -6489.0 |
PJA2 | -6466.0 |
TRIM37 | -6450.0 |
HCST | -6444.0 |
PPP3R1 | -6429.5 |
UBE3D | -6412.0 |
ANAPC13 | -6410.0 |
TYROBP | -6404.0 |
MAP3K14 | -6387.0 |
LAIR1 | -6386.0 |
UBE2C | -6382.0 |
ITGB7 | -6367.0 |
UBAC1 | -6357.0 |
ASB6 | -6352.0 |
PRKACB | -6340.0 |
BLMH | -6322.0 |
PSMB7 | -6252.0 |
KLHL3 | -6220.0 |
KLHL42 | -6206.0 |
CDC42 | -6175.0 |
CBLB | -6160.0 |
BTN2A2 | -6151.0 |
PIK3CD | -6147.0 |
UBE2E1 | -6131.0 |
FYN | -6117.0 |
NCF4 | -6094.0 |
PAK2 | -6088.0 |
SIGLEC12 | -6057.5 |
SIGLEC7 | -6057.5 |
SIGLEC8 | -6057.5 |
SIGLEC9 | -6057.5 |
TRAIP | -5968.0 |
CRTAM | -5937.0 |
CD247 | -5933.0 |
PSMB1 | -5931.0 |
RNF4 | -5915.0 |
AKT2 | -5897.0 |
FBXO40 | -5893.0 |
KIF20A | -5872.0 |
SEC61G | -5830.0 |
HLA-DOA | -5812.0 |
SYK | -5699.0 |
FBXO15 | -5695.0 |
RNF217 | -5691.0 |
RBBP6 | -5612.0 |
PSMB4 | -5607.0 |
RICTOR | -5595.0 |
SPTBN2 | -5593.0 |
UBE2Q2 | -5545.0 |
SEC13 | -5544.0 |
ACTR10 | -5539.0 |
ICAM5 | -5517.0 |
SNAP23 | -5495.0 |
UBE4A | -5481.0 |
CDC20 | -5454.0 |
COLEC12 | -5439.0 |
TREM1 | -5414.0 |
PSMD5 | -5412.0 |
HLA-DOB | -5373.0 |
ASB8 | -5356.0 |
UBR1 | -5334.0 |
CTSS | -5320.0 |
CD1D | -5308.0 |
MRC2 | -5303.0 |
PIANP | -5292.0 |
SLAMF7 | -5287.0 |
WWP1 | -5285.0 |
DET1 | -5265.5 |
GRAP2 | -5255.0 |
KIF2C | -5213.0 |
TREM2 | -5197.0 |
KIF11 | -5195.0 |
MALT1 | -5170.0 |
RASGRP1 | -5127.0 |
PSMA3 | -5078.0 |
KLRC1 | -5053.5 |
PSMA2 | -5050.5 |
IKBKB | -5045.0 |
ANAPC1 | -4990.0 |
TRIM69 | -4969.0 |
MYD88 | -4944.0 |
ASB5 | -4907.0 |
KIF3B | -4901.0 |
CD81 | -4889.0 |
CD3E | -4862.0 |
RNF138 | -4854.0 |
SEC61B | -4808.0 |
ORAI1 | -4788.0 |
ASB14 | -4769.0 |
VAV1 | -4760.0 |
DAPP1 | -4730.0 |
CDC34 | -4678.0 |
NFKBIE | -4652.0 |
ANAPC4 | -4616.0 |
UBE2G1 | -4613.0 |
HUWE1 | -4598.0 |
ITK | -4571.0 |
KIF2A | -4566.0 |
SIAH2 | -4552.0 |
SEC24D | -4488.0 |
HECTD1 | -4471.0 |
UBE2S | -4447.0 |
FBXO22 | -4409.0 |
KLHL13 | -4338.0 |
KIF5B | -4217.0 |
GLMN | -4209.0 |
ATG7 | -4196.0 |
ASB16 | -4168.0 |
DCTN6 | -4150.0 |
ARF1 | -4106.0 |
PPP3CA | -4087.0 |
PSMD14 | -4055.0 |
PRKCQ | -3997.0 |
TREML4 | -3987.0 |
DNM1 | -3955.0 |
CD80 | -3926.0 |
RAET1E | -3907.5 |
CD3D | -3905.0 |
SIGLEC10 | -3863.5 |
SIGLEC11 | -3863.5 |
PSMD8 | -3851.0 |
PDCD1LG2 | -3847.0 |
AP2S1 | -3795.0 |
PTPN11 | -3777.0 |
HACE1 | -3725.0 |
CD8A | -3675.0 |
CD79B | -3668.0 |
PSMB3 | -3665.0 |
CUL5 | -3575.0 |
MADCAM1 | -3488.0 |
ITCH | -3484.0 |
INPP5D | -3469.0 |
DCTN5 | -3442.0 |
KIR2DL1 | -3436.0 |
KIR2DL3 | -3436.0 |
KIR2DL4 | -3436.0 |
KIR3DL1 | -3436.0 |
KIR3DL2 | -3436.0 |
PSMC2 | -3419.0 |
UBE2D1 | -3359.0 |
PSMD6 | -3353.0 |
DCTN2 | -3343.0 |
RBX1 | -3219.0 |
CD3G | -3199.0 |
CD8B | -3184.5 |
HERC4 | -3166.0 |
AP1S1 | -3138.0 |
TLR4 | -3119.0 |
PSMD4 | -3118.0 |
DYNC1I1 | -3094.0 |
CDC27 | -3085.0 |
CTSC | -3056.0 |
MAP3K7 | -3011.0 |
PSMC4 | -3007.0 |
KLRK1 | -3000.0 |
SPSB2 | -2956.0 |
UNKL | -2939.0 |
CAPZB | -2925.0 |
RAP1A | -2869.0 |
CD34 | -2848.0 |
SLAMF6 | -2843.0 |
UBE2B | -2819.0 |
UBE2A | -2808.0 |
ARIH2 | -2782.0 |
LCP2 | -2749.0 |
LAT | -2726.0 |
PIK3CA | -2711.0 |
CTSV | -2661.0 |
HERC1 | -2594.0 |
PSMA7 | -2576.0 |
ASB1 | -2539.0 |
PDIA3 | -2534.0 |
BTN1A1 | -2521.0 |
KLRB1 | -2512.0 |
PTPRJ | -2509.0 |
UBA6 | -2493.0 |
CYBB | -2489.0 |
LGMN | -2445.0 |
ANAPC5 | -2429.0 |
PSMA1 | -2388.0 |
DYNLL2 | -2370.0 |
PSMD2 | -2319.0 |
KIF23 | -2270.0 |
AP1S3 | -2255.0 |
SH3GL2 | -2205.0 |
CHUK | -2181.0 |
TRAT1 | -2158.0 |
LRR1 | -2137.0 |
KLRD1 | -2105.0 |
PSMD1 | -2102.0 |
CD14 | -2079.0 |
AP1M2 | -2078.0 |
TRIM63 | -2072.0 |
PIK3R2 | -2014.5 |
LRSAM1 | -1949.0 |
RNF130 | -1887.0 |
THOP1 | -1875.0 |
KCTD7 | -1869.0 |
ASB17 | -1856.0 |
LRRC41 | -1846.0 |
CLTC | -1818.0 |
MYLIP | -1810.0 |
CD209 | -1809.0 |
IGKV1-12 | -1796.5 |
IGKV1-16 | -1796.5 |
IGKV1-17 | -1796.5 |
IGKV1-39 | -1796.5 |
IGKV1-5 | -1796.5 |
IGKV1D-12 | -1796.5 |
IGKV1D-16 | -1796.5 |
IGKV1D-39 | -1796.5 |
ICOSLG | -1745.5 |
CTSE | -1724.0 |
RNF14 | -1694.0 |
CTSA | -1693.0 |
BCL10 | -1692.0 |
PSMA8 | -1679.0 |
TRIM71 | -1667.0 |
UBE2Q1 | -1598.0 |
UBE3B | -1546.0 |
PSMC6 | -1541.0 |
SOS1 | -1475.0 |
KLHL25 | -1463.0 |
ZNRF2 | -1453.0 |
IFITM1 | -1331.0 |
IGLV6-57 | -1290.0 |
LAG3 | -1255.0 |
TRIM9 | -1241.0 |
VAMP8 | -1223.0 |
RAF1 | -1207.0 |
CTLA4 | -1200.0 |
PSMD11 | -1181.0 |
DYNLL1 | -1170.0 |
PSMD3 | -1168.0 |
ITGB2 | -1161.0 |
FBXW9 | -1016.0 |
CANX | -1011.0 |
NEDD4L | -1007.0 |
ICOS | -1002.0 |
DCTN3 | -958.0 |
FBXW2 | -936.0 |
FBXL13 | -911.0 |
SELL | -825.0 |
CYBA | -615.0 |
ORAI2 | -614.0 |
PSMA5 | -604.0 |
ICAM4 | -501.0 |
IGHV4-34 | -409.5 |
IGHV4-39 | -409.5 |
IGHV4-59 | -409.5 |
RAP1B | -396.0 |
RLIM | -359.0 |
CUL2 | -316.0 |
BTRC | -286.0 |
SEC22B | -266.0 |
DNM3 | -262.0 |
KIF3A | -186.0 |
UBE2N | -184.5 |
SEC24B | -161.0 |
AP2A2 | -158.0 |
PSMB5 | -153.0 |
FBXL20 | -149.0 |
TLR1 | -140.0 |
KLHL41 | -93.0 |
SKP1 | -82.0 |
UBE2L6 | -52.0 |
PTEN | 0.0 |
SOCS1 | 48.0 |
CD300E | 245.0 |
TPP2 | 306.0 |
PSMD7 | 321.0 |
UBE2V2 | 339.0 |
RNF115 | 347.0 |
VAMP3 | 439.0 |
FBXO11 | 455.0 |
LTN1 | 472.0 |
PPP2CA | 497.0 |
OSCAR | 529.0 |
HLA-A | 538.5 |
HLA-B | 538.5 |
HLA-C | 538.5 |
HLA-E | 538.5 |
HLA-F | 538.5 |
HLA-G | 538.5 |
HSPA5 | 605.0 |
RNF6 | 612.0 |
RNF41 | 712.0 |
XDH | 745.0 |
RNF126 | 846.0 |
LCK | 916.0 |
CDC23 | 954.0 |
ICAM1 | 971.0 |
REL | 978.0 |
TRIM41 | 981.0 |
MLST8 | 1003.0 |
UBC | 1013.0 |
PSMC1 | 1107.0 |
TNFRSF14 | 1133.0 |
KIF22 | 1149.0 |
IKBKG | 1225.0 |
UBA5 | 1329.0 |
FBXO2 | 1361.0 |
FBXL5 | 1446.0 |
MAPKAP1 | 1449.0 |
CALR | 1483.0 |
PSME4 | 1510.0 |
PSMB2 | 1548.0 |
PPP2R5B | 1592.0 |
RNF213 | 1594.0 |
RILP | 1602.0 |
ASB4 | 1606.0 |
PAG1 | 1610.0 |
TRIM50 | 1674.0 |
CD274 | 1677.0 |
HECW2 | 1715.0 |
FBXO9 | 1763.0 |
TREML1 | 1797.0 |
FBXL3 | 1810.0 |
RIPK2 | 1837.0 |
CD40LG | 1866.0 |
BLNK | 1874.0 |
PPP2CB | 1876.0 |
MIB2 | 1900.0 |
KIF15 | 1913.0 |
PLCG2 | 1922.0 |
PPL | 1950.0 |
B2M | 2072.0 |
SEC61A1 | 2087.0 |
NECTIN2 | 2095.0 |
KLHL21 | 2169.0 |
KCTD6 | 2174.0 |
ITGAL | 2183.0 |
FBXO30 | 2192.0 |
FBXL19 | 2218.0 |
PSME2 | 2230.0 |
PSMC3 | 2256.0 |
NFKBIB | 2261.0 |
SIPA1 | 2293.0 |
PPP2R5E | 2334.0 |
ZBTB16 | 2341.0 |
FBXL22 | 2422.0 |
UBE2G2 | 2507.0 |
EVL | 2510.0 |
ACTR1B | 2529.0 |
KLC2 | 2543.0 |
RNF114 | 2572.0 |
UBR4 | 2668.0 |
NCR3 | 2749.0 |
BTNL2 | 2764.0 |
PDPK1 | 2786.0 |
UBA3 | 2804.0 |
ASB2 | 2898.0 |
DYNC1LI1 | 2899.0 |
IGKC | 2909.0 |
SKP2 | 2932.0 |
CD226 | 3085.0 |
GRB2 | 3145.0 |
UFL1 | 3185.0 |
PLCG1 | 3263.0 |
UBR2 | 3270.0 |
MAP3K8 | 3271.0 |
CENPE | 3317.0 |
RACGAP1 | 3339.0 |
ASB18 | 3344.0 |
LNPEP | 3368.0 |
CDH1 | 3439.0 |
AKT1 | 3530.0 |
RNF34 | 3705.0 |
RNF19A | 3706.0 |
CXADR | 3737.0 |
LYN | 3765.0 |
SMURF2 | 3791.0 |
PPP2R1A | 3805.0 |
ANAPC2 | 3809.0 |
KLHL11 | 3855.0 |
NPEPPS | 3858.0 |
FBXL7 | 3861.0 |
FBXL18 | 3867.0 |
CD28 | 3868.0 |
BTLA | 3870.0 |
MKRN1 | 3907.0 |
GAN | 3943.0 |
RELA | 3959.0 |
DNM2 | 3996.0 |
FBXL16 | 4011.0 |
KIF5A | 4021.0 |
LONRF1 | 4045.0 |
DTX3L | 4070.0 |
PSMD12 | 4108.0 |
FBXO7 | 4174.0 |
AREL1 | 4178.0 |
ENAH | 4245.0 |
CD40 | 4249.0 |
UBE2Z | 4263.0 |
CTSB | 4265.0 |
TRAF6 | 4327.0 |
SIAH1 | 4415.0 |
NRAS | 4434.0 |
RAB7A | 4453.0 |
RNF220 | 4493.0 |
PSMD13 | 4498.0 |
PRKACA | 4516.0 |
PIK3R3 | 4535.5 |
TRIM32 | 4589.0 |
FBXW10 | 4596.5 |
AP1S2 | 4644.0 |
ITGB1 | 4674.0 |
YWHAB | 4694.0 |
ICAM2 | 4707.0 |
HERC6 | 4719.0 |
NFATC2 | 4760.0 |
KLRG1 | 4769.0 |
PTPN22 | 4790.0 |
FBXL15 | 4811.0 |
CSK | 4821.0 |
FBXL8 | 4827.5 |
TAPBP | 4863.0 |
RNF182 | 4884.0 |
UBE2K | 4934.0 |
KEAP1 | 4980.0 |
PSMB9 | 5019.0 |
ITPR2 | 5073.0 |
VHL | 5081.0 |
KIF4A | 5211.0 |
BLK | 5218.0 |
HECTD3 | 5245.0 |
AP1M1 | 5259.0 |
FBXW5 | 5268.0 |
SPSB4 | 5357.0 |
FBXO21 | 5361.0 |
SH3RF1 | 5392.0 |
UBE2W | 5409.5 |
ASB13 | 5422.0 |
TRIM11 | 5444.0 |
MGRN1 | 5507.0 |
KLC3 | 5514.0 |
CLEC4G | 5542.0 |
TAP2 | 5583.5 |
FZR1 | 5603.0 |
BTNL9 | 5608.0 |
TRAF7 | 5613.0 |
CTSF | 5650.0 |
FBXO32 | 5712.0 |
PPP2R5D | 5723.0 |
UBA7 | 5741.0 |
UBE2M | 5773.0 |
ACTR1A | 5779.0 |
CTSD | 5806.5 |
DCTN1 | 5822.5 |
AP2A1 | 5853.0 |
KLC4 | 5877.0 |
TRIB3 | 5887.0 |
FBXW11 | 5901.0 |
NFKB1 | 6004.0 |
CCNF | 6074.0 |
BTBD6 | 6075.0 |
RNF111 | 6089.0 |
TRIM36 | 6098.0 |
PSMF1 | 6184.0 |
TRIM21 | 6196.0 |
FBXO27 | 6259.0 |
BTBD1 | 6294.0 |
RNF123 | 6354.0 |
RAP1GAP | 6468.0 |
FBXO17 | 6476.0 |
FBXO6 | 6483.0 |
KIF3C | 6498.0 |
UBE2H | 6523.0 |
CD79A | 6531.0 |
IFI30 | 6556.0 |
HERC3 | 6573.5 |
ERAP1 | 6578.0 |
SMURF1 | 6601.0 |
PSME1 | 6608.0 |
CDC16 | 6620.0 |
KLHL5 | 6676.0 |
FBXO10 | 6690.0 |
UBE2J2 | 6724.0 |
KBTBD8 | 6752.0 |
AKT3 | 6761.0 |
ASB10 | 6762.0 |
KLHL2 | 6767.0 |
KBTBD6 | 6824.5 |
KBTBD7 | 6824.5 |
UBE2R2 | 6861.0 |
YWHAZ | 6876.0 |
THEM4 | 6916.0 |
ANAPC7 | 6926.0 |
C3 | 6951.0 |
ITPR1 | 6954.0 |
UBE2O | 7003.0 |
RAPGEF3 | 7075.0 |
ASB7 | 7126.0 |
ITPR3 | 7138.0 |
STUB1 | 7195.0 |
KIF5C | 7239.0 |
CD19 | 7249.0 |
ZNRF1 | 7259.0 |
NCK1 | 7272.0 |
UBA1 | 7293.0 |
CD300LG | 7303.0 |
RNF144B | 7313.0 |
VCAM1 | 7321.0 |
TLR6 | 7322.0 |
CD96 | 7332.0 |
CLTA | 7341.0 |
AP1B1 | 7359.0 |
SEC31A | 7378.0 |
FCGR3A | 7385.5 |
NFATC1 | 7397.0 |
PIK3R1 | 7450.0 |
TRPC1 | 7501.0 |
PSMB8 | 7523.0 |
CD36 | 7608.0 |
LMO7 | 7618.0 |
ASB15 | 7642.0 |
HLA-DMB | 7645.5 |
OSBPL1A | 7651.0 |
RAPGEF4 | 7690.0 |
CD200 | 7711.0 |
RAC1 | 7746.0 |
DYNC1H1 | 7820.0 |
RAP1GAP2 | 7828.0 |
ASB3 | 7830.0 |
FBXW8 | 7847.0 |
MTOR | 7871.0 |
KIF26A | 7918.0 |
AP2M1 | 7919.0 |
AHCYL1 | 7929.0 |
AP2B1 | 7931.0 |
TAP1 | 7947.0 |
RBCK1 | 7983.0 |
NCF1 | 8002.0 |
TRIM39 | 8048.0 |
ITGAV | 8087.0 |
SH3KBP1 | 8091.0 |
STIM1 | 8152.0 |
Transport of small molecules
1326 | |
---|---|
set | Transport of small molecules |
setSize | 656 |
pANOVA | 3.34e-05 |
s.dist | 0.0954 |
p.adjustANOVA | 0.00114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SLC12A7 | 8153 |
SLC4A10 | 8147 |
ABCB4 | 8143 |
SLC8A1 | 8118 |
ATP2B2 | 8113 |
ANO2 | 8082 |
ATP2A3 | 8057 |
ABCB6 | 8047 |
ALAD | 8036 |
HMOX2 | 8031 |
SLC2A1 | 8017 |
SLC12A6 | 8015 |
ATP6V1A | 8014 |
ATP6V0A2 | 8004 |
SPG7 | 7999 |
TPCN1 | 7984 |
ANO4 | 7982 |
LIPA | 7953 |
SLCO1A2 | 7943 |
AP2B1 | 7931 |
GeneID | Gene Rank |
---|---|
SLC12A7 | 8153.0 |
SLC4A10 | 8147.0 |
ABCB4 | 8143.0 |
SLC8A1 | 8118.0 |
ATP2B2 | 8113.0 |
ANO2 | 8082.0 |
ATP2A3 | 8057.0 |
ABCB6 | 8047.0 |
ALAD | 8036.0 |
HMOX2 | 8031.0 |
SLC2A1 | 8017.0 |
SLC12A6 | 8015.0 |
ATP6V1A | 8014.0 |
ATP6V0A2 | 8004.0 |
SPG7 | 7999.0 |
TPCN1 | 7984.0 |
ANO4 | 7982.0 |
LIPA | 7953.0 |
SLCO1A2 | 7943.0 |
AP2B1 | 7931.0 |
AP2M1 | 7919.0 |
ATP6V0A1 | 7887.0 |
ATP2B4 | 7877.0 |
ADCY4 | 7870.0 |
CTNS | 7866.0 |
ATP1A2 | 7846.0 |
ATP1B1 | 7826.0 |
NCEH1 | 7823.0 |
SLC5A6 | 7796.0 |
ADD1 | 7776.0 |
VDAC2 | 7762.0 |
SLC11A2 | 7747.0 |
SLC29A4 | 7735.0 |
SLC26A7 | 7695.0 |
SLC22A4 | 7678.0 |
ABCF1 | 7674.0 |
GNB3 | 7673.0 |
NGB | 7665.0 |
AKAP1 | 7638.0 |
ABCB7 | 7604.0 |
ABCA7 | 7600.0 |
LRRC8A | 7593.0 |
BSG | 7570.0 |
TFRC | 7569.0 |
SLC2A2 | 7562.0 |
SLC25A29 | 7560.0 |
NIPAL1 | 7559.0 |
PSMB8 | 7523.0 |
PHB2 | 7517.0 |
SLC44A1 | 7506.0 |
CA2 | 7502.0 |
TRPC1 | 7501.0 |
PEX19 | 7473.0 |
ADCY8 | 7470.0 |
SLC38A1 | 7441.0 |
SLC41A1 | 7439.0 |
LETM1 | 7437.0 |
SLC22A1 | 7430.0 |
SLC6A6 | 7423.0 |
ADCY6 | 7405.0 |
FXYD6 | 7395.0 |
SLC35B2 | 7343.0 |
CLTA | 7341.0 |
SLC2A12 | 7317.0 |
MCU | 7308.0 |
SLC25A22 | 7276.0 |
CYB5RL | 7268.5 |
SLC4A7 | 7242.0 |
ABCC6 | 7235.0 |
SLC6A15 | 7201.0 |
DMTN | 7200.0 |
SLCO1B1 | 7114.0 |
SLCO1B3 | 7114.0 |
ARL2 | 7084.0 |
RYR2 | 7076.0 |
SLC17A3 | 7070.0 |
CA4 | 7059.0 |
SLC4A1 | 7043.0 |
ABCG1 | 7040.0 |
PMPCA | 7035.0 |
SLC1A7 | 7013.0 |
SOAT1 | 7010.0 |
LDLRAP1 | 6882.0 |
SLC2A4 | 6860.0 |
SLC33A1 | 6857.0 |
TTYH3 | 6854.0 |
SLC20A2 | 6838.0 |
SEL1L | 6795.0 |
SLC27A1 | 6792.0 |
APOC2 | 6777.5 |
ABCD3 | 6773.0 |
WNK4 | 6772.0 |
ABCA6 | 6677.0 |
ADCY9 | 6648.0 |
PSME1 | 6608.0 |
ATP6V0C | 6595.0 |
SLC11A1 | 6568.0 |
PARL | 6562.5 |
ABCG4 | 6555.0 |
SLC26A1 | 6532.0 |
ABCB10 | 6463.0 |
SLC25A26 | 6437.0 |
ABCD1 | 6427.0 |
SLC17A7 | 6408.0 |
ATP2A2 | 6396.0 |
SLC25A5 | 6360.0 |
SLC43A2 | 6351.0 |
ATP1A1 | 6348.0 |
ATP13A2 | 6341.0 |
WNK2 | 6340.0 |
ANKH | 6248.0 |
SLC7A1 | 6232.0 |
SLC35D1 | 6230.0 |
NIPAL3 | 6187.0 |
PSMF1 | 6184.0 |
SLC30A3 | 6165.0 |
ABCB8 | 6147.0 |
SLC9A1 | 6140.0 |
MB | 6054.0 |
AQP7 | 6016.5 |
FKBP1B | 5990.0 |
LMF1 | 5971.0 |
SLC1A2 | 5955.0 |
GNG8 | 5873.0 |
AP2A1 | 5853.0 |
APOA5 | 5800.0 |
ATP7B | 5782.0 |
SLC4A5 | 5706.0 |
SLC6A1 | 5695.0 |
SLCO3A1 | 5670.0 |
ACO1 | 5632.0 |
CREB3L3 | 5616.0 |
STEAP3 | 5610.0 |
OSTM1 | 5601.0 |
AFG3L2 | 5585.0 |
SLC35D2 | 5569.5 |
MCOLN3 | 5557.0 |
TUSC3 | 5549.0 |
SLC2A7 | 5518.0 |
PCSK9 | 5483.0 |
ATP2C2 | 5482.0 |
UNC80 | 5477.0 |
SLC38A2 | 5432.0 |
APOA2 | 5339.0 |
SLC12A4 | 5332.0 |
LPL | 5325.0 |
GNG12 | 5320.0 |
ERLIN2 | 5306.0 |
LMF2 | 5276.0 |
ABCC1 | 5260.0 |
LRRC8E | 5213.0 |
ATP6V0E2 | 5189.0 |
SLC20A1 | 5121.0 |
SLC30A1 | 5060.0 |
LPA | 5058.0 |
CYB5R1 | 5022.0 |
PSMB9 | 5019.0 |
SLC6A2 | 5016.0 |
SLC9A3 | 4988.0 |
SLC22A7 | 4974.0 |
SRI | 4965.0 |
ANGPTL3 | 4942.0 |
MRS2 | 4909.0 |
ATP12A | 4907.0 |
ANO1 | 4876.0 |
SLC9A7 | 4849.0 |
SLC50A1 | 4796.0 |
TRPM4 | 4784.0 |
ABCA2 | 4783.0 |
PRKAR1A | 4751.0 |
APOD | 4746.0 |
APOC4 | 4730.0 |
LSR | 4727.0 |
EMB | 4726.0 |
ATP13A5 | 4724.0 |
SLC2A8 | 4708.0 |
APOA4 | 4672.0 |
SLC4A2 | 4654.0 |
SLC16A7 | 4632.0 |
CP | 4601.0 |
TRPV4 | 4551.0 |
ATP4A | 4543.0 |
PRKACA | 4516.0 |
ATP8A2 | 4509.0 |
PSMD13 | 4498.0 |
SLC28A1 | 4479.0 |
ABCG8 | 4478.0 |
SLC17A8 | 4468.0 |
AQP1 | 4436.0 |
CLCN6 | 4423.0 |
SLC2A6 | 4412.0 |
SLC38A3 | 4403.0 |
OS9 | 4393.0 |
CLCN4 | 4369.0 |
ADCY5 | 4361.0 |
SLC5A5 | 4347.0 |
ATP1A4 | 4344.0 |
CYGB | 4243.0 |
CLCA2 | 4231.0 |
SLC25A4 | 4136.0 |
PSMD12 | 4108.0 |
ZDHHC8 | 4101.0 |
SLC46A1 | 4034.0 |
SLC25A10 | 4009.5 |
ATP11B | 3977.0 |
APOBR | 3948.0 |
SLC6A12 | 3944.0 |
SLC44A4 | 3892.0 |
SLC36A2 | 3863.0 |
SLC39A10 | 3838.0 |
MCOLN1 | 3836.0 |
CLCN3 | 3833.0 |
SLC39A14 | 3829.0 |
ALB | 3808.0 |
ATP8B3 | 3775.0 |
SLC3A2 | 3743.0 |
SLC22A17 | 3730.0 |
SLC15A4 | 3718.0 |
STEAP2 | 3677.0 |
LCN2 | 3656.0 |
VDAC1 | 3653.0 |
SLC4A4 | 3633.0 |
LIPG | 3592.0 |
ATP13A1 | 3582.0 |
SLC44A5 | 3580.0 |
STOM | 3571.0 |
SLC8A2 | 3568.0 |
AQP11 | 3545.0 |
SLC24A5 | 3525.0 |
RHBG | 3509.0 |
MCUB | 3469.0 |
LRRC8D | 3465.0 |
SLC22A15 | 3434.0 |
ATP6V1C2 | 3394.0 |
ATP10B | 3351.0 |
ANGPTL4 | 3332.0 |
ADD2 | 3247.0 |
ATP9A | 3244.0 |
SOAT2 | 3238.0 |
SLC44A2 | 3226.0 |
ANO10 | 3213.0 |
SLC9A6 | 3203.0 |
TRPM5 | 3182.0 |
SLC27A4 | 3117.0 |
SLC13A4 | 3114.0 |
SLC16A1 | 3094.0 |
SLC12A1 | 3070.0 |
SLC30A6 | 3026.0 |
SLC7A6 | 3025.0 |
MICU2 | 2979.0 |
ASIC1 | 2969.0 |
SLC35A2 | 2960.0 |
NIPA1 | 2926.0 |
ATP6V1C1 | 2920.0 |
MICU1 | 2885.0 |
BMP1 | 2815.0 |
RAB11FIP2 | 2813.0 |
SGK3 | 2720.5 |
SLC24A2 | 2679.0 |
SLC39A2 | 2676.0 |
HMOX1 | 2671.0 |
LRRC8B | 2666.0 |
SLC12A5 | 2661.0 |
NALCN | 2641.0 |
SLC4A8 | 2612.0 |
SLC7A5 | 2601.0 |
GNB2 | 2595.0 |
GNB1 | 2583.0 |
SLC22A8 | 2502.0 |
ARL2BP | 2500.0 |
HBA1 | 2471.5 |
SCNN1A | 2420.0 |
SLC22A2 | 2395.0 |
SLCO2B1 | 2372.0 |
ANO9 | 2362.0 |
SLC25A18 | 2352.0 |
ATP6V1B2 | 2262.0 |
PSMC3 | 2256.0 |
SLC26A4 | 2239.0 |
PSME2 | 2230.0 |
GNG7 | 2130.0 |
GNB5 | 2123.0 |
SLC32A1 | 2101.0 |
PMPCB | 2100.0 |
SLC28A2 | 2079.0 |
BSND | 2054.0 |
VCP | 2037.0 |
SLC47A1 | 2003.0 |
SLCO2A1 | 2000.0 |
NIPA2 | 1938.0 |
ASIC2 | 1918.0 |
SLC6A5 | 1917.0 |
FGF21 | 1908.0 |
DERL2 | 1865.0 |
SLC6A3 | 1858.0 |
ATP8A1 | 1828.0 |
ABCD2 | 1806.0 |
AQP8 | 1799.0 |
GNG2 | 1781.0 |
WNK3 | 1769.0 |
SLC34A3 | 1735.5 |
SLC17A6 | 1732.0 |
CAND1 | 1711.0 |
AZGP1 | 1695.0 |
DERL1 | 1681.0 |
SLC12A3 | 1675.0 |
SLC36A1 | 1603.0 |
PSMB2 | 1548.0 |
SLC30A10 | 1546.0 |
TRPA1 | 1536.0 |
BEST4 | 1513.0 |
PSME4 | 1510.0 |
PRKAR1B | 1495.0 |
SLC35B4 | 1486.0 |
SLC5A1 | 1479.0 |
ABCB9 | 1461.0 |
FBXL5 | 1446.0 |
GNB4 | 1440.0 |
AQP2 | 1392.0 |
ATP6V0D1 | 1316.0 |
AMN | 1309.0 |
AQP3 | 1301.0 |
LCN9 | 1276.0 |
SLC18A1 | 1266.0 |
P4HB | 1245.0 |
ANO6 | 1195.0 |
LCN1 | 1182.0 |
ATP1A3 | 1164.5 |
SLC15A3 | 1113.0 |
CLCN2 | 1112.0 |
PSMC1 | 1107.0 |
TSC22D3 | 1052.0 |
RNF185 | 1043.0 |
SLC22A6 | 1027.0 |
RNF5 | 1020.0 |
UBC | 1013.0 |
ABCC2 | 1006.0 |
SLC36A4 | 997.0 |
ABCC10 | 973.0 |
ABCG5 | 951.0 |
MIP | 946.0 |
ATP10D | 885.0 |
SLC3A1 | 858.0 |
AQP9 | 853.0 |
BEST3 | 847.0 |
CLCN7 | 720.0 |
SLC34A1 | 663.5 |
SLC5A4 | 622.0 |
SLC15A1 | 604.0 |
SLC5A10 | 592.0 |
LIPC | 588.0 |
SLC9A8 | 512.0 |
TRPV5 | 481.0 |
SLC26A6 | 422.0 |
SLC24A3 | 417.0 |
ABCB5 | 385.0 |
CLCNKA | 369.5 |
CLCNKB | 369.5 |
NPC1 | 353.0 |
SLC7A9 | 325.0 |
PSMD7 | 321.0 |
SLC5A8 | 302.0 |
SLC1A6 | 247.0 |
AQP5 | 225.0 |
ATP6V1G3 | 225.0 |
FURIN | 60.0 |
SKP1 | -82.0 |
AVP | -90.0 |
APOE | -136.0 |
PSMB5 | -153.0 |
AP2A2 | -158.0 |
SLC6A11 | -176.0 |
BEST1 | -219.0 |
GNG10 | -219.0 |
RAB11A | -258.0 |
STOML2 | -277.0 |
RHAG | -305.0 |
VDAC3 | -325.0 |
SLC13A1 | -345.0 |
CLCA1 | -361.0 |
VLDLR | -387.0 |
ANGPTL8 | -399.0 |
TRPM3 | -437.0 |
ATP6V1B1 | -443.0 |
ATP6V0E1 | -470.0 |
SLC6A19 | -503.0 |
SLC6A18 | -520.0 |
KCNJ11 | -540.0 |
CA1 | -581.0 |
SLC31A1 | -587.0 |
SCNN1G | -594.0 |
PSMA5 | -604.0 |
SLCO1C1 | -633.0 |
SLC24A4 | -810.0 |
MBTPS2 | -837.0 |
TRPV2 | -946.0 |
SLC13A5 | -959.0 |
YME1L1 | -990.0 |
NEDD4L | -1007.0 |
SLC9B2 | -1078.0 |
FXYD4 | -1126.0 |
SLC5A12 | -1126.0 |
TRPV6 | -1126.0 |
SLC26A3 | -1162.0 |
PSMD3 | -1168.0 |
PSMD11 | -1181.0 |
NR1H3 | -1186.0 |
RAF1 | -1207.0 |
NIPAL2 | -1253.0 |
MCOLN2 | -1350.0 |
NR1H2 | -1366.0 |
SLC26A9 | -1380.0 |
SLC5A11 | -1410.0 |
SLC5A9 | -1410.0 |
MYO5B | -1444.5 |
CYB5R4 | -1479.0 |
SLC24A1 | -1486.0 |
ATP6V0D2 | -1489.0 |
SLC22A3 | -1492.0 |
ASIC5 | -1495.0 |
FTMT | -1532.0 |
AHCYL2 | -1540.0 |
PSMC6 | -1541.0 |
ATP2B3 | -1554.0 |
ABCA12 | -1617.0 |
SLC38A5 | -1653.0 |
SLC39A6 | -1676.0 |
PSMA8 | -1679.0 |
APOB | -1729.0 |
SLC16A2 | -1761.0 |
TRPC4AP | -1777.0 |
ATP13A4 | -1806.0 |
MYLIP | -1810.0 |
CLTC | -1818.0 |
A2M | -1891.0 |
SLC5A2 | -1927.0 |
TRPC3 | -1928.0 |
ANO8 | -1929.0 |
GNG11 | -1937.0 |
ATP10A | -2027.0 |
APOC3 | -2065.5 |
SLC5A7 | -2065.5 |
FXYD1 | -2086.0 |
SLC13A2 | -2101.0 |
PSMD1 | -2102.0 |
UNC79 | -2185.0 |
ATP6V1E1 | -2191.0 |
SLC13A3 | -2200.0 |
ATP6AP1 | -2220.0 |
ATP4B | -2237.0 |
ATP6V1E2 | -2246.0 |
ANO3 | -2265.0 |
TTYH1 | -2273.0 |
ADCY3 | -2277.0 |
SLC30A5 | -2293.0 |
PSMD2 | -2319.0 |
TRPM8 | -2333.0 |
RYR3 | -2364.0 |
PCSK5 | -2367.0 |
PSMA1 | -2388.0 |
SLC29A3 | -2395.0 |
ABCC4 | -2420.0 |
SLC17A1 | -2494.0 |
GLRX3 | -2542.0 |
SGK2 | -2566.0 |
PSMA7 | -2576.0 |
CFTR | -2632.0 |
SLC2A13 | -2635.0 |
SLC45A3 | -2735.0 |
ATP1B2 | -2815.0 |
SLC26A2 | -2832.0 |
SLC26A11 | -2850.0 |
ATP6V1D | -2852.0 |
SLC9A5 | -2897.0 |
MIR32 | -2910.0 |
SLC43A1 | -2923.0 |
TCIRG1 | -2929.0 |
CUTC | -2950.0 |
GNG5 | -2972.0 |
NEDD8 | -2992.0 |
PSMC4 | -3007.0 |
SLC12A2 | -3024.0 |
ATP2A1 | -3044.0 |
PSMD4 | -3118.0 |
ATP2B1 | -3182.0 |
SLCO4C1 | -3230.0 |
LCAT | -3245.0 |
ATP1B3 | -3267.0 |
TRPM2 | -3293.0 |
TRPC5 | -3297.0 |
CLCN1 | -3336.0 |
SLC4A9 | -3342.0 |
PSMD6 | -3353.0 |
SLC4A3 | -3361.0 |
TRPV3 | -3402.0 |
PSMC2 | -3419.0 |
CAMK2G | -3492.0 |
SLC28A3 | -3523.0 |
SLC22A18 | -3535.0 |
IREB2 | -3556.0 |
SLC7A3 | -3604.0 |
ASIC4 | -3648.0 |
TRPM6 | -3655.0 |
PSMB3 | -3665.0 |
ATP6V0B | -3671.0 |
SLC8B1 | -3700.0 |
ABCA3 | -3710.0 |
SLC1A1 | -3714.0 |
AP2S1 | -3795.0 |
SLC7A2 | -3828.0 |
SLC39A3 | -3841.0 |
PSMD8 | -3851.0 |
HFE | -3868.0 |
SLC34A2 | -3898.0 |
SLC6A13 | -3927.0 |
SLC35A1 | -3954.0 |
CLCA4 | -3977.0 |
ABCC9 | -3996.0 |
NPC2 | -4051.0 |
PSMD14 | -4055.0 |
SLC9A2 | -4068.0 |
TRPM7 | -4095.0 |
SLC6A9 | -4181.0 |
ERLEC1 | -4213.0 |
SLC22A12 | -4218.0 |
NIPAL4 | -4251.0 |
PEX3 | -4321.0 |
BEST2 | -4325.0 |
TRPV1 | -4342.0 |
ABCA9 | -4400.0 |
RHCG | -4437.0 |
SLC41A2 | -4454.0 |
SLC14A2 | -4481.0 |
GNG3 | -4499.0 |
SLC27A6 | -4582.0 |
SLC7A10 | -4631.0 |
SLC39A5 | -4658.0 |
ATP11A | -4665.0 |
SLC39A8 | -4683.0 |
ADCY2 | -4754.0 |
SLC9C1 | -4782.0 |
APOA1 | -4811.0 |
SLC18A2 | -4876.0 |
ASIC3 | -4952.0 |
ADCY1 | -5008.0 |
SLC35C1 | -5036.0 |
SLC16A8 | -5046.0 |
PSMA2 | -5050.5 |
PSMA3 | -5078.0 |
SLC35B3 | -5115.0 |
DERL3 | -5123.0 |
SLC1A3 | -5153.0 |
ATP8B1 | -5219.0 |
SLC30A7 | -5261.0 |
SLC44A3 | -5267.0 |
WWP1 | -5285.0 |
SLC9A4 | -5326.0 |
ADD3 | -5398.0 |
PSMD5 | -5412.0 |
ABCA5 | -5428.0 |
TPCN2 | -5457.5 |
SLC29A2 | -5514.0 |
PSMB4 | -5607.0 |
ATP6V1H | -5756.0 |
EIF2S3 | -5766.5 |
SLC40A1 | -5771.0 |
HEPH | -5816.0 |
PSMB1 | -5931.0 |
SLC39A1 | -6016.0 |
GNAS | -6021.0 |
CLCN5 | -6047.0 |
PLTP | -6098.0 |
SCARB1 | -6141.0 |
SLC2A10 | -6156.0 |
ABCA4 | -6183.0 |
SLC1A4 | -6192.0 |
PSMB7 | -6252.0 |
SCNN1B | -6270.0 |
RSC1A1 | -6272.0 |
LDLR | -6289.0 |
ABCA8 | -6320.0 |
MTTP | -6324.0 |
PRKACB | -6340.0 |
ABCA1 | -6344.0 |
ATP9B | -6355.0 |
MICU3 | -6359.0 |
ATP8B2 | -6360.0 |
TRPM1 | -6401.0 |
EIF2S2 | -6402.0 |
SLC7A7 | -6426.0 |
ANO7 | -6428.0 |
APOC1 | -6439.0 |
ADCY7 | -6487.0 |
SAR1B | -6531.0 |
PSMC5 | -6575.0 |
SLC8A3 | -6593.0 |
ATP11C | -6595.0 |
CUBN | -6631.0 |
SLC16A10 | -6644.0 |
CYBRD1 | -6662.0 |
TFR2 | -6666.0 |
SLC30A2 | -6669.0 |
CALM1 | -6675.0 |
SLC16A3 | -6714.0 |
SLC14A1 | -6788.0 |
TTYH2 | -6797.0 |
SLC9A9 | -6835.0 |
ABCC5 | -6870.0 |
ERLIN1 | -6880.0 |
RYR1 | -6915.0 |
PSMB6 | -6996.0 |
TRPC6 | -7002.0 |
PRKAR2A | -7003.0 |
SLC7A11 | -7007.0 |
SLC15A2 | -7011.0 |
EIF2S1 | -7018.0 |
SLC2A9 | -7074.0 |
CLIC2 | -7084.0 |
FXYD2 | -7136.5 |
SLC29A1 | -7191.0 |
RUNX1 | -7206.0 |
PSMA6 | -7250.0 |
MBTPS1 | -7280.0 |
SLC66A1 | -7327.0 |
ATP8B4 | -7331.0 |
CAMK2A | -7362.0 |
CIDEC | -7371.0 |
PSMA4 | -7394.0 |
CUL1 | -7405.0 |
SLCO4A1 | -7409.0 |
STOML3 | -7412.0 |
CAMK2B | -7446.0 |
SLC1A5 | -7484.0 |
PCSK6 | -7514.0 |
ANO5 | -7545.0 |
SLC38A4 | -7551.0 |
RPS27A | -7640.0 |
SGK1 | -7659.0 |
SLC10A6 | -7702.0 |
TRPC4 | -7744.0 |
ABCC3 | -7823.0 |
MFSD4B | -7888.0 |
CYB5R2 | -7891.0 |
SLC39A4 | -7900.0 |
WNK1 | -7918.0 |
SLC7A8 | -7923.0 |
HDLBP | -7956.0 |
ATP2C1 | -7973.0 |
FTL | -7977.0 |
FLVCR1 | -8055.0 |
MAGT1 | -8123.0 |
TRDN | -8124.0 |
SLC6A7 | -8151.0 |
PRKAR2B | -8171.0 |
ATP7A | -8245.0 |
AQP4 | -8269.0 |
Peroxisomal lipid metabolism
836 | |
---|---|
set | Peroxisomal lipid metabolism |
setSize | 27 |
pANOVA | 3.54e-05 |
s.dist | 0.46 |
p.adjustANOVA | 0.00118 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NUDT7 | 8063 |
SLC27A2 | 7786 |
HAO2 | 7672 |
ACOX2 | 7644 |
HSD17B4 | 7497 |
CRAT | 7368 |
ACOX1 | 7255 |
PHYH | 7045 |
ALDH3A2 | 6988 |
AMACR | 6750 |
ABCD1 | 6427 |
ACAA1 | 6125 |
EHHADH | 6024 |
NUDT19 | 5464 |
ACOT6 | 4818 |
MLYCD | 4748 |
ACBD5 | 4146 |
ACOT8 | 3216 |
HACL1 | 2573 |
ACOX3 | 2479 |
GeneID | Gene Rank |
---|---|
NUDT7 | 8063 |
SLC27A2 | 7786 |
HAO2 | 7672 |
ACOX2 | 7644 |
HSD17B4 | 7497 |
CRAT | 7368 |
ACOX1 | 7255 |
PHYH | 7045 |
ALDH3A2 | 6988 |
AMACR | 6750 |
ABCD1 | 6427 |
ACAA1 | 6125 |
EHHADH | 6024 |
NUDT19 | 5464 |
ACOT6 | 4818 |
MLYCD | 4748 |
ACBD5 | 4146 |
ACOT8 | 3216 |
HACL1 | 2573 |
ACOX3 | 2479 |
ACOXL | 2122 |
PECR | 1557 |
ACBD4 | -269 |
ACOT4 | -2617 |
SLC25A17 | -5644 |
ECI2 | -6476 |
CROT | -8187 |
Synthesis of bile acids and bile salts
1212 | |
---|---|
set | Synthesis of bile acids and bile salts |
setSize | 29 |
pANOVA | 6.39e-05 |
s.dist | 0.429 |
p.adjustANOVA | 0.00209 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AKR1D1 | 7924 |
SLC27A2 | 7786 |
OSBPL1A | 7651 |
ACOX2 | 7644 |
OSBPL9 | 7624 |
HSD17B4 | 7497 |
OSBPL6 | 7390 |
NCOA1 | 7218 |
SLC27A5 | 7037 |
AMACR | 6750 |
ABCB11 | 6290 |
NR1H4 | 5883 |
BAAT | 5784 |
OSBPL2 | 5717 |
NCOA2 | 5324 |
OSBPL3 | 4992 |
CYP7A1 | 4954 |
CYP27A1 | 4354 |
ACOT8 | 3216 |
CYP46A1 | 2984 |
GeneID | Gene Rank |
---|---|
AKR1D1 | 7924 |
SLC27A2 | 7786 |
OSBPL1A | 7651 |
ACOX2 | 7644 |
OSBPL9 | 7624 |
HSD17B4 | 7497 |
OSBPL6 | 7390 |
NCOA1 | 7218 |
SLC27A5 | 7037 |
AMACR | 6750 |
ABCB11 | 6290 |
NR1H4 | 5883 |
BAAT | 5784 |
OSBPL2 | 5717 |
NCOA2 | 5324 |
OSBPL3 | 4992 |
CYP7A1 | 4954 |
CYP27A1 | 4354 |
ACOT8 | 3216 |
CYP46A1 | 2984 |
PTGIS | 2632 |
OSBP | 2607 |
CYP8B1 | 2544 |
RXRA | -1980 |
HSD3B7 | -2383 |
CYP39A1 | -4425 |
CH25H | -7050 |
OSBPL7 | -7479 |
CYP7B1 | -7839 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
1215 | |
---|---|
set | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
setSize | 19 |
pANOVA | 8e-05 |
s.dist | 0.523 |
p.adjustANOVA | 0.00255 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AKR1D1 | 7924 |
SLC27A2 | 7786 |
ACOX2 | 7644 |
HSD17B4 | 7497 |
NCOA1 | 7218 |
SLC27A5 | 7037 |
AMACR | 6750 |
ABCB11 | 6290 |
NR1H4 | 5883 |
BAAT | 5784 |
NCOA2 | 5324 |
CYP7A1 | 4954 |
CYP27A1 | 4354 |
ACOT8 | 3216 |
PTGIS | 2632 |
CYP8B1 | 2544 |
RXRA | -1980 |
HSD3B7 | -2383 |
CYP7B1 | -7839 |
GeneID | Gene Rank |
---|---|
AKR1D1 | 7924 |
SLC27A2 | 7786 |
ACOX2 | 7644 |
HSD17B4 | 7497 |
NCOA1 | 7218 |
SLC27A5 | 7037 |
AMACR | 6750 |
ABCB11 | 6290 |
NR1H4 | 5883 |
BAAT | 5784 |
NCOA2 | 5324 |
CYP7A1 | 4954 |
CYP27A1 | 4354 |
ACOT8 | 3216 |
PTGIS | 2632 |
CYP8B1 | 2544 |
RXRA | -1980 |
HSD3B7 | -2383 |
CYP7B1 | -7839 |
Separation of Sister Chromatids
1099 | |
---|---|
set | Separation of Sister Chromatids |
setSize | 157 |
pANOVA | 0.000167 |
s.dist | -0.174 |
p.adjustANOVA | 0.0052 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DYNC1LI2 | -8117 |
KIF18A | -7894 |
RPS27A | -7640 |
MAPRE1 | -7594 |
SGO2 | -7553 |
NDC80 | -7482 |
RANBP2 | -7410 |
PSMA4 | -7394 |
DYNC1I2 | -7307 |
PSMA6 | -7250 |
NSL1 | -7209 |
PDS5B | -7204 |
CENPK | -7198 |
ZWILCH | -7171 |
CENPM | -7089 |
ANAPC10 | -7079 |
PPP2R5A | -7024 |
PSMB6 | -6996 |
PPP2R1B | -6978 |
PPP2R5C | -6762 |
GeneID | Gene Rank |
---|---|
DYNC1LI2 | -8117.0 |
KIF18A | -7894.0 |
RPS27A | -7640.0 |
MAPRE1 | -7594.0 |
SGO2 | -7553.0 |
NDC80 | -7482.0 |
RANBP2 | -7410.0 |
PSMA4 | -7394.0 |
DYNC1I2 | -7307.0 |
PSMA6 | -7250.0 |
NSL1 | -7209.0 |
PDS5B | -7204.0 |
CENPK | -7198.0 |
ZWILCH | -7171.0 |
CENPM | -7089.0 |
ANAPC10 | -7079.0 |
PPP2R5A | -7024.0 |
PSMB6 | -6996.0 |
PPP2R1B | -6978.0 |
PPP2R5C | -6762.0 |
NUP43 | -6740.0 |
ESPL1 | -6668.0 |
PSMC5 | -6575.0 |
ITGB3BP | -6486.0 |
STAG1 | -6464.0 |
BIRC5 | -6388.0 |
UBE2C | -6382.0 |
CENPL | -6358.0 |
PSMB7 | -6252.0 |
UBE2E1 | -6131.0 |
PSMB1 | -5931.0 |
NUF2 | -5692.0 |
PDS5A | -5677.0 |
NUP160 | -5641.0 |
PSMB4 | -5607.0 |
PTTG1 | -5560.5 |
SEC13 | -5544.0 |
CDC20 | -5454.0 |
NDEL1 | -5451.0 |
PSMD5 | -5412.0 |
KNTC1 | -5312.0 |
STAG2 | -5293.0 |
KIF2C | -5213.0 |
PSMA3 | -5078.0 |
PSMA2 | -5050.5 |
ZWINT | -5019.0 |
ANAPC1 | -4990.0 |
CENPA | -4978.0 |
CENPF | -4787.0 |
CENPU | -4727.0 |
NUP107 | -4634.0 |
ANAPC4 | -4616.0 |
KIF2A | -4566.0 |
SPDL1 | -4476.0 |
UBE2S | -4447.0 |
SPC25 | -4427.0 |
WAPL | -4097.0 |
PSMD14 | -4055.0 |
PSMD8 | -3851.0 |
ANAPC16 | -3705.0 |
PSMB3 | -3665.0 |
BUB1B | -3498.5 |
PSMC2 | -3419.0 |
UBE2D1 | -3359.0 |
PSMD6 | -3353.0 |
PSMD4 | -3118.0 |
DYNC1I1 | -3094.0 |
CDC27 | -3085.0 |
BUB3 | -3061.0 |
SPC24 | -3045.0 |
PSMC4 | -3007.0 |
ERCC6L | -2999.0 |
PSMA7 | -2576.0 |
CENPP | -2558.0 |
CDCA8 | -2497.0 |
KNL1 | -2495.0 |
ANAPC5 | -2429.0 |
PSMA1 | -2388.0 |
DYNLL2 | -2370.0 |
PLK1 | -2358.0 |
PSMD2 | -2319.0 |
CENPT | -2217.0 |
CDCA5 | -2194.0 |
PSMD1 | -2102.0 |
NUDC | -1938.0 |
ANAPC15 | -1852.0 |
CKAP5 | -1758.0 |
PSMA8 | -1679.0 |
PSMC6 | -1541.0 |
CENPH | -1458.0 |
CENPI | -1365.0 |
INCENP | -1351.0 |
SKA1 | -1240.0 |
PSMD11 | -1181.0 |
DYNLL1 | -1170.0 |
PSMD3 | -1168.0 |
PSMA5 | -604.0 |
CENPC | -183.0 |
PSMB5 | -153.0 |
HDAC8 | -113.5 |
TAOK1 | -79.0 |
PSMD7 | 321.0 |
NUP37 | 424.0 |
PPP2CA | 497.0 |
PAFAH1B1 | 869.0 |
CENPO | 895.0 |
CDC23 | 954.0 |
MAD1L1 | 988.0 |
UBC | 1013.0 |
PSMC1 | 1107.0 |
MAD2L1 | 1260.0 |
SMC1A | 1369.0 |
DSN1 | 1476.0 |
CENPQ | 1492.0 |
PSME4 | 1510.0 |
PSMB2 | 1548.0 |
PPP2R5B | 1592.0 |
PPP2CB | 1876.0 |
XPO1 | 2059.0 |
SKA2 | 2089.0 |
PSME2 | 2230.0 |
PSMC3 | 2256.0 |
PPP2R5E | 2334.0 |
B9D2 | 2398.0 |
AURKB | 2419.0 |
NUP85 | 2708.0 |
SGO1 | 2870.0 |
DYNC1LI1 | 2899.0 |
ZW10 | 3246.0 |
CENPE | 3317.0 |
PPP2R1A | 3805.0 |
ANAPC2 | 3809.0 |
RCC2 | 3900.0 |
PSMD12 | 4108.0 |
PSMD13 | 4498.0 |
NUP98 | 4522.0 |
NDE1 | 4587.0 |
BUB1 | 4819.0 |
PSMB9 | 5019.0 |
NUP133 | 5700.0 |
PPP2R5D | 5723.0 |
CENPN | 5911.0 |
PSMF1 | 6184.0 |
SMC3 | 6522.0 |
PSME1 | 6608.0 |
CDC16 | 6620.0 |
CLASP2 | 6800.0 |
PMF1 | 6871.0 |
ANAPC7 | 6926.0 |
AHCTF1 | 7008.0 |
RAD21 | 7098.0 |
PSMB8 | 7523.0 |
PPP1CC | 7613.0 |
RANGAP1 | 7699.0 |
DYNC1H1 | 7820.0 |
CLIP1 | 8035.0 |
CLASP1 | 8148.0 |
Generation of second messenger molecules
469 | |
---|---|
set | Generation of second messenger molecules |
setSize | 24 |
pANOVA | 2e-04 |
s.dist | -0.438 |
p.adjustANOVA | 0.00612 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
HLA-DRA | -8140.0 |
CD101 | -7849.0 |
PAK3 | -7738.0 |
PAK1 | -7605.0 |
VASP | -7374.0 |
WAS | -6934.0 |
TRBC1 | -6620.5 |
PAK2 | -6088.0 |
CD247 | -5933.0 |
GRAP2 | -5255.0 |
CD3E | -4862.0 |
ITK | -4571.0 |
CD3D | -3905.0 |
CD3G | -3199.0 |
LCP2 | -2749.0 |
LAT | -2726.0 |
LCK | 916.0 |
PLCG2 | 1922.0 |
GeneID | Gene Rank |
---|---|
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
HLA-DRA | -8140.0 |
CD101 | -7849.0 |
PAK3 | -7738.0 |
PAK1 | -7605.0 |
VASP | -7374.0 |
WAS | -6934.0 |
TRBC1 | -6620.5 |
PAK2 | -6088.0 |
CD247 | -5933.0 |
GRAP2 | -5255.0 |
CD3E | -4862.0 |
ITK | -4571.0 |
CD3D | -3905.0 |
CD3G | -3199.0 |
LCP2 | -2749.0 |
LAT | -2726.0 |
LCK | 916.0 |
PLCG2 | 1922.0 |
EVL | 2510.0 |
PLCG1 | 3263.0 |
ENAH | 4245.0 |
NCK1 | 7272.0 |
TCR signaling
1226 | |
---|---|
set | TCR signaling |
setSize | 96 |
pANOVA | 0.000289 |
s.dist | -0.214 |
p.adjustANOVA | 0.00863 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PTPRC | -8287.0 |
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
HLA-DRA | -8140.0 |
CD101 | -7849.0 |
PAK3 | -7738.0 |
RPS27A | -7640.0 |
PAK1 | -7605.0 |
CUL1 | -7405.0 |
PSMA4 | -7394.0 |
VASP | -7374.0 |
PSMA6 | -7250.0 |
PSMB6 | -6996.0 |
TAB2 | -6989.0 |
WAS | -6934.0 |
TRBC1 | -6620.5 |
PSMC5 | -6575.0 |
PSMB7 | -6252.0 |
PAK2 | -6088.0 |
CD247 | -5933.0 |
GeneID | Gene Rank |
---|---|
PTPRC | -8287.0 |
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
HLA-DRA | -8140.0 |
CD101 | -7849.0 |
PAK3 | -7738.0 |
RPS27A | -7640.0 |
PAK1 | -7605.0 |
CUL1 | -7405.0 |
PSMA4 | -7394.0 |
VASP | -7374.0 |
PSMA6 | -7250.0 |
PSMB6 | -6996.0 |
TAB2 | -6989.0 |
WAS | -6934.0 |
TRBC1 | -6620.5 |
PSMC5 | -6575.0 |
PSMB7 | -6252.0 |
PAK2 | -6088.0 |
CD247 | -5933.0 |
PSMB1 | -5931.0 |
PSMB4 | -5607.0 |
PSMD5 | -5412.0 |
GRAP2 | -5255.0 |
MALT1 | -5170.0 |
PSMA3 | -5078.0 |
PSMA2 | -5050.5 |
IKBKB | -5045.0 |
CD3E | -4862.0 |
CDC34 | -4678.0 |
ITK | -4571.0 |
PSMD14 | -4055.0 |
PRKCQ | -3997.0 |
CD3D | -3905.0 |
PSMD8 | -3851.0 |
PSMB3 | -3665.0 |
INPP5D | -3469.0 |
PSMC2 | -3419.0 |
UBE2D1 | -3359.0 |
PSMD6 | -3353.0 |
CD3G | -3199.0 |
PSMD4 | -3118.0 |
MAP3K7 | -3011.0 |
PSMC4 | -3007.0 |
LCP2 | -2749.0 |
LAT | -2726.0 |
PIK3CA | -2711.0 |
PSMA7 | -2576.0 |
PTPRJ | -2509.0 |
PSMA1 | -2388.0 |
PSMD2 | -2319.0 |
CHUK | -2181.0 |
TRAT1 | -2158.0 |
PSMD1 | -2102.0 |
PIK3R2 | -2014.5 |
BCL10 | -1692.0 |
PSMA8 | -1679.0 |
PSMC6 | -1541.0 |
PSMD11 | -1181.0 |
PSMD3 | -1168.0 |
PSMA5 | -604.0 |
BTRC | -286.0 |
UBE2N | -184.5 |
PSMB5 | -153.0 |
SKP1 | -82.0 |
PTEN | 0.0 |
PSMD7 | 321.0 |
LCK | 916.0 |
UBC | 1013.0 |
PSMC1 | 1107.0 |
IKBKG | 1225.0 |
PSME4 | 1510.0 |
PSMB2 | 1548.0 |
PAG1 | 1610.0 |
RIPK2 | 1837.0 |
PLCG2 | 1922.0 |
PSME2 | 2230.0 |
PSMC3 | 2256.0 |
EVL | 2510.0 |
PDPK1 | 2786.0 |
PLCG1 | 3263.0 |
RELA | 3959.0 |
PSMD12 | 4108.0 |
ENAH | 4245.0 |
TRAF6 | 4327.0 |
PSMD13 | 4498.0 |
PTPN22 | 4790.0 |
CSK | 4821.0 |
PSMB9 | 5019.0 |
FBXW11 | 5901.0 |
NFKB1 | 6004.0 |
PSMF1 | 6184.0 |
PSME1 | 6608.0 |
NCK1 | 7272.0 |
PIK3R1 | 7450.0 |
PSMB8 | 7523.0 |
Complex I biogenesis
210 | |
---|---|
set | Complex I biogenesis |
setSize | 46 |
pANOVA | 0.000344 |
s.dist | 0.305 |
p.adjustANOVA | 0.0101 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDUFA10 | 7483 |
NDUFA8 | 7131 |
NDUFA12 | 7130 |
NDUFAB1 | 6996 |
ECSIT | 6963 |
NDUFV1 | 6489 |
ACAD9 | 6453 |
NDUFA9 | 6209 |
NDUFB10 | 6086 |
NDUFS5 | 5612 |
MT-ND1 | 5579 |
NDUFB7 | 5573 |
NDUFV3 | 5524 |
NDUFAF7 | 5479 |
NDUFB6 | 4983 |
MT-ND5 | 4937 |
MT-ND2 | 4879 |
TIMMDC1 | 4862 |
MT-ND6 | 4767 |
MT-ND4 | 4382 |
GeneID | Gene Rank |
---|---|
NDUFA10 | 7483.0 |
NDUFA8 | 7131.0 |
NDUFA12 | 7130.0 |
NDUFAB1 | 6996.0 |
ECSIT | 6963.0 |
NDUFV1 | 6489.0 |
ACAD9 | 6453.0 |
NDUFA9 | 6209.0 |
NDUFB10 | 6086.0 |
NDUFS5 | 5612.0 |
MT-ND1 | 5579.0 |
NDUFB7 | 5573.0 |
NDUFV3 | 5524.0 |
NDUFAF7 | 5479.0 |
NDUFB6 | 4983.0 |
MT-ND5 | 4937.0 |
MT-ND2 | 4879.0 |
TIMMDC1 | 4862.0 |
MT-ND6 | 4767.0 |
MT-ND4 | 4382.0 |
NDUFS3 | 4380.0 |
NDUFB11 | 4068.0 |
NDUFAF3 | 3956.0 |
NDUFS1 | 3819.0 |
NDUFS8 | 3493.0 |
NDUFS7 | 3090.0 |
NDUFB4 | 2890.0 |
NDUFAF6 | 2862.0 |
NDUFA6 | 2222.0 |
NDUFS4 | 2132.0 |
NDUFAF4 | 1307.0 |
NDUFAF1 | 1191.0 |
NDUFB8 | 1015.5 |
NDUFA13 | 544.0 |
NDUFA3 | -953.0 |
NDUFB5 | -1930.0 |
NDUFV2 | -2183.0 |
NDUFC2 | -3052.5 |
MT-ND3 | -3112.0 |
NDUFA11 | -3345.5 |
NUBPL | -3355.0 |
NDUFA2 | -3380.0 |
NDUFS2 | -3401.0 |
NDUFAF5 | -4827.0 |
TMEM126B | -5318.0 |
NDUFB3 | -6948.0 |
PD-1 signaling
801 | |
---|---|
set | PD-1 signaling |
setSize | 15 |
pANOVA | 0.000593 |
s.dist | -0.512 |
p.adjustANOVA | 0.017 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
PTPN6 | -8219.0 |
HLA-DRA | -8140.0 |
TRBC1 | -6620.5 |
PDCD1 | -6489.0 |
CD247 | -5933.0 |
CD3E | -4862.0 |
CD3D | -3905.0 |
PDCD1LG2 | -3847.0 |
PTPN11 | -3777.0 |
CD3G | -3199.0 |
LCK | 916.0 |
CD274 | 1677.0 |
CSK | 4821.0 |
GeneID | Gene Rank |
---|---|
HLA-DQB1 | -8259.5 |
HLA-DQB2 | -8259.5 |
PTPN6 | -8219.0 |
HLA-DRA | -8140.0 |
TRBC1 | -6620.5 |
PDCD1 | -6489.0 |
CD247 | -5933.0 |
CD3E | -4862.0 |
CD3D | -3905.0 |
PDCD1LG2 | -3847.0 |
PTPN11 | -3777.0 |
CD3G | -3199.0 |
LCK | 916.0 |
CD274 | 1677.0 |
CSK | 4821.0 |
Protein localization
897 | |
---|---|
set | Protein localization |
setSize | 144 |
pANOVA | 0.000618 |
s.dist | 0.165 |
p.adjustANOVA | 0.0173 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NUDT7 | 8063.0 |
TIMM50 | 7840.0 |
SLC27A2 | 7786.0 |
GRPEL1 | 7779.0 |
MTX1 | 7773.0 |
LONP2 | 7750.0 |
LDHD | 7733.0 |
HAO2 | 7672.0 |
ACOX2 | 7644.0 |
ACOT2 | 7508.5 |
APP | 7507.0 |
HSD17B4 | 7497.0 |
PEX19 | 7473.0 |
ACO2 | 7469.0 |
TIMM44 | 7410.0 |
CRAT | 7368.0 |
CS | 7355.0 |
ACOX1 | 7255.0 |
PHYH | 7045.0 |
PMPCA | 7035.0 |
GeneID | Gene Rank |
---|---|
NUDT7 | 8063.0 |
TIMM50 | 7840.0 |
SLC27A2 | 7786.0 |
GRPEL1 | 7779.0 |
MTX1 | 7773.0 |
LONP2 | 7750.0 |
LDHD | 7733.0 |
HAO2 | 7672.0 |
ACOX2 | 7644.0 |
ACOT2 | 7508.5 |
APP | 7507.0 |
HSD17B4 | 7497.0 |
PEX19 | 7473.0 |
ACO2 | 7469.0 |
TIMM44 | 7410.0 |
CRAT | 7368.0 |
CS | 7355.0 |
ACOX1 | 7255.0 |
PHYH | 7045.0 |
PMPCA | 7035.0 |
ALDH3A2 | 6988.0 |
ABCD3 | 6773.0 |
AMACR | 6750.0 |
UBE2J2 | 6724.0 |
EMD | 6675.0 |
SAMM50 | 6561.0 |
ATP5F1B | 6480.0 |
ECH1 | 6452.0 |
ABCD1 | 6427.0 |
TIMM22 | 6422.0 |
VAMP2 | 6400.5 |
PITRM1 | 6359.0 |
IDH3G | 6298.0 |
GNPAT | 6274.0 |
TAZ | 6238.0 |
PEX26 | 6222.0 |
SLC25A12 | 6148.0 |
ACAA1 | 6125.0 |
PEX7 | 6090.0 |
HSPA9 | 6038.0 |
EHHADH | 6024.0 |
BAAT | 5784.0 |
EPHX2 | 5626.0 |
NUDT19 | 5464.0 |
TOMM40 | 5429.0 |
CAT | 5335.0 |
BAG6 | 5304.0 |
OTC | 4960.0 |
CYC1 | 4883.0 |
MLYCD | 4748.0 |
PXMP4 | 4429.0 |
PAOX | 4192.5 |
GET3 | 4148.0 |
ACBD5 | 4146.0 |
TIMM17A | 4145.0 |
SLC25A4 | 4136.0 |
DHRS4 | 4126.5 |
VDAC1 | 3653.0 |
MTX2 | 3387.0 |
CHCHD3 | 3262.0 |
ACOT8 | 3216.0 |
PEX12 | 3158.0 |
CHCHD10 | 3156.0 |
PXMP2 | 3147.0 |
HAO1 | 3075.0 |
TIMM21 | 2922.0 |
SLC25A13 | 2731.0 |
HMOX1 | 2671.0 |
CHCHD7 | 2631.0 |
HACL1 | 2573.0 |
HSPD1 | 2540.0 |
PEX11B | 2503.0 |
ACOX3 | 2479.0 |
PEX5 | 2358.0 |
PEX6 | 2282.0 |
PMPCB | 2100.0 |
FXN | 1911.0 |
HMGCL | 1875.0 |
ABCD2 | 1806.0 |
PEX10 | 1682.0 |
PECR | 1557.0 |
BCS1L | 1252.0 |
NDUFB8 | 1015.5 |
UBC | 1013.0 |
PEX14 | 982.0 |
TOMM22 | 929.0 |
SGTA | 760.0 |
COQ2 | 749.0 |
AGPS | 484.0 |
TIMM13 | 265.0 |
TOMM20 | -422.0 |
GSTK1 | -481.0 |
TIMM8A | -867.0 |
GDAP1 | -1041.0 |
OTOF | -1308.0 |
CHCHD2 | -1467.0 |
PEX1 | -1478.0 |
IDH1 | -1627.0 |
TOMM70 | -1868.0 |
DNAJC19 | -2135.0 |
STX1A | -2228.0 |
TIMM10 | -2414.0 |
ACOT4 | -2617.0 |
PRNP | -2909.0 |
HSCB | -3003.0 |
CHCHD5 | -3068.0 |
CHCHD4 | -3136.0 |
GET1 | -3137.0 |
UBE2D1 | -3359.0 |
PIPOX | -3372.0 |
GFER | -3386.0 |
PAM16 | -3641.0 |
MPV17 | -3835.0 |
STX5 | -4049.0 |
PEX3 | -4321.0 |
CAMLG | -4503.0 |
IDE | -4564.0 |
PEX16 | -4578.0 |
ZFAND6 | -4623.0 |
DAO | -4749.0 |
SEC61B | -4808.0 |
DDO | -4966.0 |
TIMM23 | -5484.0 |
TYSND1 | -5636.0 |
SLC25A17 | -5644.0 |
NOS2 | -5755.0 |
SEC61G | -5830.0 |
AGXT | -6265.0 |
CMC4 | -6302.0 |
ECI2 | -6476.0 |
GET4 | -6852.0 |
TOMM7 | -7043.0 |
TIMM8B | -7159.0 |
PEX13 | -7177.0 |
PEX2 | -7231.0 |
VAPA | -7396.0 |
UBE2D3 | -7462.0 |
COX19 | -7585.0 |
RPS27A | -7640.0 |
TIMM9 | -7663.0 |
SERP1 | -7703.0 |
USP9X | -7812.0 |
TIMM10B | -7813.5 |
CROT | -8187.0 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.0 (2022-04-22)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/liblapack.so.3
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] ggplot2_3.3.5 beeswarm_0.4.0
## [5] gtools_3.9.2 tibble_3.1.6
## [7] dplyr_1.0.8 echarts4r_0.4.3
## [9] kableExtra_1.3.4 gplots_3.1.1
## [11] mitch_1.5.1 DESeq2_1.32.0
## [13] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [15] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [17] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [19] IRanges_2.26.0 S4Vectors_0.30.0
## [21] BiocGenerics_0.38.0 reshape2_1.4.4
##
## loaded via a namespace (and not attached):
## [1] colorspace_2.0-3 ellipsis_0.3.2 rprojroot_2.0.2
## [4] XVector_0.32.0 rstudioapi_0.13 bit64_4.0.5
## [7] AnnotationDbi_1.54.1 fansi_1.0.2 xml2_1.3.3
## [10] splines_4.2.0 cachem_1.0.6 geneplotter_1.70.0
## [13] knitr_1.37 jsonlite_1.7.3 annotate_1.70.0
## [16] png_0.1-7 shiny_1.7.1 compiler_4.2.0
## [19] httr_1.4.2 assertthat_0.2.1 Matrix_1.4-1
## [22] fastmap_1.1.0 cli_3.2.0 later_1.3.0
## [25] htmltools_0.5.2 tools_4.2.0 gtable_0.3.0
## [28] glue_1.6.1 GenomeInfoDbData_1.2.6 Rcpp_1.0.8
## [31] jquerylib_0.1.4 vctrs_0.3.8 Biostrings_2.60.2
## [34] svglite_2.1.0 xfun_0.29 stringr_1.4.0
## [37] brio_1.1.3 testthat_3.1.2 rvest_1.0.2
## [40] mime_0.12 lifecycle_1.0.1 XML_3.99-0.8
## [43] zlibbioc_1.38.0 MASS_7.3-57 scales_1.1.1
## [46] promises_1.2.0.1 RColorBrewer_1.1-2 yaml_2.3.5
## [49] memoise_2.0.1 gridExtra_2.3 sass_0.4.0
## [52] reshape_0.8.8 stringi_1.7.6 RSQLite_2.2.10
## [55] highr_0.9 genefilter_1.74.0 desc_1.4.0
## [58] caTools_1.18.2 BiocParallel_1.26.2 rlang_1.0.1
## [61] pkgconfig_2.0.3 systemfonts_1.0.4 bitops_1.0-7
## [64] evaluate_0.15 lattice_0.20-45 purrr_0.3.4
## [67] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.1.2
## [70] plyr_1.8.6 magrittr_2.0.2 R6_2.5.1
## [73] generics_0.1.2 DelayedArray_0.18.0 DBI_1.1.2
## [76] pillar_1.7.0 withr_2.4.3 survival_3.2-13
## [79] KEGGREST_1.32.0 RCurl_1.98-1.6 crayon_1.5.0
## [82] KernSmooth_2.23-20 utf8_1.2.2 rmarkdown_2.11
## [85] locfit_1.5-9.4 grid_4.2.0 blob_1.2.2
## [88] digest_0.6.29 webshot_0.5.2 xtable_1.8-4
## [91] httpuv_1.6.5 munsell_0.5.0 viridisLite_0.4.0
## [94] bslib_0.3.1
END of report